









THE MYCOBACTERIUM TUBERCULOSIS KATG GENE: 
IDENTIFICATION OF A NOVEL FUNCTION AND 
ANALYSIS OF THE REGULATION OF EXPRESSION 
Michelle Anne Mulder 
Thesis Presented for the Degree of 
DOCTOR OF PHILOSOPHY 
In the Department of Medical Microbiology 
Faculty of Medicine 
UNIVERSITY OF CAPE TO\VN 
June 1998 
The copyright of this thesis vests in the author. No 
quotation from it or information derived from it is to be 
published without full acknowledgement of the source. 
The thesis is to be used for private study or non-
commercial research purposes only. 
Published by the University of Cape Town (UCT) in terms 











CERTIFICATION OF SUPERVISORS 
In terms of paragraph 9 of "General regulations for the degree of Doctor of Philosophy," 
University of Cape Town, we, as supervisors of the candidate Michelle Anne Mulder, certify 
that we approve of the incorporation in this thesis of material that has been submitted for 
publication 
Supervisor 
Associate Professor L. M. Steyn 
Dept. Medical Microbiology 
University of Cape Town 
Co-supervisor 
Dr H. Zappe 
!)/z/u Dept. Medical Microbiology 









CHAPTER 1: General Introduction 
PART A: Identification of a novel activity of the ftl tuberculosis 





CHAPTER 2: Introduction 59 
CHAPTER 3: Cloning of the M tuberculosis katG gene and 
overexpression in E. coli 75 
CHAPTER 4: Complementation of DNA repair-deficient E. coli strains 
with the M. tuberculosis katG gene 99 
PART B: Characterization of the M. tuberculosis katG promoter 






Cloning and identification of the M. tuberculosis katG 
promoter and characterization of conditions of expression 
Identification of an upstream element required for optimal 
expression of the katG promoter 
General conclusions 
APPENDIX A: Bacterial strains, plasmids, and culture conditions 
APPENDIX B: General techniques 












I would like to express my gratitude to my supervisor Lafras Steyn and co-supervisor Harold 
Zappe for their support and help in the writing of my thesis, and Val Abratt for all her help and 
advice on DNA repair. 
A special thanks to my colleagues and friends in the laboratory for their continual enthusiasm. 
support and advice. A big thank you to my family and to Gregg for their love, support and 
patience throughout my PhD, and especially to Susi and Nicky for all their friendship, help and 
encouragement. 
I gratefully acknowledge the financial assistance received from Glaxo-Wellcome and the 




















































Acyl carrier protein 
Albumin dextrose catalase 















Catabolite activator protein 
Chloramphenicol acetyl transferase 




















Ethylenediaminetetraacetic acid (disodium salt) 
Ethionamide 
Phenylalanine 
I, 5-dihydrotlavin adenine dinucleotide 
Iron 
iii 
FMN Flavin mononucleotide 




GFP Green fluorescent protein 
Gin Glutamine 




H~O~ Hydrogen peroxide 
llis I listidine 
HIV Human Immunodeficiency Virus 
Hoo· Hydroperoxyl radical 
HPI Hydroperoxidase I 
HPII Hydroperoxidase II 
I Isoleucine 
IFA Incomplete Freund' s adjuvant 






KAS P-ketoacyl synthase 
kb Kilo bases 
kDa Kilodalton( s) 












MAC Mycobacterium avium complex 
MBP Maltose binding protein 
MCP M tuberculosis catalase-peroxidase 
MDR Multidrug resistant 
Met Methionine 
mg Milligram 
























































Major polymorphic tandem repeat 
Messenger ribonucleic acid 








Nicotinamide adenine dinucleotide 
Reduced nicotinamide adenine dinucleotide 
Nicotinamide adenine dinucleotide phosphate 







Optical density at 600 nm 
Open reading frame 
Polyacrylamide gel electrophoresis 







Ribosome binding site 
Restriction fragment length polymorphism 
Rifampin 
Relative light units 
Ribonucleic acid 
Ribosomal ribonucleic acid 
Ribonuclease 




Sodium dodecyl sulfate 
Serine 
Superoxide dismutase 
Single strand conformation polymorphism 






























Single stranded deoxyribonucleic acid 
Threonine 
Thymidine 
Tris-acetate EDT A buffer 
Tuberculosis 
Trichloroacetic acid 
N, N, N', N' -tetramethyl-ethylenediamine 
Threonine 
Tumour necrosis factor 
Transfer ribonucleic acid 
Tris(hydroxymethyl )aminomethane 
Trvptophan 
Translation start codon 
Transcription start site 





Maximal velocity of reaction 
Watts 
Tryptophan 








A clone containing the terminal third of the Mycobacterium tuberculosis katG gene was 
previously shown to confer resistance to ethyl methane sulfonate on DNA repair-deficient 
Escherichia coli cells. The first aim of this study, therefore, was to examine the role played by 
the M tuberculosis katG gene in DNA repair. The strategy used was overexpression of 
different regions of the gene in DNA repair-deficient mutants of E. coli, and examination of the 
sensitivities of the transformants to DNA damaging agents. Overexpression of the gene resulted 
in an increase in the survival of recA mutants exposed to ultraviolet (UV) light irradiation (254 
run) and hydrogen peroxide, and uvr mutants exposed to mitomycin C. Both the 5' and 3' 
regions of the M tuberculosis KatG protein conferred the above effects, and this was 
independent of the catalase or peroxidase activity of the enzyme. The results suggest that the 
M tuberculosis katG gene may encode a novel function related to the repair of DNA damage, 
and this may have implications for the survival of M tuberculosis in the presence of DNA 
damaging agents, for example, in the macrophage. UV sensitivity tests on M intracellulare and 
M tuberculosis strains mutant in katG revealed that the katG gene product does not play a 
demonstrable role in the survival of repair-competent mycobacterial cells after exposure to UV 
irradiation. 
The second aim of this study was to examine the regulation of expression of the M tuberculosis 
katG gene. An E. co/i-mycobacterial shuttle vector, pJCluc, containing the luciferase reporter 
gene, was constructed and used to examine the katG promoter sequences. The region required 
for optimal expression in M. smegmatis was localized to a 559 hp fragment immediately 
upstream of the gene. Two transcription start sites were mapped and putative -10 and -35 
promoter sequences identified. It was demonstrated that expression from the promoter peaks 
during late exponential phase, and declines during stationary phase, and that the promoter is 
induced by ascorbic acid, and is repressed by oxygen limitation and growth at elevated 
temperatures. An upstream element that increased expression from the M. tuberculosis katG 
and the M. paratuberculosis PAN promoters was identified, and shown to bind to one or more 
M smegma/is proteins. Similar results were obtained in M bovis BCG. Understanding the 
regulation of gene expression in mycobacteria is essential for determining the processes that 
govern interaction with the host. This study provides information on both the mycobacterial 




The Mycohacterium tuberculosis katG gene, encoding a catalase-peroxidase, plays an important 
role in the susceptibility of the organism to the antituberculosis drug, isoniazid, and in the 
virulence of the organism. The ability of M. luherculosis to repair damage to its DNA, caused 
by mutagenic agents, may also play a significant role in the survival of the organism in the 
macrophage. A clone, designated pD3, containing the terminal third of the Mycohacterium 
tuherculosis katCi gene, in the vector pEcoR252, was previously shown to confer resistance to 
ethyl methane sulfonate on DNA repair-deficient E. cob cells. The first aim of this study. 
therefore, was to examine the role played by the M. tuberculosis katG gene in DNA repair. 
The M. tuberculosis H37Rv katG gene was amplified by PCR. The whole katG gene, the 
proximal two thirds, and the terminal third were cloned in the expression vector, pMAL TM_c2, 
in-frame with the maltose binding protein. The resulting fusion proteins were overexpressed in, 
and purified from E. coli, and used in catalase and peroxidase assays. Only the fusion protein 
containing the whole KatG enzyme exhibited enzyme activity. Constructs containing the 
terminal third of the katG gene in pMAL rM_c2 in the two other reading frames, with respect to 
the ma/£ gene, were made for use as controls in DNA repair experiments. The pMAL rM_c2-
katG constructs were introduced into 5 DNA repair-deficient strains of E. coli. The resulting 
transformants were tested for their ability to survive exposure to three DNA damaging agents, 
short wavelength ultraviolet (UV) light irradiation, mitomycin C, and hydrogen peroxide. 
Overexpression of the proteins resulted in an increase in the survival of recA mutants exposed to 
UV irradiation and hydrogen peroxide, and in the survival of excision repair mutants exposed to 
mitomycin C. UV sensitivity experiments with E. coli recA mutants harbouring derivatives of 
the pD3 insert in pMAL ™ -c2, revealed that increased resistance to UV requires expression of 
the katG gene, and is independent of sequences downstream of the gene. Both domains of the 
M tuberculosis KatG protein conferred the above effects, and this was independent of the 
catalase or peroxidase activity of the enzyme. The results suggest that the M tuberculosis katG 
gene may encode a novel function related to the repair of DNA damage, and this may have 
implications for the survival of M tuberculosis in the presence of DNA damaging agents, for 
example, in the macrophage. 
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UV sensitivity tests on a selection of mycobacterial species revealed that the M tuberculosis 
complex organisms are more sensitive than the 'atypical mycobacteria.' UV sensitivity tests on 
M intracellulare and M tuberculosis strains mutant in katG revealed no significant differences 
in the sensitivity of the cells in the absence of this gene. This suggests that the katG gene 
product does not play an additive role in the survival of mycobacterial cells after exposure to 
short wavelength UV irradiation. This function may, however, be important in the presence of 
mutations in essential DNA repair genes. 
Understanding the regulation of gene expression in mycobacteria is essential for determining the 
processes involved in interaction with the host, and hence in virulence. The second aim of this 
study, therefore, was to examine the regulation of expression of the M. tuberculosis katG gene, 
in order to provide insight into the factors which mediate cell survival within the macrophage 
and susceptibility to antituberculosis agents, particularly isoniazid, and to provide more 
information on the mycobacterial transcription signals and regulatory mechanisms. 
An E. co/i-mycobacterial shuttle vector, pJCluc, containing the promoterless firefly luciferase 
gene as a reporter, was constructed for the examination of mycobacterial promoter sequences. 
The vector was used to characterize the M. tuberculosis katG promoter. A I. 9 kb region 
immediately upstream of the katG gene was amplified by PCR and cloned into pJCluc, and 
promoted expression of the luciferase gene in E. coli and M smegmatis. A smaller promoter 
fragment (559 bp) promoted expression with equal efficiency, and was used in all further 
studies. Two transcription start sites were mapped by primer extension analysis, and used to 
identify putative -10 and -3 5 regions. These show strong similarity to previously identified 
mycobacterial promoters. M smegma/is recombinants harbouring the promoter construct were 
used to determine under what conditions the katG promoter is expressed. Luciferase activities 
revealed that expression from the promoter peaks during late exponential phase, and declines 
during stationary phase. The promoter is induced by ascorbic acid, and is repressed by oxygen 
limitation and growth at elevated temperatures. 
Other regions of the 559 bp M tuberculosis katG promoter fragment that are essential for 
promoter activity were examined. Deletions in the fragment were made using Bal31 nuclease 
and restriction endonucleases. The luciferase activities of the resulting constructs revealed that 
X 
a region between 559 and 448 bp upstream of the translation initiation codon, which forms part 
of an upstream activator region (UAR), is essential for promoter activity in £. coli, and is 
required for optimal activity in M smegma/is. Primer extension analysis on selected deletions 
revealed that an alternative promoter is used in the absence of this region, and in the absence of 
the previously identified putative katG promoters. Cloning of a fragment containing the katG 
UAR upstream of the !vi. parat11herc11/osis PA¥ promoter, in pJCluc, resulted in a 14.7-fold 
increase in luciferase activity in F. coli, and an 11 6-fold increase in Al. smegma/is, relative to 
the PA.v promoter alone. Mobility shift assays revealed that one or more Al. sme};malis proteins 
bind to the kat(; UAR This region, therefore, acts as a transcriptional enhancer, possibly by 
binding to one or more regulatory proteins. The luciferase activities of a selection of promoter 
constructs were tested in M. hovis BCG. These constructs exhibited similar activities in this 
host as they did in M. smegma/is, suggesting that the recognition and utilization of promoters is 
similar in the two mycobacterial species. 
The M tuberculosis katG gene has been extensively studied with respect to its catalase and 
peroxidase activities, its role in virulence, and its role in susceptibility to isoniazid, however, this 
study provides the first report on the involvement of the gene in DNA repair processes. In-
depth analysis of the regulation of expression of the gene has also not been previously reported. 
This study provides a foundation for the characterization of DNA sequences involved in both 
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1.1. OVERVIE\V OF TUBERCULOSIS 
Tuberculosis (TB) is a debilitating disease that accounts for approximately 7% of deaths in 
developing countries and 26% of all avoidable adult deaths worldwide (Murray et al, 1990). 
Approximately 8- l O million people are infected with TB each year and, of these, 2-3 million die. 
Approximately 95% of these TB cases occur in developing countries (WHO, 1989). In South 
Africa it is estimated that 6-10 million people are infected with TB (Glatthaar, 1982), resulting 
in 6000 registered deaths per year (Department of National Health and Population 
Development, 1990). Of all the infectious diseases known to man, tuberculosis is the most 
prevalent and widespread over an extensive time period and has recently been declared a global 
emergency by the World Health Organization (WHO, 1994). 
1.1.1. The history of tuberculosis 
Available evidence indicates that people have been infected with TB since before written 
records. It has been suggested that Mycobacterium tuberculosis, the etiological agent of TB in 
humans, evolved from a mutant of Mycobacterium bovis, which causes a similar disease in 
cattle, i.e. that TB was first spread to humans by domestic cattle (Morse, 1961; Hare, 1967). 
The reason for this is that M bovis has a broad host range (Grange and Collins, 1987), while 
M tuberculosis is non-pathogenic for cattle (Clarke et al., 1987). The earliest evidence of TB 
in humans comes from skeletal remains from approximately 5000 BC, which contained 
deformities suggestive of TB (Sager et al., 1972), and from studies on Egyptian mummies. 
These date TB infection back to about 3400 BC (Zimmerman, 1979). Recently, Salo and co-
workers (1994) reported on the recovery of DNA unique to M tuberculosis from a lung lesion 
of a spontaneously mummified 1000 year old adult female body in Southern Peru, which 
supports the idea of the pre-Columbian presence of TB in the New World. 
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The incidence of TB and mortality rates from it are only known through written records, which 
have been best kept by the British. There are accounts of the increase in TB in Britain before 
the start of the industrial revolution in about 1780 (Chalke, 1962). This may have been due to 
enlargement of urban centres caused by population growth. Industrialization resulted in a 
number of conditions which were conducive to the spread of TB, such as large-scale 
urbanization, the development of industrial slums, poorly ventilated houses, long working hours, 
overcrowded factories and poor diet (Galdston, 1942). In Europe in the nineteenth century, 
pulmonary TB accounted for more deaths than war or cholera or smallpox, measles, whooping 
cough, scarlet fever, and typhus combined, and yet, it was given less attention than these other 
infectious diseases (Kochi, 1991 ). The course of respiratory TB death rates in Britain is 
illustrated in figure 1.1. Tuberculosis mortality rates showed a decline from 183 8, possibly due 
to sanitary and labour reform, which occurred around that time. In the twentieth century, these 
mortality rates continued to decline and levels were relatively low by the 1950s, when effective 
TB chemotherapy was introduced. Similar declines in TB mortality were noted in other 
developed countries such as the United States, and these have been attributed to improved living 
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Figure 1.1 The decline in respiratory tuberculosis death rates in England and Wales since 1838. Standardized 
to the 1901 population. (Source: Mc Keown, 1979). 
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Little is known about the incidence of TB in South Africa before this century due to a lack of 
written accounts. Cummins ( 1920) and Lichenstein ( 1928) suggest that TB was virtually 
unknown in the interior of sub-Saharan Africa until the early part of the twentieth century. The 
spread of TB among the native people appears to be related to the degree of European contact, 
and the disease may have been introduced by European colonization (McVicar, 1932). The 
incidence of TB in the black population increased in the early part of the century due to 
urbanization, and, in particular, due to poor conditions on the mines. The introduction of 
effective chemotherapy in the 1950s resulted in a sharp decline in TB mortality rates, but there 
has been a continued increase in the incidence rates TB therefore remains a problem in 
developing countries (Kochi, 1991 ). 
Due to the steady decline in TB mortality in the developing world, and since the introduction of 
chemotherapy, little attention has been paid to the disease, and few attempts have been made to 
understand the pathogenesis of TB or the physiology and genetics of the causative organism. A 
new interest in TB has, however, been aroused by the recent re-emergence of the disease in the 
developed world (Bloom and Murray, 1992). In 1986 a resurgence of TB was noted in the 
United States, Britain and Europe, which coincided with the spread of HIV during this time. 
AIDS causes an increased susceptibility to and accelerated progression of TB. Another problem 
is the emergence of multidrug resistant (MDR) strains of M tuberculosis, which, together with 
HIV infection, result in an early mortality in TB patients (Young and Wormser, 1994). These 
strains are difficult to eradicate, and therefore also contribute to the spread of the disease. 
Other proposed reasons for the re-emergence of TB in developed countries include immigration 
of individuals with TB from high-prevalence areas, and the increasing incidence of TB in 
institutions such as homeless shelters, schools and prisons (Ordway et al., 1995). New 
solutions to the disease are evidently required in order to bring the epidemic under control, 
particularly in developing countries. Molecular biological techniques are now being used to 
obtain a better understanding of the pathogenesis of mycobacteria and interaction with their 
mammalian hosts. These techniques were initially applied to the study of Mycobacterium 
leprae, the causative agent of leprosy, and are now being extended to the study of 
M tuberculosis (Young and Cole, 1993). 
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l. l.2. The control of tuberculosis 
l.l.2.l. Tuberculosis chemotherapy 
Although tuberculosis has infected people for thousands of years, it was only in this century that 
chemotherapy was introduced for the treatment of the disease. Streptomycin was first used 
against TB in 1944, only eleven months after its isolation (Schatz et al., 1944; Pfuetze et al., 
1955), and isoniazid (INH) was first used in 1952 (Robitzek and Selikoff, 1952). In the same 
vear. pyrazinamide. a synthetic derivative of nicotinamide. \\'3'- introduced as a secondary drng 
(McDermott and Tompsett, 1954), and it was at this time that the potential of using more than 
one drug in combination against TB was realized. Rifampicin was introduced in 1966 (Verbist 
and Gyselen, 1968) and first used to treat TB in the early 1970s, and ethambutol was introduced 
in 1968 (Grumbach, 1969). Today, these five drugs are used as first-line antituberculosis 
agents. Ethionamide (ETH) is a structural analogue of INH which is sometimes used as a 
second-line antituberculosis drug (Hok, 1964; Riddell et al., 1960). The successful treatment of 
TB relies on the eradication of all viable tubercle bacilli within the patient. There are several 
different populations of these organisms at the site of infection. These include: actively 
multiplying bacilli at neutral pH in material lining the cavity walls; bacilli within the macrophages 
at an acidic pH, and with a slower growth rate; bacilli within solid caseous areas with low 
oxygen tension, and therefore extremely slow growth rates; and a population of dormant bacilli 
(discussed in a later section). INH and streptomycin act on the large, actively multiplying 
population and may eliminate all extracellular bacilli, except for those that have developed 
resistance. INH penetrates most tissues and macrophages (Mackaness, 1956), and also acts on 
the slower growing bacilli to eliminate the "persisters." Rifampicin and pyrazinamide are able to 
kill the semi-dormant organisms which are not affected by INH (Grosset, 1980). Pyrazinamide, 
in particular, acts optimally at acid pH, and is therefore effective against intracellular organisms 
(Cole, 1994). 
Immediately after the introduction of the various antituberculosis drugs, there were reports on 
strains which had developed resistance. Acquired resistance to drugs during or after treatment 
is usually due to non-adherence to the drug regimine. Primary resistance occurs in patients who 
have never received prior treatment and are infected with drug-resistant strains. Primary drug 
resistance is an indicator of the efficacy of TB control programs (Weyer and Kleeberg, 1992). 
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The recent resurgence of TB in developed countries has been accompanied by an increase in the 
incidence of strains which are resistant to one or more drugs. In April of 1991, for example, 
19% of all prevalent strains in New York were resistant to two or more drugs (Frieden et al., 
1993 ). In the United States as a whole, 13% of all new TB cases are resistant to at least one of 
the first-line drugs, and 3.2% are resistant to both INH and rifampin (Bloch el al., 1994). 
Understanding the genetic basis for resistance to drugs is expected to aid in the development of 
more rapid ways of detecting resistant strains, and in the rational design of new 
antimycobacterial agents (Musser. 1995 ). The modes of action of the anti tuberculosis drugs and 
mechanisms of resistance to them are discussed in a later section 
For approximately 3 0 years after the introduction of ethambutol, no new anti-TB drugs were 
reported, however, the search has been reinitiated. Some possibilties for new drugs are listed by 
Reynolds ( 1989). These include the fluoroquinolones such as ciprofloxacin and ofloxacin; the 
rifamycin derivatives rifapentine and rifabutin; macrolides such as roxithromycin; and phenazines 
such as clofazimine. There is a need to develop a new TB treatment regimine which involves 
more powerful drugs which can be used in much shorter courses of therapy. The problem with 
new, powerful antimicrobial drugs, however, is that, in many cases, for example 
immunocompromised patients, these drugs are not effective. Thus a move is being made to 
rather stimulate the immune system to deal with the infection itself. A variety of cytokines and 
growth factors involved in the regulation of the immune response have been isolated. These 
factors, for example, interleukin- I and tumour necrosis factor (TNF)-alpha, when administered 
to experimental animals, protect the animals against a number of infections (Kullberg et al., 
1994 ), and are under investigation as alternatives to drugs for the treatment of TB. 
1.1.2.2. BCG vaccine 
One of the most important control measures for prevention of the spread of tuberculosis is the 
BCG (Bacille Calmette-Guerin) vaccine. It has long been known that people who develop TB 
and recover are more resistant to reinfection with a new strain. For this reason, attempts were 
made to generate an attenuated organism which could be used as a vaccine against TB. In 
1908, two students of Louis Pasteur, Calmette and Guerin, began to attenuate a strain of 
M. bovis by serial passages on potato-bile broth. After 13 years and 23 0 passages, they had a 
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strain which was avirulent in guinea pigs, rabbits, cattle and horses. The strain was given to the 
first human in 1921. Today more than 80% of children world-wide receive the BCG vaccine. It 
is inexpensive, safe, single dose, can be administered at birth, and confers long lasting immunity. 
The efficacy of the vaccine is, however, controversial. Roche et al. ( 1995) review the past 
disappointments and future hopes of the BCG vaccine. Protective efficacy is defined as the 
incidence of TB in the unvaccinated population minus that in the vaccinated population divided 
by the incidence in the unvaccinated population. Large scale trials on the eflicacy of the BCG 
vaccination revealed that in countries with a high incidence of TB. BCG induced a lower degree 
of protection (Bloom and Fine, 1994 ). The vaccine 1s effective against childhood and 
disseminated TB but is less effective against adult pulmonary TB (Colditz et al., 1994). The 
data from various trials on the efficacy of the vaccine are difficult to interpret and consolidate 
due to large variations in the methodologies used. Various reasons have, however, been put 
forward for the variability in the efficacy of BCG in different populations and in different 
geographical locations. One major problem is that BCG has been subcultured for years in 
various laboratories using a variety of culture conditions, and it is evident that BCG from 
different localities has evolved into strains with some distinct antigenic differences. BCG is 
given as a viable vaccine but there is large variation ( 5-45%) in the proportion of viable bacilli in 
different vaccine preparations (Gheorghiu, 1990). Induction of protective immunity depends on 
active secretion of proteins from viable bacilli (Andersen, 1994), therefore the potency of the 
vaccine depends on the proportion of viable bacilli. The optimal vaccine dose has not yet been 
established. The method of administration of the vaccine differs in different parts of the world, 
and recent work suggests that the route of administration has a profound effect on the type of 
immunity induced (Barnes et al., 1992). Evidence also suggests that the immunity induced by 
BCG is not life long (Medical Research Council, 1972). In developing countries, for example, 
immunity may be waning at the age of peak exposure to TB. It is not known as yet whether 
boosting enhances efficacy. 
There are also various host factors that affect the efficacy of the vaccine. Nutrition strongly 
affects immunity and immune responses to vaccines, however no correlation has been found 
between protective efficacy and nutritional status. Efficacy may be affected by concurrent 
infections with other pathogens such as HIV, and by certain host genetic factors. The most 
likely explanation for the variation in the protective efficacy of the BCG vaccine, however, 
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appears to be exposure to environmental mycobacteria (Bloom and Fine, 1994 ), which may 
induce a cross-reactive immunity that protects against TB almost as effectively as BCG does 
(Palmer and Long, 1966). This protection is not improved by the BCG vaccine and, therefore, 
lowers its apparent efficacy. Considerable work is underway to develop new and improved 
vaccines against tuberculosis. Approaches being used include new attenuated strains of 
M. tuberculosis in which virulence genes have been deleted; subunit vaccines composed of 
immunologically dominant mycobacterial antigens in an adjuvant; vaccines using environmental 
mycobacteria such as AI mccae (Stanford et al., 1994); recombinant BCG strains expressing 
heterologous antigens or various cytokines (O'Donnell et al., l 994 ), and DNA vaccines 
(Lowrie et al., 1994). 
1.1.3. The pathogenesis of tuberculosis 
1.1.3.1. The genus Mycobacterium 
M. tuberculosis, the etiological agent of tuberculosis, is a member of the genus Mycobacterium. 
which is one of the oldest and best known bacterial genera. The two most well known 
mycobacteria are M tuberculosis and M leprae, because of their ability to cause disease in 
man. However, most mycobacteria form part of natural microbial communities in habitats such 
as the soil. Mycobacteria are aerobic actinomycetes which are morphologically intermediate 
between corynebacteria and proactinomycetes. They do not form mycelia but form slightly 
curved or straight rods which occassionally branch. They are non-motile, gram-positive and 
acid fast (i.e. cannot be decolourized by acid after staining with aniline dyes), due to the high 
levels of mycolic acid in their cell walls, which makes them wax-like and strongly hydrophobic 
(Schlegel, 1986). Mycobacterial cell walls are composed of a variety of soluble proteins, 
carbohydrates and lipids, and three insoluble macromolecules, arabinogalactan, peptidoglycan, 
and mycolic acid which, together, constitute the mycoylarabinogalactan peptidylglycan core of 
the cell wall. Mycolic acids are 2-branched, 3-hydroxycarboxylic acids (McNeil and Brennan, 
1991 ). Although the cell walls of all the mycobacteria are thought to be very similar, different 
species and strains differ in their degree of acid-fastness, which can be related to differences in 
their cell wall structure or thickness. There is a relationship between the degree of acid-fastness 
and both the degree of parasitism and the speed at which the organisms grow. Slower growing 
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mycobacteria, such as M tuberculosis, have a higher degree of acid-fastness than the faster 
growing saprophytic mycobacteria, and are more pathogenic. The order of acid-fastness is as 
follows: M leprae > M paratuberculosis > M tuberculosis (virulent) > M tuberculosis 
(avirulent or attenuated) > M avium > saprophytic mycobacteria (non-pathogenic) (Murohashi 
and Yoshida, 1968). It is not clear what genetic or physiological differences are responsible for 
the differences in the growth rates of the mycobacteria. 
The genus Mycohacterium consists of over seventy recognized species and includes intracellular 
bacterial parasites from the obligate intracellular pathogens A/. leprae, AI tuherrnlosis, 
M hovis, and M avium, to environmental species such as M gordonae, M fortuitum etc., 
which are seldom pathogenic. Between these are the opportunistic pathogens such as 
M. intracellulare, M scrofulaceum, M simiae, and M szulgai. Mycobacteria are classified 
into 4 or 5 broad taxonomic groups according to pathogenicity for humans and animals, rate of 
growth at optimum temperature, and effect of visible light on pigment production, corroborated 
by comparative I 6S rRNA sequence studies. The M tuberculosis complex consists of 
M. tuberculosis, M. hovis, M africanum, and M microti, all of which have conserved l 6S 
rDNA sequences (Frothingham et al., 1994). "Atypical" mycobacteria are those that do not 
cause tuberculosis. Runyon et al. ( 1974) classified atypical mycobacteria into four groups based 
on their laboratory culture characteristics. Group I (photochromogens) consists of 
mycobacteria that form deep yellow to orange or brick-red pigments when exposed to light but 
produce little or no pigments if grown in the dark. Group II (scotochromogens) form bright 
yellow or orange pigments when grown in light or dark. Group III (nonphotochromogens) are 
slow growers and produce little or no pigment, and Group IV grow very rapidly and are 
generally saprophytes, except for M fortuitum, which can be pathogenic in man (Runyon et al., 
1974). This classification of atypical mycobacteria is now being replaced by molecular 
classification. Mycobacterium avium complex (MAC) organisms are slowly growing bacilli 
which may produce yellow pigment in the absence of light. The complex is composed of 
opportunistic pathogens which are ubiquitous in nature and can be isolated from natural sources 
of water, pools, soils, plants and bedding material. They are found in both fresh and salt water, 
especially with relatively high acidity, and in aerosols above fresh water. M. avium causes 
diseases in poultry and swine but direct transmission to humans is rare, except in HIV-infected 
individuals who are immunodeficient (Inderlied et al., 1993). 
10 
The mycobacterial genome consists of a single length of DNA in a closed loop which is tightly 
packed but has no nuclear membrane. Their genomes are 2.8-4.5 x 109 bp in size, and most 
have a G+C content of 64-70%. M tuberculosis has a genome of approximately 4.4 x 109 bp 
and a G+C content of 63-65% (Clarke-Curtiss et al., 1985; Imaeda et al., 1982). Attempts are 
underway to characterize mycobacterial genome structures and to sequence the entire genome 
of M. leprae and M. tuberculosis, with the aim of identifying immunogenic and biochemical 
features of the organism. A number of observations have been made with respect to the 
sequence of the !vi. tuherculosis genome obtained to date. The genome contains a large number 
of insertion sequences except in the area around the oriC and the rpoH gene, possibly because 
these are essential for replication. There are also a number of genes encoding protein kinases 
and phosphatases which are involved in signalling. Other interesting features include large 
amounts of phage sequence, and many genes encoding anaerobic functions (Cole, ASM 
Presentation, 1997). 
1.1.3.2. Mechanisms of pathogenesis 
In 1882 Robert Koch described the tubercle bacillus, Mycobacterium tuberculosis, and 
demonstrated that it was the cause of tuberculosis (Koch, 1932; Sakula, 1982; Grange and 
Bishop, 1982). TB is transmitted by the airborne spread of 3-10 bacilli suspended in droplet 
nuclei, produced when people with active pulmonary TB cough or speak (Wells, 1955; Riley 
et al., 1959). The droplet nucleus is very stable and remains suspended in the air for long 
periods of time. Humans are highly susceptible to infection with M. tuberculosis, and inhalation 
of only 1 or 2 viable bacilli can cause an infection, although the risk of developing disease after 
one exposure is low (3-5%), and many who are exposed never develop clinical disease (Collins, 
1989). In general, there are three possible outcomes to infection with M tuberculosis: 
1) primary TB which results from acute infection shortly after infection, 2) reactivation TB, in 
which active disease appears many years after infection, 3) establishment of a chronic latent 
infection. Only 5-15% of people infected by the tubercle bacilli develop active disease at some 
stage in their lives. This may be determined by a number of factors such as the immune 
response to the infection, the genetic make-up of the infected individual, and various 
characteristics of the invading organism. Today much is known about the immunology of TB 
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(Reviewed in Bloom, 1994), however, little is known about the pathogenesis of mycobacterial 
infection and, as yet, a molecular basis for virulence in M tuberculosis has not been established. 
M tuberculosis is an intracellular pathogen which resides within the macrophage. The danger 
of the pathogen lies in its ability to persist in tissues and activate an immune response, rather 
than causing direct damage to host cells. Different M tuherculosis strains differ in their ability 
to cause disease, and the virulent strains presumably contain a unique set of features, referred to 
as virulence determinants, which allow them to enter macrophages and to persist and multiply in 
this environment. Macrophages have developed a number of defences against intracellular 
pathogens which are reviewed by Beaman and Beaman (1984). These include the production of 
reactive oxygen intermediates, such as the superoxide anion (Babior et al., 1973), singlet 
oxygen CO2) (Allen et al., 1974), and hydroxyl radicals (OH) (Tauber and Babior, 1978), in the 
host respiratory burst. This is accompanied by an increased oxygen consumption, and induction 
of a number of enzymes such as myeloperoxidase, acid hydrolases, and lysozyme (Bainton et al., 
1971 ), which degrade macromolecules. The latter enzymes are contained within lysosomes, 
which fuse with the plasma membrane of phagosomes and release the lysosomal contents in a 
process known as degranulation (Cohn, 1963). Human macrophages are relatively efficient at 
controlling most M. tuberculosis infections, but some organisms have adapted to overcome their 
defence mechanisms (Riley, 1995). Virulent M tuberculosis strains, for example, can interfere 
with normal lysosome function. The mechanisms involved are not clear but it may be due to the 
production of a large amount of ammonia, which also results in the raising of the intralysosomal 
pH (Gordon et al., 1980). Some components of the mycobacterial cell wall can also inhibit 
some of the lysosomal enzymes. The environment inside phagosomes is usually acidic, which 
potentiates the toxicity of other factors, however, acidification may be inhibited by the ammonia 
released by M tuberculosis. More recent evidence suggests that M tuberculosis arrests the 
maturation of its phagosome at a stage at which the phagosome interacts with early and late 
endosomes, but not with lysosomes (Clemens and Horwitz, 1996; Sturgill-Koszycki et al., 
1996), and that the lack of acidification of the vacuoles may be due to the absence of the 
vesicular proton-adenosine triphosphatase (Sturgill-Koszycki et al., 1994). 
It appears, therefore, that M tuberculosis can prevent inhibition by the acidic conditions and 
lysosomal enzymes of the phagosome, however, within these cells the organism is still exposed 
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to the toxic oxygen and nitrogen intermediates. Walker and Lowrie ( 1981) identified hydrogen 
peroxide, which is generated by the host respiratory burst (Iyer et al., 1961; Klebanoff, 1980), 
as the molecule that mediates the mycobactericidal effects of mononuclear phagocytes, and 
there is substantial evidence to suggest that hydrogen peroxide and associated reactive oxygen 
intermediates are responsible for much of the microbicidal powers of the macrophage (Andrew 
et al., 1985; Babior, 1978; Jackett el al., 1981a; 1981b; Lowrie, 1983) Chan el al. (1989) 
suggest that mycobacteria possess inherent mechanisms of resistance to these radicals by virtue 
of their cell walls. M. tuherrnlosis and other pathogenic and slow growing mycobacteria have 
an apparently unique major modification to their mycolic acids, i.e. cyclopropanation (Minnikin. 
1982). Fast growing, saprophytic mycobacteria do not cyclopropanate their mycolic acids, but 
produce a large amount of unsaturated mycolic acids. Yuan et al. ( 1995) suggest that 
cyclopropanation may be an adaptation to the hostile intracellular environment in which reactive 
oxygen species would cross-link and degrade mycolic acids containing surface-exposed double 
bonds. The authors isolated the gene responsible for cyclopropanation from M. tuberculosis 
and demonstrated that overexpression of the gene in M smegma/is resulted in a significant 
increase in resistance to killing by hydrogen peroxide (Yuan et al., 1995). The importance of 
the cell wall in virulence is also illustrated by the results of Murohashi and Yoshida ( 1965), who 
showed that the duration of ultraviolet irradiation required for the loss of acid-fastness was 
longer for virulent strains than for avirulent or attenuated strains, again suggesting a link 
between the degree of virulence and the cell wall structure. Differences in the cell wall of 
virulent and avirulent strains could, therefore, be responsible for the ability of the organisms to 
survive at initial entrance into host cells during infection. Resistance to toxic radical species 
produced by macrophages is also mediated by the maJor cell wall-associated 
phosphatidylinositonyl-anchored complex lipopolysaccharide (LAM), which is produced in large 
amounts by M tuberculosis, and has been shown to scavenge reactive oxygen intermediates and 
to downregulate the oxidative burst (Chan et al., 1991 ). Although the mycobacterial cell wall 
provides a formidable barrier against reactive oxygen species, a reasonable proportion of these 
are probably still able to enter the cell where they can cause considerable damage to cellular 
components (reviewed in Chapter 2). This is where the radical scavenging enzymes such as the 
catalases and peroxidases come into play. These enzymes probably provide the second line of 
defence to these radicals, and therefore play a vital role in the survival of M tuberculosis in 
13 
macrophages. One of these enzymes, the catalase-peroxidase, is the focus of this study and is 
discussed in detail in section 1.2. 
1.1.3.3. Dormancy 
Another factor which is important for the virulence of the organism and its ability to withstand 
drug treatment, is its ability to remain in a dormant state for years within the host. Dormant 
organisms arc those that are not actively rcplicatmg and arc metabolically inactive. As such they 
are resistant to most antimicrobial factors, and may be more accurately referred to as "non-
replicating persisters." Nothing is known about how M tuberculosis remains dormant or how it 
is activated out of latency. Under optimal conditions, M. tuberculosis takes 16-18 hours to 
undergo one cycle of replication (Wayne, 1977), and this slow growth may confer a selective 
advantage. It is possible that priority is given to cell survival rather than cell division to cause 
little perturbation of the host cells. It has been suggested that the natural physiological state of 
the cells resembles that of Escherichia coli in stationary phase, in which a set of proteins are 
induced that allow increased survival under poor external conditions. Dormant mycobacteria 
within the host may then represent an extreme form of stationary phase in which no replication 
occurs (Young and Cole, 1993 ). Very abrupt exposure to anaerobic conditions is lethal to 
actively growing M tuberculosis cultures, however, gradual depletion of oxygen causes 
M tuberculosis cultures to shift from active replication to dormancy. These dormant bacilli are 
partially or completely resistant to INH and rifampin but are sensitive to metranidazole, a drug 
specific for anaerobes and which is normally inactive against actively growing aerobic cultures 
(Wayne and Sramek, 1994). It is interesting to note that M tuberculosis contains many 
enzymes required for anaerobic metabolism (Segal and Edwards, 1984), and these may play an 
important role in dormancy. 
1.2. THE RADICAL SCAVENGING ENZYMES 
Metabolism in an oxygen-rich environment may result in the generation of reactive oxygen 
species such as superoxide anions, hydroxyl radicals, and hydrogen peroxide (Fridovich, 1986). 
These radicals can oxidize membrane fatty acids, which initiates lipid peroxidation, oxidize 
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proteins, and damage DNA. Organisms in these environments therefore possess enzymes which 
neutralize these molecules e.g. superoxide dismutase, catalase and peroxidase, as well as DNA 
repair enzymes, e.g. exonuclease III, DNA polymerase I, the RecBC nuclease and RecA, which 
will be discussed in more detail in Chapter 2. The superoxide dismutases (S0Ds) are a family of 
metalloenzymes containing either iron (Fe), manganese (Mn), or both copper and zinc (CuZn) at 
the active site. Bacteria generally contain both Mn- and FeSODs in the cytoplasm (Hassan, 
1989). The CuZnSOD is usually found in eukaryotes but is found in a small number of gram-
negative species, in which it resides in the periplasm. SODs convert the superoxide anion into 
oxygen and hydrogen peroxide (McCord and Fridovich, 1988), which is then removed by the 
catalases and peroxidases. Catalases and peroxidases are both involved in the decomposition of 
hydrogen peroxide in a two-electron transfer between two substrates, one of which is reduced 
and one of which is oxidized. The difference between the two enzyme activities lies in the 
nature of the donor and acceptor. Catalases catalyze the dismutation of hydrogen peroxide to 
form oxygen and water, while peroxidases use a variety of organic and inorganic electron 
donors to reduce hydrogen peroxide (Deisseroth and Dounce, 1970; Dunford and Stillman, 
1976). Hydroperoxidases exhibit both catalase and peroxidase activities. 
1.2.1. C:atalases 
Catalases from various higher organisms share a number of similarities. Their molecular weight 
(Mw) ranges from 225 000 to 270 000 and they consist of four subunits of equal size, each of 
which contains one ferric heme prosthetic group (protoporphyrin IX). All show a broad pH 
range (5-10.5), and are specifically inhibited by 3-amino-1,2,4,-triazole (Nadler et al., 1986; 
Schonbaum and Chance, 1976). The structure of the beef liver catalase has been examined in 
detail (Fita and Rossmann, 1985). Each subunit of the tetramer consists of four domains: 1) the 
70 residue amino terminal, which forms an arm extending from the globular region of each 
subunit and interacts with the neighbouring subunit; 2) residues 76-320, which form a large anti-
parallel f3-barrel; 3) residues 321-436, which lacks secondary structure from residues 366-420, 
but includes the essential a-helix and is known as the "wrapping domain"; 4) residues 437-506, 
consisting of 4 a-helices on the external part of the molecule. Protohemin is essential for 
activity and specificity, and is thus a major structural component of the active site. Each subunit 
contains one protoporphyrin IX moiety containing an Fe3+ ion. In catalase, the heme group is 
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the organic radical, while in peroxidase the radical is situated on the amino acid side chain or on 
a sulfur atom. The heme group is accessible by a main funnel-shaped channel in the molecule. 
Both the amino- and carboxy-terminal sections form part of the lining of the entrance of this 
channel. Another minor channel leading to the heme group has a narrow entrance between 
Lys-236 and His-304, which is associated with the NADP binding site. 
The first step in the catalytic reaction is the transfer of two electrons from the heme iron, 
Fe[III], to hydrogen peroxide to form Compound I (Fe[V]) (Schonbaum and Chance. 1976; Fita 
and Rossmann, 1985). This then reacts with a second hydrogen peroxide molecule to 
regenerate the native enzyme. Compound I can also react with H20 2 to form Compound II, 
which can then react with H202 in two different ways; I) a slow reduction to native catalase, 
and 2) irreversible oxidation to Compound Ill, which is then slowly reduced to native catalase 
(see Fig. 1.2) (Schonbaum and Chance, 1976). Since these reactions are slow, the regeneration 
of native catalase for the catalytic cycle is low, resulting in an apparent decrease in enzyme 
turnover. 
1.2.2. Peroxidases 
Peroxidases are monomeric proteins of differing molecular weight. Their heme ions are 
reducible by dithionite (Dunford and Stillman, 1976). The cytochrome c peroxidase found in 
yeast mitochondria is the most widely studied. It consists of a single chain 294-residue heme 
enzyme which catalyzes the oxidation of ferrocytochrome c by peroxides in the following 
reaction: 
2H+ + ROOH + 2 cyt c (Fe2+) ~ 2 cyt c (Fe3+) +ROH+ H20 
The cytochrome c peroxidase is a relatively small monomer, and serves as a simplified model for 
multisubunit cytochrome c oxidases. Finzel et al. (1984) used high resolution crystallographic 
refinement to obtain a structural model for the enzyme. Cytochrome c peroxidase is folded into 
two clearly defined domains, and the overall shape resembles a prolate ellipsoid. It consists of 
1 O a-helical segments, 2 antiparallel-r3-pairs, and one small r3-sheet (Poulos and Kraut, 1980). 
The amino- and carboxy-termini are situated in the same domain. A large channel at the 
interface between the two domains probably allows transport of the substrates to the active site 
(Finzel et al., 1984). 
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The first step in the peroxidatic reaction also involves the oxidation of the enzyme by hydrogen 
peroxide to form Compound I, known as Compound ES for cytochrome c peroxidase 
(Yonetani, 1976). In this state, one of the oxidizing equivalents is stored as the oxy-ferryl 
(Fe[IV]=O) state of the heme iron (Lang et al., 1976), while the other exists as a reversibly 
oxidized amino acid residue. Sivaraja et al. ( 1989) identified the primary site of the cytochrome 
c peroxidase Compound ES radical with tryptophan, most likely Trp 1')1 After the formation of 
Compound ES, two sequential one-electron transfers occur, in which ferrocytochrome c is 
oxidized ( Yonetani, 1976 ), and the native protein is regenerated Compound I of peroxidases 
also reacts with an electron donor, AH2, to form Compound II, which then reacts with another 
electron donor to regenerate the native enzyme (see Fig. 1.2). 
ROOH ROH 
E-nativc ~ L~ E-compound I E-nativc 
or 
AH2 AH. 
E-compound II or \.. 2 E-native 
E-compound III 
Figure 1.2 The oxidation and reduction reactions of catalases and peroxidases. E represents the enzyme; ROOH 
and ROH represent the oxidized and reduced forms of the peroxide, respectively; and AH2 and AH. 
represent the reduced and oxidized forms of the electron donor, respectively. 
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1.2.3. Catalase-peroxidases 
Hydroperoxidases (HPI) or catalase-peroxidases are members of the superfamily of plant, fungal 
and bacterial peroxidases (Welinder, 1992). They are mostly multimers of identical subunits of 
approximately 80 kDa each. Most form tetramers of Mw 240 000, with two protoheme IX 
groups which can be reduced by dithionite. These enzymes are different to normal catalases in 
their narrow pH ranges, sensitivity to temperature. hydrogen peroxide, and organic solvents. 
and resistance to 3-amino-1,2,4,-triazole (Goldberg and Hochman, 1989; Hochman et al.. 
I ()92) So far. these types of catalase-pemxidases have heen found in F. coli (Claihorne and 
Fridovich, 1979), Rhodopseudomonas capsulata (Hochman and Shemesh, 1987), Klebsiella 
pneumoniae (Hochman and Goldberg, 1991 ), Chromatium vinosum (Nadler et al., 1986), 
Rhodobacter capsulatus (Hochman et al., 1992), Salmonella typhimurium (Loewen and 
Stauffer, 1990), Citrobacter freundii, Edward\·iella tarda, Enterohacter aerogenes (Switala 
et al., 1990), and the alkalophilic Bacillus strain YN 2000 (Yumoto et al., 1990). These 
enzymes are highly homologous and consist of two related domains, each with strong similarity 
to the yeast cytochrome c peroxidase. The catalase-peroxidase activity is predicted to lie in the 
N-terminal domain and, as yet, no function has been assigned to the C-terminal domain, 
although it may play a role in substrate binding or subunit interaction. In bacterial catalase-
peroxidases, the first 50 residues have no counterpart in the yeast enzyme, and the N-terminal 
halves are more related to the yeast enzyme than the C-terminal halves. (Welinder, 1991; 1992). 
The catalytic mechanisms of catalase-peroxidases are thought to occur in a similar manner to 
those described above for the individual enzymes. Hochman and Shemesh ( 1987) suggest that, 
for both catalases and catalase-peroxidases, Compound I is formed at the same rate while the 
rate of transition to Compound II is significantly higher for catalase-peroxidases. This results in 
a lower steady state concentration of Compound I. This explains why, in the presence of low 
and steady state concentrations of H20 2, activity is lost, since there is an increased rate of 
conversion of Compound I to Compound II, which then takes a long time to regenerate the 
enzyme. The inhibitor 3-amino-1,2,4,-triazole reacts with Compound I. Since the conversion 
to Compound II is very rapid for catalase-peroxidases, they appear to be more resistant to 
inhibition. When there is a substrate for peroxidase, the steady state level of Compound I will 
probably be lower than when only H202 is present (Hochman and Shemesh, 1987). 
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The catalase-peroxidase enzyme, as mentioned previously, occurs in a variety of bacterial 
species. However, it has been studied most extensively in E. coli. This organism possesses two 
catalase enzymes, HPI, which has associated peroxidase activity, and HPII, which possesses 
only catalase activity. HPII, which is located in the cytoplasm (Heimberger and Eisenstark, 
1988), is encoded by the katE gene and is a hexamer of 93 kDa subunits and six heme d-like 
groups {Loewen and Switala, 1986). HPI, the catalase-peroxidase, is encoded by the katG 
gene. The E coli katG promoter contains a -35 region with poor homology to the consensus 
sequence and requires the OxyR protein for optimal expression. The 2. 18 l kb gene encodes a 
monomer of 80. I 09 kDa (Triggs-Raine et al, 1988). The protein is active as a tetramer with 
two protoheme IX groups (Claiborne and Fridovich, 1979), and is found in the periplasmic and 
cytoplasmic membrane fractions (Heimberger and Eisenstark, 1988). To establish which 
domains of the enzyme were important for activity, Loewen et al. ( 1990) generated mutants in 
HPI in£. coli using nitrosoguanidine and cloned and sequenced their katG genes. The mutants 
contained one each of the following substitutions, a Gly --) Asp change in codons 119 and 314, 
and a Leu --) Phen change in codon 13 9. The changes at positions 13 9, 119, and 314 resulted 
in 13, < I, and 18% of the wild type catalase activity and 43, 4, and 45% of the wild type 
peroxidase activity, respectively. All three bound less protoheme IX than the wild type enzyme. 
The mutant enzymes were more sensitive to high temperature and f3-mercaptoethanol than the 
wild type, but the pH profiles and sensitivities to inhibitors and activators were unchanged 
(Loewen et al., 1990). 
Another well characterized catalase-peroxidase is that from S. typhimurium. The katG gene 
from this organism was cloned and sequenced by Loewen and Stauffer (1990). The gene is 
81. 9% similar to that of E. coli at a nucleotide level and 90% similar at an amino acid level. 
The -10 region is identical to that of E. coli, while the -3 5 region differs in 2 of the 6 positions, 
and also requires OxyR for optimal expression. The gene encodes a protein of 727 amino acids 
with a predicted molecular weight of 80.042 kDa. Loprasert et al. (1988) isolated a catalase-
peroxidase from Bacillus stearothermophilus. It is a thermostable dimeric enzyme with one 
molecule of protoheme XI per molecule and an optimum temperature of 70°C. The same 
authors cloned and characterized the gene encoding the enzyme (Loprasert et al., 1989). The 
2.193 kb gene encodes a polypeptide of 731 amino acids with a predicted molecular weight of 
82.963 kDa. The B. stearothermophilus catalase-peroxidase shows 48% identity to that of 
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E. coli at the amino acid level (Loprasert et al., 1989). Brown-Peterson and Salin (1993) 
purified and characterized a hydroperoxidase from Halobacterium halobium. It exhibited 
similar properties to other hydroperoxidases but had some unique features, including a greater 
amount of peroxidase activity in relation to catalase activity, a diminished heme content, 
inability to be reduced by dithionite, a requirement for salt for activity, and stability at higher 
temperatures. Another salt-dependent catalase-peroxidase was purified from the extreme 
halophile Haloarcula marismortui (Cendrin et al., 1994). The catalase activity of this enzyme 
was enhanced by sodium chloride or ammonium sulphate, but the peroxidase activity decreased 
with increasing concentration of salt. Other catalase-peroxidases which have been characterized 
include one from Caulobacter crescentus, which is also located in both the cytoplasm and 
periplasm, associated with the outer surface of the inner membrane (Schnell and Steinman, 
1995), and one from the cyanobacterium Synechococcus PCC 7942 (Mutsuda et al., 1996). 
The latter enzyme has a molecular mass of 150 kDa, and is composed of two identical 79 kDa 
subunits with one protoheme molecule. It exhibits high catalase activity and moderate 
peroxidase activity with o-dianisidine and pyrogallol. Catalase activity is inhibited by potassium 
cyanide and sodium azide, but not by 3-amino-1,2,4-triazole (Mutsuda et al., 1996). 
1.2.4. The physiological role of catalase-peroxidases 
A number of studies have therefore been carried out on the structure of the catalase-peroxidase 
enzyme and on the gene encoding it. Hochman et al. ( 1992), however, were the first to attempt 
to elucidate the physiological function of the enzyme. They studied the catalase-peroxidase 
from Rhodobacter capsulatus, a photosynthetic, facultatively anaerobic bacterium capable of 
fixing molecular nitrogen. R. capsulatus has a catalase-peroxidase and a peroxidase, as shown 
by activity gels. The authors used transposon mutagenesis to isolate a catalase-peroxidase 
mutant, AH18. The mutant reacted to molecular oxygen in a similar way to the wild type with 
respect to generation time under aerobic conditions, pigment content, mutation rate, and in vivo 
nitrogen fixation capacity, but was affected by hydrogen peroxide with respect to viability and 
inhibition of nitrogen fixation. Under aerobic conditions, the catalase-peroxidase mutant had a 
much higher rate of cell death in the stationary phase than the wild type. These results indicate, 
as has been demonstrated for other catalases, that they do not have a crucial function in actively 
growing aerobic cultures, unless the cells are exposed to externally added hydrogen peroxide. 
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Catalase mutants of£. coli, for example, exhibit a similar growth rate to wild type cells, but are 
more sensitive to the lethal effects of hydrogen peroxide (Levine, 1977; Meir and Yagi!, 1984). 
In the absence of catalase, these cells can switch to utilizing glutathione as an antioxidant 
(Alonso-Moraga et al., 1987). There are only a few reports in the literature which suggest a 
distinct function for catalase-peroxidases. In Vitreoscilla sp., the catalase-peroxidase is thought 
to play a specific role in scavenging peroxide generated by its bacterial hemoglobin (Abrams and 
Webster, 1990), while in E coli, HPI is thought to play a general antioxidant role in 
exponentially growing cells, with a specific effect on membrane structure and function, and 
possibly active transport (Farr et al., 1988; Leven et al., 1990). In the latter organism, HPI is 
responsible for a very small part of the total catalase activity, however, it is the most important 
cellular determinant for hydrogen peroxide sensitivity (Schellhorn, 1994). Hochman et al. 
(1992) suggest that the R. capsulatus catalase-peroxidase has a minor function in exponential 
phase cells, but is crucial in stationary phase when the cells are starved or stressed. They 
suggest that, in actively growing cells, the peroxidase or damage repair systems protect against 
oxidative damage. Starved bacteria are subjected to oxidative stress, therefore catalase-
peroxidases are crucial for survival under these conditions. The peroxidase activity of this 
enzyme may also catalyze biosynthesis or degradation activities for cellular adaptation to 
starvation or oxidize NADH, NADPH, or cytochrome c, therefore lowering the cell's reducing 
activity (Hochman et al., 1992). In pathogenic bacteria, there is strong evidence to suggest that 
the catalase-peroxidase plays an important role in virulence ( discussed in a later section). 
1.2.5. Catalases in the mycobacteria 
The catalase contents of various mycobacterial species have been studied extensively. In 1958, 
Schweiger and co-workers showed that virulent, avirulent and saprophytic mycobacteria could 
be differentiated by the thermal stability of their catalase enzyme, and, in 1960, Kubica and Pool 
introduced the 68°C, pH 7.0 catalase test for the subgrouping of mycobacteria based on this 
property. Wayne (1962) subsequently developed the semi-quantitative catalase assay, which 
entails the addition of 10% Tween 80 and 30% hydrogen peroxide to a culture and measuring 
the height of the column of bubbles produced. He used this to demonstrate that different 
variants of M kansasii have differences in their catalase activity. Kubica et al. (1966) tested 
326 cultures of slowly growing mycobacteria and 204 strains of rapidly growing mycobacteria 
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for catalase activity using both the semi-quantitative and pH 7/ 68°C tests. The tests revealed 
two natural groupings, one composed of strains of M. tuberculosis, M bovis, clinically 
insignificant strains of M. kansasii, and other mycobacteria producing 40 mm or less of bubbles 
in the semi-quantitative test and showing a negative pH 7 / 68°C test, and the other containing 
the rest of the cultures which produced > 50 mm of bubbles and a positive pH 7 / 68°C test. A 
small group of strains showing no apparent catalase activity consisted primarily of tubercle 
bacilli resistant to varying levels of INH. Mycobacteria, therefore contain two types of 
catalases, the M-catalases which retain activity after heating to 68°C for 5 minutes. but are: 
inactivated by aminotriazole, and the T-catalases which are inactivated by heat but are resistant 
to aminotriazole. Other studies since have demonstrated the presence of both types of catalase 
in M. smegmatis and only the T-catalase in M gastri (Bartholomew, 1968). These results were 
independent of the age of the culture and were, therefore, not a result of the differences in the 
growth rates of the two mycobacterial species. Wayne and Diaz (l 982; 1988) have also tested 
the catalase contents of several mycobacterial species and found the following; M. terrae, 
M triviale, and M. nonchromogenicum have no T-catalase; M tuberculosis, M. bovis, 
M. intracellulare, M avium, M gastri, M marinum, and M. xenopi have a T-catalase but no 
M-catalase; M. szulgai, M simiae, M kansasii, M. gordonae, M scrofulaceum, and 
M. asiaticum have both T- and M-catalases; and M. avium and M. intracellulare have a novel 
type of catalase, A-catalase, which is heat stable, sensitive to inhibition by 3-amino-1,2,4-
triazole, has no peroxidase activity, and does not react with antibody to the M-catalase from 
M scrofulaceum. Apart from the catalases and catalase-peroxidases, mycobacteria produce 
two types of SODs, Mn- and Fe-containing. M tuberculosis produces and secretes an FeSOD 
which also plays a role in protection against reactive oxygen species (Zhang et al., 1991 ). 
1.3. THEM. TUBERCULOSIS CATALASE-PEROXIDASE 
As mentioned above, certain mycobacterial species possess only a T-catalase. This catalase has 
associated peroxidase activity, and is therefore classified as a catalase-peroxidase or 
hydroperoxidase. The katG gene encoding the M tuberculosis catalase-peroxidase enzyme was 
cloned and sequenced by Zhang et al. (1992), and characterized by Heym et al. (1993). The 
gene shows 53.3% homology with the enterobacterial HPI enzymes and 45.7% homology with 
that of B. stearothermophilus. Upstream of the gene are two copies of a 700 bp direct repeat 
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which are 68% identical. Probing of an M. tuberculosis cosmid library with a region of this 
repeat revealed that the repetitive sequence is not dispersed in the genome. The markers linked 
to katG on the chromosome are LL 105, encoding an anonymous antigen, and fbpB, encoding 
the putative fibronectin-binding protein or a-antigen. M leprae and M avium contain 
sequences homologous to the M. tuberculosis katG gene, while M. gordonae and M. szulgai do 
not (Zhang et al, 1992). 
The katG gene encodes a protein of 735 amino acids with a predicted molecular weight of 
80.029 kDa. The AI t11herc:11lusis KatG, like all catalase-peroxidases, consists of two related 
domains, each with strong similarity to the yeast cytochrome c peroxidase. The region spanning 
residues 55 to 422, and that between residues 423 and 735, are weakly related (30% identity at 
the amino acid level), although many of the catalytic amino acid residues are absent from the 
C-terminal region (see Fig. 1.3), and it may play a role in substrate binding or subunit 
interaction. Zhang et al. ( 1992) demonstrated that deletion of a BamHI-KpnI fragment from the 
3' end of the gene results in a loss of enzyme activity, and ability to confer sensitivity to INH. 
Within the N-terminal region, the putative active site regions (residues 94-154 and 257-276) are 
45% identical, and contain the putative catalytic or substrate binding residues, Arg-104, 
Trp-107, His-108, Asn-138, His-269, Thr-274, His-275, Trp-320, and Asp-380, which are 
conserved (Heym et al., 1993). 
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Figure 1.3 Schematic representation of the gene duplication observed in the M tuberculosis catalase-peroxidase 
(MCP). The residues corresponding to the conserved active site residues of the yeast cytochrome c 
peroxidase (CCP) are shown. 
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The consensus sequences for the active sites of typical peroxidases are: peroxidase 1, 
[DET]-[LIVMT]-Xr[LIVM]-[LIVMST AG]-[SAG]-[LIVMST AG]-H-[ST A ]-[LIVMFY] and 
peroxidase 2, [SGAT]-X3-[LIVMA]-R-[LIVMA]-X-[FW]-H-X-[SAC] (Bairoch et al., 1992). 
Only the first is found in the M tuberculosis KatG, since there are two deviations around 
His-269 where the second motif should be. A possible ATP-binding motif (G-X-X-X-X-G-K-
T) was also detected, although this overlaps with the active site and may not be functional. 
The M tuberculosis catalase-peroxidase was first purified by Devi et al. ( 1975). The purified 
protein was reddish-brown and had a molecular weight of 240 000. The enzyme activity was in 
the supernatant fraction, therefore it is not localized in the membrane in this organism. Johnsson 
et al. ( 1997) recently purified the protein from catalase mutants of E. coli expressing the 
M tuberculosis katG gene on a plasmid, and studied its spectroscopic and kinetic properties in 
detail. They determined the molecular weight of the protein to be approximately 161-175 kDa, 
suggesting that the protein forms a dimer in solution. This agrees with previous reports (Diaz 
and Wayne, 1974; Nagy et al., 1995), but not with that of Devi and co-workers (1975). The 
purified enzyme possessed high catalase activity which showed a significant dependence on pH, 
with a maximum activity at pH 7.0. The specific catalase activity of the recombinant KatG was 
approximately 6-fold higher than the KatG purified from M tuberculosis cell extracts (Diaz and 
Wayne, 1974), and approximately 150-fold higher than that purified from M tuberculosis 
H37Rv (Devi et al., 1975). This may be due to difficulties in purifying the enzyme from the 
native hosts and differences in the purification protocol. The peroxidase activity was 
approximately 8-fold lower than that of horseradish peroxidase (Hochman and Goldberg, 1991 ). 
This may be due to direct competition between the catalase and peroxidase activities of the 
KatG enzyme for hydrogen peroxide. The enzyme oxidizes both NADH and NADPH, and this 
may provide a regulatory role for the enzyme in controlling metabolic rates (Hochman and 
Goldberg, 1991; Marcinkeviciene et al., 1995). 
Other mycobacterial catalases which have been characterized further are the M intracellulare, 
M smegmatis, and M leprae KatG, and the M avium KatE. The M leprae katG gene was 
recently isolated and sequenced by Nakata et al. (1997). The sequence was approximately 70% 
identical to that of the M tuberculosis katG, however, the M leprae gene had several 
mutations. The M tuberculosis katG GTG initiation codon was replaced by GT A in M leprae 
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and the latter gene had two deletions of approximately 100 and 110 bp at the 5' end of the 
coding region, as well as several minor deletions, insertions, and termination codons. The same 
lesions were detected in 7 other M. leprae strains. The authors were unable to detect sequences 
homologous to the M avium kalE gene. It appears, therefore, that M. leprae produces no 
functional catalases, and this may explain both the natural resistance of the organism to INH, 
and its very slow growth in vivo due to its lack of defence against oxygen radicals (Nakata 
el al., 1997). The M. intracellulare kalG gene, which is 60% identical to that of 
AI 1uherculosis (Heym el al, 1993), has a G+C content of 70%, and encodes a protein of 74S 
amino acids with a predicted Mw of 83.5 kDa (Morris el al, 1992). The protein is 60, S9, and 
47% identical to the corresponding genes from E coli, S. lyphimurium, and 
B. stearothermophilus, respectively. The C-terminal region, in particular, shows a relatively 
high identity to the above three proteins. The M. inlracellulare kalG gene hybridized to 
homologous sequences in M. asialicum, M. avium, M bovis, M hovis BCG, M forluilum, 
M kansasii, M. smegma/is, M tuberculosis H37Ra, M. tuberculosis H37Rv, M. phlei, 
M scrofulaceum, and M terrae (Morris et al., 1992). 
The M smegmatis KatG was purified by Marcinkeviciene et al. (1995). The 330.0 kDa enzyme 
was composed of four 81.89 kDa subunits, and had a heme content of2 molecules per tetramer. 
The peroxidase activity of the enzyme was competitively inhibited by isoniazid and nicotinic acid 
hydrazide, to the same extent as that from M. tuberculosis. Interestingly, the M smegmatis 
catalase-peroxidase exhibited 10-fold greater peroxidase activity than the M tuberculosis 
enzyme. The M avium katE gene encodes a protein of 706 amino acids with a predicted 
molecular weight of 91 kDa. The gene shows 81.4; 80.8; 76.2; 76.4; and 83% similarity with 
the bovine liver, human kidney, Saccharomyces cerevisiae, Lactobacillus sake and E. coli 
catalases, respectively. The three active site residues of bovine liver catalase and the seven 
interacting with the heme group are conserved, as are 2 of the 4 residues involved in NADPH 
binding. Homologous katE sequences were identified in M aurum, M kansasii, and 
M marinum, but not in M tuberculosis (Milano et al., 1996). The authors were also able to 
amplify the gene from different M avium clinical isolates and M simiae, M xenopi, M terrae, 
M kansasii, and M gordonae, and a minor band in M smegmatis and M marinum. No bands 
were amplified in M tuberculosis, M bovis BCG, M flavescens, M fortuitum, M abcessus, or 
M cholenae. Some of these results contradict those of Wayne and Diaz ( 1982; 1988) with 
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respect to the catalase contents of certain species. Milano et al. (1996) suggest that their 
M avium A-catalase is the mycobacterial M-catalase, or HPII. The A-catalase is more similar 
to the M-catalase, but does not react with antibodies to the M-catalase from M. scrofulaceum 
(Wayne and Diaz, 1988). 
1.3.1. Association of KatG with virulence 
As mentioned previously, as an intracellular pathogen, NI. t11herc11/osis has to overcome the host 
respiratory burst in order to survive. This respiratory burst involves the release of hydrogen 
peroxide and other toxic radicals, and it follows, therefore, that the removal of these molecules 
by radical scavenging enzymes would play an important role in the persistence of the organism 
in this environment, and hence in virulence. There are a number of lines of evidence to show 
that catalase is a virulence factor in the mycobacteria. Wayne ( 1962) showed that clinically 
significant strains of M. kansasii all had high levels of catalase activity and exhibited the greatest 
virulence for the guinea pig. INH-resistant strains of M. tuberculosis which have low catalase 
activity show a reduced virulence for guinea pigs (Middlebrook and Cohn, 1953; Mitchison 
et al., 1960). A significant correlation was also found between virulence and resistance to 
hydrogen peroxide in INH-sensitive tubercle bacilli freshly isolated from patients (Mitchison 
et al., 1963; Narayanan Nair et al., 1964). Jackett et al. (1978) confirmed the association of 
hydrogen peroxide susceptibility with low virulence in native and INH-resistant tubercle bacilli, 
however, they showed that this is not the sole determinant of virulence, and that possession of 
catalase is only one of the features which confers resistance to hydrogen peroxide. Walker and 
Lowrie ( 1981) demonstrated that exogenous catalase protects M micro ti from killing by 
lymphokine-activated murine macrophages. Direct evidence for the association between 
catalase and virulence is provided by Wilson et al. (1995), who showed that integration of a 
functional M bovis BCG katG gene into an avirulent, catalase-negative M bovis strain resulted 
in full virulence. These authors point out, however, that some clinical M tuberculosis isolates 
that are resistant to INH and have lost catalase activity remain virulent. They suggest that these 
organisms have another method of coping with the oxidative burst from macrophages. More 
recently, Heym et al. (1997) showed clearly that M tuberculosis strains which produce 
catalase-peroxidase have a competitive advantage in immunocompetent hosts, once the 
macrophages have been activated to release large amounts of reactive oxygen species. More 
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evidence is provided by Kelley et al. (ASM Abstract U-96, 1997), who showed that a katG-
delcted, INH-resistant mutant of M tuberculosis H37Rv was avirulent for mice and guinea pigs 
relative to the parent, but that transformation of the mutant with the M tuberculosis wild type 
katG, one with an Arg to Leu change at codon 463, and the M avium complex katG restored 
full catalase-peroxidase activity and ability to survive in vivo. The katG gene alone, however, 
could not restore virulence, although this may have been due to other mutations in this strain. 
These observations all suggest an important role for catalase in the survival and persistence of 
mycobacteria in macrophages, however, a number of recent studies contradict this. It was 
recently shown, for example, that in M. i11lracel/11lare. resistance to peroxide does not correlate 
with catalase content and, in M. tuberculosis, susceptibility to killing by activated macrophages 
is not related to peroxide susceptibility (Gangadharam and Pratt, 1984; O'Brien et al., 1991 ). 
Further evidence was reported by Marklund and co-workers (ASM Abstract U-95, 1997), who 
found no differences in the virulence of two strains of M intracellulare with mutated katG 
genes, although they showed elevated resistance to INH and sensitivity to hydrogen peroxide 
relative to the wild type parent strains. The role of catalase in the virulence of mycobacteria is 
therefore not clear. Tubercle bacilli appear to possess at least two independent mechanisms of 
resisting the lethal effects of hydrogen peroxide, and loss of virulence evidently can occur 
without loss of resistance to hydrogen peroxide (Jackett et al., 1978). There are probably a 
number of factors involved in virulence which are interdependent. SOD has also been 
associated with virulence in some pathogenic bacteria (Babior, 1978; Beaman et al., 1983; 
Franzon et al., 1990; Welch et al., 1979), but not in others (Mandell, 1975; Bloch et al., 1989). 
No correlation was found between the SOD content and virulence of M tuberculosis (Jackett 
et al., 1978). 
Catalase has been shown to be a potential virulence factor in a number of other pathogens such 
as Haemophilus injl.uenzae (Bishai et al., 1994), Rhodobacter capsulatus (Hochman et al., 
1992), Staphylococcus aureus (Mandell, 1975), Nocardia asteroides (Filice, 1983), Leishmania 
donovani (Beaman and Beaman, 1984), and Neisseria gonorrhae (Zheng et al., 1992). Kagaya 
et al. (1992), for example, showed that purified stress-induced catalase ( catalase-peroxidase ), 
rather than constitutive catalase induces an increased protection to S. typhimurium infection in 
mice. Their results suggest that stress proteins play a major role in the induction of cell 
mediated immunity, and that the hydrogen peroxide-inducible catalase is one such effective 
antigen. The association of catalase with virulence in these organisms has also been suggested 
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to be due to its ability to protect from the oxidative burst of macrophages and other phagocytic 
cells (Beaman and Beaman, 1984). There are also some reports, however, which contradict the 
above observations. Genetically defined catalase mutants of Listeria monocytogenes, 
S. typhimurium, and Shigel/a jlexneri, for example, have been shown to be fully virulent in 
animal models (Fields et al., 1986; Franzon et al., 1990; Gaillard et al., 1986). Bishai et al. 
( 1994) showed that hktE (catalase) mutants of H. injluenzae exhibited a 2.3-fold reduction in 
their ability to produce lethal sepsis in infant rats, but were still able to produce persistent 
bacteremia. The virulence mechanisms in these organisms are evidently also complex and not 
fully understood There appear to be multiple determinants related to pathogenicity and no 
component can be singled out. 
1.3.2. Association of KatG with INH susceptibility 
As mentioned in a previous section, isoniazid (INH) was first described in 1912 (Meyer and 
Malley, 1912) and was reported to be effective against M tuberculosis and M. bovis in 1952 
(Bernstein et al., 1952; Fox, 1952; Offe et al., 1952). It has been used both as a prophylactic 
agent and as a component of the drug regime to treat TB for nearly 40 years. Mycobacterial 
species show a range of sensitivities to INH. M tuberculosis is highly susceptible (minimum 
inhibitory concentration (MIC) 0.02-0.05 µg/ml) while the saprophytic species, such as 
M smegmatis, are the most resistant (MIC 32 µg/ml) (Zhang et al., 1992). INH is chemically 
very similar to the nicotinamide in NAD and NADP (see Fig. 1.4) and is a very powerful 






Figure 1.4 Chemical structures of A) INH, and B) nicotinamide. 
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1.3.2.1. Effect ofINH on susceptible cells 
A number of observations have been made over the years with regard to the effect of INH on 
the cells, although it is only recently that the mode of action and cellular target of the drug are 
becoming apparent. Nicotinamide adenine nucleotide co-enzymes play an important role in the 
regulation of metabolism. The concentrations of the reduced and oxidized forms are dependent 
on the composition of the medium. Bekierkunst ( 1966) reported that the exposure of 
!vi. tuherculosis H37Rv and M. hovis BCG (Bekierkunst and Bricker, 1967) to INH results in a 
decrease in the content of oxidized nicotinamidc nucleotides. Their results were confirmed by 
Winder and Collins (1969), who noted that the concentrations of both NAD• and NAOP• were 
higher in BCG than in M. tuberculosis H3 7Ra, and decreased to a smaller extent in the former. 
In human and bovine bacteria, nicotinamide or nicotinic acid is not incorporated directly into 
NAO, instead nicotinamide nucleotides are synthesized from quinolinic acid (reviewed by 
Krishna-Murti, 1975). M tuberculosis has a higher capacity to produce the precursor of NAO 
than M. bovis, but has lower levels of NAO (Konno et al., l 966; Dudley and Willet, 1966). It 
has been suggested that NAO+ glycohydrolase, which cleaves NAO to degrade it, regulates the 
concentration of NAO in M. tuberculosis, and that INH antagonizes the action of an inhibitor of 
the enzyme, since the activity of NAD• glycohydrolase appears to be activated in the presence 
of INH (Bekierkunst and Bricker, 1967). In M. bovis BCG, no evidence exists for high levels of 
activity of this enzyme, therefore, the reduction of NAO concentration in the presence of INH 
would be smaller in this organism (Winder and Collins, 1968). Another suggestion is that INH 
is converted to isonicotinic acid which replaces the nicotinamide of NAO to form nicotinic acid 
analogues, which would disturb the NAO and NADP dehydrogenases (Kruger-Theimer, 1958). 
It was recently reported that sensitivity to INH could be restored to INH-resistant mutants of 
M smegmatis by introduction of the M. smegmatis ndh gene encoding NADH dehydrogenase 
(Miesel et al., ASM Abstract U-4, 1997). The authors suggest that the resistant mutants have 
elevated levels of NAOH which may interfere with the interaction of INH with its target. 
Alternatively, the drug requires the oxidized form, NAD, for activity. 
It has been shown that incubation with INH results in a loss of acid-fastness in approximately 
90% of tubercle bacilli (Middlebrook, 1952), and blocks mycolic acid synthesis m 
M tuberculosis (Winder, 1982; Winder and Collins, 1970) and in cell free extracts of 
mycobacteria (Quemard et al., 1991 ), by inhibiting synthesis of unsaturated long-chain fatty 
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acids, which are precursors of mycolic acids. Winder and Rooney ( 1968), for example, showed 
that exposure of M. bovis BCG cells to INH resulted in a decrease in the triglyceride content of 
the wax A fraction. However, the triglyceride content of the chloroform-soluble and bound 
lipid fractions increased. Further experiments revealed a marked decrease in the content of fatty 
acids of chain length> C16 relative to those of length C12-C 16 in the triglycerides of all the lipid 
fractions of cells treated with INH. The authors suggest that INH may either inhibit the 
synthesis or incorporation of a fatty acid into triglyceride. Winder and Brennan ( 1965) also 
noted a reduced lipid content and altered cell wall permeability caused by INH. Takayama and 
co-workers (Takayama t:t al, 1972; 1975) demonstrated clearly that INH inhibits the synthesis 
of unsaturated fatty acids of chain length ~ 26 in M tuberculosis, and that treatment with INH 
results in the accumulation of saturated fatty acids of the corresponding length. 
Other changes which have been noted in M tuberculosis or M. bovis BCG cells exposed to INH 
include altered pigment formation (Youatt, 1961 b ), reduced nucleic acid synthesis 
(Gangadharam et al., 1963; McClatchy, 1971 ), and reduced protein synthesis (Tsukamura and 
Tsukamura, 1963), some of which may be due to inhibition of growth. DNA synthesis requires 
the enzyme DNA ligase which, in tum, depends on NAO as a co-factor (Olivera, 1971 ). The 
reduced nucleic acid synthesis could therefore be explained by the decrease in the levels of NAO 
caused by INH. INH also acts as an antimetabolite of pyridoxal. Further effects of INH have 
been recently reported. Kumar et al. (1994) observed that INH increases the activity of gamma-
glutanyl transferase and decreases the activities of glutathione (GSH) biosynthetic enzymes in 
M smegmatis, thus resulting in depletion of GSH. Garbe et al. ( 1996), on the other hand, 
found that exposure of M tuberculosis H37Rv to INH resulted in induction and expression of 
several secreted proteins. Two of the prominent proteins induced are members of the antigen 
85 complex, which have mycolyl transferase activity. The authors postulate that INH inhibits an 
intermediate which is involved in negatively regulating genes involved in mycolic acid 
metabolism (Garbe et al., 1996). The effect of INH on susceptible cells is, therefore, varied and 
multifaceted, and may involve complex interactions between a number of cellular components. 
The mechanisms of action and cellular targets of the drug have become more apparent by the 
isolation and characterization of mutants which are resistant to it. 
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1.3.2.2. Resistance to INH - association with catalase activity 
As early as 1954, Middlebrook reported on virulent tubercle bacilli which had developed 
resistance to INH. He noted that these bacilli exhibited a reduction in catalase activity, which 
was subsequently shown to correlate with the attenuation of their virulence for guinea pigs 
(Cohn et al., 1954; Wolinsky et al., 1956). Murohashi and Yoshida (1968) suggest that the 
effect of ultraviolet (UV) irradiation on the acid-fastness of tubercle bacilli, i.e. the strength of 
the cell wall, is related to their virulence, and used this to study strains which were resistant to 
> 5 µg/ml INH, of which > 50% had greatly attenuated virulence for guinea pigs. All of these 
strains lost their acid-fastness in a shorter period of UV irradiation than both virulent strains, 
and streptomycin- and PAS-resistant mutants which were not attenuated in virulence. The 
authors therefore showed a high correlation among the degree of resistance to INH, attenuation 
of virulence and lost of acid-fastness by exposure to UV irradiation. These findings suggest that 
an increase in resistance to INH in tubercle bacilli results in changes in the cell wall structure, 
while no marked changes in the wall occur upon the development of resistance to either 
streptomycin or PAS. 
As mentioned above, the development of resistance to INH correlates with a reduction in 
catalase activity. Mycobacteria possess two different types of catalase which differ in their 
susceptibility to inactivation by heat. Winder (1960) proposed that the heat-labile catalase 
found in M tuberculosis catalyzes the oxidation of INH to produce toxic free radicals which 
then cause inhibition of these organisms. This is supported by the results of Wayne and co-
workers (1968), who noted that M tuberculosis, M bovis, and M gastri strains were 
susceptible to ~ 1 µg/ml INH and lost all catalase activity after heating to 68°C. However, they 
also showed that low-catalase M kansasii strains which also contained only the heat-labile 
catalase exhibited identical susceptibility to the high-catalase strains. M. flavescens was the only 
rapidly growing mycobacteria studied to exhibit a susceptibility to INH as low as 1 µg/ml, and 
yet it retained some catalase activity after heating. Mycobacterial cultures possessing only a 
thermolabile catalase lost all catalase activity on the development of resistance to INH, while 
those possessing both a thermolabile and thermostable catalase retained some catalase activity, 
although this activity was reduced with increasing resistance to INH. The authors showed that 
M tuberculosis, M bovis, M gastri, and the low-catalase M kansasii cultures have a high 
affinity for INH, but lose the ability either to take up the drug, or to degrade it to release a 
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14C-carbonyl group when they acquire resistance to INH. Up until 1975, loss of peroxidase 
activity had also been reported in all !NH-resistant mutants (Devi et al., 1975). This agrees 
with the fact that some atypical mycobacteria, which are naturally resistant to INH, also lack 
peroxidase activity (Winder, 1960). 
1.3.2.3. Reaction of INH with peroxidase 
When INH susceptible strains of M tuberculosis are exposed to 14C-isoniazid, a considerable 
amount of radioactivity is taken up by the cells. The maximal uptake depends on the 
concentration of INH up to 200 µg/ml, and is not determined by equilibration between the 
internal and external environments, since accumulation of INH in the cells is observed at low 
concentrations. Two non-inhibitory chemicals, isonicotinic acid and 4-pyridylmethanol have 
been identified inside the cells after exposure to INH (Youatt and Tham, 1969b). In 1961 
Y ouatt noted that extracellular pigments are produced when washed whole cell suspensions of 
M tuberculosis BCG are treated, in the presence of oxygen, with INH, its 2-methyl derivative 
or, to a lesser extent, its 2-ethyl derivative. These pigments were only produced by INH-
sensitive strains and only in the presence of INH, i.e. not with other antituberculosis drugs or 
the isomers of isoniazid, nicotinic and picolinic acid hydrazides. Youatt and Tham (1969a) 
subsequently described the occurrence of a pigment precursor upon reaction of cell-free extracts 
of BCG with INH. This precursor was readily converted by dilute acid to a pigment with 
similar spectral properties to the pigment produced by the whole cells, suggesting that this may 
be the same product which has been metabolized further in the whole cells. INH was not lethal 
under these conditions, unless nutrients were added to the system. The reaction again occurred 
only with INH and its two derivatives, and the amount of pigment produced correlated with the 
bacteriostatic activity of the agent. No reaction occurred with any other hydrazides tested, but 
these, including benzoic acid, and m- and p-amino benzoic acid, competitively inhibited the 
reaction with INH and antagonized its bactericidal activity. The rate at which the cell extracts 
reacted with INH depended on a number of factors, including protein content, pH, temperature, 
aeration (the reaction does not occur under anaerobic conditions), INH concentration up to 200 
µg/ml, NAD concentration, and other unidentified co-factors. Production of the pigment 
precursor occurred only in extracts from INH sensitive strains. Addition of 4-pyridylmethanol, 
4-pyridine aldehyde, H20 2, hydrazine and isonicotinic acid, the known and possible products of 
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INH metabolism, inhibited the reaction. This suggests that these may be later products than 
those resulting from the above reaction. Further experiments showed that the reaction of INH 
with the cell-free extracts was not affected by the addition of various growth substrates to the 
medium, but that production of the precursor increased with the age of the culture to the end of 
the stationary phase, and then declined. The binding of INH to cells, and pigment production, 
are separable from the lethal reaction, which requires the addition of nutrients and occurs later. 
From their results, the authors proposed the following theory on the primary action of INH: 
HYPOTHESIS: INH enters both sensitive and resistant cells freely (there was no indication 
that the rate of metabolism of INH by sensitive cells was controlled by the rate of entry into the 
cells). Once in the cell, INH, or a product thereof, binds to an enzyme system present in 
sensitive strains and displaces a pigment precursor molecule. If metabolic substrates are added, 
the situation becomes lethal, either due to modification of the enzyme system, or the synthesis of 
toxic molecules from the pigment precursor. Binding of INH is thought to occur through both 
the ring nitrogen and the hydrazide group, since loss of these results in a loss of bacteriostatic 
activity. The 2-methyl and 2-ethyl derivatives of INH have more bulky ring substituents, thus 
lowering the efficiency of binding, and hence the bacteriostatic activity. Other hydrazides are 
thought to bind through their hydrazide group only, and therefore do not displace the pigment 
precursor, but compete with INH for the hydrazide binding site (Youatt and Tham, 1969a). 
In 1975, Devi et al. (1975) purified the enzyme involved in the the so-called Y-reaction, i.e. the 
pigment production reported by Y ouatt. Catalase, peroxidase and Y-enzyme activities were all 
associated with the same protein peak, and the enzyme activity increased with increasing 
concentration of INH and showed a biphasic response. The Km obtained at lower INH 
concentrations was 7.69 x 10·5 M, while that at higher INH concentrations was 13.9 x 10·5 M, 
i.e. at lower concentrations of INH there is one binding site, while at higher concentrations there 
may be more than one site, suggesting a negative co-operativity. A similar effect was seen with 
NAD. The reaction was dependent on the presence of oxygen, and was inhibited by an 
analogue of INH, picolinic acid hydrazide; reducing agents such as GSH, f3-mercaptoethanol, 
dithiothreitol, L-cysteine and sodium dithionite; thiol inhibitors such as p-chloromercuribenzoate 
and N-ethyl-maleimide; metal chelating agents such as o-phenanthroline, diethyl 
dithiocarbamate, and 8-hydroxyquinoline; and other inhibitors such as cyanide and azide. The 
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authors were also able to demonstrate catalysis of the Y -reaction by horseradish peroxidase and 
lactoperoxidase, but not by any catalase preparations. The above peroxidases were of a 
different size and had different temperature optimums for the reaction, but showed similar pH 
requirements and sensitivities to various inhibitors. This suggests that the Y-enzyme reaction 
may be a peroxidatic-type reaction. Shoeb et al. ( 1985a; 1985b) also demonstrated that both 
eukaryotic and mycobacterial peroxidases can catalyze oxidation of INH by hydrogen peroxide 
to yield toxic free radicals. 
It had been demonstrated that the M. tuherculusis catalase-peroxidase reacts with INH in the 
presence of oxygen to produce pigments, however, this had not been related to its bactericidal 
activity. Shoeb et al. ( 1985), therefore, examined the possibility that oxidation of INH by 
exogenous peroxidase results in the production of active oxygen species in susceptible 
mycobacteria. Intermediates of the oxidation of INH by peroxidase include peroxy, carbonyl, 
and isonicotinyl radicals, while side reactions may yield hydroxyl radicals and superoxide anion. 
The authors found that extracts of a susceptible strain could mediate hydroxylation of phenol 
when INH and hydrogen peroxide were present, while extracts from a resistant strain could not. 
The hydroxylation rate was decreased by the addition of hydroxyl radical scavengers such as 
mannitol and dimethyl sulfoxide. The reaction between INH and peroxidase was enhanced at an 
alkaline pH and in the presence of SOD, which indicates that the superoxide anion is also 
produced. van Zyl and van der Walt (1994) recently demonstrated aromatic hydroxylation and 
the formation of thiobarbituric acid-reactive substances when INH and catalase were mixed, and 
this was stimulated by phytic acid, a potent metal chelator. This suggests that the reaction does 
not involve transition metal-catalyzed hydroxyl radical generation. Hydroxylation also occured 
with INH and phytic acid in the absence of catalase, although to a lesser extent. These authors 
suggest that peroxynitrite or a similar species is formed during INH oxidation. Johnsson and 
Schultz ( 1994) also identified isonicotinic acid, isonicotinamide, and pyridine-4-carboxaldehyde 
as products ofINH oxidation by KatG. 
INH and its meta isomer, nicotinic acid hydrazide, inhibit peroxidase enzyme activity equally, 
but the latter is not mycobactericidal, therefore, both isomers can bind through the hydrazine 
group to the enzyme and undergo initial oxidation, but oxidation intermediates may differ, 
depending on the pyrimidine ring. The differences in activities between INH and its isomer may, 
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therefore, be due to differences in the oxidation pathway. In the rate-determining step of the 
reaction, the INH carbanion species, which is the precursor of the carbonyl radical, is stabilized 
by a resonance structure in which two electrons are accommodated by the strong 
electronegative nitrogen of the rmg. In the isomer, all resonance structures have the two 
electrons accommodated by the weak electronegative carbons of the ring. The INH 
intermediate is the most stable, and has a low transition energy and is, therefore, more effective 
than the m-isomer in the reaction 
It is evident from the above studies that a number of reactive species are produced by the 
oxidation of INH, and it is thought that these are direct or indirect effectors in the mechanism of 
action of INH, i.e. they are responsible for its mycobactericidal activity. The activation of INH 
by peroxidase requires the formation of metabolic hydrogen peroxide, therefore the effect of 
11\1 f on mycobacteria decreases with reductions in metabolic rate, for example with carbon 
source depletion. The uptake and metabolism of INH also requires oxygen, therefore the MIC 
of INH against mycobacteria decreases with increasing oxygen concentration. 
1.3.2.4. The genetics of resistance to INH 
Zh,mg and co-workers (1992) were the first to study the genetics of INH susceptibility in 
M tuberculosis. They transformed a highly resistant (MICINH 500 µg/ml), low catalase 
M. smegmatis mutant strain with an M. tuberculosis H3 7R v genomic library and screened 
transformants on plates containing 32 µg/ml INH. They isolated a clone, designated pBH4, 
which conferred hypersensitivity to INH (MIC 8µg/ml), although it did not alter the MICs for 
other antituberculosis drugs, and caused a 2-3-fold overproduction of the catalase enzyme. 
Using oligonucleotide probes based on the E. coli and B. stearothermophilus hydroperoxidase I 
enzymes and enriched cloning, they isolated the gene encoding the M tuberculosis heat-labile 
catalase enzyme. This region of DNA was found to be present in the pBH4 clone and could 
confer sensitivity to INH on the resistant M smegmatis mutant. Wild type E. coli is naturally 
completely resistant to INH, even when transformed with constructs expressing the 
M tuberculosis katG gene. Overexpression of this gene in a catalase negative strain, UM2 
(katG, katE) (Mulvey et al., 1988), however, rendered the cells susceptible to high 
concentrations of INH (50-500 µg/ml). The authors, therefore, demonstrated that the katG 
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gene alone can confer sensitivity to INH and must play an important role in the action of this 
drug. When they probed genomic DNA from !NH-resistant and !NH-sensitive strains of 
M tuberculosis with the katG gene, however, they found the gene to be absent from only two 
highly resistant isolates (MIC > 50 µg/ml), suggesting that deletion of the gene is not a common 
mechanism of resistance. Zhang and Young ( 1994) later examined the kat( i region of the 
genomes of a panel of I NH-sensitive and !NH-resistant isolates of M. tuherculosis and found it 
to be highly variable and unstable in all. They isolated a 2 kb Kpnl fragment located IO kb 
upstream of the kat(; gene in NI. tuherculosis H37Rv which was specific to NI. 111hac11/o.,H 
complex members and contained three copies of an internal 75 bp repeat flanked by multipl,e 
copies of repeated sequences related to the major polymorphic tandem repeat (MPTR) sequence 
reported by Hermans et al. ( 1992). PCR amplification of the three repeats from different 
M. tuberculosis isolates resulted in products of varying size due to differences in the number of 
copies of the repeat. The presence of these repeats may stimulate recombination or other DNA 
rearrangements, and may contribute to the instability of the katG region of the genome. Goyal 
et al. (1994) report the use of the above PCR amplification to differentiate M. tuberculosis 
complex strains. They were able to identify seven different subtypes based on the product size, 
but found no correlation between the pattern of subtypes and the geographical location, HIV 
status of the patient, or the INH susceptibility of the organism. 
M aurum is another mycobacterial species that is extremely sensitive to INH. Heym and Cole 
( 1992) isolated and characterized !NH-resistant mutants of this species and of M smegmatis. 
Resistance to INH occurred at a frequency of 1 o-6 when these strains were plated on medium 
containing INH at 6x MIC. Two mutants with similar resistance levels, BHO (M aurum) and 
BHl (M smegmatis), were studied further. These mutants had unaltered MICs for other drugs 
i.e. resistance was probably not due to an increase in cell wall permeability, but grew more 
slowly than their parental strains, and the M. aurum mutants had altered colony morphology. 
Enzymological studies showed that the M smegmatis mutant, BHl, produced two-fold less 
catalase activity and showed 14-fold less peroxidase activity than its parent, while BHO 
produced barely detectable levels of catalase activity and showed a greater than 18-fold 
reduction in peroxidase activity. The authors extracted the mycolic acids from the INH-
resistant mutants and found no difference in the pattern or levels of mycolate production when 
compared with the parent strains. Southern blot analysis of chromosomal DNA isolated from 
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the mutants revealed no alterations in the banding patterns when probed with the 
M. tuberculosis katG gene. The fact that the two !NH-resistant mutants studied showed similar 
phenotypes to the corresponding mutants of M tuberculosis, suggests a common drug target 
and mechanism of resistance in most mycobacteria. The authors suggest that the residual 
catalase activity seen in the mutants may be due to low levels of expression of katG. missense 
mutations in the gene, or a second catalase gene which has no peroxidase activity, but has the 
same electrophoretic mobility as KatG. 
Since the cloning and sequencing of the M. 111herc11losis ka1G gene, and the presentation of 
direct evidence for its role in INH susceptibility, a number of studies have been carried out in 
order to elucidate the genetic basis for INH resistance in naturally occurring and laboratory 
strains of M tuberculosis. Stoeckle et al. ( 1993) examined the presence of the katG gene in 80 
strains of M. tuberculosis isolated from patients in New York City, using PCR. They observed 
that 31/4 l !NH-resistant strains were PCR-positive, and 32 exhibited catalase activity, while 
35/39 !NH-sensitive strains were PCR-positive, and 30 exhibited catalase activity. Many of the 
PCR-negative strains had catalase activity and many PCR-positive strains had no catalase 
activity. These discrepancies may be due to mutations in PCR primer binding sites, technical 
factors related to PCR, and point mutations either in a regulatory region or within the structural 
katG gene, outside of the binding region of the primers used here. Altamirano and co-workers 
( 1994) were able to amplify a fragment near the 5' end of the katG gene from 8/9 !NH-resistant 
and one !NH-sensitive isolate of M tuberculosis from Vancouver, however the products from 
the resistant strains contained randomly distributed mutations including point mutations, 
deletions of one base, and insertion of up to three bases. Seven of the resistant isolates had 
reduced catalase activity, and one had no catalase activity at all. Ferrazoli et al. (1995) studied 
53 INH-resistant and 49 INH-sensitive M tuberculosis isolates from patients in Sao Paulo, 
Brazil. They found that 43 of the INH-resistant isolates expressed catalase activity, and 48 were 
katG PCR-positive. Only one isolate with an MIC > 50 µg/ml had a complete deletion of the 
katG gene. The first comprehensive analysis of the katG gene in M tuberculosis isolates with a 
broad range of susceptibilities to INH was reported by Cockerill et al. ( 1995). These authors 
sequenced the entire katG gene from 15 isolates and used these to generate a consensus 
nucleotide sequence for use in assessing mutations. Only two strains, H37Rv and an isolate 
with an MIC of 8.0 µg/ml INH were identical to the consensus sequence. In 5/9 strains with 
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MICs ~ 1.0 µg/ml, there was a conversion of arginine at codon 463 to leucine. This base: 
alteration (G---) T) also results in the loss of an NciI-MspI restriction endonuclease site. Neil-
digested katG fragments were, therefore, used in restriction fragment length polymorphism 
(RFLP) studies with 75 M. tuberculosis strains. Results revealed that 19/43 £NH-resistant 
mutants had lost the restriction site. The authors found no consistent correlation between loss 
of catalase activity and resistance to INH (Cockerill et al.. 1995). Pretorius et al. ( 1995) 
studied the katG genes of 39 INH-resistant isolates of M. tuberculosis from different 
geographical locations by PCR-SSCP (single-strand conformation polymorphism) None of 
them had a complete deletion in katG, however 6 had point mutations, which included 
mutations in Thr-275 and Arg-463, and one had a small deletion. The authors later identified a 
mutation in codon 315 in 52% of the !NH-resistant South African isolates, using a new primer 
set, which elevated the overall incidence of katG mutations in these strains to approximately 
64% (Victor et al., 1996). Recently, Haas et al. ( 1997) reported on the characterization of the 
katG genes of 124 !NH-resistant M. tuberculosis complex isolates from south, central, and west 
Africa. They identified point mutations in codon 315 in 64% of these. As noted by others, none 
had complete katG deletions. Goto et al. ( 1995) analyzed 22 !NH-resistant isolates of 
M tuberculosis from Japan and Yemen for katG by PCR and catalase assays. Only 6 (27%) 
were PCR-negative and catalase-negative. 8 (36%) were PCR-positive and catalase-negative. 
and 8 were PCR-positive and catalase-positive. Rouse et al. (1995) observed perturbations in 
the katG genes of !NH-resistant clinical isolates of M tuberculosis from the US and South 
Korea. These included frameshift mutations in 3 highly resistant strains, a single base insertion 
at codon 521, small deletions, one of 8 bp and one of 22 bp, and the following amino acid 
substitutions, Thr-262 to Arg, Ala-350 to Ser, Gly-629 to Ser, Ala-717 to Pro, His-108 to Gin, 
Asp-63 to Glu, Ser-315 to Thr, Arg-463 to Leu, and Ile-335 to Thr. These resulted in a 
decreased catalase activity and increased resistance to INH. Of the 9 missense mutations, 6 
occurred within functionally important residues ( conserved m several bacterial 
hydroperoxidases), normally Asp-63, His-108, Thr-262, Ala-350, Ser-315, and Gly-629, while 5 
of them, His-108, Thr-262, Ser-315, Ile-335, and Ala-350 may affect the structure of the 
protein (Welinder, 1992; 1991). Heym et al. (1995) also identified distinct mutations in the 
katG genes of a panel of !NH-resistant clinical isolates of M tuberculosis. These included; 
KatGl, Arg-463 ---) Leu; KatG2, deletion of residues 120-123; KatG3, insertion of isoleucine 
between residues 125 and 126; KatG4, Thr-275 ---) Pro; KatG5, Ser-315 ~ Thr; KatG6, novel 
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N-terminus; and KatG7, Leu-587 ~ Met. Sequencing of the M. bovis BCG and BCG Pasteur 
katG genes revealed three base differences from that of M. tuberculosis H37RV, codons 29 and 
203, which were silent changes, and codon 463 which resulted in an Arg ~ Leu change, as seen 
in some INH-resistant M tuberculosis strains. The KatG I and KatG7 proteins displayed 
normal catalase and peroxidase activities and heat stability, whereas the activities of all the rest 
were reduced. The KatG2, 3, and 5 proteins showed a > I 0-fold decrease in catalase activity 
and reduced heat stability, and the KatG4 protein showed no detectable activity. Five of the 
seven mutations identified lie in the N-terminal domain of KatG, which is predicted to contain 
the catalase and peroxidase active sites (Welinder, 1991, 1992). Four of the amino acid 
substitutions occur in positions analogous to those found in the E. coli HPI (Loewen et al., 
1990), which correlate with modification of the active site. 
Because most of the !NH-resistant strains studied thus far are clinical strains, they do not 
necessarily have the same genetic background, therefore it is not possible to directly correlate 
specific mutations with !NH-resistance. For this reason, Rouse and Morris (1995) isolated and 
characterized INH-resistant mutants of M tuberculosis H37Rv. They found that substitution of 
a proline for threonine at residue 275 resulted in loss of catalase activity and decreased 
susceptibility to INH. The authors also examined the molecular mechanisms of !NH-resistance 
in 6 in vitro mutants of M tuberculosis complex strains using DNA hybridization, SSCP, 
sequence analysis, immunoblotting and catalase assays. They performed immunoblots using a 
polyclonal antibody against the 80 kDa catalase-peroxidase to assay for the presence of the 
enzyme in IO M. tuberculosis complex strains, including 4 INH-sensitive parental strains 
(H37Ra, H37Rv, and 2 M bovis BCG strains) and 6 !NH-resistant mutants (4 M tuberculosis 
and 2 M. bovis BCG). Of the !NH-resistant strains, 5 were resistant to at least 50 µg/ml INH, 
while the last was resistant to 5 µg/ml INH. The catalase-peroxidase was not detectable in 2 of 
the !NH-resistant M tuberculosis strains and the 2 !NH-resistant M bovis BCG strains. These 
strains also had no catalase activity, and neither did one of the strains which synthesizes an 
apparent full-length enzyme. A closer look at the genetics revealed that 5 of the highly INH-
resistant M tuberculosis complex strains had significant alterations in the katG gene, with 3 
having deletions, one of which was a complete deletion of the gene, and 2 having point 
mutations. As a further means of correlating mutations in katG with resistance to INH, Rouse 
et al. (1996) used site-directed mutagenesis to alter the wild type M. tuberculosis katG gene at 
codons shown to be mutated in clinical isolates, and introduced the altered genes into INH-
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resistant strains of M smegma/is and M bovis BCG. An Arg ~ Leu change at codon 104 
resulted in a 100-fold reduction in peroxidase activity in M smegmatis, while mutations in 
codons 108, 138, 148, 270, 275, 321, and 381 resulted in a 10-100-fold decrease in activity. 
Mutations in codons 463 and 3 15 resulted in a 50% decrease in activity, while mutations in 
codons 587 and 350 had no significant effect on peroxidase activity. All the genes containing 
mutations which reduced the peroxidase activity were unable to confer sensitivity to INH on the 
M. smegmatis cells, while the wild type enzyme could. Similar results were observed in BCG, 
except for the enzyme carrying the mutation in codon 463, which exhibited wild type peroxidase 
activity and ability to confer sensitivity to INH. lmmunoblot studies indicated that, for some of 
the transformants, the decrease in peroxidase activity was due to a decrease in the levels of the 
KatG protein. Therefore, some of the mutations primarily affect the intracellular concentration 
ofKatG, possibly by affecting KatG stability, some have a more direct effect on enzyme activity, 
while others may affect both the intracellular levels and the enzyme activity. Interestingly, the 
authors noted no differences in the katG mRNA levels of the transformants, suggesting that the 
regulation of the protein may occur at a post-transcriptional level (Rouse et al., 1996). These 
results confirm that residues 104 and 108, which form the catalytic sites, and residues 270, 275, 
and 315, which may be involved in heme binding, are important for both catalase and peroxidase 
activity and the ability to confer sensitivity to INH. Residue 321 may be involved in electron 
transfer, while residue 381 is critical for the formation of a hydrogen-bond with His-270. 
Residues 138 and 148 are also important for activity, however their role is undefined. 
Mutations in the C-terminal residues, which have no counterpart in the yeast cytochrome c 
peroxidase, do not significantly alter activity. Interestingly there were no mutations which 
affected only one activity, which suggests that the catalase and peroxidase activities share 
catalytic sites (Rouse et al., 1996). 
All of the above studies provide evidence that the katG gene product plays a significant role in 
the susceptibility of certain mycobacteria to INH. In general, reduction in catalase activity 
could be correlated either with mutations in important catalytic residues, frameshift mutations, 
or small deletions. So far at least 20 different mutations have been identified in the katG gene. 
Musser (1995) reviews all the studies carried out on INH-resistant strains, and suggests that a 
restricted subset of missense changes in katG are repeatedly associated with resistance. The 
mutations are summarized in table 1.1. Many of these affect either the binding sites, active sites, 
or conformation of the enzyme. Two of the frequent mutations affect a glycine-rich loop which 
40 
holds together 2 a-helices, one of which contains essential catalytic residues. The mutations 
change the length of the loop and, therefore, possibly the position of the catalytic residues. A 
Ser ~ Thr conversion distorts the plane of the heme group in the active site. In general, 
mutations in the C-terminal region of katG do not affect enzyme activity and result in very low 
levels of resistance to INH (0.1 µg/ml). The most frequent mutation in !NH-resistant 
M tuberculosis isolates (20-40%) is an arginine to leucine substitution at codon 463, which lies 
in the C-terminal repeat at the end of helix A, and not in the vicinity of the peroxidase active 
site. This may represent a substrate-binding site within a domain that interacts with INH The 
mutation appears to confer low level resistance to INH, but does not significantly affect enzyme 
activity. Interestingly, this substitution occurs in all BCG strains tested, and is also found in the 
KatG-like proteins of B. stearothermophilus (Loprasert et al., 1988) and M intracellulare 
(Morris et al., 1992). BCG and M intracellulare are both naturally more resistant to INH than 
M. tuberculosis (M. tuberculosis H37Rv is inhibited by 0.05 µg/ml INH while BCG Pasteur 
grows normally on 0.2 µg/ml INH, and the MIC for INH of M intracellulare is approximately 
5-10 µg/ml). More recent evidence, however, suggests that the substitution has no effect on 
INH-resistance, and is simply a polymorphism. For example, the introduction of an Arg ~ Leu 
substitution at codon 463 of the katG gene of M tuberculosis H37Rv by site-directed 
mutagenesis, and introduction of the altered gene into the catalase-negative, INH-resistant 
M smegmatis strain, BHl, resulted in at least a 20-fold increase in the susceptibility to INH, as 
noted for the wild type gene. Catalase and peroxidase activity was essentially the same for both, 
which suggests that the mutation does not significantly alter activity (Rouse et al., 1996). These 
results were confirmed recently by Johnsson et al. (1997), who showed that a purified KatG 
enzyme containing the mutation displayed identical spectroscopic properties, catalase and 
peroxidase activities, and ability to mediate inactivation of lnhA by INH, to the wild type 
enzyme. These authors point out, however, that the experiments were performed in vitro, and 
may differ from the in vivo situation. They suggest that, in vivo, the mutant enzyme may have a 
higher activity against another substrate which may compete with INH. However, other 
evidence suggests that codon 463 mutations are independent of !NH-resistance and are linked 
to the geographical origin of the strains (Haas et al., 1997; Shim, 1997). 
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Table 1.1 Summary of mutations identified in the katG gene of !NH-resistant strains of M. tuberculosis. 
katG mutation Catalase activity Reference 
Asp-63 - Rouse et al., l 995 
Arg-I04 - Rouse et al., 1996 
His-I08 - Rouse et al., 1995 
Thr-262 - Rouse et al., 1995 
His-270 - Rouse et al.. 1996 
Thr-275 - Rouse et al.. 1995: Pretorius et al., 1995: Rouse & Morris. 1995 
Ser-315 - Rouse et al., 1995: Pretorius et al., 1995: Haas et al.. 1997 
lle-135 - Rouse et al.. 1995 
Ala-349 - Rouse et al., 1995 
Ala-350 - Rouse eta/., 1995 
Arg-463 + Rouse et al., 1995: Pretorius et al., 1995; Cockerill et al., 1995 
Leu-587 + Rouse et al., 1995 
Gly-629 - Rouse et al., 1995 
Ala-717 - Rouse et al., 1995 
deletion of 120 - 123 - Rouse et al., 1995 
insertion of Ile-126 - Rouse et al., 1995 
insertion at codon 52 l - Rouse et al., 1995 
complete deletion - Ferrazoli et al., l 995; Rouse & Morris, 1995; Zhang et al., 1992 
frame-shift mutations - Rouse et al., 1995 
Deletion of the entire katG gene is apparently not a common mechanism of resistance to INH, 
although it results in the highest levels of resistance. It is probably not favourable for the 
growth of the organism, particularly in macrophages. In many cases, the resistant strains 
produce an altered enzyme which still has catalase activity although it is reduced. It is possible 
that the maintenance of some catalase-peroxidase activity is required in order for the organism 
to withstand the hostile environment or to grow more rapidly. The reaction between the altered 
enzymes and INH that results in activation of the drug possibly no longer occurs or occurs at a 
reduced rate in !NH-resistant strains, thus resulting in a decreased bactericidal effect (Heym 
et al., 1995). Apart from its role in INH oxidation, it has been suggested that KatG is involved 
in the transport of INH into the cell. Studies in E. coli, M bovis BCG, and M smegmatis have 
demonstrated that KatG is probably surface-associated, and therefore may be involved in 
transport processes (Heimburger and Eisenstack, 1988; Winder, 1960; Y ouatt and Tham, 
1969). Many INH-resistant, catalase-negative M tuberculosis strains have a reduced capacity 
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to take up INH (Y ouatt, 1969), and expression of katG in E. coli allows rapid recovery of 
transport processes inhibited by oxidative stress (Farr et al., 1988). However, in 
M tuberculosis the enzyme is not localized on the membrane, therefore its involvement in active 
transport in this organism is not clear. 
1.3.2.5 The cellular target/s of INH 
It is evident that the /1,/. 111herc:11/m1s KatG catalyL.es the hydrogen peroxide-dependent 
peroxidation of INH to an activated product which then acts on the target, however, no 
indication has been given as to what the target might be. Earlier observations on the effect of 
INH on mycolic acid synthesis (Takayama et al., 1975) suggest that the target must be an 
enzyme involved in the production of unsaturated 24-carbon fatty acids. In 1994, Banerjee and 
co-workers identified the inhA gene as a possible target of INH. These authors constructed a 
genomic library from a spontaneous INH-ETH-resistant mutant of M smegmatis mc265 l and an 
!NH-resistant strain of M bovis, and used these to transform wild type M smegma/is strains 
and screened for resistant colonies. They identified fragments that conferred resistance to INH 
and ETH on wild type INH-ETH-sensitive strains of M smegmatis, M tuberculosis, M bovis, 
M bovis BCG and M avium, and isolated the corresponding fragments from wild type 
M smegma/is, M. bovis, and M tuberculosis, and INH-resistant M smegmatis and M bovis. 
Each had two open reading frames (ORFs), one encoding a protein of 29 kDa, and the other 32 
kDa, the latter of which, from M smegmatis, was alone able to confer resistance to INH, and 
was renamed the inhA gene. The M tuberculosis and M bovis inhA genes lie on an operon 
with the first ORF and have a much shorter noncoding region between the two. The InhA 
protein shows 32% identity with enoyl-acyl carrier protein (ACP) reductase of Brassica napus, 
and 40% identity over 203 amino acids to the EnvM protein of S. typhimurium and E. coli, 
which catalyzes the reduction of crotonoyl-ACP (Bergler et al., 1994), and is the target of the 
diazaborine group of antibacterial compounds (Bergler et al., 1992; Grassberger et al., 1984; 
Tumowsky et al., 1989). The M tuberculosis H37Rv and M bovis inhA genes are identical, 
and have > 95% identity with the M smegmatis inhA gene. The first ORF also shows similarity 
to other fatty acid biosynthesis proteins, particularly the E. coli 3-ketoacyl-acyl carrier protein 
reductase. The InhA protein has a putative binding site for nicotinamide or flavin nucleotides, 
and may use these as substrates or co-factors (Banerjee et al., 1994). The difference between 
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the InhA of the mutant strains and that of the wild type was a single substitution of serine to 
alanine at position 94. It is interesting to note that resistance of the E. coli EnvM to the 
diazaborine group of antibacterial compounds is mediated by a Gly ~ Ser mutation at codon 
93, which lies in a similar position to codon 94 of InhA (Grassberger et al., 1984). Further 
experiments proved that this mutation mediates resistance to INH in M smegmatis. 
Dessen et al. and Quemard et al. ( 1995) further characterized the M tuberculosis InhA by 
looking at its biochemical properties and chemical structure. They showed that the protein, likie 
other ACP reductases, catalyzes reduction of 2-trans-octenoyl-ACP. It functions as a 
component of the type-II fatty acid synthesis system, responsible for the final reduction step in 
chain elongation to form conventional fatty acids (Dessen et al., 1995; Johnsson et al., 1995). 
The enzyme preferentially reduces long chain substrates (12-24 carbons), and therefore may be 
involved in mycolic acid synthesis. The authors were, however, unable to demonstrate binding 
of INH, its KatG-generated metabolites, or ETH to the enzyme or its complex with NADH. 
The authors also examined the mutated form and showed that, for the same reaction, the Km 
and V nax values were the same, but the affinity for NADH was 5-fold lower. Therefore, drug 
resistance may be related to the specific interactions between InhA and the co-factor NADH. 
Possibly activated INH binds to and inactivates InhA when bound to NADH, therefore the 
mutant enzyme, which has a lower affinity for NADH, would be less inhibited. In 
M tuberculosis H37Rv, the in vivo levels of NADH are low (Winder and Collins, 1969), 
therefore small changes in NADH affinity may have dramatic effects on the MIC of INH. The 
authors suggest that binding of NADH causes a conformational change in the active site which 
affects the substrate binding site (Dessen et al., 1995). Alternatively, the activity of InhA may 
be inhibited by incorporation of an NAD analogue containing isonicotinic acid, which would 
block mycolic acid synthesis and cause a loss of acid-fastness. Johnsson et al. (1995) report 
that oxidation of INH by KatG leads to inactivation of InhA. This inactivation is inhibited by 
the addition of the enzyme substrate, and requires the presence of NADH or NAD+. The 
inactivation of InhA also requires oxygen, the manganese ion, and INH, but occurs 2. 7 times 
faster in the presence of KatG. The KatG-independent inactivation is probably mediated by 
superoxide, since it can be prevented by the addition of SOD (Zabinski and Blanchard, 1997). 
The activated forms of ETH and INH react with Cys-243 of InhA, leading to irreversible 
inactivation (Johnsson et al., 1995). 
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There have been several reports of !NH-resistant strains with mutations in the inhA locus, and at 
least six different mutations have been identified (Heym et al., 1995; Rouse et al., 1995). 
Reported perturbations include mutations resulting in the following substitutions, Ser-94 --+ Ala 
and Ile-16-.+ Thr (the latter mutation changes the configuration of the active site) (Heym et al., 
1994; Banerjee et al., 1994; Kapur et al., 1995); and mutations near the translation start codon 
of or/I, which may be a regulatory region of the inhA gene. For example. a T-.+ G transversion 
8 bp upstream of the or/I initiation codon, adjacent to a predicted ribosome binding site, and a 
T --+ G transversion 24 bp upstream of the initiation codon. These mutations may cause 
overexpression of inhA, therefore increasing levels of the INH target, and resulting in increased 
resistance. Wilson et al. ( 1995) demonstrated that loss of catalase and mutation of inhA have a 
cumulative effect in !NH-resistance, but that the katG mutation contributes significantly more to 
the resistance than the inhA mutation. 
In total, of all the INH-resistant strains studied, 50-64% had mutations in katG, 14% had 
mutations in inhA, some of which also had katG mutations, and 22% were katG+ but had no 
detectable enzyme (Musser, 1995). Therefore several (NH-resistant clinical isolates have no 
detectable mutations in katG or inhA, suggesting either that other mechanisms of resistance to 
INH may exist, or that inhA or katG have certain regulatory defects in these strains. In the 
strains which had no mutations in katG and yet had no detectable catalase or peroxidase activity, 
expression of the katG gene may have been impaired, possibly by mutation of an unlinked 
regulatory gene. Alternatively, KatG may be subject to post-transcriptional regulation. It is 
also likely that the mode of action of INH and mechanism of resistance to it are far more 
complex and involve interactions between a number of cellular components. Dubnau et al. 
( 1996), for example, showed that expression of ribosomal protein S 13 from either M bovis 
BCG or M smegmatis on a multicopy plasmid confers sensitivity to INH and a small colony 
phenotype on M smegma/is, but not on BCG. This increased sensitivity occurs due to an 
increased KatG production. It may be that overproduction of S 13 induces a stress response 
which then induces katG, and that this response is absent in BCG. 
It is evident from the studies on !NH-resistant clinical and laboratory strains that resistance to 
INH is, in most cases, not mediated by mutations in inhA. This suggests that it may not be the 
target of INH in these strains, and this is supported by the results of Mdluli et al. ( 1996). These 
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authors showed that treatment of M. tuberculosis with INH resulted in an immediate 
accumulation of 24- and 26-carbon fatty acids. In M. smegma/is, however, there was no such 
accumulation at any INH concentration tested. Treatment with INH resulted only in inhibition 
of short chain fatty acid biosynthesis, possibly by inhibition of lnhA. These authors confirmed 
that overexpression of the M. tuberculosis inhA gene causes resistance to INH in M. smegma tis, 
but not in M. tuberculosis. InhA is, therefore, not the most significant target of INH in the 
M. tuherculosis complex organisms. Both the wild type and mutant lnhA enzymes could confer 
resistance in M. smegmati.'i, therefore resistance is determined more by the level of expression 
than by the presence of a particular mutation. The observations suggest that the target of INH 
in M. tuberculosis is much further along in mycolic acid biosynthesis. 
Barry and co-workers (Personal communication) have recently identified another possible target 
of INH in M tuberculosis. They found that treatment of M. tuherrnlosis with INH, at a 
concentration known to induce the accumulation of hexacosanoic acid (C26 ), resulted in the 
induction of the 12 kDa AcpM protein, a small acyl carrier protein (ACP), as well as a larger 
form of the same protein (80 kDa), which incorporates radio-labelled INH. ACPs are smaH 
proteins, containing a phosphopantetheine attachment, that transport the growing fatty acyl 
chain between component enzymes of type-II fatty acid synthase systems (Prescott and Vagelos, 
1972). AcpM from !NH-treated cells was shown to carry predominantly hexacosanoic acid, 
while AcpM from untreated cells carries a broader range of fatty acids ( up to 50 carbon atoms). 
This suggests that AcpM is involved in the type-II fatty acid synthase system which produces 
the meromycolate branch of mycolic acids. Further analysis of the larger form of the AcpM 
protein revealed that it is a complex of AcpM-INH-KasA, where KasA is a 13-ketoacyl synthase, 
which plays a role in fatty acid chain extension by adding 2 carbons to an ACP-bound saturated 
fatty acid. Inhibition of KasA would, therefore, be expected to stop fatty acid elongation, 
resulting in the accumulation of precursors, as observed upon treatment with INH. The gene 
encoding KasA is located immediately upstream of that encoding AcpM on the genome. 
Expression of the former gene in M tuberculosis conferred resistance to approximately 2 µg/ml 
INH, while overexpression of the latter was toxic to cells. The upregulation of the acpM gene 
by INH may, therefore, be partly responsible for killing the cells. These results strongly suggest 
that AcpM and KasA are the cellular targets of INH in M. tuberculosis (Barry, Personal 
communication). 
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1.3.2.6. Why is M tuberculosis uniquely sensitive to INH? 
A great deal of information is now available on the mechanism of activation of INH and its 
cellular targets in the mycobacteria, however, the reasons for the unique sensitivity of the 
M. tuberculosis complex organisms to INH remain unclear. The fact that other 
mycobacteria, including M. leprae, are far less susceptible to INH suggests that 
M. tuberculosis has some unique features which are targeted by the drug. Barry (ASM 
Presentation, 1997) points out that, in M. rubercu!osis, the MIC of INH correlates directly 
with mycolic acid synthesis, and that lms of myculic acids results in cell death. In 
M. avium, on the other hand, mycolic acid synthesis shuts off at a much lower concentration 
of INH than the MIC, which suggests that the organisms can survive without mycolic acids. 
The loss of the permeability barrier in the presence of INH, however, lowers the MIC of 
other drugs. All mycobacteria have similar permeability barriers, therefore differences in the 
uptake of INH are unlikely, and the mycolic acid biosynthetic pathway is present in all 
mycobacteria. The katG and inhA genes, which are known to be involved in INH 
susceptibility, are both highly conserved and are present in almost all mycobacteria, 
including those that are naturally resistant to INH. Cole (1994) suggests that the KatG of 
M tuberculosis has unique features that allow it to use INH as a substrate. However, 
peroxidases from widely different sources can react with INH, and both the E. coli and 
M. intracellulare KatG can partially restore !NH-sensitivity to !NH-resistant mutants of 
M. tuberculosis (Zhang and Young, 1993; Rouse et al., 1996). Another possibility is that the 
differences in !NH-susceptibility may be related the levels of hydrogen peroxide in the cell 
and may, therefore, depend on the presence of a second, heat-stable catalase. In the presence 
of two catalases, one of which is not inhibited by INH, destruction of hydrogen peroxide by the 
second catalase should inhibit hydrogen peroxide-dependent, peroxidase-mediated oxidation of 
INH (Shoeb et al., 1985a; 1985b; Johnsson and Schultz, 1994). Milano et al. (1996), however, 
demonstrated that introduction of the M avium katE into M tuberculosis did not alter the MIC 
for INH and, therefore, did not antagonize activation of INH. These results suggest that the 
reasons for the exquisite sensitivity of M. tuberculosis to INH lie elsewhere. 
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1.3.2. 7. The role of the oxidative stress response in susceptibility to INH 
The catalase-peroxidase, apart from its role in INH oxidation, also plays an important role in 
protection of the organism against excess hydrogen peroxide. Deretic et al. (1995) suggest the 
possibility that other enzymes which are involved in the protection of M. tuberculosis against 
oxidative stress may also play a role in the sensitivity of the organism to INH. In E. coli and 
S. typhimurium, under conditions of oxidative stress, i.e. in the presence of excess hydrogen 
peroxide. the oxyR gene induces expression of katG as well as a number of other genes 
including uhpC (small subunit of alkyl hydroperoxide reductast:), dps ( 19 kOa ONA binding 
protein from starved cells), oxyS (divergently transcribed from oxyR in E. coli), and gorA 
(glutathione reductase) (Christman et al., 1985; Tartaglia et al., 1989; Altuvia et al., 1994; 
Toledano et al., 1994; Storz et al., 1990; Farr and Kogoma, 1991). The oxidative stress 
response is discussed in more detail in Chapter 5. Mutations in either oxyR or ahpC in E. coli 
result in sensitivity of the organism to INH (Rosner, 1993). Rosner and Storz ( 1994) 
demonstrated that transcription of the oxyR-regulated oxyS gene was not induced by INH in 
wild type cells, therefore INH does not activate oxyR. However, a katG ahpCF mutant had 
constituvely high levels of oxyR transcription. The authors suggest that, in these mutants, 
endogenous oxidants accumulate which leads to constitutive oxyR activation and INH 
susceptibility. Consistent with this, was the finding that hydrogen peroxide and cumene 
hydroperoxide potentiated the INH susceptibility of wild type cells, while the antioxidant, 
ascorbic acid, protected the susceptible mutant strain from INH. Superoxide radicals generated 
by paraquat did not enhance the INH susceptibility of wild type cells. Hydrogen peroxide also 
potentiated the INH susceptibility of susceptible and resistant (katG") M smegmatis strains. 
The authors suggest that INH is converted by reaction with peroxides to a more active drug, 
and that the INH susceptibilities of enterobacteria and mycobacteria are mechanistically related 
(Rosner and Storz, 1994). Sherman et al. (1996) report that treatment of M bovis BCG with 
sub-inhibitory concentrations of both hydrogen peroxide and INH resulted in a 100-fold 
reduction in cell viability after 72 hours, while the same concentrations of the two agents added 
separately had no effect, therefore they act synergistically. This agrees with the suggestion by 
Rosner and Storz (1994) that increasing the oxidative burden on the cells should improve the 
efficacy of INH. This effect was, however, not seen in a strain in which katG had been deleted. 
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To test whether the oxidative stress proteins, AhpC and OxyR, play a role in INH susceptibility 
in the mycobacteria, Deretic et al. ( 1995) studied the corresponding genes in M. tuberculosis. 
In M leprae, the ahpC gene is linked to and divergently transcribed from the oxyR gene (Bergh 
and Cole, 1994). The authors isolated and sequenced the ahpC gene from M. t11herc11/osis and 
found it to have > 90% homology with that of M. avium and M. leprae, and to be very similar 
to other members of the ahpC family. The oxyR-ahpC intergenic region was also very similar to 
that from M. leprae, however, the oxyR gene of M. 111herculosis was shorter and carried 
multiple lesions, which prevent it from forming a single, contiguous translation product. Similar 
results were reponed by Sherman and co-workers ( 1995) (discussed in Chapter 5) To test 
whether these lesions in oxyR affected INH susceptibility, the authors introduced two cosmids 
containing the ahpC-oxyR region of M. leprae into M. tuberculosis H37Rv, and found the 
transformants to be slightly more resistant to INH. They suggest that the activated products of 
INH may be detoxified by AhpC and possibly other OxyR-controlled functions, which may be 
absent or present at low levels in M. tuberculosis (Deretic et al., 1995). 
Several studies have confirmed an indirect association between INH susceptibility and the AhpC 
protein. Sherman et al. ( 1996 ), for example, found an increase in the expression of AhpC in 
INH-resistant, katG· mutant M tuberculosis strains, relative to the INH-sensitive 
M tuberculosis H37Rv strain. However, selection for INH-resistant mutants revealed no 
upregulation of AhpC, even though katG had been mutated. The mutation resulting in increased 
AhpC expression, therefore, requires a second selection event, either during infection or by 
further passage in culture. Sequencing of the 5' regions of ahpC in katG mutants in which ahpC 
is upregulated revealed at least one mutation in the region from 39-81 bp upstream of the ahpC 
start codon in each isolate. Using the tux gene as a reporter, it was shown that these mutations 
positively affected promoter activity. Heym et al. ( 1997) recently reported results which 
confirm these observations. They detected 7 different mutations in the regulatory region of 
ahpC in 10 out of 77 !NH-resistant clinical M tuberculosis isolates (MIC 0.2 to> 10 µg/rnl). 
All strains with complete katG deletions had altered ahpC regulatory regions. They also 
showed, using lacZ fusions and immunoblot analysis, that some of the mutations resulted in 
increased transcription of ahpC. Wilson and Collins ( 1996) identified a point mutation (C --) T) 
at position 72 in the promoter region of the ahpC gene from a catalase-negative, !NH-resistant 
mutant of M bovis, as well as three other INH-resistant M tuberculosis complex strains. This 
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mutation resulted in a 6-fold increase in expression. Dhandayuthapani et al. ( 1996) also 
identified mutations or polymorphisms in the l 05 bp intergenic region between ahpC and oxyR 
in catalase-negative, INH-resistant M. tuberculosis strains. Zhang et al. ( 1996) mapped the 
transcription start site of the M. bovis BCG ahpC to 42 bp upstream of the translation start 
codon. This means that most of the identified mutations lie within the promoter region. These 
results show that INH-resistant strains mutant in katG frequently contain additional mutations 
which contribute to the overall level of sensitivity to INH. It may be that mutations which 
increase expression of AhpC compensate for the lack of catalase activity, thus allowing greater 
survival in the presence of reactive oxygen species (Sherman et al., 1996 ). AhpC is involved in 
the conversion of potentially harmful hydroperoxide derivatives of lipids and nucleic acids into 
the corresponding alcohols. The enzyme may, therefore, be involved in the detoxification of the 
products of INH activation, and may reduce the consequences of increased oxidative damage to 
cellular molecules. In contrast, Sreevatsan et al. ( 1997) recently showed that most of the fNH .. 
resistant M tuberculosis complex clinical isolates which they studied, which had reduced 
catalase and peroxidase activity, had no alterations in ahpC or the intergenic region. They were, 
however, able to detect 2 polymorphic sites in the ahpC gene and 9 in the intergenic region of 
some !NH-resistant organisms. These authors suggest that the second selection event for the 
ahpC mutation had not occured as yet in their clinical isolates. 
Despite the presence of upregulatory mutations in the ahpC of many !NH-resistant isolates, 
there was no correlation between overexpression of either the wild type or mutated ahpC genes 
from M leprae, M avium, and M. tuberculosis, and resistance to INH in M tuberculosis 
H37Rv, M bovis BCG, or M. smegma/is, in the absence of a katG mutation (Wilson and 
Collins, 1996; Sherman et al., 1996; Heym et al., 1997). AhpC, therefore, probably does not 
play a direct role in the detoxification of INH. Zhang et al. ( 1996) showed that insertional 
inactivation of the ahpC gene in M smegmatis resulted in increased susceptibility to INH. In all 
!NH-sensitive strains of M. tuberculosis and M. bovis, the AhpC protein is below detectable 
levels, possibly due to the defects in OxyR. M aurum, another strain which is naturally 
sensitive to INH, also has no detectable AhpC (Dhandayuthapani et al., 1996). It may be these 
very low levels of AhpC which prevent the removal of excess reactive oxygen species, and 
result in the high sensitivity to INH. In M. tuberculosis complex organisms, the oxyR gene is 
naturally mutated resulting in overproduction of katG. Therefore, there is a large amount of 
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enzyme per cell converting INH to its activated form. In !NH-resistant mycobacterial strains, 
stw.h as M avium, the same mechanisms of resistance to INH occur, however, there are lower 
basal levels of katG, and therefore less activation of INH. This suggests that the defects in the 
oxidative stress response are a major contributing factor to the exceptionally high sensitivity of 
M tuberculosis to INH. Other putative members of the oxyR regulon may also be involved in 
!NH-susceptibility and the effect may be cumulative (Zhang et al., 1996). 
1..1. 2.8. Mechanisms of resistance to other anti-tuberculosis drugs 
Mycobacteria show a high degree of primary resistance to most antibiotics and 
chemotherapeutic agents, probably due to their low cell wall permeability. Hydrophilic and 
lipophilic agents are slowed down by the abnormal thickness and unusually low fluidity of the 
lipid bilayer (Jarlier and Nikaido, 1994). A number of studies have been carried out on the 
mechanisms of resistance of M tuberculosis and other mycobacteria to various 
antimycobacterial drugs, using the resistance mechanisms of E. coli as analogies. Streptomycin, 
an aminocyclitol glycoside antibiotic, causes misreading of the genetic code, inhibition of the 
initiation of mRNA translation, and aberrant proof-reading (Gale et al., 1981; Moazed and 
Noller, 1987). Resistance to streptomycin can be caused by aminoglycoside-modifying enzymes 
and mutations in the ribosomal protein S 12 gene, rpsL (Bottger, 1994). Most M tuberculosis 
strains are highly susceptible to streptomycin, and only one molecule of streptomycin is required 
to inhibit one ribosome in vitro. Mutations in the M tuberculosis rpsL gene (Kenney and 
Ch•Jrchward, 1994; Finken et al., 1993; Honore and Cole, 1994), and in the 16S rDNA 
sequence (Douglass and Steyn, 1993; Meier et al., 1994; Honore and Cole, 1994), have been 
associated with resistance to this drug. In M smegmatis, however, no mutations have been 
identified in the 16S rDNA, only in rpsL (Kenney and Churchward, 1994), and this may be due 
to the presence of two copies of the gene in this organism. The slow growing mycobacteria 
possess only one copy of the l 6S rRNA gene, therefore single nucleotide changes can result in 
antibiotic resistance (Musser, 1995). Approximately 30% of resistant M. tuberculosis isolates 
st1.!rlied had wild type rpsL and l 6S rRNA genes, suggesting that other mechanisms of 
resistance occur, for example, alterations in cellular permeability, which may be responsible for 
low levels of resistance (Musser, 1995). 
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Rifampin (RIF) inhibits E. coli by binding to the ~ subunit of the RNA polymerase and 
preventing transcription (McClure and Cech, 1978). The same mechanism appears to function 
in M smegmatis (Levin and Hatfull, 1993). Resistance to rifampin in E. coli is mediated by a 
number of different mutations and deletions in the rpoB gene, encoding the ~ subunit (Jin and 
Gross, 1988), and these have been used for studying the resistance mechanisms in mycobacteria 
(Honore and Cole, 1993). Miller et al. ( 1994) cloned and sequenced the M. tuherculosis 
H37Rv rpoB gene, whose product showed 57% amino acid identity with that of E coli. 
Introduction and expression of the gene in a highly rifampin-resistant strain of M. smeKmatis 
LR22J (MIC > 200 µg/ml) resulted in an increased sensitivity to rifampin. Examination of the 
rpoB gene of rifampin-resistant strains of M. tuberculosis revealed mutations in an 81 bp region 
of the gene in > 90% of them (Heym et al., 1994; Bodmer et al., 1995; Kapur et al., 1994; 
1995). Similar mutations have been found in the rpoB gene of RIF-resistant isolates of 
M. leprae (Honore and Cole, 1993 ), M. africanum, and M. avium. In the small proportion of 
strains with wild type rpoB genes, resistance may be due to changes in cell permeability or 
mutations in other RNA polymerase subunits. 
The mechanism of action of pyrazinamide has not been elucidated, however it is known that 
susceptible strains possess a pyrazinamidase, which converts pyrazinamide into pyrazinoic acid 
and nicotinarnide into nicotinic acid (Konno et al., 1967). The activated drug is only active at a 
low pH (McDermott and Tompsett, 1954) or inside macrophages (Mackaness, 1956). 
Pyrazinamide-resistant strains of M tuberculosis and strains of M bovis, which are naturally 
resistant to pyrazinamide, lack this enzyme activity (Konno et al., 1959; Konno et al., 1967; 
Butler and Kilburn, 1983). The gene encoding pyrazinarnidase, pncA, was recently cloned and 
characterized by Scorpio and Zhang (1996). The amino acid sequence is 35.5% identical to that 
of the E. coli nicotinamidase. The authors detected the gene in 3 M bovis strains and 3 
M bovis BCG substrains, however, all had the same point mutation, C -) G at nucleotide 169, 
resulting in a His-57 -) Asp substitution, which presumably renders the enzyme inactive. A 
direct correlation was also observed between resistance to pyrazinamide and the presence of 
point mutations in the pncA gene of M tuberculosis strains. In addition, transformation of 
M bovis BCG and a pyrazinamide-resistant M tuberculosis strain with a plasmid carrying the 
gene resulted in susceptibility to the drug (Scorpio and Zhang, 1996). Scorpio and co-workers 
( 1997) analyzed a panel of pyrazinamide-resistant isolates of M tuberculosis. They detected 
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mutations, including nucleotide substitutions, insertions, and small deletions, in 33/38 clinical 
isolates and 8 in vitro mutants. Those isolates with no detectable mutations were shown to be 
"falsely resistant" to pyrazinamide. Altogether, the authors identified 26 types of mutations 
dispersed along the gene, although some conservation of mutations was observed, for example, 
Asp-12 ~ Ala or Asn, Leu-85 ~ Pro, Gly-132 ~ Ser, and Thr-142 ~ Lys or Met. No 
mutations were observed in susceptible strains. These results suggest that mutations in pncA 
are indicative of resistance to pyrazinamide, and that these are the major mechanism of 
resistance to the drug (Scorpio el al., 1997). Sreevatsan et al. ( 1997) report similar results. 
They detected mutations in the pncA gene of 72% of pyrazinamide-rcsistant Al. 111herc11/osis 
isolates from diverse geographic localities, and no mutations in the susceptible isolates. These 
results suggest that at least one other gene is involved in resistance. As yet, no resistant strains 
have been isolated which have mutations in the target, i.e. strains which are resistant to 
pyrazinoic acid, which suggests that these types of mutations may be lethal (Scorpio et al., 
1997). 
DNA gyrase is the main target of the fluoroquinolones in bacteria. The A and B subunits of the 
enzyme are encoded by the gyrA and gyrB genes, respectively. Point mutations have been 
identified in the gyrA genes of ofloxacin-resistant mutants of M. smegmatis (Revel et al., 1994), 
and ciprofloxacin-resistant mutants of M tuberculosis (Takiff et al., 1994; Kapur et al., 1995). 
Viomycin and capreomycin interfere with ribosome translocation (lnderlied, 1991 ). High level 
resistance to these antibiotics appears to be conferred by ribosomal mutations (Bottger, 1994). 
Ethionamide, a structural analogue of INH used as a second-line antituberculosis drug, also 
blocks mycolic acid synthesis in mycobacteria and, in some cases, low level resistance to INH 
involving mutations in inhA correlates with resistance to ETH (Canetti, 1965; Hok, 1964). 
Ethambutol inhibits the polymerization of cell wall arabinan, possibly by interfering with the 
transfer of arabinose to the cell wall acceptor. Resistance to this drug results from 
overexpression of the Emb proteins, encoded by embCAB, structural mutation of EmbB, or 
both (for references see Telenti et al., 1997). Mycobacteria exhibit a range of sensitivities to ~-
lactam antibiotics and this is due differences in their ~-lactamase activities. The M tuberculosis 
complex organisms possess strong ~-lactamase activity, the rapid growers possess strong to 
intermediate activity, and M avium possesses no activity (Kwon et al., 1995). Although a 
number of mutations have been identified in drug-resistant mycobacterial isolates, the exact 
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mechanisms of action of, and mechanisms of resistance to, the many of the antituberculosis 
drugs remain unclear. It is evident that both are very complex and, in most cases, more than 
one cellular component is involved. A common element in all the drug resistant mechanisms 
identified thus far in M. tuberculosis is that resistance is due to mutations in chromosomal genes 
rather than the acquisition of new genetic elements encoding antibiotic-altering enzymes. 
M. tuberculosis is an intracellular pathogen and, as such, is not exposed to the pool of drug 
determinants available in naturally occurring microbial communities. Multidrug-resistance 
appears to arise from the accumulation of sequential mutations which confer resistance to single 
agents (Musser, 1995) 
1.4. PROJECT AIMS 
Outlined above is a brief review of the history, control, and pathogenesis of tuberculosis, with 
particular reference to the M. tuberculosis catalase-peroxidase enzyme, and its role in both 
virulence and susceptibility to INH. The enzyme evidently plays an important role in these 
organisms, and has been studied by a large number of researchers. Our interest in the 
M. tuberculosis KatG was generated fortuitously during another study. As mentioned in the 
review, the virulence of the organism relies, to an extent, on the removal of reactive oxygen 
species by the radical scavenging enzymes. Those radicals which may escape degradation, as 
well as other toxic molecules within the macrophage can cause considerable damage to the 
DNA of the organism. The ability of the organism to repair damage to its DNA is, therefore, 
also expected to be an important factor involved in the survival of mycobacteria in 
macrophages. For this reason, our laboratory initiated an investigation of DNA repair enzymes 
and mechanisms in M tuberculosis. A genomic library of M tuberculosis H37Rv was screened 
for DNA repair genes by transformation of a DNA repair-deficient E. coli strain with the library 
and selection on the DNA damaging agent, ethyl methane sulfonate. One of the clones which 
conferred resistance to this agent contained a fragment of the M tuberculosis katG gene. One 
of the aims of this thesis, therefore, was to determine whether resistance was indeed due to the 
katG gene, and to examine the role of this gene in DNA repair. The results reported suggest 
that the gene product increases the resistance of E. coli DNA repair mutants to short 
wavelength ultraviolet light irradiation, mitomycin C, and hydrogen peroxide. This observation, 
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further emphasizes the importance of the M tuherrnlosis katG gene in the survival of the 
organism in the macrophage, and suggests that it may encode a novel activity. 
Obtaining a better understanding of the katG gene and its expression within the cells, was the 
second aim of this study. This section of work deals with the characterization of the 
M tuberculosis katG promoter and the manner in which its expression is regulated. The 
absence of a functional oxyR gene in this organism suggests that the regulation of katG may 
differ from that in other bacteria Examination of expression from the promoter under different 
conditions revealed that it has the same growth phase-dependence as other catalases, but that its 
response to various stresses differs from that in other bacteria. It was demonstrated that the 
katG promoter requires an upstream activator sequence for optimal activity, and that this region 
may bind an activator protein. The regulation of the gene in this organism may, therefore be 
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The ability of Mycobacterium tuberculosis to repair damage to its DNA caused by reactive 
oxygen species, and other mutagenic agents within the macrophage, probably contributes 
significantly to its survival in this environment, and hence to its virulence DNA repair has been 
extensively studied in a number of organisms, particularly F.. coli. A wealth of information is 
available on the pathways and mechanisms involved in DNA repair in this host. The subject is 
extensively reviewed by Friedberg et al. (I 995), and will not be covered in detail in this review. 
Only the pathways and mechanisms relevant to this study are outlined below. 
2.1. DNA REPAIR IN E.COLI 
2.1.1. DNA damage caused by mutagenic agents 
Ionizing radiation can cause DNA damage either directly, if energy is transferred without 
intermediates to ionize or excite components of DNA, or indirectly, through the generation of 
partially reduced oxygen species. Both forms of damage occur, therefore agents which act by 
scavenging toxic products probably only provide protection from indirect processes. Short 
wavelength ultraviolet (UV) light also causes both direct and indirect damage to DNA. The 
most common structural defects resulting from irradiation are pyrimidine dimers, formed due to 
the direct absorption of photons by the bases in the DNA, resulting in covalent linkage of 
adjacent pyrimidines (Setlow, 1966a; 1966b; 1968). These pyrimidine dimers change the 
conformation of the DNA and prevent base pairing and replication. Dimerization is reversible, 
and, if E. coli is continually irradiated, a dynamic equilibrium is established in which the rates of 
dimer formation and reversal are equal (Setlow and Carrier, 1966). Intermolecular DNA cross-
links are also a minor product of damage due to short wavelength UV irradiation (Love et al., 
1986). Mitomycin C causes covalent cross-linking of complementary DNA strands which 
prevents strand separation and causes inhibition of DNA replication and transcription (Iyer and 
Szybalski, 1963). 
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Hydrogen peroxide is lethal to many bacteria, including E. coli. Reactive oxygen species attack 
and damage DNA in a number of ways, for example: damage to sugar residues, which can cause 
fragmentation, base loss and strand breaks; modification of bases; and cleavage of DNA. The 
main source of damage caused by hydrogen peroxide is the hydroxyl radical, generated by the 
reaction of hydrogen peroxide with iron-complexed DNA (Imlay et al., 1988; Imlay and Linn, 
1988). The hydroxyl radical can also attack the double bond of thymine to form thymine glycol, 
which blocks replication, or 8-hydroxyguanine, which causes mispairing (Demple and Linn, 
1982). Strand breaks and other lesions that block DNA replication are likely to contribute more 
to the lethal effects of hydrogen peroxide than base damage (Farr and Kogoma, 199 l ). 
2.1.2. The SOS response and RecA 
Central to the survival of E. coli cells after exposure to DNA damaging agents is the SOS 
response. The SOS response in E. coli involves the induction of more than 20 genes in 
response to DNA damage, including recA, uvrA, uvrB, uvrD, polB, and umuDC. The response 
is regulated by the LexA repressor and the RecA protein. In uninduced cells, LexA binds to 
operator sequences, or SOS boxes, upstream of the genes induced by the SOS response, 
including recA and /exA. When DNA replication is inhibited, for example due to single stranded 
DNA (ssDNA) regions, the RecA protein binds to these single stranded regions, in the presence 
of a nucleoside triphosphate, and is reversibly converted to an activated form. This then 
interacts with LexA and facilitates proteolytic cleavage of the latter protein, thus inactivating it. 
Transcription of the SOS genes is, therefore, induced. As the DNA damage is repaired and the 
levels of ssDNA decrease, the RecA molecules return to their inactivated state, resulting in an 
increase in the intracellular pools ofLexA, and renewed repression of the SOS genes (Little and 
Mount, 1982; Walker, 1984; 1985). 
In addition to its role in the SOS response, the RecA protein is involved in recombination, and 
DNA repair and damage tolerance processes. These include the repair of daughter strand gaps 
generated during the replication of a damaged DNA template; repair of double strand breaks; 
and trans-lesion replicative bypass (Friedberg et al., 1995). The substrate for RecA-mediated 
strand exchange is ssDNA, bound by ssDNA binding proteins (SSBPs). These proteins remove 
hairpin formations from the ssDNA. RecA binds co-operatively to gapped duplex DNA. The 
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RecA-DNA complex then binds to the duplex DNA molecule, and RecA promotes 
unidirectional branch migration (Cox and Lehman, 1981 ). 
2.1.3. The repair of UV-induced damage 
As mentioned above, the most common structural defects resulting from UV irradiation are 
pyrimidine dimers. Cellular responses to UV damage involve either the direct reversal of DNA 
damage or its excision An example of direct reversal of damage is a mechanism known as 
photoreactivation. Photoreactivation of pyrimidine dimers in DNA is a light-dependent process, 
which is catalyzed by DNA photolyase. The enzyme is widely distributed in nature, but has 
been best studied in E. coli. In the absence of light at wavelengths between 300 and 500 nm, 
DNA photolyase binds specifically to DNA containing pyrimidine dimers in the so-called dark 
reaction. The enzyme probably binds to the dimer-containing strand in duplex DNA, and makes 
close contacts with the phosphodiester backbone and the cyclobutane ring of the dimer (Husain 
et al., 1987). The light reaction involves the absorption of photoreactivating light by 
chromophores associated with the enzyme. One of the chromophores, 5, I 0-methenyl 
tetrahydrofolyl (MTHF) polyglutamate, . captures light and transfers energy to the second 
chromophore, 1,5-dihydroflavin adenine dinucleotide (F ADH2), which then initiates electron 
transfers that destabilize the pyrimidine dimers in the DNA and result in monomerization (Joms 
et al., 1984; Sancar and Sancar, 1987; 1984; Sancar, 1994). DNA photolyase bound to the 
damaged DNA also stimulates the Uvr-dependent nucleotide excision repair pathway discussed 
below (Sancar et al., 1984). 
There are three ways in which pyrimidine dimers are removed from DNA, base excision repair, 
nucleotide excision repair, and recombinational repair. Base excision repair involves the 
removal of chemically modified moieties from the deoxyribose-phosphate backbone, as free 
bases, by DNA glycosylases (Duncan et al., 1976). DNA glycosylases have limited substrate 
specificity, and generally recognize specific forms of damage, such as pyrimidine dimers 
(Friedberg and King, 1969), thymine glycol (Breimer and Lindahl, 1984), and uracil (Duncan 
and Weiss, 1982). The removal of modified bases results in apurinic or apyrimidinic (AP) sites, 
which are then cleaved on either side by specific AP endonucleases. This is followed by gap 
repair synthesis and ligation. The repair of AP sites in£. coli DNA requires initial incisions in 
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the DNA catalyzed by specific AP endonucleases (Lindahl, 1979). The xthA gene product, 
exonuclease III (Yajko and Weiss, 1975), which is regulated by KatF (Sak et al., 1989), 
represents approximately 90% of the AP endonuclease activity of E. coli. Bacteria which are 
mutant in xthA, however, are not noticeably sensitive to alkylating agents such as methyl 
methane sulfonate (Ljungquist et al., 1976), suggesting that other AP endonuclease activities in 
the cell are sufficient to initiate DNA repair of these base-free sites (Milcarek and Weiss, 1972). 
The 5' terminal deoxyribose-phosphate residue resulting from the AP endonucleases is removed 
by exonucleases or DNA deoxyribophosphodiesterase (dRpase), to leave a single nucleotide gap 
in the DNA duplex (Kornberg and Baker, 1992). Gap repair synthesis requires the DNA 
polymerases, of which there are three in E. coli. DNA polymerase I, encoded by po/A, contains 
the catalytic functions for DNA polymerization, pyrophosphorolysis exchange, 3'-5' 
exonucleolytic degradation, and 5'-3' exonucleolytic degradation. It can promote DNA 
replication at a nick, unaided by other proteins. DNA polymerase II, encoded by po/B, has no 
5'-3' exonuclease activity. Its optimal substrate is duplex DNA with short gaps of< 100 
nucleotides, and is, therefore, ideal for repair synthesis of excision gaps generated during base 
or nucleotide excision repair. DNA polymerase III has 3'-5' and 5'-3' exonuclease activity, but 
requires a single stranded substrate (Kornberg and Baker, 1992). The DNA glycosylase/ AP 
endonuclease-mediated incision of DNA containing pyrimidine dimers is a highly specialized 
form of base excision repair observed only in E. coli cells infected with bacteriophage T4 
(Friedberg et al., 1995). 
Nucleotide excision repair is the most common repair process, and involves the uvrA, uvrB, and 
uvrC products. The UvrABC complex recognizes and removes many different types of DNA 
damage by catalyzing excision of oligonucleotides containing the altered bases from the DNA 
duplex. Resultant gaps are then filled in by gap repair synthesis, and covalently sealed by DNA 
ligase. Nucleotide excision repair is biochemically more complex than base excision repair, and 
involves many more gene products. The uvrA, uvrB, and uvrC gene products are produced 
constitutively at approximately 25, 250, and 20 molecules per cell, respectively, in E. coli, 
however, the uvrA and uvrB gene products are induced by RecA in the SOS response (Selby 
and Sancar, 1990; Van Houten, 1990; Fogliano and Schendel, 1981). UvrA is a DNA-
independent ATPase and a DNA-binding protein (Van Houten, 1990). In its dimeric form, 
UvrA binds to DNA containing various forms of damage (Selby and Sancar, 1990; Van Houten 
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and Snowden, 1993). These complexes are, however, short-lived, and dissociate rapidly, unless 
bound to UvrB. UvrB interacts specifically with UvrA to form protein-protein and protein-
DNA complexes, which are important in damage-specific recognition. ATP hydrolysis is critical 
for the formation of the (UvrA)2(UvrB)1 complex (Sancar and Sancar, 1988). It has been 
suggested that the only role played by UvrA is in delivering the UvrB protein to the damage 
sites, after which it rapidly dissociates to leave a highly stable UvrB-DNA complex (Orren and 
Sancar, 1989). The binding of UvrB to DNA results in a conformational change in the protein 
and local unwinding of the DNA (Oh and Grossman, 1986 ). The working model is that two 
molecules of UvrA associate with one of UvrB to form a complex which binds non-specifically 
to DNA, but is able to unwind DNA using energy from ATP hydrolysis, and it translocates 
unidirectionally (Grossman and Thiagalingam, 1993). When base damage is encountered, the 
complex unwinds and kinks the DNA , UvrA dissociates, and a stable UvrB-DNA complex is 
formed (Sancar and Hearst, 1993; Van Houten, 1990). UvrC binds to specific UvrB-[damaged-
DNA] complexes and allows incision of the DNA, mediated by both UvrB and UvrC (Lin and 
Sancar, 1992). Incisions are made on either side of the damaged DNA, typically 8 nucleotides 
upstream and 4 or 5 nucleotides downstream (Orren and Sancar, 1989). The uvrD gene 
product, DNA helicase II, is also induced by the SOS response (Kushner et al., l 983). This 
protein, together with DNA polymerase I, is responsible for effecting the turnover of UvrB and 
UvrC (Caron et al., 1985). DNA helicase II is required for the release of the oligonucleotide 
fragment and UvrC from the post-incision complex, while DNA polymerase I binds to the 3' OH 
terminus generated at the 5' incision, and displaces the UvrB protein during repair synthesis 
(Orren et al., 1992). All three DNA polymerases of E. coli are able to perform repair synthesis 
of UV-damaged DNA (Masker et al., 1973), however DNA polymerase I is probably the most 
important. It has been suggested that a number of other cellular functions may also be involved 
in nucleotide excision repair (Friedberg et al., 1995). 
Recombinational repair is more of a tolerance mechanism than a repair system. If altered bases 
have not been removed before the replication fork reaches them, the replication machinery may 
leave a gap and then continue synthesis after the defective base/s. The gap that is formed is then 
filled in by recombination with an intact daughter strand. The altered base is, therefore, not 
removed, but is eventually titrated out after successive rounds of replication. Recombinational 
repair requires the RecA protein as well as the RecBCD complex, and only occurs during 
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replication (Howard-Flanders et al., 1984; West et al., 1981). Therefore, during stationary 
phase when the cells are not replicating, the predominant form of repair will be excision repair. 
It has been proposed that the RecBCD enzyme enters into the DNA at a double stranded break, 
and then travels along the DNA, unwinding and rewinding it until it encounters a specific 
recombination, or chi site. It then cuts one strand of the DNA to form a single stranded tail, 
which invades the homologous intact duplex in a reaction mediated by RecA (Dixon and 
Kowalczykowski, 199 l ). Recombinational repair is responsible for the repair of single stranded 
gaps and single and double stranded DNA breaks. RecF binds ssDNA and is required for 
daughter strand gap repair (Walker, 1987), while RecBCD is required for sister duplex 
recombination (Wang and Smith, 1983). RecBCD is also important for the maintenance of cell 
viability during normal growth. It contains ATP-dependent exonuclease and helicase activity on 
double stranded DNA (dsDNA), and exonuclease and ATP-independent endonuclease activity 
on ssDNA. RecE is an exonuclease which uses double stranded breaks to produce gaps with a 
single stranded overhang, which then undergo homologous recombination with an undamaged 
sister strand. Apart from its role in recombinational repair, RecA is essential for the survival of 
cells exposed to UV irradiation due to its role in induction of the SOS response. 
2.1.4. The repair of damage caused by cross-linking 
Mitomycin C causes covalent cross-linking of complementary DNA strands which results in 
inhibition of DNA replication and transcription (Iyer and Szybalski, 1963). These DNA lesions 
are removed in a similar manner to those caused by UV, i.e. excision repair, except that both 
strands must be removed, leaving a gap in the DNA which must be repaired by recombination, 
involving RecA. An incisional-recombinational model has been proposed for the repair of this 
type of damage. In this model, the UvrABC complex effects incision of one strand, generating 
an oligonucleotide covalently linked to DNA through the cross-link. Displacement of the 
oligonucleotide generates a gap which can be repaired by recombinational repair. Subsequent 
incision of the other strand results in release of the cross-linked oligonucleotide, leaving a 
second gap, which can be repaired by repair synthesis and DNA ligation (Cole, 1973). Repair 
of cross-links in DNA has been shown to occur in uvr mutants of E.coli (Bridges, 1983; 1984; 
Bridges and Stannard, 1982), suggesting the presence of Uvr protein-independent pathways for 
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the repair of cross-links in DNA. In addition, a novel enzyme which exclusively incizes DNA 
coi1taining cross-links, has been described by Sladek et al. (1988) 
2.1.5. The repair of oxidative damage 
The exact mechanisms involved in repair of oxidative damage to DNA are not known, but may 
involve both specific and non-specific enzyme systems. Bacteria have two main mechanisms of 
protection against oxidative stress: 1) enzymes which scavenge activated oxygen species, such 
as catalases (Loewen, 1984), peroxidases (Saunders et al., 1964), and superoxide dismutase 
(Carlioz and Touati, 1986); and 2) enzymes which repair damage to DNA resulting from 
oxidative stress, such as exonuclease III (Demple et al., 1983), thymine glycol DNA glycosylase 
(Cunningham and Weiss, 1985), DNA polymerase I (Ananthaswamy and Eisenstark, 1977), 
DNA polymerase III (Hagensee and Moses, 1989), RecBC nuclease (Imlay and Linn, 1987), 
and RecA (Yoakum and Eisenstark, 1972). When bacteria are pretreated with low doses of 
hydrogen peroxide, they become resistant to subsequent doses that would otherwise be lethal, 
due to the induction of at least 30 proteins, some of which include DNA repair enzymes 
(Demple and Halbrook, 1983). Among these, 9, including catalase, alkyl hydroperoxide 
reductase, and OxyR, are regulated by OxyR (Loewen, 1984; Morgan et al., 1986). The 
oxidative stress response is discussed in more detail in Chapter 5. Treatment with low 
concentrations of hydrogen peroxide also results in the induction of recA (Greenberg and 
Demple, 1989), and Goerlich et al. ( 1989) provide direct evidence that, in E. coli, hydrogen 
peroxide induces the SOS response. They demonstrated this using a lacZ operon fusion to sfiA, 
one of the SOS response genes. The authors concluded that hydrogen peroxide makes DNA 
lesions, possibly strand breaks, which cause SOS induction, and that some of these can be 
repaired by the uvrABC-dependent excision repair pathway. E. coli cells pretreated with 
hydrogen peroxide also exhibit an increased resistance to ionizing radiation, such as gamma 
rays, but not to alkylating agents or UV irradiation (Demple and Halbrook, 1983). The 
superoxide stress response also includes an increased DNA repair capacity (Farr et al., 1985). 
It has been shown by Carlsson and Carpenter (l 980) and Ananthaswamy and Eisenstark (1977), 
that the radical-removing enzymes, such as the catalases, peroxidases, and superoxide 
dismutase, play a surprisingly small role in protection of E. coli from killing by hydrogen 
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peroxide. Carlsson and Carpenter (1980) examined the hydrogen peroxide sensitivities of a 
variety of DNA repair-deficient strains of E. coli K12. They found no correlation between the 
death rate of the strains and the ability to decompose hydrogen peroxide by intact cells, or the 
level of catalase and superoxide dismutase in cell-free extracts. The actual involvement of 
catalases in this protection is unclear, due to a number of conflicting observations. It has been 
shown that, at relatively high cell densities, wild type cells are less sensitive to hydrogen 
peroxide than RPI mutants, while at low cell densities, wild type and mutant strains are equally 
sensitive. This is, presumably, due to the efficient removal of hydrogen peroxide through the 
mass action of the cells (Ma and Eaton, 1992). Others have demonstrated that catalase mutants 
are hypersensitive to killing by hydrogen peroxide (Demple, 1991; Farr and Kogoma, 1991 ), but 
that, in wild type strains, there is no correlation between the levels of catalase and hydrogen 
peroxide killing (Hassett et al., 1990). The role of catalases in protection against hydrogen 
peroxide toxicity also differs depending on the hydrogen peroxide concentration. Catalase 
mutants are hypersensitive to millimolar concentrations (Loewen, 1984), however, in 
experiments with micromolar concentrations, the catalases provided only weak protection 
(Goerlich et al., 1989). Thus survival of cells exposed to hydrogen peroxide must rely on repair 
of the damage after it has occured. Hagensee and Moses (1989) have shown that there are at 
least two pathways for repair of hydrogen peroxide damage, both of which require DNA 
polymerase I. One of these pathways also utilizes exonuclease III and DNA polymerase III. 
Demple et al. (1983) have shown that E.coli cells mutant in xthA, encoding exonuclease III, are 
10-20-fold more sensitive to hydrogen peroxide than wild type cells, and are more sensitive than 
cells mutant in recA. This suggests that these enzymes play an important role in repair of 
oxidative damage. Demple et al. (1983) hypothesize that the free radicals formed during the 
decomposition of hydrogen peroxide may form nicks containing 3'-phosphate groups in the 
DNA, which in turn block DNA polymerase. Since > 99% of the 3'-phosphatase activity in 
E. coli is due to exonuclease III (Milcarek and Weiss, 1972), this enzyme may be vital in 
removing these groups to allow DNA replication to continue. Another possibility is that 
hydrogen peroxide causes base damages which are cleaved by endonuclease III (Demple and 
Linn, 1982). This enzyme generates 3' termini that are inefficiently used by DNA polymerase I, 
thus requiring exonuclease III for the initiation of repair synthesis (Demple et al., 1983). 
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A major form of damage caused by hydrogen peroxide is base modification, especially thymine 
glycol (Demple and Linn, 1980). N-glycosylases for thymine glycol and urea are known to act 
specifically on oxidized DNA (Demple and Halbrook, 1983). However, a mutation in nth, 
encoding thymine glycol DNA glycosylase, had no effect on the induction of the SOS response 
by hydrogen peroxide (Goerlich et al., 1989), and Cunningham and Weiss ( 1985) have observed 
that an nth mutant is not hypersensitive to killing by hydrogen peroxide Excision repair 
mutants are also far more resistant to hydrogen peroxide than xthA mutants (Demple et al, 
1983 ), \Vhich suggests that excision repair is not essential either for repair of oxidative damage 
The UvrABC complex is capable of removing thymine glycols and AP sites from oxidatively 
damaged DNA (Lin and Sancar, 1989), however, and probably does participate, to an extent, in 
repair of oxidative damage to DNA. 
2.1.6. M utagenesis 
Some lesions caused by DNA damaging agents escape repair, and can lead to the introduction 
of mutations. Most mutagenesis is induced due to trans-lesion DNA synthesis. Mutagenesis by 
UV and many chemicals is not a passive process in £. coli, and is brought about by error-prone 
repair or SOS repair (Radman, 1974; Witkin, 1976 ). In the trans-lesion synthesis model, a 
polymerase inserts one or more nucleotides directly opposite the lesion and extends the chain 
(Bridges and Woodgate, 1985). The process probably involves DNA polymerase III, and 
requires the umuD and umuC gene products. 
2.2. DNA REPAIR IN THE MYCOBACTERIA 
As mentioned in Chapter 1, M tuberculosis is exposed to hydrogen peroxide as part of the 
macrophage defence mechanism (Lowrie, 1983). Jackett et al. (1978) have shown an 
association between hydrogen peroxide-susceptibility and low virulence in native and INH-
resistant tubercle bacilli, but that this is not the sole determinant of virulence. They found that 
resistance to hydrogen peroxide depends on catalase, but also on other unknown features. 
Virulent M tuberculosis, therefore, seem to possess two independent means of resistance to 
hydrogen peroxide, but can become attenuated without losing this resistance (Jackett et al., 
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1978). The cell wall probably plays an important role in resistance. The gene encoding the 
inducer of the oxidative stress response, oxyR, of M. tuberculosis and other M tuberculosis 
complex members is naturally mutated (Sherman et al., 1995; Deretic et al., 1995; 
Dhandayathupani et al., 1996) (Discussed in Chapter 5). This suggests that this organism may 
use alternative pathways for survival in the presence of reactive oxygen species, and possibly 
other DNA damaging agents. 
2.2.1. Sensitivity of mycobacteria to UV irradiation 
Different mycobacterial species exhibit different sensitivities to UV light irradiation (254 nm). 
David ( 1973) investigated the properties of mycobacteria which give rise to their sensitivity to 
UV light irradiation. All the mycobacteria tested showed greater survival than E. coli grown in 
the same medium, and the order of UV sensitivity was as follows: M. tuberculosis > 
M fortuitum > M. avium-intrace/lulare > M phlei > M. marinum > M. kansasii > 
M. smegmatis > M flavescens. The UV sensitivity depends partly on the G+C content, but thiis 
value has a narrow range in these mycobacteria ( 63-70% ), therefore the differences in sensitivity 
could not be attributed to the base composition of their DNA. It is also evident that the UV 
sensitivities did not correlate with generation time or clumping of the cells. However, the UV 
sensitivities of six of the mycobacterial species did correlate with the sizes of their genomes. 
This suggests that the smaller the DNA molecule, the higher the probability that a lesion will be 
lethal. The mycobacteriophage Minetti reproduces lytically in both M smegmatis and 
M fortuitum and was used by the author as a means of determining the repair efficiency of each 
host. M smegmatis, which is the less UV sensitive of the two, was shown to confer higher 
survival to the mycobacteriophage than M fortuitum, suggesting that the differences in UV 
sensitivity were directly due to differences in their repair efficiencies. Unfortunately, no phag€::s 
have been identified that reproduce lytically in every species of mycobacteria. Different 
mycobacterial species produce different amounts of pigment ( carotenoids) under different 
conditions. In some, for example M marinum and M kansasii, the synthesis of carotenoids iis 
light inducible (Batra, 1967), while in others, for example M jlavescens, pigments are 
synthesized constitutively. David (1973) demonstrated that the production of pigments masks 
the UV sensitivity in mycobacteria. This may be due to the absorption of radiation by 
intermediates in the production pathway (David, 1973). The author demonstrated 
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photoreactivation in M avium-intracellulare, and both photoreactivation and dark repair in 
M kansasii to the same degree as that reported for other mycobacteria (David et al., 1971; 
Sellers et al., 1970). 
2.2.2. Sensitivity of mycobacteria to hydrogen peroxide 
Due to the lack of a functional OxyR, M tuberculosis probably has no inducible oxidative stress 
response, and, therefore, relies on the constitutive defence offered by its inert and largely 
impermeable cell wall. Only KatG is peroxide-inducible, but this induction does not protect 
against hydrogen peroxide challenge. Sherman et al. (1995; 1996) demonstrated that sub-lethal 
hydrogen peroxide concentrations did not protect M tuberculosis against subsequent lethal 
hydrogen peroxide doses, as in E. coli, S typhimurium and A1. smegmatis (Christman et al., 
1985; Rosner and Storz, 1994; Sherman et al., 1995), even though the expression of katG was 
induced. Induction of katG did, however, allow a 35-fold increase in survival of M bovis BCG 
exposed to cumene hydroperoxide. A katG-deleted strain showed a much higher sensitivity to 
oxidative stress, and no protection against organic peroxides could be induced by pre-exposure 
to sub-inhibitory hydrogen peroxide concentrations. Overexpression of the ahpC gene from M 
tuberculosis Erdman in strain H37Rv resulted in a significant increase in resistance to cumene 
peroxide. Similar results were obtained for BCG. Increased expression of AhpC therefore 
appears to compensate for the loss of katG in detoxifying the organic peroxides (Sherman et al., 
1996). These experiments do not take into consideration the possible effects of DNA repair 
systems in the recovery from oxidative damage, and little is known about this subject. 
2.2.3. The M. tuberculosis RecA 
The M tuberculosis recA gene has been cloned and sequenced (Davis et al., 1991 ). It encodes 
a protein with high homology to the E. coli RecA over the first 254 and last 96 amino acids, and 
the protein cross-reacts with antibodies to the E. coli RecA. The M tuberculosis gene, 
however, also encodes a centrally located 440 amino acid non-homologous region, which 
represents an intein. This intein must be spliced out after translation to produce the mature 
protein (Davis et al., 1991 ). It is only in the M tuberculosis complex organisms, and in 
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M leprae that unusual recA genes exist (Davis et al., 1994). The inteins from M tuberculosis 
and M leprae are, however, different in size, sequence and location in the coding sequence. 
Therefore acquisition of the inteins must have occurred independently in the two species. Only 
the spliced form ofRecA is active, and is able to bind ssDNA in the presence of ATP, promote 
pairing between ssDNA and homologous dsDNA, and possesses ATPase activity (Kumar et al., 
1996). This may provide a novel means of regulating RecA activity. In M tuberculosis 
complex organisms, integration of plasmids into the chromosome by illegitimate recombination 
occurs at a frequency of lxl0-3, therefore illegitimate recombination is a frequent event in these 
organisms. This, together with the presence of a specific protein splicing mechanism, suggests 
that the M tuberculosis RecA possesses some unique features, and it is possible that these may 
play a significant role in the virulence of the organism. Protein splicing has also been 
demonstrated for the gyrA genes of M leprae, M .flavescens, M gordonae, and M. kansasii 
(Fsihi et al., 1996). 
Davis et al. (1991) cloned the M tuberculosis recA gene under control of the lacZ promoter, 
and were able to demonstrate complementation of an E. coli recA mutant with respect to 
recombinational activity, and partial complementation of the repair and regulatory responses 
required for recovery from DNA damage. The M tuberculosis recA clone could restore 
mutability to a recA 13 mutant, but did not complement for cleavage of the ).. repressor. The 
protein is defective in displacing SSB from ssDNA, and has a reduced affinity for ATP and a 
reduced ability to hydrolyze it, which may explain the partial complementation of the E. coli 
recA mutants. It shows significant differences in its requirements for binding to DNA, and in 
the formation of joint molecules. Studies with sfiA-lacZ fusions have shown that it can bring 
about LexA cleavage and SOS induction. 
The M. tuberculosis recA promoter region contains no £. coli-like LexA-binding site or 
promoter, but it does have a sequence resembling heat shock promoters l 00 bp upstream of the 
initiation codon, and a sequence identical to a consensus GAACN4-GTTC sequence from 
various DNA damage-inducible promoters in B. subti/is (Chea et al., 1991). The promoter 
region and its interaction with the M tuberculosis LexA homologue have been examined 
further. Movahedzadeh et al. ( 1997) examined the expression from and induction of the 
promoter in M smegmatis, using a fusion to the chloramphenicol acetyl transferase reporter 
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gene. They demonstrated induction of the promoter in response to ofloxacin, mitomycin, and 
UV irradiation. The purified M. tuberculosis LexA protein bound to the Cheo box, 121 bp 
upstream of the translation initiation codon. Induction of the promoter occurred to the same 
extent in M. tuberculosis, but was delayed in this organism In the M. tuberculosis LexA 
homologue. amino acids required for autocatalytic cleavage are conserved. while those required 
for specific DNA binding are not The region upstream of the /exA gene also contains a Cheo 
box which binds to the LexA (Movahedzadeh et al., 1997) 
2.3. AIMS OF THIS STUDY 
It is evident that some elements of the SOS response of M. tuberculosis are similar to those in 
other bacteria. However, other important elements of DNA repair in this organism have yet to 
be examined. This, together with the possible importance of DNA repair pathways in the 
virulence of the organism, prompted a search for DNA repair genes from M. tuberculosis. 
Shamila Nair (PhD Thesis, University of Cape Town. 1993) initiated this investigation by 
constructing a PstI library of M. tuberculosis H37Rv genomic DNA in the suicide vector 
pEcoR252, and selecting for clones which conferred resistance to ethyl methane sulfonate on 
recA-deficient E. coli cells. One of the clones which consistently conferred resistance to this 
agent was found to contain a portion of the M tuberculosis katG gene. The aim of this study 
was, therefore, to study the effect of the M tuberculosis katG gene on the survival of DNA 
repair-deficient mutants of E. coli exposed to various DNA damaging agents, and to extrapolate 
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CLONING OF THEM. TUBERCULOSIS KA TG GENE AND 
OVEREXPRESSION IN E.COLI 
3.1. SUMMARY 
This chapter describes the sequencing and analysis of a clone that conferred resistance to ethyl 
methane sulfonate on DNA repair-deficient E. coli cells. Also described is the PCR 
amplification of the M tuberculosis H37Rv katG gene and cloning of the whole gene, the 
proximal two thirds, and the terminal third of the gene in the expression vector pMAL ™-c2. 
The resulting fusion proteins were overexpressed in, and purified from £. coli, and used in 
catalase and peroxidase assays. Only the fusion protein containing the whole KatG enzyme 
exhibited enzyme activity. Constructs containing the terminal third of the katG gene in 
pMAL ™-c2 in the two other reading frames, with respect to the ma/£ gene, were made for use 
as controls in the DNA repair experiments described in Chapter 4. 
3.2. INTRODUCTION 
The role played by DNA repair processes in the survival of M. tuberculosis in the macrophage is 
outlined in the introduction presented in Chapter 2. Little is known about DNA repair in the 
mycobacteria. The recA genes from a number of mycobacteria have been cloned and sequenced 
(Davis et al., 1991). These genes have an unusual structure in the pathogenic mycobacteria, 
M leprae and M tuberculosis, in that they encode an intein which must be spliced out after 
translation to produce the mature, functional protein (Davis et al., 1991; 1994). Another 
important determinant involved in the survival of cells exposed to agents which cause oxidative 
damage is the oxyR gene. In M tuberculosis, this gene is naturally mutated (Sherman et al., 
1995; Deretic et al., 1995; Dhandayathupani et al., 1996). This, together with the unusual 
nature of the recA gene, suggests that the pathways and mechanisms of DNA repair in this 
organism may differ from those in other, well-characterized bacteria. These unusual features 
may also contribute to the virulence of M. tuberculosis. 
77 
In an attempt to improve our understanding of the mechanisms of DNA repair m the 
mycobacteria, a search for DNA repair genes in M tuberculosis was initiated by Shamila Nair 
(PhD thesis, University of Cape Town, 1993). In this study, a PstI genomic library of 
M tuberculosis H37Rv in the suicide vector pEcoR252, was screened for DNA repair genes by 
selection of E. coli DK 1 (recA) transformants on 0.1 % (w/v) ethyl methane sulfonate. Two 
clones were isolated that were able to confer resistance to this agent, one of which was 
described earlier (Nair and Steyn, 1991 ). The other, designated pD3, is the subject of this 
study. pD3 contained an insert of 1747 hp (GenBank Accession number L 14268), whic:h 
included the terminal third of the M. t11herc11/osis katG gene. The aim of this study, therefone, 
was to determine whether the increased survival of the DNA repair-deficient E. coli cells 
observed was due to expression of the 3' portion of the M. tuberculosis katG gene. The 
strategy used for this was overexpression of different portions of the M tuberculosis katG gene 
as fusions with the maltose binding protein (MBP) in the expression vector, pMAL TM_c2 (New 
England Biolabs), in different DNA repair-deficient E. coli hosts. In pMAL ™-c2, the ma/£ 
gene, encoding the MBP (Guan et al., 1987; Maina et al., 1988), is under control of the tac 
promoter (Amann and Brosius, 1985), which is repressed under normal conditions by the 
repressor encoded by the lacr gene, which is also present on the vector. High levels of 
expression from the promoter can be obtained by induction of cells harbouring the vector with 
an analogue of lactose, IPTG, resulting in a fusion that constitutes 20-40% of the total cellular 
protein. The advantage of the pMAL ™ -c2 expression vector is that the resultant fusion protein 
can be purified by affinity chromatography, using an amylase resin (Kellerman and Ferenci, 
1982), and the protein of interest can be cleaved off from the MBP with the protease, factor Xa 
(Nagai and Thogersen, 1984; 1987), whose cleavage recognition sequence lies immediately 
upstream of the multiple cloning site of the vector. This chapter describes the analysis of the 
M tuberculosis katG sequence, the construction of the various translational fusions, and the 
overexpression, purification, and assaying of the fusions in E. coli. 
3.3. MATERIALS AND METHODS 
The bacterial strains, plasmids, and culture conditions used are described in Appendix A. 
Details of the commonly used techniques and solutions are given in Appendices B and C, 
respectively. 
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3.3.1. Isolation of pD3 and cloning into pUC19 
The isolation and sequencing of the clone, pD3, has been described elsewhere (Shamila Nair, 
PhD thesis, University of Cape Town, 1993). Briefly, a Pstl genomic library of M tuberculosis 
H37Rv was constructed in the suicide vector pEcoR252, a derivative of pEcoR25 I (Zappe 
et al., 1986). The library was used to transform E. coli DK I (recA) cells, and transformants 
were selected on 0.1% (w/v) ethyl methane sulfonate. One of the two clones that conferred 
resistance to this agent on the DNA repair-deficient /<.,'. coli cells, pDJ, was analyzed further. 
The 1747 bp insert of pDJ was cloned into the Ps1I restriction endonudease site of pUCI9, to 
form pSNS I 00. The insert of this construct was sequenced using the pUC 19 forward and 
reverse sequencing primers (Promega), and the T7 Sequencing kit (Pharmacia) (GenBank 
Accession number LI 4268). 
3.3.2. Sequence determination and analysis 
In this study, the sequence of the 1747 bp insert of pD3 and pSNS 100 was analyzed using the 
computer packages described in Appendix B. Sequencing of various regions of the insert in 
pSNSIOO was performed using the pUCl9 forward and reverse sequencing primers (Promega), 
a reverse primer designed to bind to sequences 251 hp downstream of the PstI restriction 
endonuclease site of the insert, and the T7 Sequencing kit (Pharmacia). The 18-mer katG 
sequencing primer had the sequence: 5'-GCTCCAGCACGGCAAAGG-3'. Band compressions 
in the sequencing ladder were resolved using the Sequenase™ Version 2.1 DNA Sequencing kit 
(USB, Amersham Life Science) dITP reagents, and a protocol modified for GC-rich templates 
(see Appendix B). 
3.3.3. Cloning of the 1747 bp insert in pMAL™-c2 
The 1747 bp PstI fragment from pD3 was cloned into the PstI restriction endonuclease site of 
pMAL ™-c2 (New England Biolabs, Inc., Beverley U.S.A.), to form pSMK.3'. Use of this 
restriction endonuclease results in an in-frame fusion of the terminal third of the M tuberculosis 
katG gene with the MBP. Cloning of an insert in the multiple cloning site ofpMAL ™-c2 results 
in inactivation of the f3-galactosidase a-fragment activity of the MBP-LacZ fusion. Therefore, 
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recombinants form white colonies on X-GAL plates in an a-complementing E. coli host 
(Yanisch-Perron et al., 1985). During cloning, a construct was isolated which contained the 
1747 bp insert in the opposite orientation to that in pSMK3'. This construct was designated 
pSMK3'opp· The reading frame of the M tuberculosis katG gene, with respect to the ma/E gene, 
was altered using the following strategy: pSMK3' was digested to completion with BamHI, 
which restricts the construct upstream of the insert. The resulting cohesive ends were removed 
by digestion with Mung Bean nuclease (Boehringer Mannheim) (see Appendix B), and the 
blunt-ended, linear fragment was religated to form the construct pSMK3'a, in which the katG 
sequences are translated in frame 2. The construct pSMKJ'b was made by digestion of pSMK3' 
with San, which digests the construct upstream of the insert, filling in of the resulting cohesive 
ends using T4 DNA polymerase (Amersham DNA Blunting kit) (see Appendix B), and 
religation of the blunt-ended, linear fragment. In this construct, the katG sequences are 
translated in frame 3. Another construct, pSMKd, was made by digestion of the 1747 bp 
fragment with Alu I and Pstl ( see Fig. 3. 3. b ), to generate a 961 bp fragment, containing the 
sequences downstream of the M tuberculosis katG gene. The fragment was cloned into the 
Xmnl and Pstl restriction endonuclease sites of pMAL ™ -c2 to yield pSMKd. The orientation 
and frame of the inserts of these constructs were confirmed by restriction analysis and 
sequencing over the junctions using the ma/E primer (New England Biolabs), which initiates 
sequence near the 3' end of the ma/E gene, and the pUC19 forward primer (Promega). 
3.3.4. PCR amplification of the M tuberculosis katG and cloning into pMALTM _c2 
Oligonucleotides were designed for the amplification of the whole M tuberculosis katG gene. 
The primers were based on the published sequence (GenBank/EMBL Accession number 
X68081 ), and were designed to bind to the beginning and end of the gene. Mismatches were 
introduced near the 5' end of each primer to generate convenient restriction endonuclease 
recognition sites. The forward pnmer was a 24-mer with the sequence: 
5'-AATGaatTcCCCGAGCAACACCCA-3', and the reverse primer was a 24-mer with the 
sequence: 5'-GGCAGtctaGATCAACCCGAATCA-3'. The lower case nucleotides indicate the 
mismatches, and the underlined nucleotides represent the restriction endonuclease sites for 
EcoRI and Xbal, respectively. The modifications in the forward primer resulted in the 
replacement of the GTG initiation codon of the katG gene with TTC, which encodes 
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phenylalanine. The complement of the TGA termination codon has been included at the 3' end 
of the reverse primer. The primers were designed such that cloning of the resulting PCR 
product into the EcoRI and XbaI restriction endonuclease sites of pMAL ™-c2 would result in 
an in-frame fusion of the M tuberculosis KatG with the MBP. The primers were predicted to 
amplify a 2250 bp fragment. PCR amplification was performed as described in Appendix B, 
using A,f tuberculosis H37Rv genomic DNA (0.1 µg) as the template, and an annealing 
temperature of 58°C. Control reactions included those with no template DNA or primers, or 
those with single primers only, to ensure that the PCR products were not the result of non-
specific binding of primers, or due to contaminating DNA. PCR products were separated by 
agarose gel electrophoresis, stained with ethidium bromide, and viewed under 3 IO nm UV 
transillumination. The 2250 bp PCR product was excised from an agarose gel, purified by the 
phenol squeeze method described in Appendix B, and digested to completion with the 
restriction endonucleases EcoRI and XbaI. The resulting fragment was cloned into the 
corresponding restriction endonuclease sites of pMAL ™-c2, to yield pSMKA. The 3' end of 
the katG gene was deleted from pSMKA by digestion of the construct with PstI to release a 
756 bp fragment. The restriction endonuclease, Pstl, digests the construct at a recognition site 
within the M tuberculosis katG gene (see Fig. 3. 7), and one within the multiple cloning site of 
pMAL TM _c2, on the 3' end of the insert. The 813 2 bp linear fragment, containing pMAL ™-c2 
and the 5' two thirds of the katG gene, was religated to form the construct pSMK5'. The 
756 bp PstI fragment described above was cloned into the corresponding site of pMAL ™-c2, 
with the katG sequences in-frame with the l\1BP, to form pSMK3'*. The sequence and frame of 
the inserts were verified by sequencing with the pUC 19 forward (Promega), the katG (see 
section 3.3.2.), and the malE (New England Biolabs) sequencing primers, and the katG forward 
and reverse PCR primers described above. 
3.3.5. SOS-PAGE and immunoblot analysis of proteins 
Stationary phase cultures of E. coli UM255 (katG, katE) transformants harbouring pSMKA, 
pSMK5', pSMK3', and pMAL ™-c2 were diluted 100-fold into 5ml of fresh 2x YT medium, 
containing ampicillin, and incubated at 3 7°C with shaking. When the cultures reached an 
OD6oonm of 0.4, a I ml sample was removed, and the cells harvested by centrifugation. The 
resulting pellet was resuspended in 50 µI of SOS-PAGE sample buffer (see Appendix C), and 
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represents the uninduced control. IPTG (Melford Laboratories, England) was added to the 
remainder of the culture, to a final concentration of 0.3 mM, and the cells were incubated for a 
further two hours at 37°C. The cells (1 ml) were harvested by centrifugation, and the cell pellet 
resuspended in 100 µl of SDS-P AGE sample buffer. All samples were heated to boiling for 
5 minutes, loaded on a 12.5% (w/v) SDS-polyacrylamide gel, and separated by electrophoresis 
at a constant current of 40 mA (see Appendix B). Proteins were visualized by staining with 
Coomassie'~ Brilliant Blue R-250 (Bio-Rad Laboratories). For immunoblots, the proteins iin 
unstained gels were transferred onto an Amersham C-super nitrocellulose membrane (see 
Appendix B). lmmunoblots were performed using the Chemiluminescence Blotting Substralte 
(POD) (Boehringer Mannheim), according to the manufacturers' instructions. Blots were 
probed with the anti-MBP rabbit serum supplied by New England Biolabs, and anti-rabbit IgG 
conjugated to peroxidase (POD) (Boehringer Mannheim). 
3.3.6. In vitro expression analysis of proteins encoded by the pMAL ™-c2 constructs 
The synthesis of proteins from the inserts of the pMAL ™ -c2 constructs was investigated using 
the E. coli S30 Extract System for Circular DNA (Promega, Madison U.S.A.). For the 
analysis, 1 µg of DNA was incubated for 2 hours at 37°C with 1 µl of Amino Acid Mixture 
Minus Methionine, 4 µl of Premix Without Amino Acids, 0.5 µl of 
35
S-methionine 
(Amersham, UK), and 3 µl of S30 extract, in a 10 µl reaction. The resulting radiolabelled 
proteins were precipitated with 40 µl of acetone, collected by centrifugation, and 
resuspended in 20 µl of SOS-PAGE sample buffer. The samples were boiled for 5 minutes, 
loaded on a 17 .5 % SDS-polyacrylamide gel, and separated by electrophoresis at a constant 
current of 40 mA. The gel was stained with Coomassie® Brilliant Blue R-250 (Bio-Rad 
Laboratories) for 30 minutes, and destained overnight in destaining solution, in order to 
visualize the molecular weight markers (see Appendix B). The gel was dried and the 
3sS-
labelled bands visualized by autoradiography. 
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3.3. 7. Purification of the fusion proteins by affinity chromatography 
Overnight cultures of E. coli UM255 transformants containing the recombinant plasmids, 
pS.tviKA, pSMK.5', and pSMK.3', were diluted 100-fold into fresh 2x YT medium (500 ml final 
volume) containing ampicillin. The cultures were grown to an OD6oonm of 0.5 (approximately 
2 x I 08 cells/ml). One millilitre of culture was centrifuged to collect the cells, as an uninduced 
control. The pellet was resuspended in 50 µI of SOS-PAGE sample buffer. IPTG was added to 
the remainder of the culture to a final concentration of 0.3 mM, to induce expression of the 
fusion proteins from the tac.: promoter, and the culture was incubated at 3 7°C for a further 
3 hours, with shaking. The cells were harvested by centrifugation, and I ml of supernatant was 
retained as a control. The pellet was resuspended in 30 ml column buffer (see Appendix C), and 
frozen at -20°C overnight. The cells were lyzed by passing the cell extract twice through an 
Arninco® French Pressure Cell (SLM Instruments, Inc., IL, U.S.A.), and the cell debris removed 
by centrifugation. An aliquot of the supernatant and pellet were retained for SOS-PAGE 
analysis. The fusion protein was purified from the whole cell extract by affinity 
chromatography, as recommended in the New England Biolabs Protein Fusion and Purification 
manual. The amylose resin (New England Biolabs) was poured into a 2.5 x 10 cm column, and 
washed with 8 bed volumes of column buffer. The crude extract was diluted to a protein 
concentration of 2.5 mg/ml and loaded onto the column. The flow rate of the column was 
adjusted to approximately 1 ml/minute. The column was washed with 10 volumes of column 
buffer, and the fusion protein eluted with column buffer containing IO mM maltose (BDH 
Chemicals Ltd., Poole England). Twenty 3 ml fractions were collected and the optical density 
at 280 nm measured. Fractions with the highest 00280nm values were pooled, and the protein 
concentrated using an Arnicon Centriprep-10 (Arnicon Inc., Beverley U.S.A.). The entire 
purification procedure was performed at 4°C. The concentration of the purified fusion proteins 
was determined using the Bio-Rad Protein Assay kit (see Appendix B). Digestion of the 
purified fusion proteins with the restriction protease, factor Xa (Boehringer Mannheim), was 
carried out at room temperature with the protease at a concentration of 200 µg/ml. 
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3.3.8. Preparation of cell extracts and enzyme assays 
E. coli UM255 (katG, katE) cells harbouring the pMAL ™-c2 constructs were grown and 
induced with IPTG, as described in section 3.3.5. The cells were collected by centrifugation, 
and resuspended in 500 µl of potassium phosphate buffer (pH 7.0) (see Appendix C) and 500 µ l 
of lysozyme (4 mg/ml) (Sigma Chemicals, St . Louis U.S.A.). The cell suspensions were 
incubated at 3 7°C for 60 minutes and frozen at -20°C overnight. The extracts were thawed in 
ice water, and the cellular debris removed by centrifugation. The supernatants were recovered, 
and the pellets were resuspended in I ml of potassium phosphate buffer. The protein 
concentrations of the supernatant and pellet fractions were determined using the Bio-Rad 
Protein Assay kit. Gel-staining catalase and peroxidase activity assays were performed by the 
method of Clare et al. ( 1984) and Wayne and Diaz (1986). Briefly, 70 µg each of the 
supernatant and pellet fractions were separated on 7.5% (w/v) non-denaturing polyacrylamide 
gels. For catalase stains, the gels were immersed first in 5 mM hydrogen peroxide (Saarchem, 
Krugersdorp S.A.) for 20 minutes, and then in a 50:50 solution of 2% ferric chloride (Sigma) 
and 2% potassium ferricyanide (Sigma). Peroxide stains were performed by immersing the gels 
in a solution containing 5 mM hydrogen peroxide and 0.5 mg/ml 3,3-diaminobenzidine (Sigma). 
Catalase activity bands were visualized as clear bands on a dark green background, and 
peroxidase activity bands were visualized as brown bands on a clear background. The semi-
quantitative catalase test of Wayne (1962) was performed using 80 µl of 10% (v/v) Tween 80 
(Sigma), 80 µI of 30% hydrogen peroxide and 50 µg of purified fusion protein. Catalase 
activity was assessed by monitoring the production of bubbles from the reaction mixture. 
Quantitative catalase activity assays were performed by the method of Beers and Sizer (1951 ). 
A total of 42.5 ng of purified fusion protein was mixed with 5 mM hydrogen peroxide in 50 mM 
potassium phosphate buffer (pH 7.0), and the decomposition of hydrogen peroxide was 
monitored by measuring changes in 00240nm for 60 seconds. One unit of catalase activity was 
defined as the amount of enzyme that catalyzes the decomposition of I µmo) of hydrogen 
peroxide per minute at 25°C. 
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3.4. RESULTS 
3.4.1. Confirmation of the sequence of the pD3 insert 
The insert of the clone, p03, which conferred resistance to ethyl methane sulfonate on DNA 
repair-deficient £. coli cells, was sequenced in both orientations (Shamila Nair, PhD thesis, 
University of Cape Town, 1993). The 1747 bp insert contains the 724 bp (241 amino acid) 
terminal portion of the M tuberculosis katG gene, as well as approximately l kb of downstream 
sequence Since the above study. the sequencing of the entire katG genes from M tuhercu/osis 
H37Rv and !NH-resistant clinical isolates of M. tuberculosis has been reported. One such 
sequence from the GenBank database (Accession number X68081) was aligned with the 
sequence obtained from the pD3 clone, using CL UST AL W (see Appendix B). The sequences 































gctgcag 174 7 
Figure 3.1 Nucleotide sequence of the 1747 bp PstI insert of pD3. The C and G residues indicated with arrows 
were absent from the sequence determined by S. Nair (PhD thesis, University of Cape Town, 1993), 
but present in the published katG sequence (GenBank Accession number X6808 l ). The katG coding 
sequence is underlined, and the PstI restriction endonuclease sites are in bold print. 
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In order to clear up these discrepancies, these regions of the insert were resequenced using the 
construct pSNS 100, which contains the 17 4 7 bp insert of pD3 in p UC 19. Sequencing reactions 
generated with the Pharmacia T7 sequencing kit resulted in band compressions in these areas. 
Separation of the reactions on a polyacrylamide gel containing 40% (v/v) formamide, and 
sequencing in the reverse direction with a custom designed katG sequencing primer (see section 
3.3.2.) did not resolve these compressions. The sequencing reactions were, therefore, repeated 
using the SequenaseTh1 Version 2.1 DNA Sequencing kit, and the base analogue deoxyinosine 
triphosphate (dlTP). The resulting sequencing ladder (Fig. 3.2) confirmed the presence of a 
fourth C at position 33, and a fourth G at position 40, labelled with respect to the beginning of 
the PstI restriction endonuclease recognition site (see Fig. 3.1). The sequence of the p03 insert 
was, therefore, identical to the published katG sequence. 
dlTP dGTP 
G A T C G A T C 
4Gs 
4Cs ] 
Figure 3.2 Sequencing ladders generated using the Sequenase™ Version 2.1 dITP and dGTP reagents. The 
positions of the band compression (dGTP) and the corresponding resolved regions (dlTP) are 
indicated. 
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3.4.2. Computer analysis of the 1747 bp insert sequence 
The experiments outlined in the introduction showed that a clone containing 1747 bp of 
M tuberculosis H37Rv DNA could confer resistance to ethyl methane sulfonate on DNA 
repair-deficient £. coli cells. In order to determine a possible basis for this observation, the 
DNA sequence of the fragment was analyzed. Analysis of the sequence on GENEPRO Thi 
Version 6.10 revealed three putative ORFs in the forward orientation (Fig. 3.3.a) . The 
truncated katG gene is encoded in frame I. Downstream of this are two putative open reading 
frames of 168 (ORF 168, frame 2) and 56 (ORF56, frame I) amino acids, encoding putative 
proteins of approximately 19 and 6 kDa, respectively. BLAST searches of these open reading 
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Figure 3.3 a) Open reading frame pattern of the 1747 bp Pstl insert from pD3 , generated using GENEPRO™. 
b) Linear restriction endonuclcase map of the 174 7 bp insert, including the more common restriction 
cndonuclcase sites and the putati\"e ORFs identified using GENEPRO™. 
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3.4.3. Cloning of the 1747 bp fragment in pMAL™-c2 
In order to assess the protective effects of the insert of pD3 on DNA repair-deficient cells E. 
coli, the insert was cloned into the expression vector pMAL Th1-c2 (Fig. 3.4). The use of 
pMAL Th1-c2 as an expression vector involves cloning the gene of interest downstream of, and 
in-frame with, the ma/£ gene, which encodes the maltose binding protein, to form a translational 
fusion . The ma/£ gene is under control of the tac promoter, which is repressed under normal 
conditions by the repressor encoded by the lac~ gene, which is also present on the vector. High 
levels of expression from the promoter can be obtained by induction of cells harbouring the 







XmnI Eco RI Bamlll XbaI San PstI Hindlll 
ma/E ... ATC GAG GGA AGG ATI TCA GAA TIC GGA ICC TCT AGA GTC GAC CTG CAG GCA AGC TIG ... /acZ 
i 
Factor Xa cleavage site 
Figure 3.4 Restriction endonuclease map of the expression vector, pMAL Thi _c2, and sequence of the polylinker 
region. 
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The I 7 4 7 bp PstI fragment from pD3 was cloned into pMAL ™ -c2, with the truncated katG 
ORF in-frame with the MBP, to form the construct pSMK.3' (see Fig. 3.7). To determine 
whether the resistance to ethyl methane sulfonate, conferred on the E. coli DK 1 cells, was due 
to expression of the truncated katG gene, or whether other regions of the insert were involved, 
the following constructs were made, as described in the materials and methods; pSMK.3'*, 
pSMK3 'a, pSMK3'b, pSMK3'opp, and pSMKd. The construct pSMK.3 '* contains only the katG 
portion of pSMK3', and no downstream sequences (see Fig. 3.7). Both pSMK3'a and pSMK3 'b 
have bases either removed or added to change the frame of the insert with respect to the MBP. 
In pSMK3',,pp, the 1747 bp insert is cloned in the opposite orientation to that in pSMK3' The 
latter three constructs, therefore, contain the katG sequences but do not express the gene 
product. The construct pSMK.d contains the region downstream of the Alu I site of the insert 
(see Fig 3.7), i.e. no katG sequences. 
3.4.4. Analysis of expression of proteins from the pSMK3' derivatives 
The vector, pMAL TM_c2, encodes an MBP-LacZ ex-fragment fusion protein of 50.8 kDa, while 
the ma!E gene alone encodes a protein of 42. 7 kDa. In pSMK.3 ', the truncated katG ORF 
encodes a 241 amino acid, or 26 kDa, portion of the KatG enzyme. Thus the construct encodes 
an :MBP-KatG3' fusion protein of 68 kDa. In pSMK.3'a, frame 2 of the insert contains a 
termination codon 160 bp downstream of the Pstl site. Thus, the construct should produce a 
MBP fusion of 49 kDa. Similarly, construct pSMK.3'b should produce a fusion protein of 
56 kDa, and pSMK.3'0pp should produce a protein of 52 kDa, due to fusion of the ma!E gene 
with sequences on the 3' end of the insert. The synthesis of proteins encoded by the constructs 
was analyzed using the E. coli S30 cell-free transcription and translation system (Promega) 
(Fig. 3.5). Fusion proteins of 50 kDa, 68 kDa, 52 kDa, 49 kDa, and 56 kDa were produced by 
pMAL ™-c2, pSMK.3', pSMK.3'opp, pSMK.3'a, and pSMK.3'b, respectively, as predicted. The 
construct pSMK.d produced a protein of < 49 kDa, possibly due to termination of translation 
immediately after the end of the ma!E gene. No differences were observed in the proteins 
produced by pSMK.3' and pSMK.3'*, which suggests either that the downstream sequences 
present in pSMK3' do not encode any proteins, or that they do not contain promoters which 
function in E. coli. The transcription/translation results were confirmed by immunoblot analysis 
using anti-MBP antibodies (results not shown). 
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Figure 3.5 Autoradiogram of proteins produced by the pSMK3' derivatives, using the E. coli S30 cell-free 
transcription and translation system (Promega). The lanes were loaded as follows: 1) pMAL ™-c2; 
2) pSMK3'; 3) pSMK3'opp; 4) pSMK3'*; 5) pSMK3'a; 6) pSMK3'b; and 7) pSMKd. The positions 
of the molecular weight markers (Pharmacia) are indicated. The major protein bands 
corresponding to the MBP fusion proteins are indicated with black dots. 
3.4.5. Amplification and cloning of the whole katG gene in pMAL ™-c2 
Oligonucleotides were designed for the amplification of a 2250 bp fragment containing the 
M tuberculosis katG gene. The primers were used in a PCR with M . tuberculosis H37Rv 
genomic DNA as the template. Reactions containing no template DNA or no primers yielded 
no product, while a reaction containing the forward primer yielded two products of 
approximately 700 and 800 bp. Only a reaction containing both primers at equal concentrations, 
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Figure 3.6 Agarose gel of the amplified katG gene from M tuberculosis H37Rv and the control PCR reactions. 
The lanes were loaded as follows: l) DNA molecular weight marker VI (Boehringer Mannheim); 
2) Both primers and M tuberculosis H37Rv template DNA; 3) Forward primer only; 4) Reverse 
primer only; 5) No primers; and 6) No template DNA. 
The resulting 2250 bp fragment was cloned into the EcoRI and XbaI sites of pMAL n.1-c2, in-
frame with the MBP, to form the construct pSMKA. A total of 1.1 kb of the insert was 
sequenced, in order to ensure that no errors were introduced during amplification, and found to 
be identical to the published M tuberculosis katG sequence. Another construct, pSMK5', was 
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Figure 3. 7 Linear restriction endonuclease map of the M tuberculosis katG gene and downstream sequences. 
The restriction endonuclease sites, EcoRI and Xbal, were introduced by PCR. The position of the 
katG coding region is indicated. The regions present in the pMAL ™ -c2 constructs are shown 
below. 
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3.4.6. Analysis of expression and activity of the MBP-KatG fusion proteins 
Expression of the fusion proteins from pSMKA, pSMK.5', and pSMK.3' was examined by IPTG-
induction of E. coli UM255 cells carrying the plasmids, and separation of the resulting proteins 
by electrophoresis on a 12.5% (w/v) SDS-polyacrylamide gel (Fig. 3.8.a) . The pSMKA 
construct was predicted to produce a fusion protein of approximately 125 kDa, due to fusion of 
the 82 kDa KatG with the MBP, while the MBP-KatG5' fusion protein was predicted to be 
99 kDa. The fusion proteins were only visible after induction with IPTG, due to repression of 
the tm: promoter by the Lacf 'l reprcssor. The fusion proteins had relative mobilities of 
approximately 50.8 kDa (MBP-LacZ), 125 kDa (MBP-KatGAll), 99 kDa (MBP-KatG5'), and 
68 kDa (MBP-KatG3'), as predicted. The two larger fusion proteins, however, appeared 
predominantly as cleavage products of approximately 90 kDa, which cross-reacted with anti-
MBP antibodies (Fig. 3.8.b), suggesting that the cleavage site lies within the KatG protein, near 
the C-terminal. Analysis of the bands on the autoradiograph in figure 3. 8. b, using a Shimadzu 
CS-9000 dual wavelength flying spot scanner, revealed that 94.6% of the MBP-KatGAll, and 
92 .8% of the MBP-KatG5' fusion protein was present as the cleavage product. In an attempt to 
prevent the formation of the cleavage product, expression of the fusion proteins was tested in a 
variety of E. coli strains, namely LKl 11, LKl 12, TBl, DH5a, JM109, and HBlOl, and by 
induction at different temperatures, using different amounts of IPTG, and for different time 
periods. Under all of these conditions, the same pattern of protein synthesis was observed 
(results not shown). Cloning of the insert in-frame with the maltose binding protein in 
pMAL TM -p2 did not resolve this problem either. In this vector, the malE gene contains a signal 
peptide, which directs fusion proteins to the periplasm. However, fusion protein expressed from 
pMAL TM -p2 constitutes only 5-10% of total cellular protein, and could not be detected on an 
SDS-polyacrylamide gel (results not shown). The cleavage is probably due to an E. coli 
protease. 
Cell extracts from uninduced and IPTG-induced E. coli UM255 cells harbouring the pMAL TM_ 
c2 constructs were separated by electrophoresis in 7.5% (w/v) non-denaturing polyacrylamide 
gels. Gel staining catalase and peroxidase assays (Fig. 3. 9) revealed that only the fusion 
containing the whole KatG protein was active. Activity, therefore, requires both domains of the 
protein, and is not affected by the presence of the MBP. The E. coli UM255 cells are mutant in 
both katG and katE, and therefore display no endogenous catalase activity. 
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Figure 3.8 Expression of the MBP-KatG fusions in E. coli UM255. The proteins were separated on 12.5% 
(w/v) SDS-polyacrylamide gels. Proteins were visualized by a) staining with Coomassie® Brilliant 
Blue R-250, and b) immunoblotting with anti-MBP serum. The lanes were loaded as follows: 
1) Molecular weight standards (Pharmacia); 2) untransformed E. coli UM255 induced; 3) and 4) 
uninduced and induced fractions from E. coli (pMAL ™-c2); 5) and 6) corresponding fractions 
from E. coli (pSMKA); 7) and 8) corresponding fractions from E. coli (pSMK.5'); 9) and 10) 
corresponding fractions from E. coli (pSMK.3'). 
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Figure 3.9 Gel-staining catalase and peroxidase activity assays. Approximately 70 µg of total protein isolated 
from uninduced and induced cultures of E. coli UM255 harbouring the pMAL n.,1-c2 constructs 
were separated by electrophoresis in a 7.5% non-denaturing polyacrylamide gel, and stained for 
A) peroxidase, and B) catalase activity. The lanes were loaded as follows: 1) untransformed E. 
coli UM255 uninduced 2) untransformed E. coli UM255 induced; 3) and 4) uninduced and 
induced fractions from E. coli (pMAL ™-c2)~ 5) and 6) corresponding fractions from E. coli 
(pSMKA); 7) and 8) corresponding fractions from E. coli (pSMK.5'); 9) and 10) corresponding 
fractions from E. coli (pSMK.3'). 
3.4. 7. Purification of the MBP-KatG fusion proteins and analysis of enzyme activity 
The MBP-KatG fusion proteins were purified by affinity chromatography, as described in the 
materials and methods. The purity of the fusion proteins was analyzed by SDS-polyacrylamide 
gel electrophoresis of samples taken during the purification process (Fig. 3 .10). These results 
indicated that the fusion proteins were present after induction of the cells, in the supernatant 
after lysis, and in the fractions eluted from the column with column buffer containing maltose. 
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Figure 3.10 Separation of protein purification products on a 12.5% (w/v) SDS-polyacrylamide gel. a) 1) Purification of MBP-KatGAll. The lanes were loaded as follows: 1) Molecular weight standards (Pharmacia); 2) E. coli UM255 (pSMKA) uninduced; 3) E. coli UM255 (pSMKA) induced; 4) E. coli UM255 (pSMKA) cell extract; 5) Cell extract passed through the amylose column; 6) Eluant from the amylose column. 2) Cleavage of the MBP-KatGAll fusion protein with 
factor Xa: 1) Molecular weight standards; 2) No factor Xa; 3) 200 ng factor Xa digested at 4°C; 4) 200 ng factor Xa digested at room temperature; 5) 400 ng factor Xa digested at room 
temperature; 6) 1 µg factor Xa digested at room temperature. All of the lanes contain 20 µg of fusion protein. b) Purification of MBP-KatG5'. The lanes were loaded as follows: 1) E. coli UM255 (pSMK5') uninduced; 2) E. coli UM255 (pSMK5') induced; 3) Cell extract; 4) Pellet fraction; 5) Cell extract passed through the amylose column; 6) Eluant from the amylose column. 2) Cleavage of the fusion protein with factor Xa: 1) Molecular weight standards; 2) No factor Xa; 3) 200 ng factor Xa digested at 4°C; 4) 200 ng factor Xa digested at room temperature; 5) 400 ng factor Xa digested at room temperature; 6) I µg Xa digested at room temperature. All of the lanes contain 20 µg of fusion protein. c) Purification ofMBP-KatG3' and cleavage with factor Xa. The lanes were loaded as follows: I) E. coli UM255 (pSMK3') uninduced; 2) E. coli UM255 (pSMK3') induced; 3) Supernatant after harvesting of the cells; 4) Pellet fraction of the cell extract; 5) Supernatant fraction of the cell extract; 6) Eluant from the amylose column; 7) Molecular weight standards; and 8) MBP- KatG3' cleaved with factor Xa. 
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The total yield of MBP-KatGAll was I 0.2 mg/I of culture, however, the full-size product is only 
present as 31.5% of the preparation (as calculated from a densitometer scan of Fig. 3.10.a.1, 
lane 6), therefore, the yield of the full-size MBP-KatGAll protein is approximately 3.57 mg/I of 
culture. Cleavage with factor Xa was performed using increasing amounts of the protease, at 
room temperature and at 4°C. The most efficient digestion was obtained at room temperature 
with I µg of factor Xa per 20 µg of fusion protein (Fig. 3 .10.a.2). Cleavage of MBP-KatGAII 
resulted in proteins of 35, 42.7, 47, and 82 kDa. The 42.7 k.Da protein is the MBP, and the 82 
kDa protein is the full-size M. tuherc:u/usis KatG. The smaller proteins, 35 and 47 kDa, 
represent the cleavage products of the KatG enzyme. The total yield of MBP-KatG5' was 27.6 
mg/I of culture. The yield of the full-size fusion protein, which is present as 40.4% (as 
calculated from a densitometer scan) of the total preparation, is 11 .6 mg/I of culture. Cleavage 
with factor Xa resulted in proteins of approximately 42.7, 47, and 56 k.Da, representing the 
MBP, the KatG cleavage product, and KatG5', respectively. The 56 k.Da KatG5' protein is 
present in lower levels and appears to have a retarded mobility in the polyacrylamide gel (Fig. 
3 .1 O.b.2). The yield of MBP-KatG3' was 50 mg/I culture, and the purity was > 95%, as 
estimated from an SDS-polyacrylamide gel (Fig. 3.1 O.c). Cleavage of the fusion with protease 
factor Xa resulted in the release of the 42.7 k.Da MBP, and the 26 k.Da KatG3' protein. The 
yields of fusion protein obtained from affinity chromatography were similar to those predicted 
by the manufacturers (10-40 mg/litre culture) (New England Biolabs Protein Fusion and 
Purification manual) . The variations in the yield and purity of the fusion proteins may have been 
due to the size differences of the proteins. Alternatively, the low yield may have been due to the 
retention of significant levels of the larger fusion proteins in the pellet fractions of the cell 
extracts. The full-size KatG and the 51 two thirds may have formed non-specific associations 
with other proteins in the cell extract, thus resulting in protein contaminants after 
chromatography. 
A semi-quantitative catalase assay, using 50 µg of purified fusion protein, revealed activity with 
MBP-KatGAll, but not with the other fusions. Catalase activity was quantified by measuring 
the decomposition of hydrogen peroxide by the fusion proteins at 240 nm. A total of 42.5 µg of 
the full-size MBP-KatGAII caused a decrease in the concentration of hydrogen peroxide of 
198630 µM/minute . Thus the specific catalase activity of the preparation was calculated as 
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2336.824 units/mg of protein at 25°C. The fusion proteins containing the 5' or 3' segments of 
KatG exhibited no detectable catalase activity. 
3.5. DISCUSSION 
The primary subject of this study was a clone, designated pD3, which conferred resistance to 
ethyl methane sulfonate on DNA repair-deficient E coli cells. Analysis of the sequence of the 
174 7 bp insert of pOJ revealed two putative open reading frames downstream of the 
M tuberculosis katG gene. Analysis of protein synthesis by constructs containing the insert, 
however, revealed no additional proteins in the presence of these sequences. If the sequences 
downstream of the katG gene were transcribed on a polycistronic message with the malE-katG 
fusion, the level of proteins encoded by downstream sequences would be high, due to the high 
activity of the IPTG-induccd tac promoter. Thus the protein bands would be present at 
approximately equal intensity to those of the fusion proteins on an SDS-polyacrylamide gel, 
which they clearly were not. Little is known about transcription termination in mycobacteria. 
Nair et al. (1993) identified a 12 bp inverted repeat, 36 bp downstream of the termination codon 
of the gene encoding Ml43 from M. intracel/ulare. The authors suggest that the formation of 
stable hairpin-loop secondary structures in regions of dyad symmetry may be a common 
mechanism of terminating transcription in mycobacteria (Collins et al., 1990; Nair et al., 1992; 
Shinnick et al., 1989). Immediately downstream of the M tuberculosis katG gene is a 7 bp 
inverted repeat sequence with dyad symmetry, which may be analogous to that described by 
Nair et al. (1993). The lack of detectable protein production by the sequences downstream of 
the M tuberculosis katG gene suggests that, either no proteins are encoded in this region, or 
they are not transcribed as a part of the malE-katG mRNA message, and do not contain 
promoters which function in E. coli. 
Expression of the whole M tuberculosis katG gene, as well as the 5' two-thirds, as a 
translational fusion with the maltose binding protein resulted in the formation of a cleavage 
product. As mentioned in section 3.4.5, only half of the amplified katG gene was sequenced to 
check for PCR errors. However, the region sequenced included the area between nucleotides 
3180 and 3240, labelled with respect to the published sequence (GenBank Accession number 
X6808 l ). This is the approximate region of the gene which should contain the cleavage site in 
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order to produce a fusion protein of 90 kDa. No discrepancies in the sequence were noted in 
this region, suggesting that the cleavage was not due to an error in the coding sequence 
introduced during the PCR amplification. This is substantiated by the fact that the full-size 
MBP-KatGAJI fusion protein exhibits both catalase and peroxidase activities. The presence of 
cleavage products of the M tuberculosis KatG has been noted by Johnsson et al. ( 1997) and 
Heym et al. ( 1997). The first-mentioned authors observed a cleavage product of approximately 
77 kDa, and suggest that this is due to proteolytic degradation of the protein. In addition., 
proteolytic cleavage has been observed in the catalase isolated from rat liver (Robbi and 
Laza row, 1978; Crane et al., 1982). Cleavage of the fusion proteins in 1~·- cult cells could not be: 
prevented by using another E. coli strain, or by varying the concentration of IPTG, or the time 
period of induction (results not shown). Only the full-size fusion product exhibited catalase and 
peroxidase activity. This agrees with the observations of Zhang et al. ( 1992), who 
demonstrated that deletion of the 3' end of the M. tuberculosis katG gene resulted in loss of 
enzyme activity. Although the catalase and peroxidase activities are predicted to lie in the 
N-terminal region of the protein (Welinder, 1991; 1992), the C-terminal region may play an 
important role in substrate binding or subunit interaction. The specific activity of the MBP-
KatG fusion was 2336.824 units/mg of protein. This is similar to that recently reported by 
Johnsson et al. (1997) for a recombinant M tuberculosis KatG isolated in £. coli (2420 
units/mg). The fact that fusion of the KatG protein with the maltose binding protein did not 
affect the activity of the enzyme, shows that dimerization and correct folding of the enzyme still 
occur. Similarly, Zhang et al. (1992) demonstrated that fusion of the M tuberculosis KatG to a 
portion of the Lacz protein did not interfere with enzyme activity. 
The pMAL TM -c2 vector provides a convenient and efficient means of overproducing a protein of 
interest in E. coli cells. IPTG-induction of the translational fusion with the maltose binding 
protein results in large quantities of the fusion which can easily be detected by SDS-
polyacrylamide gel electrophoresis. The purification of the fusion protein from total cell 
extracts by affinity chromatography is also rapid and simple. The constructs described in this 
chapter allow overexpression of different regions of the M. tuberculosis KatG gene in E. coli, 
and provide a useful means of assessing the effects of the various regions of the KatG protein on 
E. coli cells exposed to various DNA damaging agents, which is the focus of the next chapter. 
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COMPLEMENTATION OF DNA REPAIR-DEFICIENT E. COLI 
STRAINS WITH TI-IE M. TUBERCULOSIS KATG GENE 
4.1. SUMMARY 
This chapter describes complementation studies with the M tuberculosis katG gene in E. coli 
strains mutant in DNA repair enzymes. The whole KatG, the proximal two thirds, and the 
terminal third of the enzyme were overexpressed, as translational fusions to the maltose binding 
protein, in 5 DNA repair-deficient strains of E. coli. The transformants were tested for their 
ability to survive exposure to three DNA damaging agents, short wavelength ultraviolet (UV) 
light irradiation, mitomycin C, and hydrogen peroxide. Overexpression of the proteins resulted 
in an increase in the survival of recA mutants exposed to UV irradiation and hydrogen peroxide, 
and in the survival of excision repair mutants exposed to mitomycin C. Both regions of the 
M tuberculosis KatG protein conferred the above effects, and this was independent of the 
catalase or peroxidase activity of the enzyme. The results suggest that the M tuberculosis katG 
gene may encode a novel function related to the repair of DNA damage, and this may have 
implications for the survival of M tuberculosis in the presence of DNA damaging agents, for 
example, in the macrophage. UV sensitivity tests on a selection of mycobacterial species 
revealed that the M tuberculosis complex organisms are more sensitive than the 'atypical 
mycobacteria.' UV sensitivity tests on M intrace/lulare and M tuberculosis strains mutant in 
katG revealed no significant differences in the sensitivity of the cells in the absence of this gene. 
This suggests that the katG gene product does not play a significant role in the survival of 
mycobacterial cells after exposure to short wavelength UV irradiation, in the absence of 
mutations in essential DNA repair genes. 
4.2. INTRODUCTION 
The previous chapter describes the construction and testing of systems for the overexpression of 
different regions of the M tuberculosis KatG enzyme in E. coli cells. Fusions of the katG gene 
with the ma/E gene, encoding the maltose binding protein, were constructed in the vector 
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pMAL ™-c2, and shown to express fusion proteins of the predicted size. Only a fusion 
containing the full size KatG enzyme exhibited catalase and peroxidase activity, as expected 
from previous reports (Zhang et al., 1992). The effect of these fusions on DNA repair-deficient 
E. coli cells exposed to various DNA damaging agents was tested. 
Five DNA repair-deficient E. coli strains were selected for the study, based on their sensitivity 
to short wavelength (254 nm) UV light and mitomycin C. In E. coli strain DK l, the recA gene:: 
is deleted, and the reel: gene is non-functional due to a point mutation. These cells are, 
therefore, unable to induce the production of many of the DNA repair genes in the SOS 
response, in response to DNA damaging agents, and do not have a functional recombinational 
repair system. Strain CC 118 contains a mutation in the N-terminal recombinase domain of 
RecA, and in the recE gene (Manoi} and Beckwith, 1985). The cells are, therefore, able to 
induce the SOS response, but are defective in recombinational repair. The strains AB 1884, 
AB 1885, and AB 1886 are derived from strain AB 1157, in which the recE gene is deleted 
(Howard-Flanders et al., 1966). These strains are mutant in the uvrC, uvrB, and uvrA genes, 
respectively, which are required for Uvr-dependent nucleotide excision repair. The cells mutant 
in uvrA and uvrB are completely defective in excision repair, while cells mutant in uvrC exhibit 
residual nucleotide excision repair activity. This may be due to the sufficient stabilization of 
damaged DNA by the (UvrA)2(UvrB) complex to increase the efficiency of other repair systems 
(Van Houten, 1990). These cells are also mutant in recE, but are able to undergo 
recombinational repair via a RecE-independent pathway. The different strains were used in this 
study in an attempt to identify which aspects or pathways of DNA repair were complemented by 
the M tuberculosis katG gene. In addition, three different DNA damaging agents were used. 
These agents each cause different lesions in the DNA, which are repaired via specific pathways. 
As reviewed in Chapter 2, short wavelength UV irradiation primarily causes pyrimidine dimers, 
mitomycin C causes cross-linking of complementary DNA strands, and hydrogen peroxide 
causes a variety of lesions, including base modification, strand breaks, and base fragmentation. 
Until recently, attempts to introduce mutations m or to inactivate specific genes in 
M tuberculosis complex organisms have been unsuccessful. Experiments have been hampered 
by the high frequency of illegitimate recombination in these organisms (Kalpana et al., 1991; 
Aldovini et al., 1993; Colston and Davis, 1994). Thus the availability of appropriate DNA 
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repair-deficient mutants of the mycobacteria has been limited. The construction of mutants of 
M. smegmatis, in which the recA gene has been inactivated by allelic exchange, has recently 
been reported (Scholtz et al., ASM Abstract U-117, 1997). These mutants exhibited a > I 00-
fold reduction in viability after exposure to ethyl methane sulfonate, relative to wild type 
M. smegmatis cells. These mutants may be useful for future complementation studies with the 
M. tuberculosis katG gene as described in this chapter with E. coli mutants. 
In an attempt to examine the role played by the katG gene in the survival of mycobacteria 
exposed to DNA damaging agents, in the absence of DNA repair mutants of mycobacteria. the 
association between the presence of a functional KatG and sensitivity to UV was examined. 
Interspecies differences in the sensitivity of mycobacteria to short wavelength UV irradiation 
have been reported (Collins, 1971; David et al., 1971 ). The UV sensitivities of a range of 
mycobacteria were examined by David ( 1973 ). The order of sensitivity was found to be: 
M. tuberculosis > M. fortuitum > M. avium-intracellulare > M. kansasii > M. smegma/is. The 
author examined the underlying factors related to the variable responses of these organisms to 
UV irradiation. It was demonstrated, using phage reactivation experiments, that the different 
responses of, at least, M. smegma/is and M. fortuitum were due to differences in the efficiency 
of their respective repair systems. The UV sensitivity of the mycobacteria was shown to be 
independent of the growth rate, and G+C content, but correlated with the size of the genome 
and the cellular concentration of carotenoids. 
4.3. MATERIALS AND METHODS 
The source and characteristics of the DNA repair-deficient E. coli strains and the mycobacterial 
strains used in this study are given in Appendix A. 
4.3.1. Transformation of DNA repair-deficient E. coli strains with the pMAL™-c2 
constructs 
Competent E. coli OKI, CCI 18, ABI884, ABI885, and ABI886 cells were prepared by the 
method of Chung and Miller (1988), using DMSO. The cells were transformed with the 
plasmids pMAL ™-c2, pSMKA, pSMK5', and pSMK3', and selected on 2x YT agar plates 
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containing ampicillin. Transformants were verified by analysis of protein production after 
IPTG-induction, as described in section 3.3.5. 
4.3.2. UV sensitivity tests 
IPTG-induced cultures of E. coli mutants, transformed with the pMAL TM_c2 constructs ( see 
section 3.3.5), were diluted IO-fold in water, and 5 ml placed in a glass petri dish. These were 
irradiated with short wavelength (254 nm) UV light, at a dose of I J/m2, for different time 
periods, with a Model UVG-1 l 254 nm single wavelength lamp (UV Products, Upland U.S.A.). 
UV doses were measured using a Model J-225 short wavelength Blak-Ray UV meter (UV 
Products, Upland U.S.A.). Samples were withdrawn before irradiation and at the indicated 
times, diluted in water, and plated on 2x YT agar containing ampicillin. After overnight 
incubation at 3 7°C, colonies were counted, and surviving fractions calculated relative to the 
unirradiated sample. All experiments were performed in the absence of direct light, and the 
plates were incubated in the dark to avoid photoreactivation (Jones and Woods, 1981; Abratt 
el al., 1985). Semi-quantitative UV sensitivity tests were performed by streaking 10 µI of 
stationary phase E. coli cells on a 2x YT agar plate, and selective exposure to short wavelength 
UV irradiation at a dose of I J/m2. Sections of the plate were shielded from irradiation with 
cardboard for the appropriate time periods (Sambrook et al., 1989). The UV sensitivities of a 
selection of mycobacterial species were tested using the quantitative method described above. 
Mycobacterial cells were grown to stationary phase in 5 ml Middlebrook-ADC-Tween (3-4 days 
for the rapid growers, and 14 days for the slower growers). Irradiated samples were plated on 
Middlebrook-ADC agar plates containing 0.01% (w/v) cycloheximide (Fluka Biochemicals), 
and incubated at 37°C for 5 days (rapid growers) or 4-6 weeks (slow growers). Clumping of 
the mycobacterial cells was minimized by including Tween 80 in the medium, and by vigorous 
stirring of the cell suspension before diluting and plating, to facilitate accurate colony counts. 
All experiments were performed in triplicate. 
4.3.3. Mitomycin C sensitivity tests 
IPTG-induced cultures of the E. coli transformants were diluted l 0-fold in fresh medium, and a 
sample was removed for plating. Mitomycin C (Merck, Darmstadt Germany) was added to a 
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final concentration of 6 µg/ml, and the cells were shaken at 3 7°C. Samples were removed at 
different time points, diluted in water and plated on 2x YT agar plates containing ampicillin at a 
concentration of 50 µg/ml. Colonies were counted after overnight incubation at 3 7°C, and 
surviving fractions calculated as described for the UV sensitivity experiments. Mitomycin C 
was freshly prepared for each set of experiments, and kept on ice between experiments. Semi-
quantitative mitomycin C sensitivity tests were performed by plating stationary phase E. coli 
cells on plates containing mitomycin C at a concentration of I µg/ml, and on control plates 
without mitomycin C. Sensitivity to mitomycin C was determined by comparison of growth on 
the mitomycin C plates with those on the control plates. 
4.3.4. Hydrogen peroxide sensitivity tests 
Hydrogen peroxide sensitivity tests were carried out by the method of Demple et al. (1983), as 
described for mitomycin C, except that hydrogen peroxide (Saarchem) was added to a final 
concentration of 50 mM. Results were processed in the same way as for the UV and mitomycin 
C experiments. 
4.4. RESULTS 
4.4.1. Selection of E. coli DNA repair-deficient mutants for this study 
The following DNA repair-deficient E. coli strains were tested for their ability to survive 
treatment with short wavelength UV light and mitomycin C, using semi-quantitative methods: 
DKI(recA, recE), HBIOI (recA), JC5519 (rec£, recBC), JC8679 (recBC), CCI 18 (recAJ, 
recE), AB 1157 (recE), AB 1884 (uvrC, recE), AB 1885 (uvrB, recE), and AB 1886 (uvrA, 
recE). Five strains, DK I, CC 118, AB 1884, AB 1885, and AB 1886, exhibited significant 
sensitivity to either or both of the agents (results not shown}, and were selected for further 
experiments. Strain MC I 060, the parent strain of DK 1, and AB 1157, the parent strain of 
AB 1884, AB 1885, and AB 1886, were included as controls. Pilot experiments were performed 
to determine the doses of UV irradiation, mitomycin C, and hydrogen peroxide which resulted 
in a significant difference between the survival curves of parent and mutant strains, but which 
allowed sufficient survival of mutants such that colony counts remained accurate. Doses of 
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8 J/m2/s UV irradiation, 6 µg/ml mitomycin C, and 50 mM hydrogen peroxide were selected for 
further experiments. 
4.4.2. Transformation of the mutant E.coli strains with the pMAL™-c2 constructs 
Competent E. coli DKl, CCI 18, AB1884, AB1885, and AB1886 cells were transformed with 
the pMAL ™-c2-katG constructs, pSMKA, pSMK.5', and pSMK.3', described in Chapter 3, as 
well as the vector control. In addition, competent E. coli DKI cells were transformed with the 
pSMK.3' derivatives, pSMK.3'*, pSMK3'a, pSMK3'b, pSMK3'0 pp, and pSMKd. Transformants 
were verified by SDS-P AGE analysis of proteins produced after IPTG-induction. The 
transformants all overproduced the predicted size fusion proteins after induction (results not 
shown). 
4.4.3. The UV sensitivities of the E. coli DNA repair-deficient transformants 
The transformants described in section 4.4.2. were examined for their ability to survive exposure 
to short wavelength (254 nm) UV light irradiation. The parent strains, MC1060 and ABI 157, 
were included as controls. A representative selection of survival curves is shown in figure 
4.1.a, and the results are summarized in table 4.1. The recA+ and uvr+ parent strains, MCI060 
and ABl 157, showed < 1% killing at the doses used, due to the presence of efficient DNA 
repair systems for the removal of damaged DNA. E. coli DKl (pMAL ™-c2) had a similar UV 
survival curve to that of untransformed OKI (not shown), i.e. a shoulderless curve representing 
exponential killing of the cells, which levels out as the damage sites on the DNA become 
saturated. When DK I was transformed with pSMKA or pSMK.5', the survival curves levelled 
out with a higher surviving fraction (Fig. 4.1.a, panel 1), and the cells exhibited a > 200-fold 
increase in survival at a UV dose of 8 J/m2/s {Table 4.1). A similar effect was observed with 
DKI (pSMK.3'), with the increase in survival being 108-fold. The presence of the katG 
constructs, therefore, restored a level of resistance to the cells, although not to wild type levels. 
The UV survival curves for the CC 118 transformants were similar to those of DK 1, but this 
strain is naturally more resistant to UV (Fig. 4.1.a, panel 2). The presence of both pSMKA and 
pSMK.5' increased the survival of the cells 36.7- and 28.2-fold, respectively, at a dose of 
6 J/m2/s (Table 4.1). For CCI 18 (pSMK.3'), survival was approximately 2-fold greater than the 
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control at 6 J/m2/s. From the AB 1886 survival curves (Fig. 4.1.a, panel 3), and the relative 
survival values given in table 4.1, it is evident that none of the katG constructs conferred any 
resistance to UV on the excision repair mutants. In fact, in some cases the constructs increased 
the sensitivity of the cells. 
Table 4.1 Analysis of the UV sensitivities of E. coli DNA repair mutants transfonncd with the katG constructs. 
Strain Construct Sun-. fraction (6 J/m1/s)1 Rel. sun-. x/c2 
DKl pMAL™-c2 2.07 (± 0. 79) X 10-5 1.00 
pSMKA 4.56 (± 1.01) X 10-3 220.3 
pSMK5' 4.36 (± 1.25) X 10-3 210.6 
pSMK3' 2.25 (± 1.01) X 10-3 108.7 
CCI18 pMAL™-c2 6.24 (± 2.45) X 10-5 1.00 
pSMKA 2.29 (± 0.63) X 10-3 36.7 
pSMK5' I. 76 (± 0.63) X 10-3 28.2 
pSMK3' 1.52 (± 0.68) X 10-4 2.40 
ABI884 pMAL ™-c2 1.50 (± J.45) X 10-4 1.00 
pSMKA l.06(±0.2I)x 10-5 0.07 
pSMK5' 1.26 (± 1.4 7) X 10-4 0.84 
pSMK3' 4.13 (± 3.09) X 10-5 0.28 
ABI885 pMAL™-c2 1.13 (± 1.07) X 10-5 1.00 
pSMKA 6.98 (± 0.78) X 10-6 0.62 
pSMK5' 1.11 (± 0.50) X 10-5 0.98 
pSMK3' 1.22 (± 0.62) X 10-5 1.08 
AB1886 pMAL™-c2 2.07 (± 0.56) X 10-5 1.00 
pSMKA J.48 (± 0.46) X )0-5 0.71 
pSMK5' 8.89 (± 3.63) X J0-6 0.43 
pSMK3' 9.57 (± 2.46) X 10-6 0.46 
1 Surviving fraction at a dose of 6 J/m2/s. The mean of three independent experiments ± the standard error of the mean. 
2 Relative survival i.e. the surviving fraction of the construct al a dose of 6 J/m2/s divided by the surviving fraction of the 
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Figure 4.1 Effect of the pMAL ™-c2- katG constructs on the survival of E. coli DNA repair mutants exposed to A) UV, B) mitomycin C, and C) hydrogen peroxide. The UV and hydrogen peroxide survival curves represent the average of 3 experiments, and the mitomycin C survival curves represent the average of two experiments performed on the same day. Error bars were calculated using the standard error of the mean. Curves are shown for DKI (first column), CCI 18 (second column), and AB1886 (third column). - pMAL ™-c2;-- pSMKA;-·- pSMK5'; ..• ,, pSMK3'. The survival curves of the AB1884 and AB1885 transformants showed similar trends to those of the AB1886 transformants, and have, therefore, not been included. The survival curves of the parent strains, 
MC1060 and ABl 157 arc shown in A and B. 
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4.4.4. The UV sensitivities of E. coli DKl cells harbouring the pSMK3' derivatives 
To determine whether the protective effects observed with the pSMK.3' construct were due to 
the presence of the M. tuberculosis katG, or sequences downstream of the gene, E. coli DK I 
cells harbouring the pSMK.3' derivatives, pSMK.3'*, pSMK3'a, pSMK.3'b, pSMK3'opp, and 
pSMKd, were tested for their ability to survive exposure to short wavelength UV irradiation. 
The characteristics of these constructs are described in section 3.4.3. Briefly, pSMK.3'* 
contains only the katG portion of pSMK.3', and no downstream sequences, pSMK3'a and 
pSMK3'b have bases either removed or added to change the frame of the insert with respect to 
the maltose binding protein, pSMK3'opp, contains the 1747 bp insert in the opposite orientation 
to that in pSMK.3', and pSMKd contains the region downstream of the katG gene. Only the 
constructs pSMK.3' and pSMK.3'* express the MBP-KatG3' fusion protein. The results of three 
independent UV sensitivity experiments are represented in figure 4.2. It is evident that only the 
constructs expressing the MBP-KatG3' fusion, pSMK.3' and pSMK.3'*, conferred resistance to 
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Figure 4.2 UV sensitivity curves of E. coli DKI cells harbouring the pSMK3' derivatives. The curves represent 
the average of 3 e,qx:riments. Error bars were calculated using the standard error of the mean. 
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4.4.5. Sensitivities of the transform ants to mitomycin C 
The DKI, CCI 18, ABI884, ABI885, and ABI886 transformants were tested for their ability to 
survive exposure to mitomycin C ( 6 µg/ml) for various time periods. A representative selection 
of survival curves is shown in figure 4.1.b, and the results are summarized in table 4.2. 
Table 4.2 Analysis of the mitomycin C sensitivities of E.coli DNA repair mutants transformed with the katG 
constructs. 
Strain Construct Surv. fraction (12 min)' Rel. surv. x/c1 
DKl pMAL™-c2 l.05 (± 0.84) X 10-8 l.00 
pSMKA 9.28 (± 4.82) X 10·8 8.84 
pSMK5' 2.42 (± 0.80) X 10-7 23.05 
pSMK3' 2.61 (±0.66) X 10-7 24.86 
CC118 pMAL™-c2 l.29 (± 0.42) X 10-8 1.00 
pSMKA 3.06 (± l.71) X 10-8 2.37 
pSMK5' 7.48 (± 5.38) X 10-8 5.84 
pSMK.3' 5.74 (± 5.89) X to·? 44.50 
AB1884 pMAL ™-c2 1.81 (± 0.01) X to-4 l.00 
pSMKA 1.01 (± o. to) x w-2 59.11 
pSMK5' 3.18 (± 0.59) X 10-3 17.57 
pSMK3' 3.25 (± 0.50) X to-4 1.80 
ABI885 pMAL™-c2 4.53 (± 2.26) X 10-4 1.00 
pSMKA 3. 13 (± 0.03) X 10-3 6.91 
pSMK5' 7.38 (± 1.24) X 10-3 16.29 
pSMK3' 4.15 (± 0.19) X 10-3 9.16 
AB1886 pMAL™-c2 3.85 (± 0.08) X 10-4 1.00 
pSMKA 2.95 (± 2.37) X 10-2 76.6 
pSMK5' 2.04 (± 1.03) X 10·2 52.99 
pSMK.3' l.22(±0.3l)x w-2 31.69 
1 Surviving fraction after 12 minutes of exposure. lbe mean of three independent experiments ± the standard error of the mean. 
2 Relative survival i.e. the surviving fraction of the construct after 12 minutes of exposure divided by the surviving fraction of the control, pMAL ™-c2, after 12 minutes of exposure. 
Mitomycin C enters the cell using a specific uptake system, and is metabolically activated within 
the cell. Once activated, it is very unstable, and rapidly loses its DNA cross-linking ability (Iyer 
and Szybalski, 1963). As a result, mitomycin C sensitivity experiments showed relatively large 
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variation, depending on the age of the mitomycin C preparation, and the metabolic state of the 
cells. There were, therefore, large variations in the surviving fractions obtained in the different 
experiments, although the shapes of the curves and the relative survival values were similar. 
The values plotted in the curves have, therefore, been calculated from two independent 
experiments performed on the same day, to minimize the standard errors, but are representative 
of the general trend observed in each of three separate experiments. 
The growth of repair-competent MC1060 and AB1157 cells was not significantly affected by 
exposure to mitomycin C at the doses used in these experiments. The OKI cells harbouring 
pSMKA, pSMK5' and pSMK3' exhibited 8.8-, 23.0-, and 24.9-fold higher survival, respectively, 
than cells harbouring the control, pMAL ™ -c2, after exposure to mitomycin C for 12 minutes, 
while the corresponding CC118 transfonnants exhibited 2.4-, 5.8-, and 44.5-fold increases in 
survival respectively (Table 4.2). These E. coli strains are particularly sensitive to mitomycin C, 
and it may be that small effects due to the presence of the katG constructs are more noticeable 
on this low background. In general, the AB1884, AB1885, and AB1886 mutants showed a 
greater natural resistance to mitomycin C than DKl and CCl 18 (Fig. 4.1.b, panel 3). This 
resistance was enhanced by the presence ofpSMKA, pSMK5' and, in some cases, pSMK3'. The 
effect of the constructs on survival was greatest for AB 1886. In AB 1885, pSMKA and 
pSMK5' conferred approximately 7- and 16-fold greater survival, respectively, after 12 minutes 
of exposure, while in AB1884 and ABI886 the resistance conferred was even greater (up to 76-
fold). The pSMK3' construct also conferred resistance to AB 1885, and especially to AB 1886 
(9- and 31-fold increase in survival respectively). 
4.4.6. Sensitivities of the transformants to hydrogen peroxide 
The same transfonnants discussed above were tested for their ability to survive exposure to 
hydrogen peroxide (50 mM) for various time periods. A representative selection of survival 
curves is shown in figure 4.1.c, and the results are summarized in table 4.3. OKI cells exhibit a 
high natural resistance to hydrogen peroxide, however, the lack of a shoulder region on the 
survival curve suggests a lack of an efficient repair system. OKI cells harbouring pSMK.3' 
exhibited a similar sensitivity to the oxidizing agent to cells harbouring the vector control. The 
presence of pSMK5' and pSMKA, however, resulted in an increase in the survival of the cells, 
particularly at longer exposure times. The relative increase in survival after 12 minutes of 
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exposure was 20- and 30-fold, respectively (Fig 4.1.c, panel 1 ). In the case of CC 118, however, 
the presence of all three katG constructs conferred a disadvantage to the cells, and survival was 
reduced by more than 100-fold at longer exposure times. Strain CC118 has a different genetic 
background to the other 4 E. coli strains used, and it is possible that, in these cells, the 
expression of the M tuberculosis katG, or portions thereof, results in negative regulation of the 
native katG gene. This would explain the reduced survival of the cells relative to cells 
harbouring the vector control, upon exposure to hydrogen peroxide. The hydrogen peroxide 
survival curves of the excision repair mutants, AB1884, AB1885, and AB1886, had a different 
shape to those of the recA mutants (Fig. 4.1.c, panel 3). Little killing was seen up to 
approximately 9 minutes of exposure, after which there was a dramatic reduction in survival as 
the repair mechanisms became saturated. It is evident that no resistance to hydrogen peroxide 
was conferred by the katG constructs in any of these mutants. 
Table 4.3 Analysis of the hydrogen peroxide sensitivities of E. coli DNA repair mutants transformed with the 
katG constructs. 
Strain Construct Surv. fraction (9 min)' Rel. surv. x/c2 
OKI pMAL ™-c2 1.31 (± 0.05) X 10-2 1.00 
pSMKA 1.14 (± 0.20) X 10-l 8.70 
pSMK5' 4.24 (± 0.35) X 10-2 3.20 
pSMK3' 1.93 (± 0.56) X 10-2 1.47 
CCII8 pMAL™-c2 2.83 (± 2. 78) X 10-4 1.00 
pSMKA 5.41 (± 1.70) X 10-6 0.02 
pSMK5' 2.67 (± 1.06) X 10-6 0.009 
pSMK3' 1.19 (± 0.35) X 10-6 0.004 
AB1884 pMAL ™-c2 3.49 (± 4.09) X 10-2 1.00 
pSMKA 4.12 (± 3.91) X 10-2 1.18 
pSMK5' 5.17 (± 2.69) X 10-2 1.48 
pSMK3' 3.42 (± 1.34) X 10-2 0.98 
AB1885 pMAL ™-c2 6.61 (± 9.19) X 10-2 1.00 
pSMKA J.32 (± 4.63) X 10-2 O.SO 
pSMK5' l.82 (± l.69) X 10-4 0.003 
pSMK3' 8.56 (± 9.81) X 10-3 0.13 
AB1886 pMAL ™-c2 3.27 (± 4.60) X 10-2 1.00 
pSMKA 1.11 (± 1.57) X 10-l 3.39 
pSMK5' 1.11 (± 0.60) X 10-2 0.34 
pSMK3' 3.73 (± 1.14) X 10-2 1.14 
1 Swviving fraction after 9 minutes of exposure. The mean of three independent experiments ± the standard error of the 
mean. 
2 Relative swvival i.e. the surviving fraction of the construct after 9 minutes of exposure divided by the surviving fraction of 
the control, pMAL ™-c2, after 9 minutes of exposure. 
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4.4. 7. UV sensitivity tests on different mycobacterial species 
A selection of mycobacterial species were tested for their ability to survive exposure to short 
wavelength UV irradiation. The UV doses used in this experiment were high in comparison to 
those used in the experiments described above, due to the fact that the mycobacterial species 
were not mutant in any known DNA repair genes. The mycobacterial strains tested included 
M smegmatis, M intracellulare, M. fortuitum, M bovis BCG, M tuberculosis H37Ra, and 
M tuberculosis H37Rv. Also tested were a katG mutant of M intracellulare and its parent 
strain, 1403 (Marklund, personal communication), and 4 clinical isolates of M tuberculosis, 
strain 255, 463, 519 (T. C. Victor, University of Stellenbosch S.A.), and 34 (Heym et al., 
1994). Strain 255 has no detectable mutations in the katG gene, strain 463 has mutations in 
codons 463 and 315, and strain 519 has a mutation in codon 315 of the katG gene (T. C. Victor, 
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In general, the mycobacterial strains exhibited a high natural resistance to UV irradiation. The: 
order of sensitivity was found to be as follows: M bovis BCG > M tuberculosis H37Ra > 
M tuberculosis H37Rv > M intracellulare > M fortuitum > M smegmatis, although the 
differences in the sensitivities of these organisms were small. The katG+ and katG" 
M intracellulare strains exhibited no differences in their sensitivity to UV (Fig. 4.4.a). 
M. tuberculosis cells containing no detectable mutations in katG (strain 255) exhibited a similar 
sensitivity to cells containing a mutation in codons 463 and 315 of katG (Fig. 4.4.b ). These 
strains both exhibited approximately a 36-fold reduction in survival at a UV dose of 60 J/m2/s, 
relative to strain 519 and 34, but exhibited comparable survival to the latter strains at 
120 J/m2/s. Strains containing a mutation in codon 315 or complete deletion of the katG gene 
(strain 519 and 34, respectively) exhibited a higher resistance to UV than the laboratory strains, 
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Figure 4.4 UV survival curves of mycobacterial katG mutants. The curves represent the mean of 3 experiments. 
Error bars were calculated using the standard error of the mean. Graph a) M intracel/ulare 1403 
katG mutant and parent strains, and graph b) M tuberculosis clinical isolates. 
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4.5. DISCUSSION 
It is evident from the results presented in this chapter that the M. tuberculosis KatG plays a role 
in the protection of DNA repair-deficient mutants of E. coli against DNA damaging agents. 
Possible explanations for these observations are found by examining the DNA repair 
mechanisms at work in each of the repair mutants in response to the DNA damaging agents. 
In general, in repair-competent hosts, DNA damage is repaired as it occurs, due to the presence 
of efficient repair systems, and the cells survive. However, if the damaging agent is continually 
administered, the repair mechanisms become saturated, damage accumulation overcomes repair 
ability, and exponential killing occurs. The presence of functional repair mechanisms in cells, 
therefore determines the shapes of survival curves. The characteristic shoulder seen in survival 
curves is due to these efficient repair systems. When a threshold value is reached, however, the 
repair processes become saturated, and the DNA repair enzymes are progressively inactivated. 
This results in an exponential drop in cell survival, which is determined by the number of lethal 
lesions (Haynes, 1966; Word et al., 1991 ). In repair-deficient hosts, if at least one repair 
mechanism is present, the survival curves will exhibit a shoulder as well, but the threshold value 
will be lower as the repair mechanisms are saturated sooner, and exponential killing occurs at 
lower doses of the damaging agent. The levelling out of the curve at higher doses is due to the 
induction of alternative repair systems or the saturation of damage sites on the DNA. 
The most common structural defects caused by short wavelength UV irradiation are pyrimidine 
dimers, which block DNA synthesis (Setlow, 1966a; 1966b ). Recovery from UV irradiation 
depends on direct activation of RecA in recombinational repair, and indirect action by 
derepressing other DNA repair genes in the SOS response. The lesions are repaired primarily 
by excision repair involving the UvrABC exinuclease, encoded by the uvrA, uvrB, and uvrC 
genes. In £. coli DK l cells, the recA gene is completely deleted and, as a result, no 
recombinational repair is possible, and no induction of the SOS genes occurs. If these cells are 
treated with UV, therefore, the only DNA repair that can occur is a small amount of excision 
repair due to the basal levels of the Uvr A, B, and C proteins. This is not sufficient to overcome 
the damage and exponential killing begins immediately after exposure. The presence of 
constructs expressing the M. tuberculosis katG, however, resulted in a reduced killing and a 
levelling off of the curve with a high surviving fraction. It is unlikely that KatG replaces RecA 
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in either the induction of the SOS response or in recombinational repair, which suggests that it 
may be enhancing the Uvr-dependent nucleotide excision repair process in these cells. In 
CCl 18, there is only a point mutation in the N-terminal recombinase domain of recA, therefore, 
although recombinational repair is impaired, induction of the SOS genes is probably unaffected. 
As a result the excision repair process is more efficient and CC 118 cells are more resistant to 
UV damage. The survival patterns seen in the presence of the constructs are similar to those of 
DKl, but to a lesser extent, and this may be due to the masking of the positive action of KatG 
by having a RecA which retains some functions. The M. tuberculosis KatG may, therefore, also 
enhance excision repair in these mutants. In the excision repair mutants, AB1884, AB1885, and 
AB1886, no Uvr-dependent nucleotide excision repair is possible, therefore damage tolerance 
mechanisms, such as recombinational repair are responsible for continued cell survival. This 
repair mechanism is, however, quickly saturated and the exponential drop-off in cell survival 
occurs at low UV doses. No increase in survival was observed in the presence of the katG 
constructs in these mutants. If KatG does enhance the excision repair pathway, as suggested 
above, it would not be expected to have an effect on these mutants, since no Uvr-dependent 
nucleotide excision repair occurs in these cells. 
Mitomycin C causes covalent cross-linking of complementary DNA strands which causes 
inhibition of DNA replication and transcription (Iyer and Szybalski, 1963). These DNA lesions 
are removed in a similar manner to those caused by UV, i.e. excision repair, except that both 
strands must be removed, leaving a gap in the DNA which requires replacing by recombination. 
The order of sensitivity of the mutants used in this study to mitomycin C is as follows: DK 1 ;::: 
CCI 18 > AB1884 = AB1885 = AB1886, indicating that recombinational repair is the most 
effective means of removing this type of damage. DK 1 and CC 118 showed a high degree of 
sensitivity to mitomycin C, and the survival of the cells dropped exponentially immediately after 
exposure. The presence of the katG constructs resulted in enhanced survival. The cells are 
particularly sensitive to this agent, thus resulting in extremely low colony counts, particularly at 
higher exposure times. This increases the error margin, and may result in small effects of the 
katG constructs being exaggerated. In these mutants, KatG may enhance the excision repair 
pathway, however, the lesions resulting from removal of both DNA strands cannot be repaired 
due to the lack of a functional RecA. As a result, the apparent effect of KatG is small. The 
ABI884, ABI885, and ABI886 mutants exhibited a much higher natural resistance to 
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mitomycin C than the recA mutants, due to the presence of an efficient recombinational repair 
system. The standard errors on these curves were, therefore, smaller, and the results were 
easier to interpret. The presence of the katG constructs resulted in a significant increase in cell 
survival. The effect observed was greatest in the uvrC mutant, AB 1886, which suggests 
complementation of defects in this function. It is possible that, in these cells, KatG either 
enhances the recombinational repair pathway, or that it enhances a Uvr-independent nucleotide 
excision repair pathway utilized by the cells. 
As outlined in Chapter 2, reactive oxygen species attack and damage DNA in a number of ways. 
The exact mechanisms involved in repair of oxidative damage to DNA are not known but 
probably involve the oxygen radical scavengers as well as the DNA repair enzymes. It has been 
demonstrated, however, that, in E. coli, the radical-removing enzymes such as the catalases, 
peroxidases, and superoxide dismutases play a surprisingly small role in protection from killing 
by hydrogen peroxide (Carlsson and Carpenter, 1980). Thus survival after exposure relies on 
repair of DNA damage. The excision repair mutants exhibited a far higher resistance to 
hydrogen peroxide than the recA mutants, which suggests that recombinational repair is more 
important than the nucleotide excision system for the repair of oxidative damage. Survival of 
the cells in the presence of the KatG fusion proteins was enhanced only in the DK l strain. This 
increase in survival was observed with an inactive KatG fusion (pSMK5'), suggesting that it was 
not due to the removal of toxic oxygen products by the catalase and peroxidase activities of the 
enzyme. The reasons for the enhancement of survival in DK I, but not CC 118 are not clear. 
The observations suggest that KatG enhances an oxidative damage repair system that is not 
functional in the latter mutant. In the excision repair mutants, survival up to 9 minutes of 
exposure to hydrogen peroxide was comparable to that of the parent strain, therefore, any 
effects due to KatG would be masked. 
The fact that resistance to the three DNA damaging agents was not enhanced in all five mutants, 
suggest that KatG does not increase the general repair capacity of the cell, but rather that it acts 
on specific pathways. Collectively, the results suggest that KatG may enhance the excision 
repair pathway in the E. coli cells. The possible mechanisms involved in this enhancement are 
speculative. The KatG may act by stabilizing intermediates in the excision repair pathway, for 
example the UvrB-[damaged-DNA] complex, which may be vulnerable after excision of the 
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short oligonucleotide. The effect of the protein is probably not due to direct complementation 
of the DNA repair genes. The resistance levels of the cells were not restored to wild type levels 
by the enzyme, therefore complementation was only partial. Another possible explanation for 
the observed results is that KatG protects DNA from damage rather than stimulating repair. 
This possibility could be tested in the future by exposure of the cells to the DNA damaging 
agent, and then induction of KatG. If KatG protects the cells by preventing DNA damage, the 
cells would be sensitive to the agent, since KatG would be expressed after the damage had 
occurred. The experiment would also provide evidence as to whether the repair enhancement is 
direct, i.e. is seen immediately after induction of KatG, or delayed due to the induction of other 
genes involved in DNA repair. 
It is interesting that all three katG constructs showed similar effects in the various mutants in 
response to DNA damage. If the "repair enhancing" activity was encoded in the 5' portion of 
the gene, one would expect only pSMKA and pSMK5' to confer resistance, and that pSMK3' 
would have no effect. This is not the case, suggesting that both domains of the protein can 
carry out the function independently, although the 3' domain is less effective. A possible 
explanation for this is the duplication seen in the katG gene. The N- and C-terminal sequences 
are similar, and it has been suggested that the C-terminal arose from a gene duplication event 
(Welinder, 1991). It is possible, therefore, that both domains encode this function. The 
presence of both domains, however, did not have an additive effect, since mutants harbouring 
pSMKA generally exhibited similar resistances to those harbouring pSMK5'. A possible: 
explanation for the activity being encoded by both domains of the protein is that the effect of the 
protein on the sensitivity of cells to DNA damaging agents is due to saturation of the 
intracellular iron pool, since both the 5' and 3' portions of KatG contain contact sites for heme. 
The fact that both the 5' and 3' regions of the KatG protein could produce the protective effects. 
also suggests that the effects are not due to the removal of reactive oxygen species produced as. 
a result of the DNA damaging agents, since neither of these domains of the protein are active on 
their own. This demonstrates that the activity observed in this study is independent of the 
catalase and peroxidase activities of the enzyme, and implies that the effects may be due to a 
novel, as yet undefined activity oftheM. tuberculosis enzyme. 
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The question that is raised by this study is, why would M. tuberculosis have evolved an 
additional activity in its katG gene involved in DNA repair? As mentioned in Chapter 2, 
M. tuberculosis has some unusual features with respect to DNA repair and oxidative stress 
mechanisms, and it is possible that it has evolved this activity in order to compensate for these 
differences. A review of the literature on the E. coli katG gene, however, suggests that this 
feature may not be unique to the M. tuberculosis katG gene A number of links have been 
observed between the presence of KatG in E. coli cells and their resistance to various DNA 
damaging agents. Hoerter et al. ( 1989) showed that, in an /:·. coli strain lacking both the Mn-
and Fe-superoxide dismutase, near-UV (300-400 nm) radiation, which is normally only weakly 
mutagenic, induced a 9-fold increase in mutation relative to wild type cells, which was reduced 
to wild type levels when a plasmid carrying the katG gene was introduced into the double 
mutant. The same effect was seen in triple mutants which also lacked exonuclease III. The 
effect may have been due to the removal of toxic oxygen species by KatG, produced as a result 
of the irradiation, however, the indirect effects of ionizing radiation due to radical species 
contribute only partly to its lethal effects. Other mutagenic lesions in DNA result from the 
direct transfer of energy to components of the DNA, and the possibility that the katG gene 
enhances the repair of these cannot be excluded. KatF, which is required for the stationary 
phase induction of katG, has also been shown to play a regulatory role in near-UV resistance, 
and mutations in katF result in sensitivity to near-UV and hydrogen peroxide (Sammartano 
et al., 1986; Mulvey et al., 1990). Eisenstark (1989) has demonstrated that katG is induced in 
response to oxidative agents other than hydrogen peroxide, including near-UV radiation, and 
this may be due to the induction of katF under these conditions. 
Greenberg and Demple (1988) observed that mutations which caused overproduction of KatG 
in !ioxyR mutants resulted in an increase in resistance of the cells to redox cycling agents, such 
as paraquat and menadione, and to N-ethylmaleimide, and reduced the spontaneous mutation 
rate approximately 10-20-fold. The authors concluded that the scavenging enzymes play an 
important role in protecting aerobic cells from spontaneous mutations due to intrinsic oxidative 
damage, however, the effects seen may again be due to enhancement of DNA repair processes 
in addition to the removal of reactive oxygen species. 
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Farr et al. (1988) have reported that the induction of katG by OxyR is necessary, and sufficient, 
for the rapid recovery from inhibition of membrane function observed after exposure to 
hydrogen peroxide. The nature of the damage responsible for the loss of membrane function by 
hydrogen peroxide is not known. If it is directly due to damage to membrane components. then 
recovery of these functions would imply the existence of constitutive enzymes able to catalyze 
the reverse reaction. However only katG was induced here, and this suggests a possible role for 
the product in the reversal of damage. Cells mutant in katG also experienced a large decrease in 
uptake processes after near-UV exposure, however, a strain carrying a kat(i' plasmid showed 
considerably less reduction in uptake after near-UV exposure, and uptake quickly recovered 
after incubation. These observations with respect to the effect of katG on the survival or 
mutation rates of E. coli cells exposed to DNA damaging agents have all been suggested by the 
authors to be due to the production of reactive oxygen species by these agents, and their 
subsequent removal by the catalase or peroxidase activity of KatG. In the light of the results 
presented in this study with the M. tuberculosis katG gene, however, the above explanations 
may need to be reassessed. This study has demonstrated that the katG gene is actively involved 
in the survival of DNA repair mutants of E. coli exposed to various DNA damaging agents, and 
that this is independent of its catalase and peroxidase activities. All bacterial catalase-
peroxidases are suggested to have arisen due to a gene duplication event (Welinder. 1991). As 
mentioned previously, the catalase and peroxidase activities are predicted to lie in the 
N-terminal domain of the protein, and, as yet, no definite function has been assigned to the 
C-terminal domain. This study suggests that the gene may encode an, as yet undefined, function 
involved in DNA repair. 
The possibility of the E. coli KatG playing a role in DNA repair raises the question as to its role 
in the experiments described in this chapter. In all of the DNA repair mutants of E. coli used, 
the katG gene is unaltered. The gene product is, therefore, probably produced at normal levels, 
and may have its own effect on the survival of cells after exposure to the various DNA 
damaging agents. This effect will, however, be present in strains carrying the vector control as 
well as the fusion constructs. Thus what is being measured in these experiments is whether the 
M tuberculosis KatG, which is present in excess to the E. coli KatG, has an additional effect on 
survival in comparison to cells not expressing this protein. It is possible that overexpression of 
the M. tuberculosis katG results in a decrease in the expression of the native katG, for example 
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in strain CC 118, which is more sensitive to hydrogen peroxide in the presence of the katG 
constructs. If the native KatG also has an effect on the survival of the cells, then the decreased 
levels of the protein in these cells, in the presence of the M. tuberculosis KatG, further 
emphasizes the role played by the latter protein in protection against damage caused by UV 
irradiation and mitomycin C. 
Another point which needs to be addressed is whether the overexpression of the foreign proteins 
is responsible for the effects observed in the experiments. Kanemori et al. ( 1994 ), for example, 
have demonstrated that the production of abnormal proteins in E co/J results in enhanced 
synthesis of heat shock proteins due to an increase in the stabilization of cr32 . In addition, Tsui 
et al. (1996) have demonstrated an induction of DNA repair pathways upon induction of the 
heat shock response. Thus it is possible that the modification of DNA repair seen in E. coli 
upon expression of the M. tuberculosis katG gene could be the result of non-specific effects due 
to the high level expression of a heterologous protein. However, overexpression of the MBP-
LacZ fusion and the fusions produced by the pS:MK3'a, pSMK3'b, pSMK3'opp, and pSMKd 
constructs did not result in increased resistance to UV light. Only fusion proteins containing the 
M tuberculosis KatG had this effect. Thus it is unlikely that the observed effects in these 
experiments are due to the non-specific effects described above. 
The mycobacterial UV sensitivity tests m this study were all performed on species of 
mycobacteria that contain a KatG (see Chapter 1 ). The order of sensitivity of the different 
species was found to be as follows: M bovis BCG > M tuberculosis H3 7Ra > M tuberculosis 
H37Rv > M intracellulare > M fortuitum > M. smegmatis, although the differences in the 
sensitivities of these organisms were small. All of the survival curves, except that of M bovis 
BCG, exhibited a smoothly bending shoulder, characteristic of repair-competent hosts. This is 
due to the efficient repair of DNA damage by the cells. When a threshold UV dose is reached, 
the repair mechanisms become saturated and the survival of the cells is determined by the 
number of lethal lesions. The threshold UV doses were different for each of the mycobacterial 
species tested, but were followed by exponential killing of the cells in all. The reasons for the 
shoulderless curve of M bovis BCG are unclear. This shape of curve is usually indicative of 
deficiencies in DNA repair. However, the survival of this species at higher UV doses (90 -
120 J/m2/s) was comparable to that of the other mycobacterial species tested. This suggests that 
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these cells have a similar sensitivity to UV to other mycobacterial species, but that the induction 
or activation of repair mechanisms is delayed in this organism. This strain of M bovis is 
attenuated and may be impaired in one or more of the enzymes involved in DNA repair. 
Deficiencies in DNA repair may, in fact, contribute to the attenuation of the organism. 
No differences were observed in the UV sensitivities of katG' and ka1c· strains of 
M. illfracellulare. The mutant strain was constructed by allelic exchange, and is, therefore, 
isogenic with the parent strain, except with respect to the katG gene. The results suggest that. 
in repair-competent hosts (i.e. cells in which no DNA repair genes have been mutated), the katG 
gene does not play a significant role in repair of damage caused by UV irradiation. The 
M tuberculosis clinical isolates tested in this study are not isogenic, therefore, the effect of 
mutations in the katG gene on sensitivity to UV cannot be directly correlated. Strain 34, for 
example, has recently been shown to overexpress the AhpC product, due to mutations in the: 
promoter region of the ahpC gene (Heym et al., 1997). The increased expression of this. 
product may compensate for the lack of KatG in this strain, thus masking any effects of deletion 
of the gene, and may be responsible for the higher levels of resistance of this strain to UV 
relative to the laboratory strains M tuberculosis H37Ra and H37Rv. An M tuberculosis isolate 
containing a mutation in codon 315 of katG also exhibited higher levels of resistance to UV than 
the laboratory strains. The mutation has been demonstrated to result in a 50% reduction in 
peroxidase activity (Rouse et al., 1996). This strain may also contain upmutations in the ahpC 
or other genes, to compensate for the reduced KatG activity. The reasons for the lower survival 
of strains 255 and 463 in the middle range of UV doses used here are not clear. It may be due 
to more rapid saturation of repair processes. The levelling off of the curves at higher UV doses 
may be due to the induction of alternative repair processes or saturation of the damage sites on 
the DNA. 
It is evident from the results presented in this chapter that the katG gene does not play a 
significant role in the sensitivity of mycobacterial cells to short wavelength UV irradiation. The 
experiments were all performed using repair-competent hosts which exhibit a high natural 
resistance to UV irradiation. Any effects of katG on the UV sensitivities of these strains may, 
therefore, be masked. Extrapolation of the role of katG in DNA repair to the mycobacteria will, 
therefore, require complementation studies with the gene in repair-deficient mycobacterial hosts. 
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The recent advances in the construction of defined mutants of both the rapid growmg 
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Time, effort, and resources have been put into the sequencing of the M. t11herc11/osis and 
M. leprae genomes. Results from these projects will provide a great deal of information on 
both the genetics of the organisms, and their metabolic pathways However, sequencing data 
alone will not identify the mechanisms involved in mycobacterial gene regulation. This requires 
molecular biological input. There are a number of different mechanisms of regulation of gene 
expression in prokaryotes. The majority of these occur at the level of transcription initiation. A 
closer look at the promoter structures and sequences, and cellular proteins which are involved in 
transcription initiation is, therefore, essential to the understanding of gene regulation. 
5.1. TRANSCRIPTION INITIATION IN PRO KARY OTES 
5.1. l. The transcription machinery and promoter structures 
Transcription initiation in prokaryotes has been extensively studied, and has been reviewed by 
McClure (1985) and Busby and Ebright (1994). Transcription initiation requires the RNA 
polymerase holoenzyme and specific promoter sequences on the DNA. The most widely 
studied RNA polymerase is that from E. coli. It consists of p, pt, a and cr subunits. The core 
enzyme, ppta2 (E), contains the catalytic machinery required for synthesis of the RNA 
transcript. When bound to the sigma factor, E(cr), the enzyme can bind specifically to promoter 
sites and initiate transcription. This specific binding occurs over a region of 65 bp (von Rippel 
et al., 1984), and is followed by the formation of an open complex, which results in a 
topological unwinding of the DNA of 540° (Gamper and Hearst, 1982). The end of the 
initiation process occurs with the release of the cr factor, and only once the transcription 
complex has been translocated out of the promoter region, can another RNA polymerase 
molecule bind and repeat the process. The formation of the open complex is probably what 
determines the frequency of RNA chain initiation (McClure, 1985). E. coli has approximately 
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3000 molecules of the RNA polymerase core enzyme per cell (Burgess, 1976). Generally genes 
occur at one copy per cell, and only one enzyme is responsible for transcribing most of them. 
Some are transcribed once every few seconds, and others only once per generation or less 
(Hahn et al., 1977). The relative rate of synthesis of a full length RNA product from a given 
promoter depends on the promoter strength. Many organisms have more than one CJ factor, 
each specific for the initiation of a distinct class of genes. Alternative CJ factors are required in 
many organisms for developmental growth or response to environmental conditions (McClure, 
1985). 
In E. coli, the vegetative CJ factor, CJ70, is responsible for initiating transcription of the genes 
required for normal vegetative growth. A consensus sequence has been proposed for E. coli CJ70 
promoters, the -3 5 and -10 hexamers TTGACA and TAT AA T, respectively (Rosenberg and 
Court, 1979), which are usually separated by 17-19 nucleotides. The TTG of the -3 5 hexamer, 
and T A---T of the -10 hexamer are highly conserved. In general, divergence from the 
consensus sequence results in decreased promoter activity. The strength of a promoter is, 
therefore, determined by the degree of similarity of its -10 and -3 5 regions to the consensus 
sequences, which themselves give maximal promoter strength. E. coli promoters that bind ECJ70 
have at least 2 of the 3 most highly conserved bases at the -10 region, and at least I of the 3 at 
the -35 region. Changes in these highly conserved bases can result in a 100-fold or morn 
decrease in promoter strength, while mutations in weakly conserved bases can result in a 10-fold 
decrease in strength (McClure, 1985). Although the -10 and -35 hexamers play a central role in 
expression, there are also some conserved and weakly conserved sequence homologies on either 
side of these hexamers, which may be important in promoter function. These regions of the 
DNA probably also interact with the RNA polymerase, and it is likely, in fact, that the entire: 
60 bp between -50 and + 10 are important for transcription. For example, upstream of the -35 
region in most E. coli promoters, is an 8-10 hp AT-rich region with a conserved A at position 
-45 (Hawley and McClure, 1983; Staden, 1984). The Tat -18, Tat -16, and the G at -15 an:: 
also weakly conserved. Promoters with spacings between the -10 and -35 regions of 17 are the 
strongest, however, those with spacings of 15 and 20 bp retain partial function. Of 263 E. coli 
promoters compiled and analyzed by Harley and Reynolds (1987), 92% had a spacing of 17 :!:: 
1 bp between the -10 and -3 5 regions. Spacings of less than 16 or more than 18 result in the 
conserved contact points not lying on the same face of the DNA helix. Transcription usually 
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initiates with a purine (A or G), and a sequence of CAT is preferred around the transcription 
initiation codon, but no significant homologies are found downstream of +2. The spacing 
between the -10 hexamer and the transcription start site varies between 4 and 8 nucleotides, but 
is usually 6 or 7 (Hawley and McClure, 1983). There are, therefore, a number of factors which 
determine promoter strength, and the additivity rule states that the individual promoter strength 
contribution of base pairs, spacer length, DNA conformation, and electrostatic binding within 
the promoter can be added together to obtain total promoter strength (McClure, 1985). 
The conformation of the DNA within the promoter region may play an important role in 
promoter function, and may be determined by specific sequences. A recently discovered third 
element in some E. coli promoters is an AT-rich sequence upstream of the -3 5 sequence (Ross 
et al., 1993). Such a sequence, of approximately 20 bp, immediately upstream of the E.coli rm 
-35 region, called the upstream or UP element, increases activity JO-fold, in the absence of other 
protein factors. The region adjacent to the UP element contains binding sites for the activator 
protein, Fis, which is not required for activation of transcription by the UP element, but 
increases the activity of the promoter by a factor of 10. The UP element must be in the correct 
orientation relative to the promoter but its position can be varied, provided that the face of the 
helix phasing is maintained. DNasel footprinting revealed that the a subunit of RNA 
polymerase interacts directly with the UP element. Ross et al. (1993) found UP elements with 
the same properties in three other E. coli promoters, rrnB P2, /euV and RNA II. Although all 
UP elements are AT-rich, no consensus sequence is evident. Ramalingam et al. (1995) 
identified an AT-rich 81 bp sequence between -664 and -584 upstream of the translation 
initiation codon, which is required for temporal transcription of the ce/A gene of Dictyostelium 
discoideum. The sequence comprises two cis elements each active on its own. A factor binds 
in this region, and is involved in expression of ce/A. Another promoter which requires an AT-
rich upstream region for maximal expression, is that of the Bacillus subtilis spoVG gene 
(Banner et al., 1983). Fredrick and Heimann (1997) recently demonstrated that the UP element 
enhances the initial association of RNA polymerase with the DNA, and that this is independent 
of the presence of a cr factor. AT-rich sequences are a frequent feature of gram-positive 
promoters (Graves and Rabinowitz, 1986; Moran et al., 1982). These sequences may be 
involved in modulating promoter strength. 
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Another reg10n found to be important in some prokaryotic promoters is that immediately 
upstream of the -10 region. Keilty and Rosenberg (1987) showed that the T at position -15 and 
the G at -14 are essential for constitutive function of the lambda p.) promoter Pre. Mutations in 
these positions can be compensated for by the addition of the phage transcriptional activator 
protein, ell. The authors suggest that the extended -10 region may be an important contact site 
for RNA polymerase, which is critical for promoter recognition and function in the absence of a 
consensus -3 5 recognition sequence. The T and G at positions -15 and -14 are conserved in 
other promoters which do not require a specific -3 5 consensus sequence, for example, Raf PI, 
gal P2, and the ompF, and uvrA promoters. The P22 Pant promoter contains highly conserved 
-10 and -3 5 regions. However, in mutants with severe -3 5 downmutations, promoter function 
could be recovered by replacement of an A with a G at position -14 (Grana et al., 1985). 
Therefore, the extended -10 sequence is probably very important to promoters in the absence of 
conserved -3 5 sequences (Keilty and Rosenberg, 1987). Sabelnikov et al. ( 1995) showed that a 
promoter for the Dpnll restriction-modification system of Streptococcus pneumoniae consists 
of an extended -10 site (TaTGgTAT AA T), with no required -35 site. In fact, S. pneumoniae 
promoters frequently require an extended -10 which can function without a -3 5 region 
(Sabelnikov et al., 1995). 
Lisser and Margalit (1994) also hypothesized that nucleotides surrounding the -10 and -35 
regions and the presence of specific sequence-dependent, physical-chemical, and structural 
characteristics are required for promoter function. They demonstrated that both the consensus. 
and flanking regions are less stable, more flexible, and show a greater tendency for B 
conformation, in comparison to random sequences. Curved DNA upstream of the -35 region 
has been implicated in the function of a large number of E. coli promoters, and a correlation has 
been found between promoter activity and sequence-dependent curvature. It has been 
demonstrated that sequence-dependent curvature used to replace the upstream binding sites for 
the catabolite activator protein (CAP) can stimulate transcription (Gartenberg and Crothers, 
1991 ), suggesting a relationship between protein-mediated DNA bending and sequence-
dependent DNA curvature in the initiation of transcription. In B. subtilis, the position of the 
curvature in relation to the promoter is essential for activation (McAllister and Achberger, 
1989). Nickerson and Achberger (1995) showed that intrinsically curved DNA upstream of the 
-35 region affects the interaction of the RNA polymerase with supercoiled and relaxed DNA 
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templates. The authors proposed a model in which curved DNA upstream of the -35 region 
facilitates binding of the RNA polymerase. It was found that the rotational orientation, and not 
the linear displacement, was most important in stimulating promoter binding to the RNA 
polymerase in B. sublilis (Nickerson and Achberger, 1995). 
DNA supercoiling has also been shown to have a direct effect on certain promoters, both 
positive and negative (Galan and Curtiss, 1990). lt can also indirectly affect transcription 
initiation, by affecting the binding of ancillary proteins. For example. the CAP-cyclic AMP 
activated promoters are sensitive to drugs that inhibit DNA gyrase, an enzyme required for the 
introduction of negative supercoils in an energy-dependent manner (Sanzey, 1979), and 
supercoiling directly reduces the promoter strength of the gyrA and gyrB promoters encoding 
the DNA gyrase enzyme (Menzel and Gellert, 1983). In E. coli, transcription by RNA 
polymerase involves unwinding of the DNA at the site of initiation to form an open complex 
(McClure, 1985), and this may be facilitated by supercoiling of the DNA substrate (Pruss and 
Drlica, 1989). 
The region upstream of genes also contains information required for translation of the mRNA 
transcripts into protein. Approximately 5-12 bp upstream of the translation initiation codon lies 
a purine (A+G) rich sequence of approximately 3-6 bp known as the Shine and Dalgamo 
sequence. The 3' end of the I6S rRNA is complementary to this sequence, and facilitates 
binding of the ribosome to the mRNA transcript (Shine and Dalgamo. 1974). Studies in E. coli 
have shown that gene expression also depends on the region downstream of the ATG (Jacques 
and Dreyfus, 1990). Jacques and Dreyfus ( 1990) review the properties of mRNAs which 
determine where, and how efficiently, translation is initiated. On average, translation initiation 
occurs every four seconds on E. coli mRNAs. Initiation rather than elongation is usually the 
rate-limiting step in translation, and depends on the mRNA (Ray and Pearson, 1975). However, 
ribosomes are packed close together on mRNAs (Miller et al., 1970), therefore, if translation of 
certain codons is slow, elongation will become rate-limiting. Both the nucleotide composition, 
and the precise sequence around the translation start site contribute to the lack of local 
structure, which allows free accessibility to the ribosome. Certain other sequences may make 
favourable contacts with the translational machinery, thereby facilitating translation initiation. 
The tight coupling of transcription and translation is probably required for the prevention of 
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secondary structures forming in the mRNA, which could interfere with translation (Jacques and 
Dreyfus, 1990). Although the interaction of the ribosome binding site on the mRNA transcript 
with sequences of the 16S rRNA is regarded to be essential for translation of prokaryotic 
mRNA, a number of genes have been identified that encode mRNA lacking 5' leader sequences 
(Reviewed by Janssen, 1993). The mechanisms by which these mRNAs bind ribosomes and are 
translated have yet to be elucidated. 
5.1.2. Regulation of transcription 
Many bacterial promoters are regulated by activator proteins which bind within or upstream of 
the promoter and interact with the a subunit of RNA polymerase to increase expression 
(lshihama, 1993 ). Raibaud and Schwartz ( 1984) review the positive control of transcription 
initiation in bacteria. Activators are usually negatively autoregulated, and are, therefore, only 
produced in small amounts. Promoters which require activation usually have poor homology at 
the -35 region, and deviate from the consensus sequence in the first T of the -10 region All 
known activator binding sites are located near or upstream of the -35 region (Raibaud and 
Schwartz, 1984). An example is CAP, which binds to a site centred between positions -61 and 
-62 on the lac promoter and activates transcription. It has been suggested that CAP directs the 
a subunit of RNA polymerase to the DNA immediately upstream of the -35 region, 
compensating for the lack of a UP element (Zhou et al., 1993a; 1993b). The location of the 
CAP binding site differs on different CAP-dependent promoters. It has been shown that the 
interaction between CAP and the a subunit is the same, and is provided by bending of the 
intervening DNA (Zhou et al., 1994a; 1994b ). Many activators which do not interact with the 
a subunit bind to sites which overlap the -35 region, for example 11. cl, which binds at a site 
centred at position -42, and activates transcription of Prm (Hochschild et al., 1983). Li et al. 
(1994) provide evidence that cl makes direct contact with a region of a 70 . The fact that there 
are at least two separate targets for activators, suggests that some promoters may be regulated 
by more than one activator. Activators may act by helping to recruit DNA-binding proteins to 
DNA, thereby supplementing sub-optimal protein-DNA interactions with protein-protein 
contacts. Therefore an activator must bind to a DNA site adjacent to or within a promoter, and 
must make energetically favourable protein-protein contacts with the RNA polymerase (Busby 
and Ebright, 1994). 
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Repressors bind to specific sites, operators, near the promoter and inhibit transcription initiation. 
Operators can be located as far as 60 bp upstream and 12 bp downstream of the promoter 
sequence, although many overlap the promoters. Inhibition is most likely due to a steric 
blocking mechanism. There are differences in the tightness of binding of repressors to 
operators. Very tightly binding repressors, such as E. coli lac and P22 mnt, result in absolute 
shut-off of chain initiation, while the weaker binders contribute to down modulation (McClure, 
1985). 
5.2. TRANSCRIPTION INITIATION IN MYCOBACTERIA 
Our understanding of the regulation of gene expression in mycobacteria has been impeded by 
the lack of knowledge on mycobacterial transcription signals. Mycobacterial DNA, as 
mr.Ptioned previously, has a high G+C content. Since the G+C content of an organism's 
genome affects codon usage and promoter recognition sites (Nakayama et al., 1989; Ohama 
et al., 1987), it is expected that transcription and translation signals in mycobacteria will differ 
slightly from those in other bacteria, such as E. coli. GTG is often used as a start codon in 
mycobacteria, possibly due to the higher G+C content, and mycobacterial genes show a 
relatively high degree of codon bias, reflected by a predominance of G or C at position 3, 
especially in M. tuberculosis. This probably reflects the distribution of tRNA species in 
mycobacteria. The upstream regions of mycobacterial genes also have a higher G+C content 
than the corresponding genes from E. coli (Bashyam et al., 1996). It has been suggested that 
mycobacteria have a low transcription rate and a low RNA content per unit DNA (Harshey and 
Ramakrishnan, 1977), probably due to a low rate of transcription initiation. Understanding the 
reasons for this low level of transcription, and the possible mechanisms of regulation of gene 
expression, requires a closer look at the mycobacterial transcription machinery, and the 
structure of mycobacterial promoters. 
5.2.1. The mycobacterial transcription machinery 
Several aspects of the mycobacterial transcription machinery have been studied. The rpoB and 
rpoC genes encoding the p and pi subunits of RNA polymerase, respectively, from M leprae 
135 
and M. tuberculosis H37Rv have been sequenced (Honore et al., 1993; Miller et al., 1994). 
The M tuberculosis RpoB is 57% identical to that of E. coli at an amino _acid level. A number 
of mycobacterial er factors have also been identified. The M smegmatis mysA and mysB genes 
encode proteins of approximately 52 and 36 kDa, respectively, which are involved in 
transcription initiation. The amino acid residues important for recognition of the -3 5 and - I 0 
regions are identical in both, suggesting a similar promoter specificity. Both also show strong 
similarity to the principal er factor. HrdB. of Streptomyces aureofaciens and Streptomyces 
coelicolor, although MysA is more similar. and is thought to be the principal er factor (Predich 
et al., 1995 ). Doukhan et al. ( 1995) sequenced the corresponding genes from M. leprae and 
M tuberculosis. Between the mysA and mysB genes is a highly conserved ORF, approximately 
l kb upstream of mysB. Its function is unknown, but the very high hydrophobicity of the 
predicted protein suggests that it may be an integral membrane component with 7 putative 
transmembrane segments. A similar ORF is found in the same region in M. smegmatis. In both 
M. tuberculosis and M. leprae, immediately downstream of mysB is an ORF with high similarity 
to DtxR, the iron-binding repressor of iron uptake and production of toxin in Corynebacterium 
diphtheriae, which is discussed in section 5.4.2. Bashyam et al. (1996) compared the domains 
of the M smegmatis MysA and MysB responsible for binding to the -10 (2.4) and -35 (4.2) 
regions, to those from the principal er factors of S. aureofaciens (HrdB) and E. coli (RpoD). 
The amino acids of the 2.4 region were identical in MysA and HrdB but differed from RpoD in 
only 3 out of 23 positions, two of which are conserved changes. Therefore, the -10 binding 
regions are nearly identical, and would be expected to bind similar consensus sequences. There 
was, however, larger variation in the -35 binding domain. MysA and MysB differed from each 
other in 18 of the 39 amino acids of the 4.2 region, 12 of which are non-conserved. This 
suggests that they probably recognize and express genes with different -35 sequences. MysA 
and HrdB differed by 2 amino acids, but MysA and RpoD differed in 14 positions, 9 of which 
are non-conserved changes. There is, therefore, probably poor interaction between 
mycobacterial -35 sequences and the E. coli 4.2 region. These observations may explain the 
fact that mycobacterial promoters function better in Streptomyces than in E. coli (Kieser et al., 
1986). This is not unexpected, since mycobacteria and streptomycetes belong to the same 
bacterial order, i.e. Actinomycetales. 
Mycobacteria may contain multiple er factors, a situation found in Streptomyces (Westpheling 
et al., 1985), which allow for greater transcriptional flexibility (Bashyam et al., 1996). As 
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mentioned previously, alternative cr factors are a common means of regulating gene expression 
in bacteria. Demaio et al. ( 1996) identified and cloned the sigF gene from M. tuberculosis, 
which had significant similarity to the SigF sporulation cr factors from S. coelicolor and 
B. subtilis, and to SigB, a stress response cr factor from B. subtilis. The sigF gene was present 
in M. avium and M. bovis BCG, but not in M. smegma/is or M. abscessus. The authors showed 
that sigF mRNA is not present during exponential growth in M. hovis BCG, but is strongly 
induced during stationary phase, nitrogen depletion, and cold shock, and weakly induced during 
late exponential phase, oxidative stress, anaerobioses, and alcohol shock (Demaio et al.. 1996 ). 
Levin and Hatfull (l 993) purified the M. smegmatis RNA polymerase enzyme and were able to 
demonstrate efficient transcription initiation in vitro. SOS-PAGE analysis of the purified 
products revealed the characteristic f3, f3', and a subunits, as well as several minor proteins, 
which may represent cr factors. The authors were able to demonstrate in vitro transcription 
from the M bovis BCG hsp60 promoter (Stover et al., 1991), using supercoiled plasmid DNA, 
and the RNA polymerase preparation. They also present evidence that the M smegma/is RNA 
polymerase preparation directs transcription from the ColE I replicon of E. coli, although this 
does not support plasmid replication in M smegmatis (Snapper et al., 1988). This suggests that 
the preparation contains a form of holoenzyme with a similar specificity to that of the major 
cr factor of E. coli. The M smegmatis transcription machinery appears to use the hsp60 
promoter in a similar manner to BCG, but there may be some differences between the two 
systems, due to the fact that only one transcription start site is used in M smegmatis. Bashyam 
et al. (1996), on the other hand, demonstrated that the efficiency and specificity of 
transcriptional recognition is conserved in M. tuberculosis, M. smegmatis, and M. bovis BCG. 
They suggest, therefore, that M smegmatis may be used as a surrogate host, at least for 
studying the constitutively expressed M tuberculosis genes. Predich et al. (1995) used a similar 
method to Levin and Hatfull to purify the RNA polymerase from M smegmatis. They used an 
antibody specific for a conserved region of the E. coli a 70 to show that two cr factors ( 40 and 
65 kDa) were present in the holoenzyme preparations, but absent after phosphocellulose 
chromatography. Peptide sequencing of fragments of these two proteins confirmed that the 
65 kDa protein corresponded to MysA, and the 40 kDa protein to MysB. The authors were 
able to demonstrate in vitro transcription from linear and supercoiled forms of the heterologous 
B. subti/is sin P3 promoter, and the M smegmatis rmB promoter, using the M smegmatis 
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RNA polymerase preparation. The M. smegmatis promoter was, however, not transcribed by a 
B. subtilis RNA polymerase preparation. The lack of requirement for a supercoiled template 
demonstrated here is in contrast to the observations of Levin and Hatfull (1993), that in vitro 
transcription of the M bovis BCG h.,p60 promoter depends on the superhelical state of the 
template, although the method of template relaxation used in the two experiments differed. The 
results suggest that the M. smegma/is RNA polymerase has a broader specificity than that of 
B. J11btilis, although this may be due to the fact that the preparation contains a mixture of two 
holoenzymes. A higher transcriptional flexibility may be useful in responding to variations in 
environmental conditions and for complex interactions with the host (Bashyam et al., 1996 ). 
5.2.2. Mycobacterial promoters 
Little is known about the structure and activities of mycobacterial promoters. In general, they 
function poorly in E. coli (Das Gupta et al., 1993; Sirokova et al., 1989), although there are 
exceptions. Heat shock promoters, which are active in E. coli, are the most widely studied 
(Stover et al., 1991 ). There are some sequence similarities between these and consensus 
promoters recognised by cr70 and cr32. Comparative studies by Kieser et al. (1986) have shown 
that mycobacterial genes are better expressed in Streptomyces than in E. coli. Many 
mycobacterial promoters are similar to Streptomyces promoters, and are usually GC rich ( 69-
78%) (Janssen and Bibb, 1990). Strohl (1992) compiled a list of 139 promoters from 
Streptomyces, and showed that 21% of them resembled the typical E. coli cr70 promoters, and 
most of these directed transcription of housekeeping genes. It is possible that a similar situation 
occurs in the mycobacteria. A number of mycobacterial promoters have either been used to 
drive expression of cloned genes in BCG, or have been examined in more detail. These are 
summarized in table 5.1. The transcriptional start sites of some of these have been mapped. 
Some resemble the E. coli cr70-type promoter but most have a higher G+C content (65-70%) 
and different consensus sequences. Many are specifically regulated and may not be considered 
to be typical of mycobacterial promoters. Some of these promoters have been studied in more 
detail and have shed some light on mycobacterial transcription signals. 
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Table 5.1 Comparison ofmycobacterial promoter sequences. 
-35 
M. tubercu1o•i• 
# 65 TTGCCG 
# 10-12K TTGAGT 
# 38K GAAATT 
* 35K TCGACA 
# 32K TTGAGA 
* v.a.p. TTGACA 
* gyrB TCGTGG 
85A TTGACT 
or TACACG 
16S rRNA TTGACT 
cpn60 TGCTCA 
* rpsL TTGACC 
M. bovia BCG 
* 23 K TCGTCG 
* 18 K TTGAGG 
# alpha TCGACA 
# MPB64 TCGTCG 






* rpsL TTGACC 
M. 1eprae 






























* pKGRl TCGACA 
* pKGR9 TCGTCA 
* pKGR25 TGCACT 
* pKGR38 TCGACG 
* ORFl TCGAGG 
* ORF2 TCGACA 
Nl(cobacteriophage LS 





-10 R.B.S. T.S.C. 
17 TTTCAT 9 GGAGGAA 10 ATG 
17 TAGAGT 160 TGGAGGG 8 GTG 
11 AAAGGT 5 GTG 
TAAATT 
16 AAGAAT 37 GGGAAGC 4 ATG 
TATCAT 
CATATT 
22 CGCCTG 71 ATG 
1 7 CGCCTG 71 ATG 
18 TAGACT 7 
17 GGCGGC 37 ATG 
18 TATTGT 8 
TATGTT 
TACAGG 
18 TATGTT 27 AGGGGCA 5 ATG 
17 TATGTT 69 GGAGGA 8 GTG 
TTTCAT 
15 TATTAG 197 
1 7 TAAGAA 172 CGGAGGA 11 ATG 
18 AAGAAT 
11 CCCGGT 214 CGGAGGA 11 ATG 
17 CATCAG 183 ATG 
18 TATTGT 
18 TAAAAA 149 GAGGAA 10 ATG 
18 CTATAT 58 GCGAGGT 8 ATG 
19 TATATC 
18 GATTAT 59 AGGAAGG 6 GTG 
17 TACGTT 14 0 GGAAGGT 5 ATG 
16 ATTAAT 
14 TACCAT 7 5 GAGGAGA 4 GTG 
18 TATTGT 
12 CACGAT 





17 TACACT 33 AGAAGGAG 6 ATG 







19 TATCCT 54 GGAGGGA 3 ATG 
1~ TACATT l~l GGAGGGA 3 ATG 
l ij CATTC'l 
Reference 
(Shinnick, 1987) 
(Baird et al., 1989) 
(Andersen and Hansen, 1989) 
(O'Connor et al., 1990) 
(Borremans et al., 1989) 
(Gupta and Tyagi, 1993) 
(Madhusudan et al., 1994) 
(Kremer et al., 1995) 
(Ji et al., 1994; Verma et al., 1994) 
(Kong et al., 1993) 
(Kenney and Churchwacd, 1996) 
(Yamaguchi et al., 1989) 
(Terasaka et al., 1989) 
(Matsuo et al., 1988) 
(Yamaguchi et al., 1989) 
(Thole et al., 1987) 
(Suzuki et al., 1991) 
(Stover et al., 1991) 
(Dellagostin et al., 1995) 
(Dellagostin et al., 1995) 
(Radford et al., 1990) 
(Kenney and Churchward, 1996) 
(Mehra et al., 1986) 
(Dellagostin et al., 1995) 
(Thangaraj et al., 1989) 
(Thole et al., 1990) 
(Sela and Clarke-CUrtiss,1991) 
(Dellagostin et al., 1995) 
(Honore et al., 1993) 
(Cirillo et al., 1994) 
(Cirillo et al., 1994) 
(Mahenthiralingam et al.,1993) 
(Predich et al., 1995) 
(Kenney and Churchward, 1996) 
(Murray et al., 1992) 
(Tirrrn et al., 1994) 
(Ramesh and Gopinathan, 1995) 
(Ramesh and Gopinathan, 1995) 
(Ramesh and Gopinathan, 1995) 
(Ramesh and Gopinathan, 1995) 
(Ramesh and Gopinathan, 1995) 
(Ramesh and Gopinathan, 1995) 
(Nesbit et al., 1995) 
(Nesbit et al., 1995) 
(Nesbit et al., 199~) 
The positions of the -35 and -10 regions, the ribosome binding site (R.B.S.), and the translation start codon 
(f.S.C.) are indicated. The distances between the -35 and -10 regions, the -10 region and the R.B.S., and the 
R.B.S. and the T.S.C. arc given. 
# 
• 
Promoters identified by Dale and Patki ( 1990), using the method of Staden (1984) (see Dale and Patki for 
references). The transcription start sites for these have not been mapped. 
Transcription start sites have not been mapped. The list docs not include the M smegmatis and 
M tuberculosis promoters sequenced by Bashyam et al. (1996). 
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Suzuki et al. (1991) identified two possible transcription intitiation sites upstream of the l 6S 
rRNA gene of M bovis BCG, one of which had promoter sequences similar to the E. coli 
consensus sequences, and the other of which contained a B. subtilis-like -10 sequence and no 
defined -35 region (Ogasawara et al., 1983). In vitro transcription assays showed that a 
promoter recognized by the E. coli RNA polymerase is situated approximately 200 bp upstream 
of the gene. The strengths of the E. coli and M bovis BCG rrn promoters were identical in 
E. coli. The E. coli RNA polymerase did not utilize the other putative promoter of the BCG 
rrn. This suggests that the second promoter may be recognized by a specific cr factor not 
present in E. coli. Cirillo et al. (1994) identified the transcription start site of the promoter 
region oftheM smegmatis ask gene. The -10 region for this did not correspond well to E. coli 
consensus sequences, although a region further upstream, corresponding to the -10 region of the 
weaker transcription start site, did show some correlation but was > 20 bp upstream of the 
transcription start site. The ask gene has a long leader sequence which may be important for 
regulation. There are several regions that may form large hairpin loops which need to be further 
studied with respect to their role in regulation. Dellagostin et al. (1995) identified the 
transcriptional start point of the M leprae 18 kDa promoter region. Immediately upstream of 
this are putative -10 and -35 regions which are similar to E. coli cr70 consensus promoter 
sequences, except for a mismatch of a conserved T residue of the E. coli -IO hexamer. The 
authors suggest that theM leprae -IO region may be a pentamer. Kremer et al. (1995) studied 
the promoter region oftheM tuberculosis 85A antigen gene. They made progressive deletions 
of the 5' end using nuclease Bal3 l. All of the deletions gave less expression than the full length 
fragment. Removal of the first 44 bps resulted in a 40% decrease in promoter activity. Further 
deletions revealed that the essential region lies between nucleotides -26 and -136, with respect 
to the initiation codon. Neither the full length nor the truncated forms could drive expression in 
E. coli. The transcriptional start site was located 63 bp upstream of the proposed ATG 
initiation codon. The -10 region showed 50% homology with the BCG mpb 70 promoter, and 
50% homology with the putative -10 region of the M smegmatis ask gene. The 85A antigen 
promoter -10 region also showed some similarities to some Streptomyces promoters which are 
not expressed in£. coli. Two putative -35 regions were identified. The one (17 bp from the 
-1 O region) showed 50% sequence similarity with that of cr70 promoters, while the other (located 
22 hp from the -10 region) showed 83% identity with the consensus sequence, and was identical 
to the -35 region oftheM leprae and M tuberculosis 16S rDNA promoter regions. Increasing 
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the distance between the -3 5 and -10 regions by 64 bp did not affect the activity of the 
promoter, a characteristic which is similar to Streptomyces promoters, although the presence of 
the -35 region was essential. 
Nesbit et al. ( 1995) studied the expression of gene 71 of mycobacteriophage LS in detail. A 
number of gene 7 l-lacZ fusion reporter plasmids were constructed, containing differing 
amounts of the region upstream of the gene 71 translation initiation codon. The largest fusion 
(2607 bp) and one with 450 bp of upstream sequence were active in M. smexmalis, however, 
when only 244 bp were present, a reduction in activity was observed. Activities of the fusions 
were also measured in an L5 lysogen of M. smegma tis, and found to be only 3 0-40% of those in 
a non-lysogen, suggesting that expression may be regulated by prophage-encoded proteins. 
Three transcription start sites were found, 58, 166, and 267 bp upstream of the initiation codon 
of gene 71, corresponding to promoters Pl, P2, and P3, respectively. Pl and P2 are recognized 
by E. coli RNA polymerase in vitro, while P3 is not, and the latter appears to be a weaker 
promoter. The authors showed that P3 is recognized by the M. smegmatis RNA polymerase in 
vi:ro, and that the sequences between -11 and -35 are required for promoter function. In a 
thermoinducible and normal L5 lysogen, all three promoters were active, however, induction of 
the thermoinducible lysogen resulted in a significant decrease in activity in all three. The 
authors identified another promoter, Piefl, in the opposite orientation, which is repressed in 
lysogeny and induced in early lytic growth, and, therefore, may be regulated by gene 71. 
Significant amounts of Piefl mRNA were also observed during late lytic growth, and this was 
shown to be due to the stability of the P1efl mRNA transcript. The promoter is recognized by 
the M smegmatis RNA polymerase in vitro and, therefore, does not require any phage-encoded 
activator proteins. 
Ramesh and Gopinathan (1995) studied the promoter regions of the temperate, transducing 
mycobacteriophage 13. They constructed a phage 13 library in a vector containing the 
promoterless chloramphenicol acetyl transferase (CAT) gene, and isolated a total of 48 
promoter-containing clones. Four of the strongest promoters were sequenced, and a -10 and 
-35 region was identified for each. They suggest that, in general, there is a good sequence 
similarity between E. coli and mycobacterial promoters at the -35 consensus, but significant 
variation at the -10 region. In E. coli, the distance between the -10 and -3 5 regions varies 
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between 17 and 19 bp, while in mycobacteria it varies between 13 and 24 bp. The authors used 
these and other mycobacterial promoter sequences to generate the following probable 
consensus; -35, T (100%), T (55%), G (100%), A (67%), C (75%), A (50%), and -10, 
T (70%), A (75%), T (60%), A (60%), A/T (40%), T (75%). However, confirmation of these 
sequences as -10 and -3 5 regions has not yet been done for all and, in many cases, the 
transcription start site has not been mapped. This study is limited to mycobacterial promoters 
that are active in £. coli, which may not be representative of most mycobacterial promoters. 
Kenney and Churchward ( 1996) analyzed the promoter region of the M. smegma/is rpsL gene, 
encoding the ribosomal protein S 12. They mapped the transcription start site to a G residue, 
199 bp upstream of the translation initiation codon, and possibly a second 80 bp upstream of 
this. The 267 bp promoter region was tested using the xy/E gene as a reporter. Deletion 
analysis and subcloning showed that sequences important for promoter activity lay between 
nucleotides 200 and 23 1, upstream of the start codon, and that a second weaker promoter may 
be present further upstream. Analysis of the region upstream of the transcription initiation site 
revealed two potential -10 hexamers, one 6 bp upstream of the transcription start site, which 
had 3/6 nucleotides matching the typical E. coli cr70 region, and one 9 bp upstream, which had 
4/6 matching nucleotides. There were also two potential -35 hexamers, one 17 bp from the first 
-10 region, which had 2/6 matching nucleotides, and the other 18 bp from the second -10 
region, which had 3/6 matching nucleotides. Kenney and Churchward used oligonucleotide-
directed mutagenesis to change conserved positions in the - IO and -3 5 regions ( all to a CG base 
pair). Only one change, T ~ C at position -9, abolished promoter activity, while a T ~ C 
change at position -10 reduced activity by 50%. No changes in the -35 region affected activity., 
in fact, a T ~ C change at -34 increased promoter activity by 10%. The results suggest that the 
second -10 region is recognized in vivo. The authors then used random PCR mutagenesis and 
found 5 different independent promoter mutations that abolished activity in vivo. All mutations 
were in the second -10 region; T ~Cat -14, substitution of either G or Cat -3, deletion ofT at 
-12 (or -11), and T ~ A at -9. These results suggest that the -35 region is not required for 
promoter function. Other promoters that do not require a -35 region have been reported (Chan 
and Busby, 1989; Keilty and Rosenberg, 1987; Kumar et al., 1993; Ponnambalam et al., 1988). 
These promoters usually have an extended -10 region, produced by a TGn motif immediately 
upstream of the -1 O region. Kenney and Churchward ( 1996) note the presence of a TGG 
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immediately upstream of the rpsL -10 region. They found that mutation of these nucleotides 
resulted in a 15% reduction in promoter activity, and, if combined with mutations at -37 or -38, 
resulted in a 70% reduction in activity. This indicates that either an extended -10, or a 
functional -35 region is needed for normal promoter activity. It has been proposed that when a 
-3 5 region is absent, the extended -10 region is responsible for binding of RNA polymerase and 
other steps in transcription initiation (Chan and Busby, 1989; Keilty and Rosenberg, 1987). An 
alignment of the rpsL upstream sequences from M leprae, M hovis, M. tuberculosis, and 
!vi. smeKmatis, revealed a 45% conservation in the untranslated mRNA leader sequence, but a 
75% conservation of the -10 and -35 sequences (the -10 region was absolutely conserved). 
There was also sequence conservation around the translation start site, and a 20 bp sequence 
140 bp upstream of the initiation codon. Only the M. smegmatis promoter contained the 
extended -10 TGn motif The M hovis hsp60 promoter, P2 (Stover et al., 1991 ), and the 
M. leprae 16S rDNA promoter (Sela and Clarke-Curtiss, 1991) also show an extended -10 
motif The slow growers, M leprae, M tuberculosis, and M bovis do not have an extended 
-10 in the rpsL promoter, but have 5/6 matches with E. coli in the -3 5 region. This may reflect 
differences in the primary o factors of fast and slow growing mycobacteria (Kenney and 
Churchward, 1996). 
Das Gupta et al. (1993) constructed an E. co/i-mycobacterial shuttle vector, pSD7, containing a 
CAT reporter cassette for studying mycobacterial promoters in a mycobacterial host. The 
authors made libraries of M tuberculosis H37Rv and M smegmatis in the vector and selected 
for clones expressing CAT. The frequency of promoter clones was 10-20% for M smegmatis 
(350 altogether), and 1-2% for M tuberculosis (125 altogether). The strengths of the 
promoters were determined by assaying for CAT activity. Most of the promoters from 
M tuberculosis gave CAT activities between 5 and 100 nmol/min/mg protein, while most of the 
M. smegmatis promoters gave much higher activity (> 500 nmol/min/mg protein). None of the 
M tuberculosis-derived promoters, and only 12% of the M smegmatis-derived promoter 
plasmids, conferred chloramphenicol resistance in E. coli, and all exhibited very low levels of 
expression in this host (2-100-fold less than in M smegma/is). Therefore, stronger promoters 
occur less frequently in M tuberculosis than in M smegmatis. This is also consistent with the 
lower frequency of isolation of promoters from M tuberculosis (Das Gupta et al., 1993), and 
may be due to a lower rate of transcription, lower RNA content/unit of DNA, and slower 
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growth rate (Harshey and Ramakrishnan, 1977). Bashyam et al. (1996) have analyzed the 
promoters isolated in this study further. Of these promoters, 75% were active in M smegmatis, 
and approximately two thirds exhibited 10% or higher CAT activities in M smegma tis than in 
E. coli. This indicates that the M. smegmatis transcription machinery can tolerate a larger 
variety of -35 sequences than the E. coli machinery. The authors sequenced 14 of the 
M. smegmatis and 10 of the M. tuherculosis promoters, and aligned them on the basis of their 
transcription start sites. All contained a conserved -10 region at nearly identical positions 
upstream of their transcription start sites. The conserved sequences were; T ( 100% ), A (93% ). 
T (50%), A (57%), a (43%), and T (71%) for M. smegmatis, and T (80%), A (90%), Y (60%), 
g (40%), A (60%), and T (100%) for M. tuberculosis, where Y indicates a pyrimidine base. 
The first, second, and sixth bases are most strongly conserved, as in E. coli. The less conserved 
bases tend more towards G and C substitutions. None of the -35 regions of the promoters 
studied here were homologous to the E. coli consensus sequence, and none were conserved in 
the mycobacteria. The authors suggest that the absence of a conserved -3 5 region is a 
distinctive feature of mycobacterial promoters. This is in contrast to the results of Ramesh and 
Gopinathan (I 995), but is supported by the results of Sarkis et al. ( 1995), Kremer et al. ( 1995)., 
and Kenney and Churchward ( 1996), and is also observed in Streptomyces species. Strohl 
(1992) reports that 80% of Streptomyces promoters contain diverse sequences in their -35 
regions, and do not function in E. coli. Deletion analysis in one M smegmatis and one M. 
tuberculosis promoter revealed that the -35 region alone is insufficient to support transcription, 
and that the -10 region is essential. In 9/14 M smegmatis and 7 /10 M tuberculosis promoters, 
transcription initiated at a purine. Interestingly, the M tuberculosis promoters had a higher 
G+C content (57%) from positions -1 to -50, with respect to the translation initiation codon, 
than theM smegmatis promoters (43%), which may have a bearing on the lower strength of the: 
M tuberculosis promoters. The authors suggest that weaker promoters may have an advantage: 
in pathogenicity (Bashyam et al., 1996). 
It is evident from the above-mentioned studies that mycobacterial transcriptional signals share 
some features in common with those from other, unrelated organisms. Most similarities, 
however, are found with the promoters of Streptomyces, a genus which is closely related to the 
mycobacteria. As yet, too few mycobacterial promoters have been characterized to make 
accurate predictions on promoter structures and consensus sequences. It is likely that 
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promoters from M tuberculosis will contain a unique set of features, which account for the very 
low rate of transcription initiation, and possibly also the slow growth and pathogenicity of the 
organism. 
5.2.3. The regulation of gene expression in mycobacteria 
Some evidence exists for gene regulation mechanisms in mycobacteria which are similar to those 
described in other bacteria. The !vi. 111herc11/os1s 65 kOa and I 0-12 kOa heat shock proteins, for 
example, have potential heat shock promoter sequences which may be recognized by cr32 
(Cowing et al., 1985), and overlap the cr70 sequences. The BCG h\p60 promoter is expressed 
constitutively when present on an extrachromosomal vector, but shows an increase in response 
to stress with acid, heat, and peroxide when present on an integrative vector, although 
expression is lower (Stover et al., 1991 ). Levin and Hatfull ( 1993) found that transcription of 
the hsp60 promoter by the M. smegmatis RNA polymerase relied on supercoiling of the DNA 
substrate. The authors suggest that the differences in expression noted by Stover et al. ( 1991) 
may be explained by the differences in the superhelical state of the DNA, which may play a 
direct role in the regulation of gene expression (Pruss and Drlica, 1985; 1989; Mark et al., 
1988; Galan and Curtiss, 1990). They also suggest that the high G+C content of mycobacterial 
DNA may be responsible for the need for DNA superhelicity, to unwind promoter regions. 
Bacterial virulence genes which respond to stress require DNA supercoiling for regulation 
(Higgins and Dorman, 1990; Higgens et al., 1990; Mekalanos, 1992). Environmental stimuli 
such as osmolarity, temperature, oxygen levels, and starvation affect DNA supercoiling, and 
pathogenic organisms may use this system to respond to these stimuli (Galan and Curtiss, 1990). 
Dale and Patki (1990) have identified a region that partially resembles a pho box, found 
upstream of genes regulated by phosphate, and a region with homology to the Fur binding site 
upstream of the M leprae 28 kDa antigen. This is not a perfect match but is situated in the 
correct position, i.e. it overlaps the -35 region. Some evidence exists for the 28 kDa antigen 
being involved in iron uptake (Cherayil and Young, 1988; Hall et al., 1987; Barclay and 
Wheeler, 1989), and a gene involved in iron regulation has been identified in M tuberculosis 
(discussed in section 5.4.2). Other regulated genes in mycobacteria include glycerol 
3-phosphate dehydrogenase for the utilization of glycerol, which is induced by glycerol (Segal 
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and Edwards, 1984); aspartokinase, which is repressed by threonine and methionine; 
homoserine dehydrogenase, which is repressed by threonine and valine (Karasevich and 
Butenko, 1966, cited by Segal and Edwards, 1984; Sritharan et al., 1989; 1990); and amidase, 
which is induced by acetamide (Draper, 1967). As mentioned in Chapter 2, the promoter of the 
M tuberculosis recA gene has recently been shown to be inducible in response to a variety of 
DNA damaging agents. This induction involves the LexA protein (Movahedzadeh et al., 1997a; 
1997b ). There is also some evidence for the induction of some mycobacterial genes during in 
vivo growth in macrophages. Dellagostin et al. ( 1995) showed that the !vi. li!prae 18 kDa 
promoter shows high levels of expression in BCG cells which have infected macrophages. This 
is consistent with the fact that the 18 kDa protein is a major antigen in natural infection, and 
suggests upregulation of the gene during infection. This was recently confirmed by McBride 
et al. (ASM Abstract U-103, 1997). These authors determined the minimum sequences 
required for in vitro expression and in vivo upregulation of the promoter. Post-translational 
modification has been studied to a small extent in mycobacteria. Several secreted proteins and 
possible signal peptide sequences have been identified, and there have been some studies on 
biotinylated proteins (Takayama and Qureshi, 1984; Collins et al., l 990; Young et al., 1985:, 
Moss, 1987). These observations indicate that the mycobacteria possess some mechanisms of 
gene regulation in common with other bacteria. It is likely, though, that these organisms also 
contain a unique set of regulatory mechanisms which are responsible for some of their unique 
properties. 
5.2.4. Tools for studying gene expression in mycobacteria 
The significant increase in the information available on the regulation of gene expression in the 
mycobacteria over the past decade has been facilitated by the development of molecular tools 
and techniques for the genetic manipulation of these organisms. These methods are reviewed by 
Jacobs et al. (1991). E. coli and Streptomyces lividans have been used to study the expression 
of mycobacterial genes, with variable success (Jacobs et al., 1986; Kieser et al., 1986; Labidi 
et al., 1985b; Thole et al., 1985). It is evidently more ideal to study the expression and 
regulation of these genes in a homologous system, in which response to physiological 
constraints is expected to be similar. Molecular biological approaches to studying mycobacteria 
have been facilitated by the development of efficient electroporation methods for mycobacteria 
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(Snapper et al., 1988; 1990a; 1990b ), the isolation of high transformation frequency mutants of 
M smegmatis (Snapper et al., 1990a), and the characterization and use of the pALSOOO plasmid 
of M fortuitum, which replicates autonomously in mycobacterial species (Labidi et al., 1985a). 
The oriM of pALSOOO is located on a 1.8 kb fragment, and can direct plasmid replication in 
M smegmatis and BCG (Stover et al., 1991 ). Another naturally occurring mycobacterial 
plasmid is pMSC262, isolated from M. scrofulaceum (Goto et al., l 99 l ). The minimum 
replication region of this plasmid is contained in a l. 5 kb fragment, which has no homology with 
the replication region of pALSOOO. Plasmid pMSC262 is compatible with pALSOOO and, like 
the latter, requires different regions for replication in Al. for111i111111 and Al. smegmatis (Qin el al., 
1994). These plasmids have been used to construct a number of different vectors for use in the 
mycobacteria, many of which have possible applications in vaccine development. Some of these 
are reviewed briefly below. 
Stover et al., ( 1991) constructed a vector containing the following: the l. 8 kb oriM of 
pALSOOO, in which some restriction endonuclease sites had been mutated using PCR 
mutagenesis; the £. coli oriE from pUC 19; the kanamycin resistance gene from Tn903; and an 
expression cassette containing the BCG hsp60 promoter, including the first 6 amino acids of this 
protein (Thole et al., 1987), a multiple cloning site, and the rmABt l transcriptional terminator 
(Sarmientos et al., 1983). The resultant vector, pMV26l, has a copy number of approximately 
5 in BCG. To ensure that these plasmids are stably maintained in BCG, the authors replaced the 
oriM of pMV26 l with a DNA fragment containing the attachment site (attP), and integrase 
gene (int) from the mycobacteriophage LS (Lee et al., 1991), to form the vector pMV361. The 
vector becomes stably integrated into the BCG host chromosome at the attB site, and is 
compatible with oriM-containing plasmids. The authors used the vectors to drive expression of 
antigen genes from a variety of pathogens, including HIV. Introduction of these into BCG 
resulted in significant levels of expression of the recombinant antigens, and a greater antibody 
response than to the antigens of BCG itself. An advantage of these recombinant BCG is that 
they can provide continuous boosts to the foreign antigen from a single immunization. Other 
similar vectors have been constructed using different transcription signals and antigens (Matsuo 
et al., 1990; Aldovini and Young, 1991; Snapper et al., 1988; Ranes et al., 1990; Dellagostin et 
al., 1993). A number of vectors have also been constructed for studying promoter sequences. 
These usually contain the following: a reporter gene with no promoter, ribosome binding site or 
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initiation codon; the aph gene from Tn903 or Tn5, encoding resistance to kanamycin; the E. coli 
oriE from pUC18; and the oriM from pALSOOO (Barletta et al., 1992; Das Gupta et al., 1993; 
Curcic et al., 1994). 
Another useful tool for studying the genetics of mycobacteria and mycobacterial gene 
expression is the mycobacteriophage. Phage vectors, called shuttle phasmids, have been 
constructed from the mycobacteriophage TM4 and L l (Jacobs et al., 1987; Snapper et al ... 
1988). These can replicate in mycobacteria as phage (undergo lysis and lysogeny), and in 
E. cvli as cosmids, and can be packaged into ). phage heads to facilitate the cloning of additional, 
genes (Jacobs et al., 1989). They normally contain an E. coli plasmid, often a cosmid, inserted 
in a non-essential region of the phage genome. Shuttle cosmids, such as p YUB 18, have also 
been constructed with the following features: E. coli and mycobacterial origins of replication; a 
kanamycin gene functional in E. coli and mycobacteria; a phage ). cos sequence, which allows 
packaging into A. phage heads; and unique restriction endonuclease sites for the construction of 
libraries. These cosmids allow the cloning of very large DNA fragments, and have been used 
extensively for constructing mycobacterial genomic libraries (Jacobs et al., 1991 ). 
Insertional mutagenesis is useful for the selection of mutants arising from a single mutagenesis 
event directly. Guilhot et al. (1994) were the first to report on the construction of 
mycobacterial insertional mutant libraries by transposition directly into M smegmatis. They 
used transposon Tn61 l in a temperature-sensitive plasmid isolated from an E. coli-
mycobacterial shuttle vector, containing the pAL5000 and pUCI8 replicons. This system may 
be useful for the study of M smegmatis genetics, and possibly those of other mycobacteria too. 
Random shuttle mutagenesis has been developed by Kalpana et al. (1991). It involves firstly 
cloning the desired gene into a vector that replicates in E. coli, but not in the organism of 
interest, secondly introduction of a selectable marker on a transposon into the gene of interest, 
and thirdly homologous recombination to return the mutagenized gene into the chromosome of 
the organism of interest. The authors used Tn5 sequences containing the neo gene, which 
confers resistance to kanamycin in E. coli and mycobacteria, and hyper-resistance to neomycin. 
The transposon transposes preferentially into GC-rich sequences. 
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A number of different reporter genes have been used for studying expression from 
mycobacterial promoters. Curcic et al. ( 1994) and Kenney and Churchward ( 1996) used the 
xylE gene from Pseudomonas putida as a reporter for studying mycobacterial gene expression. 
The gene product, catechol 2,3-dioxygenase, converts catechol, a small aromatic compound, 
into a bright yellow product, which is easily measured. The advantages of xylE are: activity can 
be rapidly detected by spraying bacterial colonies with catechol; this assay does not alter the 
viability of the cells; the catechol is inexpensive, and penetrates the lipid-rich cell wall of 
mycobacteria, therefore analysis can be done on whole cells; the xy/1~ gene product is stable; the 
gene derives from a GC rich organism and, therefore, may have a similar codon usage to 
mycobacteria; and the assay is highly reproducible (Curcic et al., 1994). The phoA expression-
secretion system is very useful for evaluating the efficiency of mycobacterial promoters and 
signal peptides, and has been used to study the promoter region of an M. fortuitum ~-lactamase 
gene in M smegmatis (Timm et al., 1994), and the 85A antigen promoter from M tuberculosis 
(Kremer et al., 1995). The gene product is only functional if secreted, therefore, Lim et al. 
(1995) used the reporter in a vector, pJEM 11, for isolating genes encoding exported proteins 
from mycobacteria. Another frequently used reporter is the E. coli P-galactosidase enzyme. It 
is easily detected, and is known to induce an antibody and T-cell proliferative response in the 
presence of IF A It is, therefore, useful for studying the in vivo expression of mycobacterial 
promoters (Stover et al., 1991; Murray et al., 1992; Barletta et al., 1992). The green 
flourescent protein (GFP) of the jellyfish Aequorea victoria has been used by Dhandayuthapani 
et al. ( 1995) for studying expression of the ahpC promoters from M tuberculosis and 
M leprae, mtrA, a response regulator from M tuberculosis, hsp60 from M bovis BCG, and 
tbprc3 from M tuberculosis, in M. smegmatis and M. bovis BCG hosts. The reporter requires 
no exogenously added substrate or co-factors, only irradiation with blue light. The authors used 
epiflourescence microscopy, laser scanning confocal microscopy, flourescence spectroscopy, 
and flow cytometry to monitor expression. They were able to identify bacteria expressing GFP 
from a strong promoter, and to localize and isolate phagocytic vesicles containing mycobacteria. 
It may therefore be a useful tool for studying the interactions of mycobacteria with macrophages 
(Dhandayuthapani et al., 1995). The chloramphenicol acetyl transferase gene (CAT) has also 
been used extensively as a reporter (Sela and Clarke-Curtiss, 1991; Das Gupta et al., 1993; 
Verma et al., 1994; Ramesh and Gopinathan, 1995). Selection for promoters driving expression 
of this gene is simple and rapid, and involves growing on chloramphenicol. 
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The luciferase enzyme is another useful reporter for studying gene expression. The luciferase 
genes from Vibrio jisheri, Vibrio harveyi, and the firefly, Photinus pyrulis, have been used for 
this purpose (Engelbrecht et al., 1985; Legocki et al., 1986; Schmetterer et al., 1987; Cam1i 
et al., 1987). The bacterial luciferase system requires up to 7 genes in the lux operon, however, 
luminescence can be obtained from just the two subunits of the luciferase enzyme, encoded by 
the luxA and luxB genes (Meighen, 1988). In luminous bacteria, the luciferase enzyme catalyzes 
the following reaction: RCHO + FMNH2 + 0 2 ~ RCOOH + FMN + H20 + hv (490 nm), in 
which R is an aliphatic moiety containing at least 7 carbon atoms, FMN is a flavin 
mononucleotide, and FMNH2 is its reduced form. One luciferase molecule gives rise to 
approximately one photon of light, therefore very small amounts of luciferase can be detected 
using a luminometer. The reaction, however, requires the addition of exogenous substrates such 
as decanal. The substrate is generally added in excess to ensure that it is not limiting, however, 
it becomes strongly inhibiting at high concentrations, therefore complicating the interpretation 
of results. Other problems with decanal are that it is highly volatile, poorly soluble in aqueous 
systems, lipophilic, and is cytotoxic at higher concentrations (Blouin et al., 1996; Olsson et al., 
1988). The bacterial luciferase has been used as a reporter in the mycobacteria (Gordon 
et al., 1994). 
The firefly luciferase enzyme, which catalyzes the oxidation of luciferin in the presence of ATP, 
has also been used as a reporter in the mycobacteria. Hickey et al. (1996) constructed vectors 
expressing high levels of Iuciferase in M bovis BCG, and used them to monitor the in vivo 
growth of the recombinant BCG strain in mice. The authors were able to detect activities of 
standard antimycobacterial drugs directly in mice by reductions in spleen luminescence:. 
Similarly, Arain et al. (1996) used strains of M. tuberculosis and M bovis BCG expressing the 
firefly luciferase to assess the activities of INH and rifampin against mycobacteria in human 
macrophages. Sarkis et al. (1995) introduced the firefly luciferase gene into the tRNA region of 
the mycobacteriophage LS genome. When used to infect M smegmatis, these recombinant 
phages resulted in expression of the luciferase gene and light emission. The gene is fortuitously 
expressed continuously in lysogens surviving infection. These authors, again, suggest the use of 
these reporter phages for discrimination between drug-sensitive and drug-resistant strains of 
M smegmatis, and possibly for rapid identification and classification of antimycobacteria.l 
agents. 
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5.3. THE REGULATION OF CATALASES IN PROKARYOTES 
Outlined above is an overview of the information available on the regulation of gene expression 
in the mycobacteria, and the tools available for further studies. Many of these have been applied 
in this study to the examination of the M tuberculosis katG promoter and its mechanisms of 
regulation. Chapter l outlines the importance of the M. t11berc11/osis KatG in INH sensitivity 
and in virulence. It would, therefore, be useful to improve our understanding of the way in 
which the gene is regulated in these organisms. This is the focus of the next few chapters. As 
mentioned m Chapter I, a number of I NH-resistant clinical isolates of !vi. 111herc11/osis have been 
described which have reduced catalase and peroxidase activity, but have no mutations in the 
katG gene. This suggests that they may have mutations in an unlinked regulatory gene. In 
order to provide clues as to the mechanisms of regulation of the M. tuberculosis katG gene, the 
regulation of catalases in other bacteria is reviewed. 
5.3.1. The oxidative stress response 
Central to the regulation of catalase expression in many bacteria is the oxidative stress response. 
Active oxygen molecules are produced as a byproduct of oxygen metabolism, and their 
production is enhanced by exposure to certain environments or by dietary or disease conditions. 
These radicals can oxidize membrane fatty acids and proteins, and damage DNA When the 
degree of oxidative stress is greater than the ability of the cell to defend against it, oxygen 
toxicity results. Much progress has been made in understanding bacterial responses to oxidative 
stress, particularly in E. coli and S. typhimurium, and is reviewed by Farr and Kogoma (I 991 ). 
Molecular oxygen (02) has two unpaired electrons in its molecular orbitals with the same spin 
quantum number (parallel spins), i.e. is spin restricted, and cannot easily accept a pair of 
electrons. It is, therefore, unreactive with most compounds, except radicals. Molecular oxygen 
is a poor acceptor of one electron, but in the presence of metal catalysts, one-electron reduction 
can occur. Its reactivity increases with acceptance of I, 2, or 3 electrons to form the superoxide 
radical (02"), hydrogen peroxide (H202), and hydroxyl radical (OH), respectively. A 4-electron 
reduction results in the formation of water. Under acidic conditions, molecular oxygen can be 
protonated to form the hydroperoxyl radical, HOO· (Bielski, 1985), which is much more 
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reactive than 02·. The superoxide radical oxidizes thiols and ascorbate (Hill and Allen, 1978), 
attacks proteins containing (Fe-S)4 clusters (Gardner and Fridovich, 1991 ), and reduces 
transition metals and metal complexes. It spontaneously dismutates to H20 2 and 0 2. Hydrogen 
peroxide acts as a weak oxidizing agent, and will attack thiol groups of proteins or reduced 
glutathione, and can react with some keto acids (Wefers and Sies, 1983). It reacts with reduced 
iron or copper ions in the Fenton reaction to generate hydroxyl radicals (OH), which react with 
most molecules in the cell at diffusion-limited rates (Singh and Singh, 1982). Iron-oxygen 
complexes may also be important in oxidative damage. A superoxide anion may form a 
complex with Fe3• to yield [2Fe2·02J, which undergoes a series of reactions to form the ferryl 
radical [2Fe2+0l (Aust et al., 1985), which is electron rich and has radical characteristics. 
Active oxygen species therefore arise from a variety of intracellular and extracellular sources, 
and can cause extensive damage to cells if not removed. 
Organisms which grow under aerobic conditions have developed a number of defences against 
these active oxygen species. These include, enzymes which degrade these species, such as 
superoxide dismutases, which dismutate 0 2• to H20 2, catalases and peroxidases, which break 
down H20 2 to water and oxygen, and alkylhydroperoxide reductase, encoded by ahpC and 
ahpF, which reduces various organic hydroperoxides to their corresponding alcohols 
(Christman et al., 1985; Tartaglia et al., 1989). DNA repair enzymes, e.g. exonuclease III, 
DNA polymerase I, the RecBC nuclease, and RecA, repair damage to DNA caused by oxygen 
radicals that escape removal by the scavengers. As mentioned previously, when the 
concentration of active oxygen exceeds the basal level of the scavenging capacity of the cell, an 
oxidative stress results. Bacteria then invoke one or both of two known stimulons, the peroxide 
stress response, and the superoxide stress response. These responses are distinct and differ 
slightly in E. coli and S. typhimurium. The superoxide stress response involves the induction of 
approximately 30 proteins, at least 6 of which are regulated by SoxR and SoxS (Greenberg 
et al., 1990; Wu and Weiss, 1991), in response to superoxide-generating agents, such as 
paraquat (Hassan and Fridovich, 1977). Other induced proteins include two associated with the 
HPI catalase, two proteins of Ahp, heat shock protein GroEL, and endonuclease IV, resulting in 
an increased DNA repair capacity (Farr et al., 1985). The first enzyme identified as being 
induced is MnSOD (Gregory and Fridovich, 1973), which dismutates 02· to hydrogen peroxide, 
which is then thought to induce the peroxide stress response. 
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5.3.1.1. The peroxide stress response and OxyR 
When bacteria are pretreated with low doses of hydrogen peroxide, they become resistant to 
subsequent doses that would otherwise be lethal. This is due to the induction of at least 30 
proteins, including RecA (Greenberg and Demple, 1989). Other organic peroxides, such as /er/-
butyl hydroperoxide and cumene hydroperoxide, induce a similar response. Adaptation to 
hydrogen peroxide in S. typhimurium requires de novo protein synthesis, and is independent of 
RecA. There are two temporal classes of hydrogen peroxide inducible proteins, as revealed by 
pulse-labelling with 3~S-methionine. The early proteins, of which there are 12, are synthesized 
maximally during the first l O minutes, while the late proteins, of which there are 18, are 
synthesized maximally l 0-30 minutes after treatment with hydrogen peroxide. In both E. coli 
and S. typhimurium, at least 9 of the peroxide-induced proteins are positively regulated by 
OxyR. These include: two heat shock proteins; two electromorphs of HPI, encoded by the katG 
gene; the two subunits of Ahp, encoded by the ahpCF operon; glutathione reductase, encoded 
by gorA; dps, a 19 k.Da DNA binding protein from starved cells, which has been implicated in 
the protection of DNA from oxidants; oxyS, which is a small, untranslated RNA, divergently 
transcribed from oxyR in E. coli; and superoxide dismutase (Christman et al., 1985; Tartaglia 
et al., 1989; Altuvia et al., 1994; Toledano et al., 1994; Storz et al., 1990; Farr and Kogoma, 
1991; VanBogelen et al., 1987). Among the proteins induced by hydrogen peroxide 
independently of OxyR are some involved in DNA repair. The negatively autoregulated oxyR 
gene encodes a 34 k.Da protein (Christman et al., 1989), with significant homology to the LysR 
family of bacterial regulatory proteins (Henikoff et al., 1988). Induction of the OxyR regulon 
by hydrogen peroxide does not involve an increase in OxyR expression. Instead, upon oxidative 
stress, OxyR is oxidized to a form which then activates expression of the OxyR regulon (Storz 
et al., 1990). Both the reduced and oxidized forms of OxyR bind to the regulatory regions of 
ahpCF, katG and oxyR, but in a different manner. Storz et al. (1990) suggest that the 
conformational change resulting from oxidation alters the way in which it interacts with RNA 
polymerase. The precise mechanisms involved, however, have not yet been elucidated. 
The OxyR-binding sites upstream of the katG, ahpCF operon, and oxyR genes of E. coli have 
been identified by DNase I footprinting. The ahpC site lies between -79 and -35, and that of 
katG lies between -76 and -35. In the katG promoter, 14/20 bases match the consensus 
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sequence recognized by the oxidized form of OxyR (Toledano et al., 1994). The OxyR-binding 
sites extend into the -35 cr70 binding site, suggesting that OxyR interacts with the RNA 
polymerase to activate transcription. Members of the LysR family of transcriptional regulators 
usually bind to a site containing a core T-NwA motif. embedded within a larger dyadic 
sequence (Goethals et al., 1992; Schell, 1993). The E. coli OxyR binds an 
AT AGnTnnnAnCT AT motif (Toledano et al., 1994). OxyR also regulates expression of the 
phage Mu mom gene which encodes a DNA modification function (Bolker and Kahmann, 
1989). The protein binds to a 5' region of the mom structural gene, containing 3 methylation 
sites, and prevents transcription, but only when unmethylated. It can, therefore, discriminate 
between methylated and unmethylated states of the mom promoter region, and there may be 
other OxyR-regulated genes whose repression or induction depends on correct methylation. 
The OxyR-binding sites of the mom and oxyR genes share significant homology, therefore, the 
modes of interaction of OxyR with DNA may differ depending on whether it functions as a 
repressor or activator (Bolker and Kahmann, 1989). 
A greater understanding of the oxidative stress response has been facilitated by the isolation and 
characterization of oxyR mutants. Christman et al. ( 1985) isolated a hydrogen peroxide--
resistant mutant of S. typhimurium, designated oxyRJ. This strain was highly resistant to 
hydrogen peroxide and constitutively expressed 9 of the 12 early hydrogen peroxide-inducible 
proteins. It was also more resistant to organic hydroperoxides, such as cumene hydroperoxide 
and I-butyl hydroperoxide, and heat killing, but was more sensitive to killing by quinones, such 
as menadione and other oxidants including diamide, paraquat, and N-ethylmaleimide. The 
mutant had a 45-50x greater specific catalase activity than the wild type associated with HPI 
and HPII, elevated levels of glutathione reductase, MnSOD, and alkyl hydroperoxide reductase, 
and constitutively overexpressed three heat shock proteins. Morgan et al. ( 1986) also found 
that the steady-state level of katG mRNA increased more than SO-fold in the Salmonella oxyR.l 
mutant, resulting in a SO-fold increase in catalase activity. Another Tn/ deletion mutant, oxyR2, 
was hypersensitive to hydrogen peroxide, and did not induce the 9 proteins. It contained a 
missense mutation which inactivates the oxyR gene (Christman et al., 1989). Kullik et al. 
(1995a) isolated 6 non-repressing oxyR mutants impaired in DNA binding. Five of these 
mapped near the N-terminal helix-tum-helix motif conserved among LysR family members. The 
same authors ( 1995b) used site-directed mutagenesis to show that a cysteine residue at position 
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199 is responsible for its redox sensitivity, and that mutations in the C-terminal region result in 
constitutive activity. They showed that activation under both oxidizing and reducing conditions 
is due to the ability of the mutants to induce co-operative binding of RNA polymerase. The 
active form of OxyR is readily reduced to an inactive form, and, therefore, only lasts until 
hydrogen peroxide has been decomposed by catalase (Storz et al., 1990). 
Oxidative stress also induces some proteins which are induced under other stresses, for 
example, heat shock and DNA damage (Christman et al., 1985; Greenberg and Demple, 1989; 
l\torgan ct al., 1986 ). GroEL and GroES are induced by peroxide and superoxide-mediated 
oxidative stress, heat shock, starvation, and the SOS response in E. coli. Cells which are 
adapted to peroxide stress, therefore, also exhibit increased resistance to heat shock. Glucose-
starved, stationary phase cells of E. coli also have enhanced resistance to other stresses, 
including oxidative stress and heat (Jenkins et al., 1988). Morgan et al. (1986) have, similarly, 
noted overlaps in the hydrogen peroxide, heat, ethanol, and nalidixic acid responses in 
S. typhimurium. Therefore several stress responses overlap, and the extent of the overlap 
varies. Each stress, however, induces its own characteristic group of proteins, therefore there 
is probably not a common intracellular signal, but it is possible that the genes have cis-acting 
regulatory sequences required for several forms of regulation. 
5.3.2. The role of RpoS in the regulation of catalases 
Apart from the oxidative stress response, other mechanisms of regulation of catalases exist in 
prokaryotes. The regulation of expression of catalase in E. coli has been extensively studied. 
Catalases are repressed under strictly anaerobic conditions (Morgan et al., 1986), but are 
induced by a shift from anaerobic to aerobic growth (Gregory and Fridovich, 1974). E. coli 
produces two catalases, HPI and HPII, which are regulated differently. HPI, encoded by katG, 
is produced under both aerobic and anaerobic conditions, and is transcriptionally induced by 
OxyR (> 100-fold), in response to hydrogen peroxide, as a part of the oxidative stress response 
(Christman et al., 1985; Loewen et al., 1985; Storz et al., 1990; Tao et al., 1991). It is, 
therefore, also induced by reagents which produce hydrogen peroxide, and other oxidative 
agents, including near-UV irradiation (Eisenstark, 1989), the organic peroxides cumene 
hydroperoxide and tert-butyl-hydroperoxide (Belkin et al., 1996), and superoxide-generating 
155 
drugs (Greenberg and Demple, 1989). Ascorbic acid, which reacts with oxygen in the presence 
of metal ions to produce dehydroascorbate and hydrogen peroxide, also induces katG. The 
presence of 5. 7 mM ascorbic acid results in an 8-fold increase in catalase activity after 30 
minutes in E. coli (Richter and Loewen, 1981 ). Similarly, catalase activity in exponential 
cultures of S. typhimurium is induced 4-5-fold after 1 hour exposure to 60 µM hydrogen 
peroxide in minimal glucose medium (Christman et al., 1985; Kagaya et al., 1992). 
HPI activity also increases 6-fold in an oxyl( strain, and 5-fold in an oxyR" deletion strain as 
cultures enter stationary phase. Growth phase-dependent induction begins at mid exponential[ 
phase, and reaches a maximum during late exponential phase, and is probably independent of 
OxyR (Mukhopadhyay and Schellhorn, 1994 ). Mukhopadhyay and Schellhorn ( 1994) treated 
exponential phase cells with spent media from cultures expressing high catalase and peroxidase 
activity. They observed a 3-4-fold increase in RPI peroxidase activity in both oxyR" and oxyl( 
strains, relative to cells resuspended in fresh medium. These results suggest that extracellular 
metabolites which accumulate during growth are responsible for the growth phase-dependent 
induction of HPI. There is a marked increase in the extracellular concentration of acetate as the 
cells enter late exponential phase, and treatment of early exponential phase cells with medium 
containing O to 80 mM sodium acetate (pH 7.0) results in induction of RPI activity in an oxyR" 
(5-fold) and oxyR+ (7-fold) strain. Other weak acids such as sodium benzoate, and sodium 
lactate also induce RPI activity, independently of OxyR (2-fold). The induction of RPI as the 
cells enter stationary phase depends on RpoS or KatF (Loewen et al., 1985; Mulvey et al., 
1990; Mukhopadhyay and Schellhorn, 1994 ), a cr factor involved in the regulation of a group of 
stress proteins induced during the transition to stationary phase, and during starvation (Tanaka 
et al., 1993). Cells mutant in rpoS exhibit a 9. 75-fold lower expression of katG during 
stationary phase, and a significantly lower expression throughout the life cycle (Ivanova et al., 
1994). Tao et al. (1993) showed that wild type Ecr70 cannot bind to the katG promoter without 
OxyR. RpoS may act directly through binding of RNA polymerase, or indirectly by synthesis of 
a new transcriptional activator, which allows Ecr70 to bind to the katG promoter, in the absence 
of OxyR (Ivanova et al., 1994). Ivanova et al. (1994) provide evidence that the basal levels of 
katG expression are regulated by RpoS. It is not known whether crs and cr70 recognize the same 
katG promoter. Greenberg and Demple (1988) and Loewen (1992) have isolated and 
characterized mutations in the katG promoter that cause overproduction of HPI in oxyffuP 
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mutants. All contained a C ~ T change at position -58, which is approximately in the middle of 
the OxyR-binding site, separate from the RNA polymerase binding site. Loewen (1992) 
suggests that this mutation may enhance RNA polymerase binding in the absence of OxyR. 
Other possibilities are that it changes promoter specificity, with respect to the cr factor, or that 
there is another transcriptional activator protein that increases expression of katG without OxyR 
(lvanova et al., 1994). Kim and Kim (l 995) demonstrated that non-oxyR regulators may be 
responsible for regulating transcription at the basal level, and that multiple binding proteins can 
specifically interact with the katG promoter in E. coli. 
Synthesis of HPII, or KatE, in E. coli increases with increased respiratory activity, accumulation 
of tricarboxylic acid cycle intermediates (Loewen et al., 1985), osmotic changes (Jenkins et al., 
1990), and entry of cells into stationary phase (Mulvey et al., 1990), and relies largely on KatF. 
HPII expression is low during exponential phase, but is induced 30-fold upon entry into 
stationary phase (Mulvey et al., 1990), independently of hydrogen peroxide or anaerobiosis. As 
noted for HPI, when exponentially growing cells are treated with spent medium from stationary 
phase cultures, HPII is induced (Schellhorn and Hassan, 1988; Mukhopadhyay and Schellhorn, 
1994), and this is probably due to the accumulation of weak acids, such as acetate, in the 
supernatant (Schellhorn and Stones, 1992). The expression of KatE relies largely on RpoS. 
RpoS expression is induced by aromatic amino acids, and this in tum activates katE 
transcription, although the mechanism of induction by the amino acids is not known. Maximal 
induction of rpoS results in a I 0-fold increase in the level of katE. Further increases in katE 
expression occur without any change in rpoS levels, suggesting that another factor may be 
involved (Mulvey et al., 1990). 
The two catalases of E. coli are, therefore, regulated in a different manner, but have at least one 
regulatory mechanism in common. Schellhorn and Stones (1992) suggest that signalling by the 
accumulation of weak acids may allow the cells to produce additional catalase during the switch 
from fermentative to oxidative metabolism, as cells begin to use weak acids as carbon sources. 
Oxidation of these acids in the presence of oxygen may result in partially reduced toxic oxygen 
species, such as hydrogen peroxide, which would require the catalases for detoxification. Acid-
linked induction of HPI may also be important, for example, in macrophages which have as a 
part of their defence mechanisms a low pH and toxic levels of hydrogen peroxide. 
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Mukhopadhyay and Schellhorn (1994) suggest, therefore, that cytoplasmic acidification or 
alteration of the proton motive force may function as a metabolic signal for induction of the 
stationary-phase regulon. Other mechanisms of regulation of catalase may also occur. For 
example, Mukhopadhyay et al. (ASM Abstract H-150, 1997) recently demonstrated that the 
bacterial adaptive response gene, barA, encoding a membrane bound sensory kinase, may affect 
catalase expression in E. coli, possibly through its role in iron uptake. The regulation of 
catalase may be finely tuned by a complex network of regulatory proteins. It was recently 
shown that OxyS, a small, untranslated RNA, induced by OxyR, regulates the translation of 
rpoS. Thus, when OxyR is activated in response to hydrogen peroxide, both kaLG and oxyS arc 
induced. The OxyS then inhibits rpoS expression, therefore preventing redundancy. During the 
stationary phase, OxyR is inactive, and RpoS is induced by starvation signals and, in turn, 
induces the catalases (Zhang et al., ASM Abstract H-151, 1997). 
5.3.3. Catalase synthesis in other bacteria 
Catalases are regulated in a similar manner in other gram-negative and gram-positive bacteria, 
with some variations. The Bacteroidesfragilis catalase enzyme, encoded by katB, is regulated 
in a similar manner to the E. coli HPII. It is upregulated by oxygenation and stationary phase 
but not by peroxides (Rocha and Smith, 1995). In contrast, expression of the catalase gene,, 
katX, of Xanthomonas oryzae pv. oryzae, a plant pathogen, is highest during exponential phase. 
It is highly inducible by superoxide generators and methyl methane sulfonate (8-10-fold), and 
weakly inducible by hydrogen peroxide (2.5-fold) (Chamnongpol et al., 1995). Interestingly,, 
katX expression in E. coli was temperature- and growth phase-dependent (Mongkolsuk et al.,, 
1996). The HPII homologues of Haemophilus influenzae, hktE, and Rhizobium meliloti, katA,, 
are induced by hydrogen peroxide (Bishai et al., 1994; Herouart et al., 1996). The activity of 
the Caulobacter crescentus catalase-peroxidase, like that of E. coli, increases in the transition 
from exponential to stationary phase. Peroxidase activity increases approximately 100-fold after 
50 to 70 hours, and this is partly responsible for the large increase in resistance to hydrogen 
peroxide killing in the stationary phase (Schnell and Steinman, 1995). In Rhodobacter 
capsulatus, catalase-peroxidase activity is 10-15-fold higher under aerobic-dark than anaerobic-· 
light conditions, i.e. it is regulated by oxygen (Hochman and Shemesh, 1987). This is due to a 
20-50-fold higher activity of the cpeA promoter region (Fork! et al., 1996). No further 
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increases in activity occur when the cultures reach stationary phase. Treatment with 200 µM 
hydrogen peroxide also results in an 8-10-fold induction of expression from the promoter. 
Forkl et al. (1996) showed, using deletion analysis of the promoter region, that a palindromic 
sequence (-143 to -130, with respect to the transcription start site) was required for induction. 
The palindromic sequence (TCGGCGCGCGCCGA) resembles a recognition site for DNA 
binding regulatory proteins, and is probably required for induction of expression under the two 
conditions described. The region (-68 to -40) shows high homology to the complementary 
upstream region of the oxyR and katG genes of E. coli at which OxyR binds (Farr and Kogoma. 
1991 ). This region may function as a second regulatory domain, since deletion results in a 2-3-
fold reduction in Lacz activity. It does not, however, closely match the extended OxyR 
consensus sequence. The results support the idea that, during exponential growth, the enzyme 
acts as a catalase for the detoxification of hydrogen peroxide, while during stationary phase it 
may act mainly as a peroxidase for adaptation to starvation conditions (Fork! et al., 1996). 
In B. subtilis, the peroxide stress response is regulated by a repressor that senses both metal ion 
levels and hydrogen peroxide. The vegetative catalase, KatA, is induced by hydrogen peroxide, 
and upon entry of the cells into stationary phase. The post-exponential induction of KatA 
requires Arb, a transition state regulator (Strauch and Hoch, 1993), and is inhibited by Mn(II). 
The B. subtilis mrgA gene, which also forms a part of the peroxide response regulon, encodes a 
homologue of the stationary phase E. coli protein, Dps (Almiron et al., 1992). Both katA and 
mrgA contain similar Per boxes, centred 15 bp upstream of the -3 5 region, which may be 
responsible for regulation (Chen et al., 1995). 
Pseudomonas aeruginosa possesses two catalases, KatA (170 kDa), which is produced 
throughout the growth phase, and KatB (228 kDa), which is produced in response to paraquat 
or hydrogen peroxide (Brown et al., 1995). Catalase activity in this organism is also regulated 
by the fur gene product ( discussed below). Mutations in the P. aeruginosa fur locus result in a 
decrease in total SOD and catalase activity, and increased sensitivity to hydrogen peroxide 
(Hassett et al., 1996). The region upstream of the katB gene contains a sequence 
CGCATTGATATTCCTAAT at position -114 to -97, with respect to the ATG start codon, that 
has 13/19 matches with the consensus E. coli iron box, however, the authors were unable to 
demonstrate binding of the purified Fur to this region. Possibly katB is regulated by Fur, since 
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the mutants here resulted in increased activity, but indirectly, since it does not bind to the 
promoter region. 
5.3.4. The role of Fur in the regulation of catalases 
As mentioned in Chapter 1, catalase has been shown to be a virulence factor in several 
organisms (Mitchison et al., 1960; Wilson et al., 1995; Bishai et al., 1994; Hochman et al.. 
1992; Mandell. 1975: Filice. 1983: Beaman and Beaman, 1984; Zheng et al.. 1992). Another 
factor involved in virulence is the ability to acquire and store iron, which is an essential element 
for all bacteria, but is not readily available under aerobic conditions, at neutral pH (Litwin and 
Calderwood, 1993). Free iron is limited in mammalian hosts due to the presence of transferrin 
in the serum and lactoferrin in mucosal secretions (Bullen et al., 1978). The available iron is 
also in the incorrect ionic form for bacterial use. The low iron concentrations, as well as other 
environmental conditions within host cells, such as temperature, calcium, osmolarity, and 
anaerobiosis, may be signals for the derepression of virulence factors (reviewed by Mekalanos, 
1992), including those involved in iron metabolism (Litwin and Calderwood, 1993). The Fur 
protein controls iron acquistion in £. coli (Hantke, 1987), S. typhimurium (Foster and Hall, 
1992), Legionella pneumophi/a (Hickey and Cianciotto, 1994), Vibrio cholerae (Litwin et al., 
1992), Vibrio anguillarum (Tolmasky et al., 1994), Campylobacter jejuni (Woolridge et al., 
1994), Yersinia pestis (Staggs and Perry, 1991), Neisseria meningitidis (Thomas and Sparling, 
1994), and Neisseria gonorrhoeae (Berish et al., 1993). Fur also governs iron transport 
systems (Hantke, 1987), and regulates expression of sodA (Mn-SOD) in E. coil (Niederhoffer 
et al., 1990), as well as a number of other virulence factors, such as the Shiga-like toxin of 
E. coli (Calderwood and Mekalanos, 1987; DiRita and Mekalanos, 1989; Hale, 1991 ), and the 
P. aeruginosa exotoxin A (Bjorn et al., 1978). It is, therefore, essential for a number of cellular 
processes including iron metabolism, response to oxidative stress, the acid-tolerance response, 
sugar metabolism, and toxin synthesis (Litwin and Calderwood, 1993; Tsolis et al., 1995; 
Hassett et al., 1996). In the presence of sufficient iron, Fur complexes to F e(II), and binds to a 
highly conserved Fur box upstream of iron-regulated genes, which overlaps the promoter, and 
blocks transcription. When iron is deficient, the genes are no longer repressed by Fur 
(de Lorenzo et al., 1988; O'Sullivan et al., 1994). Sequences regulated by Fur contain the "iron 
box" palindromic consensus sequence, GAT AA TGAT AA TCA TT A TC, (Bagg and Neilands, 
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1987; de Lorenzo et al., 1987). Fur is also activated to bind to iron-regulated promoters by 
other divalent metal ions, including manganese, zinc, cobalt, copper, and cadmium (Bagg and 
Neilands, 1987). 
Another regulator of the iron response is DtxR, which shares little significant ammo acid 
sequence homology with Fur (Boyd et al., 1990; Schmitt and Holmes, 1991 ). The 
C. diphtheriae dtxR gene encodes an iron-responsive repressor of the diphtheria toxin, tax, 
promoter, (Pappenheimer, 1977; Boyd et al., 1990). It plays the same role as Fur, i.e. regulates 
siderophore expression (Schmitt and Holmes, 1991). The DtxR-binding site contains a region 
of dyad symmetry, and overlaps the -10 region of the tox promoter. The consensus binding site 
contains a perfect 9 bp inverted repeat, interrupted by a single base pair. It has no significant 
similarity to the E. coli Fur-binding site (Litwin and Calderwood, 1993), and the two proteins 
do not bind each others' operator sequences (Schmitt et al., 1992; Schmitt and Holmes, 1991). 
A DtxR homologue has been found in Brevibacterium lactofermentum (Oguiza et al., 1995), 
S. lividans, and Streptomyces pilosus (Gtinter-Seeboth and Schupp, 1995), and DtxR-like 
binding sites have been identified upstream of iron-regulated genes in S. pilosus (Gunter et al., 
1993). 
5.4. THE REGULATION OF CA TALASE IN MY CO BACTERIA 
5.4.1. The mycobacterial oxidative stress response 
As is evident from Chapter 1, the study of the mechanisms of action of, and resistance to, 
isoniazid has led to an improved understanding of the oxidative stress response in the 
mycobacteria. In M leprae, the ahpC gene is linked to, and divergently transcribed from the 
oxyR gene (Bergh and Cole, 1994). The same situation occurs in M tuberculosis, except that 
the oxyR gene is altered. The M tuberculosis ahpC gene has > 90% homology with that of 
M avium and M leprae, and is also very similar to other members of the ahpC family. The 
oxyR-ahpC intergenic region is also similar to that of M leprae, however, the oxyR gene of 
M tuberculosis is shorter and carries multiple lesions, including in-frame stop codons, deletions, 
and a frameshift, which prevent it from forming a single, contiguous translation product. The 
oxyR gene is, therefore, naturally inactivated in this organism. The M. tuberculosis oxyR gene is 
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also transcribed at a much lower level than that of M leprae. A study of the ahpC-oxyR region 
in 20 clinical isolates of M tuberculosis, as well as other members of the M tuberculosis 
complex, revealed identical lesions in the oxyR gene in all, suggesting that they are specific to 
members of the M tuberculosis complex (Sherman et al., 1995; Deretic et al., 1995). The 
latter authors suggest that the oxyR lesions must have occurred after the divergence from the 
common mycobacterial ancestor. 
The important question 1s, therefore, in the absence of a functional OxyR, how does 
M tuberculosis regulate the expression of ka1G and other OxyR-regulated genes? Deretic et al. 
( 1995) showed that the M tuberculosis katG gene was not induced by either high or low 
concentrations of hydrogen peroxide, suggesting that this gene, and probably ahpC too, is 
regulated differently from that in enteric bacteria. Growth of the organisms at 40°C resulted in 
a slight increase in KatG labelling in the presence of hydrogen peroxide, suggesting that a 
combination of factors is required for an appreciable induction of the gene. This is in contrast to 
the results of Sherman et al. ( 1995; 1996). These authors demonstrated a moderate increase in 
the mRNA and protein levels of katG, but no change in the levels of ahpC, in M. tuberculosis 
and BCG upon exposure to hydrogen peroxide. They also cloned the M tuberculosis katG 
promoter upstream of the luciferase gene, and monitored expression in BCG. Expression 
increased 7-fold upon treatment with hydrogen peroxide, however, these exposures did not 
protect M tuberculosis against subsequent lethal hydrogen peroxide doses, as they do in 
E. coli, S typhimurium, and M smegma/is (Christman et al., 1985; Rosner and Storz, 1994; 
Sherman et al., 1995). Induction of katG did, however, allow a 35-fold increase in the survivail 
of BCG exposed to cumene hydroperoxide. A katG-deleted strain showed a much higher 
sensitivity to oxidative stress, and no protection against organic peroxides could be induced by 
pre-exposure to subinhibitory hydrogen peroxide concentrations. This may explain the 
attenuated virulence resulting from loss of katG. The authors overexpressed the ahpC gene 
from M. tuberculosis Erdman in strain H37Rv, which was then tested for sensitivity to cumene 
hydroperoxide. The recombinant was significantly more resistant to the peroxide than the wild 
type. Similar results were obtained for BCG. 
Sherman et al. (1995) and Dhandayuthapani et al. (1996) examined the oxidative stress 
response in M smegmatis. The former authors demonstrated the induction of> 12 proteins in 
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M. smegmatis in response to hydrogen peroxide. The authors cloned and sequenced the ahpC 
gene from this organism, and showed that it encoded the 25 kDa peroxide-inducible protein. It .. 
has 63% identity with the C. diphtheriae DirA, which is functionally interchangeable with the 
AhpC from E. coli (Tai and Zhu, 1995). The AhpC enzyme is involved in the conversion of 
potentially harmful hydroperoxide derivatives of lipids and nucleic acids into corresponding 
alcohols (Christman et al., 1985; Tartaglia et al., 1989), and probably has the same function in 
the mycobacteria. The region upstream of the ahpC gene has no detectable similarities with the 
corresponding conserved region in other mycobacteria, and does not contain an oxyR gene. 
This suggests that the genomic organization of M. smegma/is is different to other mycobacteria 
Pagan-Ramos et al. (ASM Abstract U-130, 1997) recently reported an inability to detect any 
sequences homologous to oxyR in M smegmatis. Dhandayuthapani et al. ( 1996) also showed. 
using metabolic labelling of newly synthesized proteins, that a distinct pattern of proteins is 
induced in M. smegma/is upon exposure to hydrogen peroxide, most of which were also 
inducible by two alkyl peroxides, cumene hydroperoxide and tert-butyl hydroperoxide. Nine 
proteins were induced by peroxide altogether, of which 6 ( l 7, 19, 25, 4 2, 64, and 68 kDa) 
responded to hydrogen peroxide treatment. A 50 kDa protein was induced only at very high 
concentrations of hydrogen peroxide (> 125 µM), but not by organic peroxides. Two of the 
proteins induced by both organic peroxides, 16 and 59 kDa, were not inducible by hydrogen 
peroxide. M smegmatis, therefore, has a significant peroxide stress response. 
Downstream of ahpC in M tuberculosis, M bovis, M smegma/is, and M leprae is an ORF 
encoding a putative protein of 18-19 kDa, ahpX, which shows no homology to the second 
component of alkyl hydroperoxide reductase, AhpF of E. coli and S. typhimurium (Sherman et 
al., 1995). The C. diphtheriae DirA antibody recognizes the M tuberculosis AhpC, but its 
basal levels are too low for detection by immunoblotting. Previous studies by Dhandayuthapani 
and co-workers (1995) have shown that the M. tuberculosis ahpC is transcribed at lower levels 
than that of M. leprae, and these studies showed that there are dramatic differences in the levels 
of AhpC in M smegmatis and M tuberculosis. The authors (1996) were also unable to detect 
AhpC in M aurum ATCC 23366 by immunoblot analysis, even after exposure to hydrogen 
peroxide and organic peroxides. Interestingly, this species also contains no detectable oxyR 
sequences. Protein labelling studies showed that only one protein (18 kDa) was induced by 
peroxide stress in this organism. This was induced by organic peroxide but not H20 2. Both 
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M marinum and M. xenopi produce detectable basal levels of AhpC, which are induced upon 
exposure to hydrogen peroxide (Pagan-Ramos et al., ASM Abstract U-130, 1997). 
Dhandayuthapani et al. ( 1997) recently examined the interaction of the M leprae OxyR with the 
oxyR-ahpC intergenic region. They identified two transcription start sites for both the ahpC and 
oxyR genes of M. leprae. The second transcription start sites of each overlapped by 28 
nucleotides, while the first transcription start site of oxyR coincided with the translation 
initiation codon of the oxyR gene. This phenomenon has been described in some Streptomyces 
promoters (Strohl, 1992). The authors overexpressed and purified the !vi. leprae OxyR in 
E. coli, and demonstrated binding of it to both the M. tuberculosis and M. leprae oxyR-ahpC 
intergenic region, although the former had a lower affinity for the protein. The OxyR-binding 
site was located in a region spanning the initiation codon of oxyR. The authors demonstrated a 
significant decrease in the transcription of the M. leprae ahpC, in the absence of the M. leprae 
oxyR. A putative OxyR recognition site, CTT A TCACTCA T ACCGA T AAG, was located 65 bp 
upstream of the first ahpC transcription start site. The authors examined the same region in 
other mycobacterial species and proposed the following mycobacterial OxyR consensus 
recognition sequence, CTT A TCGGC-N3-GCCGAT AAG, which shows limited similarity to that 
of E. coli, but contains the LysR T-Nn-A motif The sequence is well conserved in other 
mycobacteria, except M tuberculosis. The M tuberculosis OxyR-binding site deviates in the 
left side of the core motif, by substitution of the ATC with GGC, which destroys the T-N w A 
motif, and may account for its lower affinity for OxyR (Dhandayathupani et al., 1997). Pagan-· 
Ramos et al. (ASM Abstract U-130, 1997) recently characterized the oxyR and ahpC genes of 
M. marinum and M xenopi. They compared the OxyR binding sites in these organisms with 
those of M leprae and M tuberculosis, and proposed a consensus mycobacterial OxyR 
recognition sequence, CTT ATCGGt-N3-ACCGAT AAG, which differs slightly from that 
proposed by Dhandayathupani et al. ( 1997). Mutation of T and A nucleotides in the M. leprae 
sequence resulted in a decrease in the binding of the purified M. leprae OxyR protein, while 
mutation of the M tuberculosis binding site to the consensus resulted in an increased binding 
(Pagan-Ramos et al., ASM Abstract U-130, 1997). 
It is evident from the above-mentioned studies that the oxidative stress response in most 
mycobacteria is similar to the well-characterized responses of E. coli and S. typhimurium. Due 
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to the lack of a functional OxyR, however, M tuberculosis probably has no inducible oxidative 
stress response, and therefore relies on the constitutive defense offered by its inert and largely 
impermeable cell wall. Only KatG is peroxide-inducible but not to a sufficient extent to protect 
against hydrogen peroxide challenge. It appears quite paradoxical that organisms which require 
additional help in surviving oxidative stress imposed by host defence systems have an impaired 
system for induction of the oxidative stress response. It may be that these organisms are highly 
specialized, and express these genes constitutively at a high enough level to protect the cells 
during infection, or that they use other mechanisms of regulation of these genes. The lack of an 
oxidative stress response may explain the rapid loss of viability which results when 
M tuberculosis is subjected to sudden changes in aeration conditions (Wayne, 1976). 
5.4.2. The regulation of iron metabolism in the mycobacteria 
The acquisition of iron by M. tuberculosis is probably essential for growth and virulence. 
Mycobacteria produce a number of proteins involved in the acquisition and storage of iron from 
the environment (Snow, 1970; Barclay and Ratledge, 1983; Wheeler and Ratledge, 1994; Fiss 
et al., 1994). The presence of an iron acquisition system in mycobacteria suggests the presence 
of an iron regulation system. A Dtx.R homologue, IdeR, has been described in M. tuberculosis 
H37Rv, M bovis BCG, M leprae, M. avium, and M smegma/is (Doukhan et al., 1995). In 
M tuberculosis and M leprae, the dtxR gene is located immediately downstream of the mysB 
gene. The predicted product has an overall identity of 58% and conservation of 70% with the 
C. diphtheriae Dtx.R. The two proteins are 78% identical over 140 residues at the amino 
terminal. The N-terminal region of DtxR, which is conserved in mycobacteria, contains the 
DNA binding motif, the protein-protein interaction domain, and the metal binding site (Doukhan 
et al., 1995; Qui et al., 1995; Schiering et al., 1995; Ding et al., 1996). No function has been 
assigned to the 90 amino acid C-terminal region. The fxbA genes from M smegmatis and 
M bovis BCG have an iron-regulated promoter and a potential DtxR iron box (Fiss et al., 
1994 ), and Dale and Patki (I 990) have identified a region with homology to the Fur binding site 
upstream of the M leprae 28 kDa antigen. This is not a perfect match but is situated in the 
correct position, i.e. overlaps the -35 region. 
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Schmitt et al. ( 1995) showed that the M. tuberculosis IdeR regulates transcription from the 
C. diphtheriae tax promoter, in an iron-dependent manner, as efficiently as the C. diphtheriae 
DtxR. Dussurget et al. ( 1996) constructed isogenic IdeR-deficient mutants in M smegmatis, 
which were defective in their ability to repress synthesis of exochelin and mycobactin. They 
showed a greater sensitivity to hydrogen peroxide, and had decreased catalase, peroxidase, and 
superoxide dismutase activities. The authors constructed two mutant strains, SM 1 and SM3, 
which showed derepression of secreted siderophore production. Derepression was not 
complete, however, suggesting the existence of a second repressor. The ideR mutants did not 
show significant sensitivity to acid compared with the wild type strain, but did show an 
increased sensitivity to hydrogen peroxide on solid medium. Both mutants showed a dramatic 
decrease in Mn-SOD activity and catalase and peroxidase activity, associated with KatG, while 
a strain that had been complemented with the gene showed wild type activities. The KatE 
activity levels were unchanged. The authors therefore provide evidence that the mycobacterial 
IdeR is a repressor of exochelin and mycobactin synthesis in response to the environmental iron 
concentration, and that it is involved in the oxidative stress response. It is not known whether 
IdeR acts directly on the sod and katG promoters, or indirectly via other regulatory genes. The 
authors suggest that IdeR may be responsible for regulation of hydrogen peroxide-inducible 
expression of katG in M t11berc11/osis. E. coli fur mutants are also more sensitive to hydrogen 
peroxide (Touati et al., 1995), possibly due to an iron overload which generates ferry! and 
hydroxyl radicals through the Fenton reaction, which damage the DNA (Imlay et al., 1988). 
Accumulation of intracellular free iron in the presence of oxygen generates oxidative stress and 
cellular damage, therefore, iron metabolism and oxidative stress are closely linked in enteric 
bacteria and mycobacteria (Dussurget et al., 1996). 
Some catalase regulatory mechanisms, therefore, exist in the mycobacteria, which are similar to 
those in other organisms. Mulder et al. (Manuscript in preparation) recently reported evidence 
that the M tuberculosis MysB regulates synthesis of the katG gene in a similar manner to the 
E. coli RpoS, and suggests that MysB is the RpoS homologue of M tuberculosis. This cr factor 
is probably responsible for the basal levels of katG expression in this organism, as well as thi:! 
growth phase induction of the gene, noted in this study. Some evidence also exists for the post-
transcriptional regulation of the gene. Rouse et al. ( 1996) have noted discrepancies between the 
amounts of katG mRNA transcript, and the levels of KatG protein, in some katG mutants of 
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M. tuberculosis. The authors suggest that the mutations may alter the stability of the katG 
mRNA transcript or KatG protein, and that the KatG protein synthesis may be regulated at a 
post-transcriptional level. Mutations in the E. coli katG, which alter the conformation, also 
reduce the stability of the active tetramer (Loewen et al., 1990). 
5.5. THE AIMS OF THIS STUDY 
In an attempt to improve our understanding of both the regulation of gene expression 111 
mycobacteria, and, particularly, the regulation of virulence factors, this study reports the 
examination of the M tuberculosis katG promoter. The katG gene has been extensively studied 
with respect to its role in INH sensitivity, and the product has been purified and studied with 
respect to its enzyme activities, however, very few observations on the mechanisms of 
regulation of the gene have been reported. This study, therefore represents the first extensive 
report on this subject. The firefly luciferase gene was used as a reporter for characterizing the 
katG promoter, and for testing under which conditions it is expressed in the mycobacteria. Both 
M smegmatis and M bovis BCG were used as mycobacterial hosts. The transcription start 
sites were mapped and putative -10 and -3 5 regions identified. Deletion analysis of the 
promoter-containing fragment revealed an upstream element required for optimal promoter 
expression. This element was also able to increase expression of an unrelated promoter, and 
may contain a binding site for regulatory proteins. The results of this study suggest a complex 
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CLONING AND IDENTIFICATION OF THE 
M. TUBERCULOSIS KATG PROMOTER AND 
CHARACTERIZATION OF CONDITIONS OF EXPRESSION 
6.1. SUMMARY 
This chapter describes the construction of an /~. co/i-mycobacterial shuttle vector, pJCluc, 
containing the promoterless firefly luciferase gene as a reporter, for the examination of 
mycobacterial promoter sequences. The vector was used to characterize the M. tuberculosis 
katG promoter. A I. 9 kb region immediately upstream of the katG gene was amplified by PCR 
and cloned into pJCluc, and promoted expression of the luciferase gene in E. coli and 
M. smegmatis. A smaller promoter fragment (559 bp) promoted expression with equal 
efficiency, and was used in all further studies. Two transcription start sites were mapped by 
primer extension analysis, and used to identify putative -IO and -35 regions. These show strong 
similarity to previously identified mycobacterial promoters. M. smegmatis recombinants 
harbouring the promoter construct were used to determine under what conditions the katG 
promoter is expressed. Luciferase activities revealed that expression from the promoter peaks 
during late exponentia1 phase, and declines during stationary phase. The promoter is induced by 
ascorbic acid, and is repressed by oxygen limitation and growth at elevated temperatures. 
6.2. INTRODUCTION 
The importance of the M tuberculosis katG gene, and its role in virulence and drug 
susceptibility, have been emphasized in Chapter 1. Understanding the mechanisms of regulation 
of this gene may, therefore, provide insight into the processes that govern interaction with the 
host and mediate susceptibility to antimycobacterial agents, particularly isoniazid. At the same 
time, a study of this sort may provide more valuable information on the mycobacterial 
transcription signals and gene regulatory mechanisms. 
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As discussed in Chapter 5, studies on mycobacterial promoters in heterologous hosts are 
generally not successful. It is more favourable to examine mycobacterial transcription signals in 
a mycobacterial host, in which response to physiological constraints and regulatory mechanisms 
are conserved. However, due to various limitations in the genetic manipulation of 
mycobacteria, E. coli provides a more favourable host for the propagation and amplification of 
cloned and altered DNA fragments. For this reason, an E. co/i-mycobacterial shuttle vector was 
employed. The requirements for the vector for this study were: a mycobacterial ori for 
replication and propagation in mycobacteria; an E. coli ori for replication and propagation in 
F co/1, an antibiotic resistance gene for selection of recombinants; a cloning site with selection 
for cloning of the reporter; and the reporter gene itself The E. co/i-mycobacterial shuttle 
vector, pJC86 (Jack Crawford, CDC Atlanta), provides all these requirements, except for the 
reporter. The firefly Iuciferase gene was chosen as a reporter, and was cloned into pJC86 to 
yield pJCluc. The source of the reporter gene was the pGEM1~ -/uc plasmid (Promega). The: 
firefly luciferase gene in pJCluc contains no promoter or ribosome binding site. These must be: 
provided by the DNA fragment under investigation. Measurement of luciferase activity 
expressed off a cloned promoter, therefore, allows quantitation of transcription initiation, 
promoter strength, and efficiency of ribosome binding. 
The primary advantage of the firefly luciferase as a reporter is the extreme sensitivity of the 
assay. Less than 10·20 moles (0.001 pg) of luciferase have been detected under ideal conditions 
(Wood, 1991a), which enables the study of low level expression, for example from weak 
promoters (Williams et al., 1989). Sensitivity is approximately 100-fold greater than with the 
chloramphenicol acetyltransferase assay (Alam and Cook, 1990). Other advantages are that the 
assay is rapid, easy to perform and relatively inexpensive. Endogenous luminescence is absent 
from most biological samples, therefore there is no interference with the signal generated by 
luciferase, and no background. The luciferase gene encodes a 62 kDa protein which requires no 
post-translational modifications for activity, and can function immediately after translation 
(Wood et al., 1984; de Wet et al., 1985). It is also structurally very simplistic and contains no 
prosthetic groups, bound metals or disulfide bonds, and can therefore be expressed in virtually 
any host or cell type (Wood, 1990). The protein is stable at room temperature and loses only 
5% of its activity after 10 hours. As mentioned in Chapter 5, the firefly Iuciferase catalyzes the 
oxidation of beetle luciferin with concomitant production of a photon of light. The oxidation 
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normally occurs from an enzyme intermediate, luciferyl-AMP, however, in the presence of 
co-enzyme A, it occurs through luciferyl-CoA, resulting m light production without the 
characteristic self-inhibition of luciferase (Wood, 1991 b ). In conventional luciferase assays 
(Wood, 1991 a), a flash of light is generated, which rapidly decays after the enzyme and 
substrate are mixed. The Promega luciferase assay system, on the other hand, allows for greater 
enzymatic turnover of luciferase (Wood, 1991 b ), resulting in greater light intensity which 
remains nearly constant for several minutes. Thus this system does not require rapid mixing 
protocols or automated injection devices. 
The vector constructed in this study provides a useful tool for the assessment of mycobacterial 
promoters and has been used to study the promoter regions of the M tuberculosis whiB 
(Mulder et al., Manuscript in preparation) and cspA (Ros Chapman, Unpublished) homologues, 
and the conditions of expression of the M. tuberculosis mysB gene (Mulder et al., Manuscript in 
preparation). In this study, the vector facilitated the assessment of the regions essential for 
optimal promoter activity (Chapter 7), the mapping of the transcription start sites and 
identification of putative -10 and -3 5 sequences, and the quantitation of expression under 
different growth conditions and at different growth stages, of the M. tuberculosis katG 
promoter. Ideally, gene regulation should be studied in a single-copy situation, however, the 
pALSOOO-based vector used in this study is present in the mycobacteria in a low copy number 
(3-5 copies per cell) and should, therefore, be adequate to use, unless a very tight regulatory 
network governs katG expression. 
6.3. MATERIALS AND METHODS 
The bacterial strains, plasmids, and culture conditions used are described in Appendix A. 
Details of the commonly used techniques and solutions are given in Appendices B and C, 
respectively. 
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6.3.1. Construction of pJCluc 
The E. co/i-mycobacterial shuttle vector, pJCluc, was constructed as shown in figure 6.1. The 
vector, pJC86 (Jack Crawford, CDC Atlanta), was prepared by digestion with KpnI, removal of 
the resulting protruding ends with T4 DNA polymerase (DNA Blunting kit, Amersham Life 
Science) (see Appendix B), and subsequent digestion with HindllI. The 1748 bp Hi11dlll-St11I 
fragment from the luciferase cassette vector, pGEM~ -luc ( GenBank Accession number 
X653 l 6) (Promega), containing the promoterless firefly lucifcrase gene, was ligated to pJC86 to 
form pJCluc. The construct pJCluc"PP• was made by insertion of a blunt-ended luc cassette into 
pJC86 digested with Kpnl and blunt-ended as described above. This construct contains the 
luciferase gene in the opposite orientation to that in pJCluc. E. coli cells harbouring 
recombinant plasmids were identified as white colonies on 2x YT agar plates containing X-GAL 
(100 µg/ml) and IPTG (0.3 mM) (Melford Laboratories, England), due to interruption of the 
pJC86 /acZ gene. The recombinant plasmids were verified by restriction analysis. The pUC 19 
forward and reverse 17-mer sequencing primers (Promega) were used to sequence over th1! 
junctions of the recombinant plasmids, to confirm the sequence and orientation of the inserts. 
6.3.2. PCR amplification of the katG promoter region and cloning into pJCiuc 
Oligonucleotides were designed for the amplification of the region immediately upstream of the 
M tuberculosis katG gene. The primers were based on the published sequence (GenBank 
Accession number X68081 ). Mismatches were introduced near the 5' end of each primer to 
generate convenient restriction endonuclease recognition sites. The forward primer was a 
25-mer with the sequence: 5'-CTGGT AAGCttGGCCGCAAAACAGC-3', and the reverse 
primer was a 25-mer with the sequence: 5'-CACAGggaTCCTTCCAGGAGTTGGT-3'. The 
lower case nucleotides indicate the mismatches, and the underlined nucleotides represent tht;: 
restriction endonuclease sites for HindIII and BamHI, respectively. The complement of tht;: 
GTG initiation codon of the katG gene is included at the 5' end of the reverse primer. The: 
primers were predicted to amplify a 1943 bp fragment. PCR amplification was performed as 
described in Appendix B, using M tuberculosis H37Rv genomic DNA (0.1 µg) as the template, 
and an annealing temperature of 50°C. Control reactions included those with no template DNA, 
or those with single primers only, to ensure that the PCR products were not the result of non-
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specific binding of primers, or due to contaminating DNA PCR products were separated by 
agarose gel electrophoresis, stained with ethidium bromide, and viewed under 310 nm UV 
transillumination. The 1943 bp PCR product was excised from an agarose gel, purified by the 
phenol squeeze method described in Appendix B, and digested to completion with the 
restriction endonucleases Hindlil and BamHI. The resulting fragment was cloned into both 
pJCluc and pUC 18, which had been digested to completion with the same restriction 
endonucleases, to yield pJClucK and pKup, respectively (see Fig. A. I, Appendix A). 
6.3.3. Subcloning of the katG promoter fragment 
In order to localize the katG promoter region to a smaller fragment, the sequences upstream of 
the Smal site of the pJClucK insert were deleted (see Fig. 6.2). To achieve this, the 559 bp 
Smal-BamHI fragment from pKup was cloned into the EcoRV and BamHI restriction 
endonuclease sites of pBluescript-SK (Stratagene), to produce pKup0.6. Immediately upstream 
of the EcoRV restriction endonuclease site in this vector lies a Hind III restriction endonuclease 
site. This restriction endonuclease was, therefore, used, together with BamHl, to remove the 
insert, which was then cloned into the Hindlll and BamHI restriction endonuclease sites of 
pJCluc to produce pJCLK0.6 (see Fig. A.2, Appendix A). This cloning strategy via 
pBluescript-SK resulted in the addition of 3 bp of vector sequence upstream of the Smal 
restriction endonuclease site. The entire 559 bp insert of pKup0.6 was sequenced, using the 
pUC 19 forward and reverse sequencing primers (Promega). 
6.3.4. Electroporation of M smegmatis 
M smegmatis cells were prepared for electroporation by the method of Jacobs et al. ( 1991 ). A 
stationary phase culture of M smegmatis LR222 (Beggs et al., 1995), in Middlebrook-ADC-
Tween, was diluted 100-fold into fresh medium, and grown for 48 hours at 37°C with shaking. 
The cells were harvested by centrifugation, washed 3-4 times in ice-cold I 0% (v/v) glycerol, and 
resuspended in a final volume of 2 ml/100 ml original culture volume in 10% (v/v) glycerol. For 
electroporation, 60 µl cells were combined with 140 µI of 10% (v/v) glycerol and 1 µg of DNA, 
in a 5 µI volume, and incubated on ice for 5 minutes. Electroporations were performed in O. I 
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cm gap Gene Pulser® cuvettes (Bio-Rad Laboratories, CA U.S.A.) at 1.8 kV, 25 µF and 1000 
n, using a Gene PulserTM apparatus (Bio-Rad Laboratories, CA U.S.A.), which resulted in a 
field strength of 18.0 kV/cm. After electroporation, 900 µI of Middlebrook-ADC was added, 
and the cells were incubated at 37°C for 3-4 hours to facilitate expression of the kanamycin 
resistance gene. Transformants containing the recombinant plasmids were selected on 
Middlebrook-ADC agar plates containing kanamycin at a concentration of 50 µg/ml. A control 
electroporation with no added DNA was included to monitor the frequency of spontaneous 
mutation to kanamycin resistance After incubation at 37°C for three days. transformants were 
cultured in liquid medium for plasmid preparations. Plasmids were prepared as described in 
Appendix B and their structure verified by restriction analysis. 
6.3.5. Preparation of cell extracts and lucif erase activity assays 
For the luciferase activity assays, cells were grown to late exponential phase in a 5 ml volume at 
3 7°C with shaking. E. coli cell extracts were prepared by harvesting cells from I ml of culture 
and resuspension of the cells in I 00 µI of ice-cold Ix Cell Culture Lysis Reagent (Luciferase 
Assay System, Promega). The cells were lyzed by sonication in ice water (3 bursts of 40 
seconds each) in a Branson 1200 Ultrasonic Cleaner (Branson, Danbury CT). Cell debris was 
removed by centrifugation, and the supernatant equilibrated to room temperature before being 
assayed for luciferase activity. For the activity assays, 20 µI of cell extract was mixed with 
100 µI of Luciferase Assay Reagent (Promega), which had also been equilibrated to room 
temperature. Light output was measured in a Bio-Orbit 1253 luminometer (Turku, Finland). 
M smegmatis cell extracts were prepared by resuspension of cell pellets in Cell Culture Lysis 
Reagent, followed by processing in a FastPrepTM FPI20 instrument (Savant Instruments Inc., 
Farmingdale, NY, U.S.A.) for two 40 second cycles at a setting of 6. Samples were incubated 
on ice before and after each cycle, to compensate for heat generated during processing. 
Unlyzed cells and cell debris were removed by centrifugation. The supernatants were assayed 
for luciferase activity as described above. The protein concentrations of the cell extracts were: 
measured using the Bio-Rad Protein Assay kit (Bio-Rad Laboratories) (see Appendix B), and 
the luciferase activities are quoted as relative light units (RLU)/mg of protein used in each assay 
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6.3.6. RNA extractions 
RNA was extracted from E. coli and M smegmatis using the FastPrep™ system (FastPrep™ 
FP120 instrument (Savant Instruments Inc., Farmingdale, NY, U.S.A.) and FastRNA'~ Kit-Blue 
(°'1Bio 101 Inc., Vista, CA, U.S.A.)), according to the manufacturers' instructions. RNA pellets 
were resuspended in an appropriate volume of SAFE (FastRNA'~ Kit). RNA yields and quality 
were assessed by measurement of the optical density at 260 and 280 nm, and electrophoresis in 
a MOPS-formaldehyde gel {Appendix C). The concentration was calculated using the 
relationship OD26o = I for 40 µg/ml of RNA. 
6.3.7. Primer extension analysis 
Potential transcription start sites of the M tuberculosis katG gene were identified using primer 
extension analysis. The method used was adapted from that of Sambrook el al. (1989). A 
complementary 18-mer primer was designed to anneal 5 8 bp downstream of the ATG initiation 
codon of the luciferase gene. The primer had the sequence: 5'-GCAGTTGCTCTCCAGCGG-3'. 
Approximately I 00 ng of primer was end-labelled with [ y-32P] dA TP using polynucleotide 
kinase (Boehringer Mannheim), in a 30 µI reaction with the supplied buffer. After incubation at 
30°C for 30 minutes, the unincorporated nucleotides were removed using a Promega G25 spin 
column, according to the manufacturers' instructions. RNA samples (100 µg) were precipitated 
with sodium acetate and ethanol, resuspended in 30 µl of RNA hybridization buffer (Ambion 
Inc., Texas U.S.A.), and added to 25 ng of labelled primer. The nucleic acids were denatured at 
85°C for IO minutes, and annealed overnight at 50°C. Approximate primer annealing 
temperatures were calculated according to the formula: Th = Td - 5°C, where Th = annealing 
temperature and Td = denaturing temperature= 4°C for every G or C and 2°C for every A or T. 
The annealed RNA was precipitated with sodium acetate and ethanol, and resuspended in 
diethyl pyrocarbonate (DEPC)-treated water. The primer was extended on the mRNA template 
at 37°C for 60 minutes, using 200 units of M-ML V Reverse Transcriptase (Promega), in a 
reaction containing 40 units of RNase inhibitor (Boehringer Mannheim), Ix Reverse 
Transcriptase buffer (Promega), and an equal mixture of dNTPs (1 mM each) (Boehringer 
Mannheim). The primer extension products were precipitated and resuspended in the Stop 
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buffer supplied in the Pharmacia T7 Sequencing kit. The products were denatured at 90°C for 
2 minutes and separated on a 6% (w/v) polyacrylamide sequencing gel adjacent to dideoxy 
sequencing reactions primed with the same 18-mer primer. Gels were dried and the bands 
visualized by autoradiography. 
6.3.8. ATP assays 
ATP concentration was measured as an indication of cell mass, using the Promcga EnlitenT'.t 
LuciferaselLuciferin (LIL) bioluminescence detection reagent. The ATP levels were monitored 
by measuring the production of light when ATP, luciferin and oxygen were combined in thie 
presence of the enzyme luciferase. The assay system was calibrated using an ATP standard of 
known concentration (Stanley et al., 1989; Prioli et al., 1985). For M. smegmatis, 55.8 µl of 
cells were added to 4.2 µl of 20% (w/v) trichloroacetic acid (TCA), and incubated on ice for 30 
minutes. The precipitation was terminated by the addition of 50 µl of neutralization buffer ( l 
M tris-acetate pH 7.75) and 622 µl of distilled water. The light output generated from a 
mixture of 50 µl of LIL reagent in 347.5 µl of LIL buffer (see Appendix C), and 100 µl ofTCA-
treated sample, was measured in a Bio-Orbit 1253 luminometer (Turku, Finland) (reading B). A 
blank containing LIL reagent in LIL buffer was used to measure the background relative light 
units (reading A). The light output of a mixture of the LIL reagent, LIL buffer, TCA-treated 
sample, and 2.5 µI of 10-7 mM ATP represents reading C. The ATP concentration was 
calculated using the formula: [ATP] = (B-C)/A x 5 x 65.5914 x 10-10 mM. At higher cell 
densities, the TCA-treated samples were diluted for the assay and the ATP calculation adjusted 
accordingly. 
6.4. RESULTS 
6.4.1. Construction and testing of pJCluc 
The E. co/i-mycobacterial promoter probe vector, pJCluc, was constructed as shown in figurn 
6.1. The vector pJC86 contains the 2. 8 kb EcoRV-HpaI backbone of pAL5000, with the 
sequences necessary for replication in mycobacteria (Snapper et al., 1990b ), the lacZ gene and 
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oriE from pUC 18, and the kanamycin resistance gene from Tn5, for selection of cells containing 
the plasmid (Jack Crawford, Personal Communication). The resultant construct, pJCluc, 
contains the luc gene in the opposite orientation to the /acZ gene, with no promoter or Shine-
Dalgamo sequence. Upstream of the luciferase A TG are two unique restriction endonuclease 
sites for the cloning of promoter fragments, HindIII and BamHl. The construct pJClucopp 
contains the luc gene in the same orientation as lacZ. The constructs pJCluc, pJClucopp, and 
pJC86 were electroporated into M. smegmatis strain LR222. A control electroporation 
containing no DNA, yielded no kanamycin resistant colonies, suggesting that the frequency of 
spontaneous mutation to kanamycin resistance is below detectable levels under the conditions 





5720 bps Eco RI 
Ncol 































Late exponential-phase E. coli and M smegmatis cells harbouring pJC86, pJCluc, and pJCluc0 PP 
were assayed for luciferase activity (Table 6.1). Cells containing pJC86 exhibited a luciferase 
activity of 0.001 RLU (results not shown), the same value obtained with the luciferase assay 
reagent alone, indicating no endogenous luminescence in either E. coli or M. smegmatis. Cells 
harbouring pJCluc exhibited a low level of activity in E. coli (44.55 RLU/mg protein), but 
slightly higher levels in M smegmatis (142.74 RLU/mg protein). This small amount of activity 
may be due to readthrough from an upstream promoter, which appears to be more active in 
M. smegmatis, and may, therefore, be located on the pAL5000 region of the plasmid. The 
region upstream of the luciferase gene contains no known transcriptional terminators, thus 
allowing readthrough. However, it was demonstrated in later experiments that the luciferase 
activity resulting from pJCluc is extremely low in comparison to clones containing promoters. 
The pJClucopp construct exhibited approximately I I-fold greater activity than pJCluc in E. coli 
(489.31 RLU/mg protein), but less than background activity in M. smegmatis (25.71 RLU/mg 
protein). In this construct, the luciferase gene is expressed from the /acZ promoter, which 
normally has low constitutive expression in E. coli, but is induced by IPTG. This promoter 
apparently functions inefficiently in mycobacterial cells. 
6.4.2. Analysis of the sequence upstream of the M. tuberculosis katG gene 
The region upstream of the M tuberculosis katG gene (GenBank Accession number X6808 l) 
has been analyzed by Heym and co-workers (1993). These authors detected no open reading 
frames with high coding-probability values on either strand of the DNA fragment upstream of 
the katG gene. However, Song and Deretic have identified an open reading frame within this 
region which has 28, 27, and 25% identity, at an amino acid level, with the Fur proteins of 
Pseudomonas aeruginosa, Legione/la pneumophi/us, and Bordetella pertussis, respectively, and 
has been called Fur A. The ORF encodes the signature of the putative metal-binding site:, 
HHH:xHxxCxxC (GenBank Accession number AF002 l 94). Also within the katG upstream 
region are two copies of a 700 bp repeat, which are 68% identical, with the longest stretch of 
identity comprising 58 bp (Heym et al., 1993) (Fig. 6.2). This sequence is not dispersed in the 
M tuberculosis genome. 
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Figure 6.2 Linear restriction endonuclease map of the region upstream of the M. tuberculosis katG gene. 
corresponding to nucleotides 18 to 198 I of the published sequence (GcnBank Accession number 
X6K08 l ). The positions of the repeat sequences arc indicated with arrows. The Fur A open reading 
frame is represented by a wide arrow. The HindIII and BamHl restriction endonuclease sites were 
introduced by PCR. The regions present in pJClucK and pJCLK0.6 are shown. 
6.4.3. Amplification and cloning of the region upstream of the M. tuberculosis katG gene 
Oligonucleotides were designed for the amplification of a 1943 bp fragment immediately 
upstream of the M tuberculosis katG gene. The reverse primer, which includes the katG start 
codon and a BamHI restriction endonuclease site, was designed such that the distance between 
the BamHI site and the GTG start codon was equal to that b~tween the BamHI site and the 
ATG of the luciferase gene in pJCluc, i.e. 2 hp. This was done to eliminate any differences in 
promoter function which may occur due to alterations in the distance between the translation 
initiation codon and the ribosome binding site. A large fragment was amplified to ensure the 
capture of all possible promoter and regulatory sequences. The primers were used in a PCR 
with M. tuberculosis H37Rv genomic DNA as the template. Reactions containing no template 
DNA or only single primers yielded no product, while those containing both primers at equal 
concentrations, together with the template DNA, resulted in a product of the predicted size 
(Fig. 6.3). The resulting 1943 hp fragment was cloned into the BamIIl and Hindlll sites of both 
pJCluc and pUC18 to yield the constructs pJClucK and pKup, respectively (see Fig. A. I). 
Approximately 100 hp at the beginning and end of the insert of pKup were sequenced using the 
pUC19 forward and reverse sequencing primers (Promega), to ensure that the amplified product 
was as predicted. A smaller promoter fragment containing sequences downstream of the Smal 
site was cloned separately into pJCluc, as shown in figure A.2 (Appendix A), to yield 
pJCLK0.6. Sequencing of the 559 bp insert in pKup0.6 revealed that the amplified fragment 
was identical to the published sequence, except for one A -)- T change at position -210 with 
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respect to the translation initiation codon. This base substitution may have been introduced as a 
result of an error in the PCR reaction, alternatively, it may be a polymorphism. 
1 2 3 4 5 
. kb 
-1.943 
Figure 6.3 Agarose gel of the amplified katG promoter product and the control PCR reactions. The lanes were 
loaded as follows: l) DNA molecular weight marker VI (Boehringer Mannheim); 2) No template 
DNA; 3) Forward primer only; 4) Reverse primer only; 5) Both primers and M tuberculosis H37Rv 
template DNA. 
6.4.4. Lucif erase activity assays on the katG promoter constructs 
Both pJClucK and pJCLK0.6 were electroporated into M smegmatis, and tested for luciferase 
activity in M smegmatis and E. coli (Table 6.1). M smegmatis cells harbouring pJClucK and 
pJCLK0.6 exhibited high activity (41 787.32 and 38 545 .22 RLU/mg protein, respectively), 
while E. coli transformants exhibited similar levels of activity to the uninduced lacZ promoter 
(380.71 and 474.45 RLU/mg protein, respectively). These results indicate that the katG 
promoter lies within the amplified fragment and is recognized by the E. coli and M smegmatis 
transcription machinery. The luciferase activities of both E. coli and M smegmatis cells 
harbouring pJClucK and pJCLK0.6 did not differ significantly, suggesting that the promoter 
region lies within the smaller Smal-BamHJ. fragment, and that no additional sequences required 
for optimal expression are located in the 1374 bp region upstream of the Smal restriction 
endonuclease site. The smaller construct, pJCLK0.6, was therefore used for all further studies. 
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Table 6.1 Luciferase activities of the pJCluc constructs in E.coli andM smegma/is. 
E.coli M. smegmatis 
Construct RLU/mg protein 1 Rel. act. 2 RLU/mg protein 1 
pJCluc 4-U5 ± 17.83 1.00 142.74 ± 27.62 
pJCIUCopp 489.31 ± 61.68 10.98 25 .71 ± 12.72 
pJClucK 380.71 ±99.68 8.55 41787.32 ± 2372.55 
pJCLK0.6 474.45 ± 13 .06 10.65 38545 .22 ± 10694.53 
1 The mean of threc in<lcpcndcnt assays ± thc standard error of thc mcan. 
2 Rclativc activity- nonnali1cd to thc lucifcrasc activity of pJCluc 






Primer extension analysis was performed using an antisense strand primer complementary to 
sequences near the 5' end of the luciferase gene, and total RNA isolated from late exponential 
phaseM smegma/is and E.coli cells harbouring pJCLK0.6. In both E. coli and M smegmatis, 
transcription was initiated at two sites located 47 (tssA) and 56 (tssB) bp upstream of the 
translation initiation codon (Fig. 6.4). The possibility that the bands may be due to a premature 
stop site of the reverse transcription reaction can probably be excluded, as sequencing of this 
region revealed no signs of band compressions, suggesting no tendency for secondary structure 
formation. The putative -10 and -3 5 sequences relative to these transcription start sites are 
represented in figure 6.5.a and b. The putative -10 hexamer for tssA, GACACT, lies 8 bp 
upstream of the transcription start site, and shows a high degree of similarity to other 
mycobacterial -10 sequences (see Table 5.1). It matches the -10 hexamer of the 
M paratuberculosis P AN promoter (Murray et al., 1992) in 5/6 positions, and the -10 hexamers 
of the mycobacteriophage L5 gene 71 P2 (Nesbit et al., 1995), the M tuberculosis l6S rDNA 
(Ji et al., 1994), theMfortuitum bla (Timm et al., 1994), and the M smegmatis promoter S69, 
identified by Bashyam et al. (1996), in 4/6 positions. The first G of the hexamer is the least 
conserved. Associated with this -10 hexamer are three possible -35 sequences; 1) TCTATG 
19 bp upstream, 2) TGTCCT 15 bp upstream, and 3) TCCTGA 13 bp upstream. Only the first 
is represented in figure 6.5.a. This hexamer shows 4/6 matches with the -35 sequences of the 
mycobacteriophage 13 pKGR38 and ORFl (Ramesh and Gopinathan, 1995), while the second 
matches the putative M leprae 36K promoter (Dale and Patki, 1990) in 5/6 positions, and the 
mycobacteriophage 13 pKGR25 (Ramesh and Gopinathan, 1995) in 4/6 positions. The third 
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-35 sequence shows 4/6 matches with the mycobacteriophage 13 pKGR9 (Ramesh and 
Gopinathan, 1995), mycobacteriophage LS gene 71 Pl (Nesbit et al., 1995), and 
M tuberculosis gyrB (Madhusudan et al., 1994) and cpn60 (Kong et al., 1993) -3 5 sequences. 
T-> 
M E 
P GA TC P 
Figure 6.4 Primer extension analysis of the M tuberculosis katG upstream region using RNA isolated during 
late exponential phase from E. coli and M smegmatis cells harbouring pJCLK0.6. Two potential 
transcription start sites were identified, 47 and 56 bp upstream of the GTG translation initiation 
codon. M- M smegmatis RNA; E- E. coli RNA. 
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The putative -IO hexamer for tssB, GATATC, lies 6 bp upstream of the transcription start site. 
This hexamer matches the M leprae 18 kDa -10 hexamer (Dellagostin et al., 1995) in 5/6 
positions, and the M tuberculosis gyrB (Madhusudan et al., 1994), M smegma/is acetamidase 
(Mahenthiralingam et al., 1993), and M smegmatis S30 (Bashyam et al., 1996) -10 hexamers in 
4/6 positions. Again, the first G of the hex am er is the least conserved. Associated with this -10 
region are two possible -35 sequences, TCTACT, 22 bp upstream, and T ACTGG, 20 bp 
upstream. The first, which is represented in figure 6.5.a, matches the -35 hexamers of a number 
of other mycobacterial promoters in 4/6 positions. These include the Af hovis rDNA (Suzuki 
et al., 1991) and a antigen (Matsuo et al., 1988), M leprae l6S rDNA (Sela and Clarke-
Curtiss, 1991), M smegmatis acetamidase (Mahenthiralingam et al., 1993) and rrnB (Predich et 
al., 1995), the M paratuberculosis PAN (Murray et al., 1992), M tuberculosis 85A antigen 
(Kremer et al., 1995), and some of the mycobacteriophage 13 promoters (Ramesh and 
Gopinathan, 1995). The second putative -35 hexamer matches that of the M tuberculosis gyrB 
(Madhusudan et al., 1994) in 4/6 positions. Some of the promoters to which the katG promoter 
has been compared have not had their transcription start sites mapped. The -10 and -3 5 regions 
for these promoters are, therefore, not confirmed, and are based purely on similarities to E. coli 
promoter sequences. However, the putative -IO and -35 sequences identified here for the 
M tuberculosis katG promoter appear to be fairly well conserved. 
a) GCGAGGCACCCTGTCTGACGGCCTCGGACCATAACGGCTTCCTGTTGGACGAGGCGGAGG 1879 
-355 -35A -105 -lOA Pa PA 
TCATCTACTGGGGTCTATGTCCTGATTGTTCGATATCCGACACTTCGCGATCACATCCGT 1939 
t t 
GATCACAGCCCGATAACACCAACTCCTGGAAGGAATGCT GTG CCC GAG 1987 
R.B.S. M p E 
b) -35 region spacing -10 region spacing +l spacing start codon 
p_.. TCTATG 19 bp GACACT --- 8 bp --- A --- 46 bp ---- GTG 
TGTCCT 15 bp GACACT 
TCCTGA 13 bp GACACT 
Ps TCTACT 22 bp GATATC --- 6 bp --- T --- 55 bp ---- GTG 
TACTGG 20 bp GATATC 
Figure 6.5 a) The nucleotide sequence of the M tuberculosis katG promoter region, including the first 3 
codons, labelled with respect to the published sequence (GenBank Accession number X68081). 
The transcription start sites are indicated with arrows. The putative -10 and -35 hexamers for each 
transcription start site are underlined, and the putative ribosome binding site is in boldprint. b) 














6.4.6. Growth phase-dependent expression of the katG promoter in M smegmatis 
Expression of the katG promoter in M smegmatis was monitored over a 68 hour period of 
growth by measurement ofluciferase activity. The values used to plot the curves in figure 6.6 
are from one experiment, but are representative of the trend observed in three independent 
experiments. Stationary phase cultures of M smegmatis, harbouring pJCLK0.6, were diluted 
100-fold into 500 ml of catalase-free Middlebrook-ADC-Tween, and incubated at 37°C with 
shaking. Growth was monitored using absorbance readings at 600 nm to measure cell density, 
and ATP concentration to measure cell mass. Samples were removed at various times and 
assayed for luciferase activity. The growth curves generated by absorbance readings and ATP 
concentration showed similar trends (Fig. 6.6). According to the curves, the cells reach late 
exponential phase at approximately 30 hours, after which both curves form a plateau, indicative 
of stationary phase. It is evident that expression of luciferase from the katG promoter is low in 
early exponential phase, but increases steadily and reaches a peak at late exponential phase, 
followed by a rapid decline as the cells enter stationary phase. 
a b 
14Hi , ..... e 
-/ , .. o 1.2e+il 
, .. 1 / 
/ c . ii 
/ e 1.0..e 
/ c.. 
"" ,..a / Ii E 
I , .. , 8 :5 a.o..s ...J 




I ~ ·;;: e.o..s 0 ·:: 
1e-9 I .. u .&l • -( 
j 
1e-2 4.0..5 ·g 
..J 
- ATP conccnlrallOn 2.0..5 
- - Absort,ance 600 nm 
\ 
1e-11 1e-3 O.Oe+O 
___.J 
I I I I I 
0 10 20 30 40 50 60 0 10 20 30 40 50 
Time (hours) Time (hours) 
Figure 6.6 a) Growth curve of M smegma tis (pJCLK0.6) plotted as a measure of ATP concentration and 
absorbance at 600 nm. b) Luciferase activity of the M tuberculosis katG promoter monitored over 




6.4. 7. Expression of the katG promoter in response to stress in M smegmatis 
Previous reports on the regulation of expression of the katG gene in other bacteria have 
revealed a number of agents or conditions which regulate expression. Some of these were 
tested for their ability to influence the expression of the M. tuberculosis katG. For the 
experiment, 800 ml of an M. smegma/is (pJCLK0.6) culture were grown to mid exponential 
phase (24 hours), and split into 8 separate cultures of I 00 ml each. The cells were harvested by 
centrifugation and resuspended in catalase-free Middlebrook-ADC-Tween with the following 
additions. I) hydrogen peroxide to a final concentration of IO mi\.1; 2) ascorbic acid to a final 
concentration of IO mM; 3) sodium acetate to a final concentration of 60 mM (pH 7.0); and 
4) 2,2'-dipyridyl to a final concentration of 200 µM. The chemical 2,2'-dipyridyl is an iron 
chelator, and removes all available iron from the medium. In the 5th culture, the pH was 
adjusted to 4.0 with glacial acetic acid. The remaining three cultures were resuspended in 
medium with no additions. One of these was heat shocked by incubation at 45°C for 4 hours, 
one was incubated in a I 00 ml bottle with no head volume and without agitation, to simulate 
oxygen limitation (Wayne and Sramek, 1994), and the last had no alterations and served as a 
control. For the standing culture, the cells that had settled at the bottom of the bottle were used 
as the anaerobic sample. Unless otherwise stated, the cultures were incubated at 3 7°C with 
shaking. After 4 hours, samples were removed and assayed for luciferase activity. The 
experiment was performed in triplicate, and the luciferase activities of one representative 
experiment are given in table 6.2. Treatment with IO mM ascorbic acid resulted in an almost 
two-fold (86%) increase in luciferase activity. Growth under oxygen limiting conditions and at 
45°C resulted in a 10.7- and 41.8-fold decrease in luciferase activity, respectively. The other 
changes in the culture conditions did not significantly affect luciferase activity. 
Table 6.2 Luciferase activities of }vf smegma/is (pJCLK0.6) exposed to various stresses. 
Stress RLU/µg protein Rel. Act.1 
Control 88.60 1.00 
Hydrogen peroxide 87.82 0.99 
Sodium acetate 80.02 0.90 
Ascorbic acid 164.48 1.86 
Oxygen limitation 8.25 0.09 
..J.. iron 78.26 0.89 
..J..pH 79.52 0.90 
4s 0 c 2.12 0.02 
1 Relative activity- normalized to the lucifcrase activity of the control 
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6.5. DISCUSSION 
In the luciferase assay system, light intensity is proportional to luciferase concentration in the 
range 10-16 to 1 o-s M, and is a measure of the rate of catalysis by luciferase. The light output is, 
therefore, a measure of the levels of luciferase enzyme present, which is directly related to the 
rate of transcription of the luciferase gene by upstream promoters. In pJCluc, the level of 
transcription of the firefly luciferase gene was low, and the detectable activity was probably due 
to readthrough from an upstream promoter present in the vector. When a specific promoter 
fragment was cloned upstream of the gene, the levels of transcription, i.e. lucifcrase activity, 
increased at least 10-fold, and can, therefore, be attributed to the cloned promoter. Neither 
E. coli nor M smegma/is cells exhibited endogenous luminescence. 
The 1943 bp and 559 bp M tuberculosis katG promoter fragments promoted expression of the 
luciferase gene with approximately equal efficiency under the conditions used in this study. This 
suggests that sequences upstream of the SmaI site are not essential for optimal promoter 
efficiency during normal growth. The possibility that this region may be involved in the 
regulation of the gene cannot, however, be excluded. The promoter functioned in E. coli, 
suggesting that the transcriptional signals are recognized by the E. coli transcription machinery. 
Expression in this host, however, was low, therefore the transcriptional signals probably do not 
closely match those of consensus E. coli promoters (discussed below). It is not known whether 
the RNA polymerase holoenzyme responsible for recognition of the M tuberculosis katG 
promoter in this host is bound to the principal cr factor, cr
70
, or an alternative cr factor, such as 
crs, which is responsible for transcription of the E. coli katG promoter during normal growth 
(Ivanova et al., 1994). As mentioned in Chapter 5, there are a number of other mycobacterial 
promoters which have been shown to function in E. coli. 
The activity of the M tuberculosis katG promoter was high in M smegmatis in comparison to 
its activity in E. coli. Its relative promoter strength in the mycobacterial host cannot be 
predicted without comparison with luciferase activities generated by other mycobacterial 
promoters in the same system. The activities of the promoter in M smegmatis and E. coli can 
also not be accurately compared due to differences in the copy number of the plasmid in the 
different hosts. In E. coli, pUC 18-based plasmids generally have a copy number of 500-700 
(Minton et al., 1988), while the pAL5000 plasmid only has a copy number of 3-5 in 
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M smegmatis (Ranes et al., 1990; Stover et al., 1991 ). The luciferase activities measured in 
M smegmatis should, therefore, be increased by a factor of approximately 100, to compensate 
for the differences in plasmid copy number. This study, however, is not concerned with 
absolute promoter strengths, but rather with relative promoter strengths. 
Two transcription start sites were identified for the M tuherculosis katG promoter in pJCLK0.6 
in both E. coli and M. smegma tis. This suggests that the gene is transcribed off two promoters 
and that the same promoter sequences are recognized by both hosts. The presence of two 
promoters upstream of mycobacterial genes is not uncommon and has been reported for the 
M. bovis BCG hsp60 (Stover et al., 1991) and rDNA (Suzuki et al., 1991), theM tuberculosis 
recA (Movahedzadeh et al., 1997b) and whiB homologues (Mulder et al., Manuscript in 
preparation), and the M leprae oxyR and ahpC genes (Dhandayathupani et al., 1997). It is 
possible that the promoters are recognized by different RNA polymerase holoenzymes, and that 
they are utilized to different extents during growth. In primer extension experiments using 
different RNA preparations of the same recombinants, the proportions of the transcripts 
differed, possibly due to slight differences in the growth stage or conditions under which the 
RNA was isolated. This suggests that the two promoters are differentially expressed, but this 
observation will require further investigation. It was recently demonstrated that removal of the 
sequence between the ribosome binding site and transcription start site B of the katG promoter 
results in a 45-50% reduction in luciferase activity (Gavin Rush, Unpublished data). This 
suggests that the promoters are used to similar extents under the conditions of the above 
experiment. Primer extension analysis on total RNA isolated from M tuberculosis H37Ra was 
not successful, possibly due to low levels of the katG mRNA transcript. However, the 
determination of the transcription start site from RNA isolated from a recombinant 
M smegmatis and M bovis BCG containing the promoter of interest in a promoter probe 
vector, has been shown to correlate with results obtained from native mRNA transcripts (Levin 
and Hatfull, 1993; Dhandayuthapani et al., 1997; Movahedzadeh et al., 1997b), and has been 
used as a substitute in many cases (Murray et al., 1992; Kremer et al., 1995; Nesbit et al., 
1995). 
The putative -10 and -35 sequences identified for the katG promoter show significant homology 
to many mycobacterial promoters characterized thus far, and may, therefore, be "typical 
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mycobacterial promoters." The -10 hexamer associated with tssA matches the consensus 
E. coli sequence in 3/6 positions, two of which, A at position 2 and T at position 6, are highly 
conserved. All three putative -35 sequences match the E. coli consensus sequence in 2/6 
positions, 1 of which, T at position 1, is highly conserved. The putative -10 hexamer for tssB 
also matches the E. coli consensus sequence in 3/6 positions, however, only one of these is 
highly conserved, the A at position 2. The first putative -35 hexamer for tssB matches the 
E. coli consensus in 3/6 positions, one of which, the T at position 1, is highly conserved, while 
the second putative -35 region has only the T at position 1 in common with the E. coli 
consensus sequence. The two putative katG promoters are, therefore, probably recognized and 
bound by Ecr70 in this host. The spacing between the -10 and -35 regions differs from that found 
in most E. coli promoters (17 ± 1) (Harley and Reynolds, 1987). This, together with the 
divergence from the consensus sequences, may be responsible for the poor efficiency of the 
promoters in E. coli. It has been noted that the distance between the -10 and -3 5 region is not 
critical in mycobacterial promoters (Kremer et al., 1995), and varies between 13 and 24 bp 
(Ramesh and Gopinathan, 1995). Both -10 hexamers are least conserved in the first position, 
where the T is replaced by a G. This may be due to the high G+C content noted in many 
M tuberculosis promoter sequences (Bashyam et al., 1996). Bashyam et al. ( 1996) have noted 
that the less conserved bases in M tuberculosis promoters tend towards G and C substitutions. 
E. coli promoters which deviate from the consensus in the first T of the -10 region often require 
activator proteins for maximum promoter activity (Raibaud and Schwartz, 1984). This 
possibility is investigated in Chapter 7. It is not known which -35 regions are utilized, or 
whether a -35 region is necessary for this promoter. Recent evidence suggests that this region is 
not essential in many mycobacterial promoters and can withstand large variation (Kenney and 
Churchward, 1996; Bashyam et al., 1996). The confirmation of the identified sequences as 
promoter sequences, and their importance in promoter activity will require more in-depth 
analysis, such as site-directed mutagenesis. 
The growth phase-dependent expression of the M tuberculosis katG promoter in M smegmatis 
is similar to that in other bacteria (see Chapter 5), and to the M smegmatis katG (Mulder et al., 
Manuscript in preparation). Many bacterial catalases are produced at low levels during 
exponential growth and are induced either during late exponential phase or during the transition 
to stationary phase (Mukhopadyay and Schellhorn, 1994; Rocha and Smith, 1995; Schnell and 
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Steinman, 1995). This probably reflects the function of the enzyme in the cells. The 
M tuberculosis KatG may be produced in steadily increasing levels during exponential phase to 
detoxify the oxidative products of normal aerobic metabolism. As the cells enter stationary 
phase, the oxidative challenge increases resulting in an increased requirement for KatG for 
survival. As mentioned in Chapter 5, in E coli, the induction of katG as the cells enter 
stationary phase is dependent on the stationary-phase or starvation response cr factor, KatF or 
RpoS {Loewen et al., 1985; Mulvey et al., 1990; Mukhopadyay and Schellhorn, 1994). The 
MysB has been identified as the putative KatF homologue in !vf tuherrnlosis (Mulder et al. 
Manuscript in preparation). It was shown that the levels of mysB mRNA in !vi. tuberculosis 
H37Ra increase during stationary phase. Analysis of the luciferase activities of M smegmatis 
cells harbouring a pJCluc derivative containing the M. tuberculosis mysB promoter, revealed a 
similar growth phase-dependence. In fact, the trend seen in the luciferase activities relative to 
the growth phase was identical to that with the katG promoter. Expression was low during 
early exponential phase, peaked at late exponential phase or during the transition to stationary 
phase, and declined during stationary phase. The authors also demonstrated that overexpression 
of the M tuberculosis mysB and E. coli katF genes in M. smegmatis resulted in 7.9- and 4.2-
fold increases in the mRNA levels of the M smegmatis katG, respectively. Similar increases in 
katG mRNA levels were demonstrated in M hovis BCG overexpressing mysB, although to a 
smaller extent. These results suggest that the MysB is either directly or indirectly involved in 
the expression of the katG gene in the mycobacteria. The fact that the two genes show similar 
levels of induction during growth, suggests that MysB is responsible for the growth phase-
dependence of the katG gene noted in this study, and that it may direct basal levels of 
transcription of the gene during normal growth. 
The experiments designed to measure the effect of various stresses on expression of the katG 
promoter produced interesting results. In E. coli, most stress responses occur within the first 
hour, however, M smegmatis has a much slower growth rate in comparison to E. coli, and may 
take longer to respond to stress. A heat shock response has been noted in M smegma/is within 
the first hour (Bongi Ntolosi, Unpublished data), while it takes between 3 and 6 hours for the 
cells to respond to cold shock (Karen Shires, Unpublished data). A time period of 4 hours for 
exposure to the stresses in this experiment was chosen in order to accomodate these differences 
in response time and to allow for lag phases. It is possible that this time period is either too 
long or too short to accurately measure the effects, and may not represent maximal induction or 
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repression of the promoter. Resolution of these issues will require a more exhaustive series of 
experiments, involving exposure of the cells to each stress for a variety of time points. As 
revealed in the materials and methods, the cells were removed from the relevant media or stress 
conditions and the proteins extracted for the luciferase assay. Thus the luciferase activity 
measurements are not influenced by the nature of the stress. Instead, the luciferase activities are 
indicative of the amount of luciferase protein induced by exposure to the stress. The repression 
of the katG promoter under anaerobic conditions has also been noted for other catalases 
(Morgan et al., 1986), and is probably due to a reduced requirement for the enzyme The 
factor/s responsible for this repression, and the repression of the promoter at elevated 
temperatures, have not been identified. In E. coli, treatment with 5.7 mM ascorbic acid results 
in an 8-fold increase in catalase activity, and this is due to the reaction of ascorbic acid with 
oxygen, in the presence of metal ions, to produce dehydroascorbate and hydrogen peroxide 
(Richter and Loewen, 1981 ). The treatment of M smegma/is (pJCLK0.6) with IO mM ascorbic 
acid resulted in less than 2-fold induction of the M tuberculosis katG promoter. This, together 
with the lack of induction of expression in the presence of hydrogen peroxide, suggests that the 
promoter is not significantly affected by hydrogen peroxide, and that the effect of ascorbic acid 
observed here is not due to the production of this agent. Belkin et al. ( 1996) have shown, using 
the V. fischeri luciferase as a reporter, that the E. coli katG promoter is induced approximately 
20 minutes after exposure to hydrogen peroxide, and that induction peaks at 45 minutes and 
then declines. This observation raises the question whether the M tuberculosis katG promoter 
is induced by hydrogen peroxide but that, either the lag phase had not yet ended, or the 
induction had already declined, at the stage at which the luciferase activity was measured in this 
study. The lack of induction of the promoter by hydrogen peroxide agrees with the results of 
Deretic et al. (1995), but not those of Sherman et al. (1996). The latter authors detected a 7-
fold increase in expression from the M tuberculosis katG promoter in an M bovis BCG host in 
response to hydrogen peroxide, however, the exposures used did not protect M tuberculosis 
against subsequent lethal doses. The differences in the response of the katG promoter to 
hydrogen peroxide may have been due to the use of different mycobacterial hosts. As 
mentioned in Chapter 5, M tuberculosis does not have a functional OxyR, which is responsible 
for the hydrogen peroxide-dependent induction of the katG gene in most bacteria. In addition, 
no homologous oxyR sequences have been detected in M smegmatis. These observations 
suggest that the katG gene is regulated differently in these organisms, and that induction of the 
192 
gene m response to hydrogen peroxide is unlikely, unless it occurs through an alternative 
mechanism. The treatment of E. coli with 0-80 mM sodium acetate (pH 7.0) induces catalase 
activity 7-fold (Mukhopadyay and Schellhorn, 1994). However, no induction of the 
M tuberculosis katG promoter in response to sodium acetate was observed in this study, 
suggesting, again, that there are differences in the regulation of the gene in the two organisms. 
Dussurget et al. ( 1996) have shown that IdeR-deficient mutants of A1. smegma/is exhibit 
reduced catalase and peroxidase activities, associated with KatG. This suggests that the protein 
is responsible for the regulation of the katG gene in response to iron limitation in this organism, 
either directly by activating the katG promoter, or indirectly, via other regulatory genes. In this 
study, no changes in expression from the katG promoter were noted under iron limiting 
conditions. It is possible that the M tuberculosis katG promoter is not recognized by the 
M. smegma/is IdeR or the factor/s induced by the protein, or that regulation in response to iron 
limitation occurs at a post-transcriptional level in this organism. Alternatively, the 
M smegmatis IdeR may not be induced or active under the conditions used in this study. 
The examination of the regulation of expression of the M. tuberculosis katG promoter in this 
study has been carried out in the homologous host, M smegmatis. The katG gene is native to 
both M smegma/is and M tuberculosis, but numerous studies have shown important 
differences between the two mycobacterial species with respect to the oxidative stress response. 
Thus, although the experiments described above represent a good starting point for the study of 
the regulation of the gene, these studies need to be extended to the natural host, 
M tuberculosis, in which there are likely to exist unique mechanisms of regulation during 
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IDENTIFICATION OF AN UPSTREAM ELEMENT 
REQUIRED FOR OPTil\1AL EXPRESSION OF THE KATG 
PROMOTER 
7.1. SUMMARY 
This chapter describes the identification of regions of the 559 bp AI 111herc.:11/osis katG promoter 
fragment that are essential for promoter activity. Deletions in the fragment were made using 
Bal3 l nuclease and restriction endonucleases. Analysis of the luciferase reporter protein 
activities of the resulting constructs revealed that a region between 559 and 448 bp upstream of 
the translation initiation codon, designated the upstream activator region (UAR), is essential for 
promoter activity in E. coli, and is required for optimal activity in M. smegma/is. Primer 
extension analysis on selected deletions revealed that an alternative promoter is used in the 
absence of this region, and in the absence of the putative katG promoters identified by primer 
extension analysis in Chapter 6. Cloning of a fragment containing the katG UAR upstream of 
the M paratuberculosis PAN promoter, in pJCluc, resulted in a 14. 7-fold increase in luciferase 
activity in E. coli and an 11.6-fold increase in M smegma/is, relative to the PAN promoter 
alone. Mobility shift assays revealed that one or more M smegma/is proteins bind to the katG 
UAR. This region, therefore, acts as a transcriptional enhancer, possibly by binding to one or 
more regulatory proteins. The luciferase activities of a selection of promoter constructs were 
tested in M bovis BCG. These constructs exhibited similar activities in this host as they did in 
M smegmatis, suggesting that the recognition and utilization of promoters is similar in the two 
mycobacterial species. 
7.2. INTRODUCTION 
In the previous chapter, the M tuberculosis katG promoter region was localized to a 559 bp 
fragment immediately upstream of the GTG initiation codon of the gene. Two putative 
promoters were identified, which showed some similarity to previously identified mycobacterial 
promoters. It was demonstrated that expression of the katG promoter is highest at the end of 
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exponential phase and declines during stationary phase, and that it is induced by ascorbic acid 
and repressed by oxygen limitation and growth at elevated temperatures. 
Although the -10 and -3 5 promoter sequences are essential for expression, it is evident from the 
data presented in the introduction in Chapter 5 that a number of other sequences and regions 
adjacent to the promoter may also play a crucial role in promoter activity, and in determining 
promoter strength. For example, the AT-rich sequence identified upstream of the -35 sequence 
of the E. coli rmB P2, leuVand RNA II promoters (Ross et al., 1993). It was noted in Chapter 
6 that the putative - l O hexamers of the !vi. tuberculosis katG promoters, PA and P8 , deviate 
from the consensus sequence in the first position, which normally has a conserved T. E. coli 
promoters which deviate in this position usually require other upstream regions or activator 
proteins for optimal promoter activity (Raibaud and Schwartz, 1984). Therefore, other regions 
of the M tuberculosis katG promoter fragment, which may play a role in promoter activity were 
examined. It was demonstrated that a region between 559 and 448 bp upstream of the 
translation initiation codon is essential for promoter activity in E. coli, and is required for 
optimal expression in M. smegmatis. This region lies within the 262 bp HindlII-SphI fragment 
shown in figure 7.1, and will be referred to as the 'upstream activator region' or UAR. The 300 
bp Sphl-BamHI fragment, immediately downstream of this, contains the two putative promoters 
identified in Chapter 6, and is described as the promoter region (see Fig. 7.1). The possible 
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Figure 7.1 Linear restriction endonuclease map of the 562 bp HindIII-BamHI insert of pJCLK0.6 and pKup0.6. 
The Smal site on the 5' end of the insert was destroyed during cloning of the fragment into the 
EcoRV restriction endonuclease site of pBluescript-SK. The Hindlll restriction endonuclease site 
originates from this cloning vector. The restriction endonuclease sites used in the construction of 
the deletions in this chapter are shown. The positions of the putative promoters, PA and Pa, 
identified in Chapter 6, and the positions of the upstream activator and promoter regions are 
indicated. 
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The PAN promoter was used in this study to determine whether the UAR of the M. tuberculosis 
katG could increase expression of an unrelated promoter. The promoter was isolated by 
Murray et al. (1992) from M paratuberculosis. It was found upstream of an unknown open 
reading frame, ORF2, which may form part of the M. paratuberculosis IS900 insertion element. 
The promoter fragment was able to promote efficient expression of the firefly luciferase gene in 
pJCluc. 
7.3. MATERIALS AND 1\IETIIODS 
The bacterial strains, plasmids, and culture conditions used are described in Appendix A. 
Details of the commonly used techniques and solutions are given in Appendices B and C, 
respectively. 
7.3.1. Deletions in pJCLK0.6 using restriction endonucleases 
Derivatives of pJCLK0.6 were constructed, making use of the restriction endonuclease sites 
present in the insert (see Fig. 7.1). Deletion p0.6DelEN 13 was constructed as follows: pKup0.6 
was digested to completion with EcoRV and Nrul, both of which produce blunt ends, and 
religated to form pKup0.6D with the 13 intervening base pairs deleted. The 549 hp Hindlll-
BamHI fragment from pKup0.6D was cloned into the Hindlll and BamHI restriction 
endonuclease sites of pJCluc to produce p0.6DelEN13 (see Fig. A.3, Appendix A). Deletion 
p0.6DelAB111 was constructed by cloning of the 448 hp Alul-BamHI fragment of the pKup0.6 
insert into pJCluc digested to completion with Hindlll, blunt-ended with the Amersham DNA 
Blunting kit, and digested to completion with BamHI (see Fig. A.4). To construct deletion 
p0.6DelAS155, the 300 hp Sphl-BamHI fragment of pKup0.6 was cloned into the SphI and 
BamHI restriction endonuclease sites of pUCBM21, to produce pUC2I0.3. The 111 hp 
Hindlll-Alul fragment of pKup0.6 was then cloned into pUC2I0.3 which had been digested to 
completion with Sphl, blunt-ended, and digested to completion with HindIII, to produce 
pUC210.4. This construct essentially contains the insert from pKup0.6 with the 155 hp Alul-
Sphl fragment deleted. The insert of pUC210.4 was removed by digestion with Hindlll and 
BamHI, and cloned into the corresponding restriction endonuclease sites of pJCluc to form 
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p0.6DelASm (see Fig. A.5). To delete the 106 bp Safl-EcoRV fragment from the katG 
promoter region, pKup0.6 was digested with San and EcoRV, blunt-ended, and religated in the 
absence of the 106 bp insert fragment to produce pKup0.5. The 456 bp Hindlll-BamHI insert 
from this construct was then cloned into the Hindlll and BamHl restriction endonuclease sites 
of pJCluc to produce p0.6DelSE1o6 (see Fig. A.6). The inserts of all the constructs described 
above were sequenced over the relevant areas using the pUC 19 forward sequencing primer 
(Promega), and a reverse primer complementary to sequences immediately downstream of the 
luciferase A TG translation start codon, to confirm that the appropriate sequences had been 
removed. The custom-synthesized luciferase reverse pnmer had the sequence: 
5'-CTTTATGTTTTTGGCGTC-3'. 
7.3.2. Electroporation of M. smegnwtis and luciferase assays 
The electroporation of M smegma/is and the luciferase assays were performed as described in 
sections 6.3.4, and 6.3.5, respectively. 
7.3.3. Bal31 nuclease deletions in pJCLK0.6 
Bal3 l nuclease was used to delete successive bases from the 5' end of the 559 bp 
M tuberculosis katG promoter fragment. A pilot experiment using 3 µg of DNA and doubling 
dilutions of BaI3 1 nuclease was performed in order to determine the optimal enzyme 
concentration. In the scale-up, 30 µg of pJCLK0.6 was digested to completion with HindlII, 
extracted with phenol/chloroform/isoamyl alcohol and precipitated with ethanol. The linear 
fragment was incubated at 37°C with 3 units of Bal3 l Nuclease (Boehringer Mannheim) in a 
reaction containing 0.02 M tris-Cl (pH 8.0), 0.012 M calcium chloride, 0.012 M magnesium 
chloride, 0.2 mM EDTA (pH 8.0), and 0.6 M sodium chloride. An aliquot was removed before 
addition of the enzyme, and every 90 seconds thereafter, for 10. 5 minutes, and extracted with 
phenol/chloroform/isoamyl alcohol, and the DNA precipitated with ethanol. The DNA was 
religated and used to transform competent E. coli LKIII cells. Plasmids were prepared from 
transformants corresponding to the various time points and analyzed by restriction enzyme 
digestion. The inserts were sequenced using the reverse luciferase primer described in section 
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7.3.1. To test whether the reductions in luciferase activity observed were not due to the 
deletion of important vector sequences, the 262 bp HindIII-SphI fragment of pJCLK0.6 (see 
Fig. 7 .1) was removed, without alteration of any vector sequences. The cloning strategy was as 
follows: pKup0.6 was digested to completion with Sphl, the resulting protruding ends were 
filled in using the Amersham DNA Blunting kit, and the construct digested with BamHI. The 
resulting 300 bp fragment was gel-purified and cloned into pJCluc digested to completion with 
HindIII, blunt-ended with T4 polymerase (Amersham DNA Blunting kit), and digested to 
completion with BamHI, to form the construct pJCLK0.3 (see Fig. A. 7, Appendix A). To test 
whether the region upstream of the Sphl site was able to promote expression of the luciferase 
gene on its own, this fragment was cloned separately into pJCluc. The cloning strategy was as 
follows: the 262 bp Hindlll-SphI fragment of pKup0.6 was cloned into the HindIII and SphI 
restriction endonuclease sites ofpUCBM21 to produce pUC21E. The insert was removed from 
this construct using the restriction endonucleases HindIII and BamHI, and cloned into the 
corresponding restriction endonuclease sites of pJCluc to yield pJCLKE. Cloning of the 
fragment via pUC2 l E resulted in the addition of 56 bp of lacZ coding sequence between the 
Sphl restriction endonuclease site of the insert and the BamHI restriction endonuclease site of 
pJCluc (see Fig. A.8). 
7.3.4. Primer extension analysis 
Primer extension analysis was performed as described in section 6.3. 7, using total RNA isolated 
fromM smegmatis cells harbouring pJCLK0.3, p0.6DelSE106, and p0.6De1EN13 . The synthetic 
oligonucleotide complementary to sequences near the 5' end of the luciferase gene, described in 
section 6.3.7, was used in the experiments. 
7.3.5. Cloning of the katG UAR upstream of the PAN promoter 
The transcription enhancing properties of the M tuberculosis katG UAR were tested on the PAN 
promoter from M paratuberculosis. The construct pANIIIW (Karen Kempsall, Glaxo-
Wellcome ), consisting of a 170 bp PCR fragment containing the PAN promoter cloned into the 
T-tailed EcoRV restriction endonuclease site of the vector pT7Blue(R) (Novagen), was used as 
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a source of the promoter. The PCR fragment contains the PAN ribosome binding site, but no 
ATG start codon. The 218 bp HindIII-BamHI fragment from pANIIIW was cloned into the 
Hindlll and BamHI restriction endonuclease sites of pJCluc to form pJCLpan. The use of the 
vector restriction endonuclease sites resulted in the addition of 45 bp of vector sequence on the 
5' end of the insert and 3 hp on the 3' end. In this construct, the PAN promoter is in the correct 
orientation to promote expression of the luciferase gene. The following strategy was used to 
clone the katG UAR upstream of the PAN promoter: The construct pKup0.6 was digested to 
completion with HindIII and Sphl to release the 262 hp activator region, which was purified by 
agarose gel electrophoresis and phenol extraction. This was then ligated to pANlllW which had 
been digested to completion with SphI. The linear ligated fragments were cleaned by 
phenol/chloroform extraction and ethanol precipitation, and digested to completion with 
BamHI. The digested products were electrophoresed in a 2% (w/v) agarose gel and a fragment 
of 486 bp containing the katG UAR ligated to the PAN promoter was excised. The fragment 
was purified using the phenol squeeze method described in Appendix B, and cloned into the 
HindIII and BamHI sites of pJCluc to form pJCLpanE. The inserts of both pJCLpan and 
pJCLpanE were verified by sequencing with the pUC 19 forward primer (Promega), and the 
reverse primer complementary to sequences near the 5' end of the luciferase gene described in 
section 7.3.1. 
7.3.6. Gel mobility shift assays 
Gel mobility shift assays were performed as described by Ausubel et al. (1987). The gel-
purified 262 hp HindIII-Sphl and 300 hp Sphl-Bamm fragments from pKup0.6 containing the 
M tuberculosis katG activator and promoter regions, respectively, were used as templates. The 
fragments were radiolabelled by filling in of the 5' protruding ends generated by digestion with 
HindIII and Bamm using Kienow polymerase (Boehringer Mannheim) and dTTP, dGTP, 
dATP, and [a-32P] dCTP, in a buffer containing 10 mM tris-Cl (pH 7.6), 10 mM magnesium 
chloride, 50 mM sodium chloride, I mM dithiothreitol (DTT), and 50 µg/ml bovine serum 
albumin (BSA). AnM smegmatis cell extract was prepared, as described in section 6.3.5, from 
a late exponential phase culture. In this method, the cells are lyzed with Cell Culture Lysis 
Reagent (Promega) and by mechanical disruption in the FastPrep™ FP 120 instrument (Savant 
Instruments Inc., Farmingdale, NY, U.S.A.). The protein concentration of the extract was 
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measured with the Bio-Rad Protein Assay kit (Bio-Rad Laboratories, CA U.S.A.). Labelled 
template DNA was incubated with the cell extract for 15 minutes at 3 7°C in a binding reaction 
containing the following: 12% (v/v) glycerol, 300 µg/ml BSA, 4 mM tris-CI (pH 7.9), 60 mM 
potassium chloride, l mM EDTA, l mM OTT, and 0.5 µg herring sperm DNA (Boehringer 
Mannheim). For competition studies, l µg of unlabelled competitor DNA was mixed with the 
labelled probe before the addition of the extract. The reactions were loaded on a 6% (w/v) non-
denaturing polyacrylamide gel, and separated by electrophoresis in a high ionic strength tris-
glycine buffer ( see Appendix C) at a constant current of 30 mA The gel was dried and exposed 
to X-ray film. 
7.3.7. Preparation and electroporation of Nl bovis BCG 
Electrocompetent M bovis BCG cells were prepared and electroporated using the method of 
Jacobs et al. ( 1991 ), with minor variations. A stationary phase culture of M bovis BCG grown 
in Middlebrook-ADC-Tween was diluted l 00-fold in freshly prepared Middlebrook-ADC-
Tween, and grown to mid-exponential phase (8 days) on a roller at 37°C. Cells were harvested 
by centrifugation at 4°C and washed 4-5 times in sterile, deionized water, to remove all traces of 
medium and salts. Washed cells were resuspended in a final volume of 1 ml of ice-cold 10% 
(v/v) glycerol/100 ml of cells (original volume). For electroporation, 60 µI of cells were 
incubated with 240 µI 10% (v/v) glycerol and I µg of DNA on ice for 10 minutes. 
Electroporations were performed in 0.1 cm gap Gene Pulser® cuvettes (Bio-Rad Laboratories) 
at 1.8 kV, 1000 n and 25 µF n, using a Gene Pulser™ apparatus (Bio-Rad Laboratories, CA 
U.S.A.), which resulted in a field strength of 18.0 kV/cm. The cells were incubated for a further 
5 minutes on ice before the addition of 700 µI Middlebrook-ADC and incubation for 3-4 hours 
at 37°C without agitation. Expression mixes were plated on Middlebrook-ADC agar plates 
containing kanamycin at a concentration of 3 0 µg/ml and O.01 % ( w/v) cycloheximide (Fluka 
Biochemicals), and incubated at 37°C for three weeks. Plasmids were prepared from the 
recombinants as described in Appendix B, and verified by restriction analysis. 
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7.4. RESULTS 
7.4.1. Subcloning and testing of the katG upstream region 
To determine whether other regions of the M tuberculosis katG upstream region were required 
for promoter activity, a number of deletions were made using the restriction endonuclease sites 
present on the insert. The regions present in the various deletions and the resulting decreases in 
luciferase activity are summarized in figure 7.6 (see discussion). Deletion p0.6DelAB 111 has the 
first 111 bp up to the Alul site deleted pO 6De1EN 13 has the 13 bp FcoRV-Nrul fragment 
deleted. In p0.6DelASm the 155 bp AluI-SphI fragment is deleted, and in p0.6De1SE 106, the 
106 bp San-EcoRV fragment is deleted. The constructs were electroporated into 
M smegmatis, and tested for luciferase activity in E. coli and M. smegmatis (Table 7. I). 
Table 7.1. Luciferasc activities of the pJCLK0.6 deletion constructs. 
E.coli M. smegmatis 
Construct RLU/mg protein1 Rel. Act.2 RLU/mg protein
1 Rel. Act.2 
pJCLK0.6 8695.44 ± 1714.8 1.000 50291.26 ± 14354.2 1.000 
p0.6De1EN 13 2787.34 ± 697.94 0.3206 38399.91 ± 9793.484 0.7636 
p0.6De1AB 111 105.89 ± 23.00 0.0122 921.31 ± 93.10 0.0183 
p0.6De1ASIS5 6101.43 ± 837.54 0.7017 59506.86 ± 5043.60 1.1832 
p0.6De1SE106 2848.22 ± 726.80 0.3276 49606.81 ± 8819.99 0.9864 
1 The mean of three independent assays ± the standard error of the mean. 
2 Relative Activity- nonnalized to the lucifcrase activity of the parent construct, pJCLK0.6 
Removal of 111 bp from the 5' end of the insert (p0.6DelAB111) resulted in an 82.1- and 54.6-
fold reduction in activity in E. coli and M smegmatis, respectively, suggesting that this region is 
essential for optimal promoter activity. Removal of the 13 bp between the EcoRV and NruI 
restriction endonuclease sites in the promoter region resulted in a 3.12-fold decrease in 
promoter activity in E. coli. This deletion removes the putative -10 hexamer associated with 
transcription start site A, as well as transcription start site B and a region of its putative -10 
hexamer (see section 6.4.5). The deletion should, therefore, abolish promoter activity 
completely. In M smegmatis, deletion of this region had no significant effect on expression. 
The transcription machinery evidently uses different promoter sequences for transcription 
initiation in this construct. Removal of sequences upstream of the Eco RV site gave a similar 
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result, i.e. a 3.05-fold decrease in activity in E. coli, and no significant change in M. smegma/is. 
Deletion of the Sall-EcoRV fragment results in the removal of half of the -10 hexamer of 
transcription start site B and the -35 sequences of transcription start sites A and B. It is 
conceivable that, in this construct, the promoter associated with transcription start site A is used 
to promote expression, and that the presence of a -3 5 sequence is not essential. Alternatively 
other promoter sequences may be recognized in place of those previously identified. The 
absence of the 155 bp Alul-Sphl fragment had no significant effect on promoter activity in either 
E coli or M. smegma/is, which suggests that this region is not important for promoter activity. 
The sequences necessary for maximal promoter activity, therefore, lie upstream of the Alul site 
(see Fig. 7.6). This region does not contain a promoter but may act as a regulatory region 
which enhances transcription initiation, i.e. an upstream activator region (UAR). The results 
also indicate that the distance between the UAR and the promoters is not critical. 
7.4.2. Deletion analysis of the katG promoter fragment using Bal31 nuclease 
In a further attempt to locate the sequences required for promoter activity, the pJCLK0.6 insert 
was progressively deleted from the HindIII restriction endonuclease site at the 5' end, using 
Bal3 l nuclease. Bal3 l nuclease possesses single strand-specific endonuclease activity and 
double strand-specific exonuclease activity, which removes successive DNA bases 
bidirectionally. As a result, the enzyme deleted some vector sequences upstream of the Hindlll 
site. The deletion reaction was stopped at various time points to give a range of progressively 
shortened products. DNA from time points 4 and 6 yielded no transformants. One colony from 
time points 5, 7, and 8, and three from time point 3 were examined further. All six 
recombinants were sequenced to determine the size of the deletions (Table 7.2). In all the 
deletions, the successive removal of nucleotides in both directions was uneven. With the 
exception of deletions p0.6Dell23 and p0.6Del283, the Bal3 l nuclease enzyme removed more 
vector sequence than insert sequence. The reason for this is unclear. It may be due to the fact 
that the insert sequences have a higher G+C content and may form secondary structures, which 
are more resistant to digestion with Bal3 l nuclease. To determine whether the deletion of 
vector sequences was responsible for the observed differences in luciferase activity, a construct 
was made containing the 300 bp SphI-BamHI katG promoter region in pJCluc. This construct, 
pJCLK0.3, contains approximately the same amount of insert sequence as p0.6Del283, but has 
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no vector sequences removed. The plasmid pJCLKE was constructed to determine whether the 
UAR on its own was able to promote expression of the luciferase gene. These constructs were 
electroporated into M. smegma/is. E. coli and M smegma/is cells harbouring the deletion 
plasmids, as well as the undeleted and vector controls, pJCLK0.6 and pJCluc, respectively, were 
tested for luciferase activity (Table 7.2). 
Table 7.2. Luciferasc activities of derivatives of pJCLK0.6. 
Lucifcrasc acfo·ity 
No. bp deleted E.coli M. smegmatis 
Construct Insert Vector RLU/mg1 Rel. Act.2 RLU/mg1 Rel. Act.2 
pJCluc - - 132.30 ± 34.49 0.0838 106.93 ± 13.22 0.0105 
pJCLK0.6 - - 1578.00 ± 257.43 l.000 10164.19 ± 1270.98 l.000 
p0.6Del0 0 300 1170.48 ± 52.73 0.7417 11830.69 ± 1010.69 l.1640 
p0.6Del18 18 350 1671.54 ± 64. 72 1.0593 6024.54 ± 304.03 0.5927 
p0.6Del123 123 100 41.46 ± 4.06 0.0263 1585.16 ± 389.48 0.1560 
p0.6De1167 167 268 45.84 ± 3.87 0.0290 905.43 ± 83.64 0.0891 
p0.6Del173 173 489 18.39 ± 0.09 0.0117 14.28 ± 2.63 0.0014 
p0.6Del283 283 271 45.56 ± 5.01 0.0289 972. 10 ± 118.31 0.0956 
pJCLK0.3 262 0 73.33 ± 9.58 0.0465 2640.14 ± 246.44 0.2597 
pJCLKE 300 0 26.506 ± 12. 77 0.0168 35.01 ± 8.21 0.0034 
1 The mean of three independent experiments ± the standard error of the mean. 
2 Relative Activity- normalized to the luciferase activity of the parent construct, pJCLK0.6 
Removal of the first 18 bp (pO. 6Dell 8) of the insert resulted in approximately a 40% reduction 
in promoter activity, while the removal of 123 bp from the 5' end (p0.6Del123) resulted in a 
reduction in luciferase activity to below background levels in E. coli (38-fold decrease) and a 
6.4-fold reduction in M smegmatis. Removal of a further 160 bp (p0.6Del283) had no 
additional effect on promoter activity in E. coli, but resulted in a 10. 5-fold reduction in activity 
in M smegmatis. These results suggest that the region up to 123 bp from the 5' end of the 
insert is essential for promoter activity in E. coli, and is required for maximal activity in 
M smegmatis, and that the region between 123 and 283 bp from the 5' end is not additionally 
important. Deletion p0.6Del0 has no insert sequences deleted, but has 300 bp of vector 
sequence removed. The construct exhibited similar luciferase activities to the parent plasmid, 
pJCLK0.6, suggesting that deletion of at least the first 300 bp of vector sequence upstream of 
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the katG promoter fragment has no effect on promoter activity. In addition the construct 
pJCLK0.3, in which no vector sequences are deleted but 262 bp of insert are removed, exhibited 
a similar decrease in luciferase activity to pO. 6Del 123, pO. 6Dell 67, and pO. 6Del283 . These 
results indicate that the decreases in luciferase activity are due to removal of essential insert 
fragments, rather than vector sequences. Deletion p0.6Del 173, on the other hand, exhibited 
larger reductions in luciferase activities (83 .3- and 714-fold in £. coli and M smegmatis, 
respectively) than other deletions plasmids in which similar or smaller amounts of insert 
sequence had been removed. In this plasmid, 489 bp of vector has been removed, and this may 
have a significant effect on the stability or copy number of the plasmid. Therefore, in this case, 
the reduction in luciferase activity cannot be directly correlated with the absence of insert 
sequences. The below background luciferase activity of cells harbouring pJCLKE suggests that 
the 262 hp HindIII-SphI UAR contains no promoter sequences capable of promoting 
expression of the luciferase gene. The MIC of kanamycin for M smegmatis and £. coli cells 
harbouring a selection of the restriction endonuclease- and Bal3 I-generated deletion constructs 
were determined as a measure of the relative copy number of the relevant plasmids (results not 
shown). £. coli cells harbouring the plasmids were far more resistant to kanamycin than the M. 
smegma/is recombinants, as expected, however, there were no significant differences in the 
MI Cs of the cells harbouring different deletion constructs in either of the two species. Thus the 
effects of the deletions on the luciferase activities observed were not due to differences in the 
copy number of the plasmid. 
7 .4.3. Primer extension analysis of selected deletions 
It was demonstrated in section 7.4.1, that the M tuberculosis katG upstream region could 
promote expression of the luciferase gene in the absence of some of the putative promoter 
sequences identified in section 6.4.5. To test whether alternative promoter sequences were 
being employed in these cases, primer extension analysis was performed on total RNA extracted 
from M smegmatis cells harbouring the deletions pJCLK0.3, p0.6De1EN13, and p0.6De1SE106 
(Fig. 7.2). In all three cases, transcription initiated at a C residue located 23 bp upstream of the 
translation initiation codon. Therefore, in the absence of the UAR or the usual promoter 
sequences, a third promoter on the katG fragment, designated Pc, becomes active. 
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Located 7 bp upstream of transcription start site C, is the putative -10 hexamer, CACAGC 
(Fig. 7.3). This matches the putative -10 hexamers of the M bovis 18 kDa (Terasaka et al. , 
1989) and MBP70 (Dale and Patki, 1990) genes in 4/6 positions. Associated with this are two 
putative -3 5 regions, 1) TTCGCG, 14 bp upstream of the -10 hexamer, and 2) TCCGAC, 22 bp 
upstream of the -10 hexamer. The first matches in 4/6 positions the -3 5 hexamers of the 
M leprae SOD (Dale and Patki, 1990), the mycobacteriophage LS gene 71 P 1 (Nesbit et al. , 
1995), and the M smegma/is rpsL (Kenney and Churchward, 1996) genes. The second matches 
in 4/6 positions the M. smegma/is rpsL (Kenney and Churchward, 1996), and the 
mycobacteriophage LS gene 71 P 1 (Nesbit el al., 1995) -3 5 hexamers. 
a Px GA TC b Px GA TC C Px GA TC 
C--'> 
c-. 
Figure 7.2 Primer extension analysis of the M tuberculosis katG upstream region using RNA isolated during 
late exponential phase from M smegma/is cells harbouring a) pJCLK0.3, b) p0.6DelEN13, and 
c) p0.6De1SE106. The potential transcription start site, tssC, is indicated with an arrow. This 
corresponds to a C residue, 23 bp upstream of the GTG translation initiation codon. 
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GGCTTCCTGTTGGACGAGGCGGAGGTCATCTACTGGGGTCTATGTCCTGATTGTTCGATA 1913 
-10 Pc R.B.S. 
TCCGACACTTCGCGATCACATCCGTGATCACAGCCCGATAACACCAACTCCTGGAAGGAA 1973 
TGCT GTG CCC GAG 
M P E 
t 
1987 
Figure 7.3 The nucleotide sequence of the M. tuberculosis katG promoter region associated with tssC. including 
the first 3 codons. labelled with respect to the published sequence (GcnBank Accession number 
X68081). The transcription start site is indicated with an arrow. The putative -10 and -35 hcxamcrs 
arc underlined, and the putative ribosome binding site is in boldprint 
7.4.4. Testing of the katG UAR on the P.-1N promoter. 
The possibility that the 5' end of the insert of pJCLK0.6 contains a region which enhances 
transcription was tested by cloning the 262 bp HindIII-SphI fragment from pKup0.6 (see 
Fig. 7.1) upstream of the M paratuberculosis PAN promoter. The M paratubercu/osis PAN 
promoter was cloned into pJCluc on its own (pJCLpan) and downstream of the HindIII-SphI 
katG UAR (pJCLpanE). The constructs were electroporated into M smegmatis and cell 
extracts from the resulting transformants were tested for luciferase activity. 
Table 7.3. Luciferase activities of the katG and PAN promoters in the presence and absence of the katG UAR 
E.coli M. smegmatis 
Construct RLU/mg protein1 Rel. Act.1 RLU/mg 11rotein1 Rel. Act.1 
pJCLK0.3 73.33 ± 9.58 1.00 2640.14 ± 246.44 1.00 
pJCLK0.6 1897 ± 569.88 25.88 11029.62 ± 1297.62 4.18 
pJCLpan 278.36 ± 71.79 1.00 9944.93 ± 1881.99 1.00 
pJCLpanE 4085.67 ± 1407.4 14.68 115594.49 ± 24219.2 11.62 
1 The mean of three independent assays ± the standard error of the mean. 2 Rel. Act. - Luciferase activity relative to the construct without the katG UAR 
The presence of the katG UAR resulted in a 14.7-fold increase m expression of the PAN 
promoter in E. coli, and an 11 .6-fold increase in M smegmatis. This result confirms the 
suggestion that the region acts as an enhancer of transcription initiation. 
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7.4.5. Gel mobility shift assays. 
The 262 bp HindIII-SphHI fragment from pKup0.6, containing the katG UAR, was used as a 
template in DNA binding studies with total cellular proteins extracted from M smegma/is 
' 
(Fig. 7.4). Incubation of the probe with increasing amounts of cell extract resulted in the 
formation of two DNA-protein complexes, C1 and C3, seen as shifts in the electrophoretic 
mobility of the probe. All of the probe was bound in the presence of 30 µg of extract. The 
addition of an excess of unlabelled non-specific competitor DNA (pUCBM21) had no effect on 
the formation of the DNA-protein complexes, suggesting that the binding of the probe to the 
protein/s in the cell extract was sequence-specific. The addition of unlabelled pKup0.6, 
however, also had no effect on complex formation. This construct contains the UAR present in 
the probe, as well as the downstream promoter region, and should result in full competition. 
The addition of a competitor fragment containing the same sequences as the probe (pUC21E), 
resulted in a further retardation in the mobility of the probe in the gel to form complex 2 (C2) , 
while the addition of competitor DNA containing the SphI-BamHI katG promoter region 
resulted in a small amount of competition for the bound protein of complex 1. These results 
suggest that one or more proteins in the M smegmatis extract bind to the katG UAR, and that 
the promoter region binds to the same protein and partially competes for it if added on a 
plasmid. The addition of the unlabelled probe fragment should have also resulted in full 
competition for the protein and loss of the complex, but, instead, the size of the complex 
changed. This suggests that a new complex was formed, possibly containing both the labelled 
and unlabelled probe fragments bound together with one or more M smegmatis proteins. This 
is indicative of co-operative binding, rather than competition. The formation of complex 3 was 
not inhibited by any competitor DNA fragments. 
Similar results were observed using the SphI-BamHI promoter region as a template (Fig. 7.5). 
The addition of anM smegmatis cell extract resulted in the formation of two complexes, C1 and 
C3. Unlabelled pUCBM21 DNA competed with the labelled template for the formation of both 
complexes. These may, therefore, be the result of binding of the RNA polymerase holoenzyme 
to the promoter sequences. The same holoenzyme could be expected to bind to the promoters 
present in pUCBM21. The addition of pKup0.6 had no effect on the formation of either 
complex. This is surprising, since the plasmid contains the same promoter region used ~s a 
template as well as the vector sequences of pUCBM21. The addition of unlabelled pUC21E 
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resulted in an increase in the size of complex 1, to form complex 2 (C2), as noted for the 
HindIII-Sphl template, and an increase in the amount of complex 3, while the addition of 
unlabelled pUC210.3 resulted in partial competition for the bound proteins of complex I and 3. 
These results suggest that the upstream activator and the promoter regions both bind to the 
same protein/s in the cell extract, and that when both regions are present on the same fragment, 
binding of the protein/s to either region is reduced. The fragment containing the UAR and 
promoter region may contain an intrinsic bend which is not present when the two regions are 
cloned separately. This may explain the fact that the regions on their own have different effects 
on complex formation to when they are added on the same plasmid. The competitor DNAs 
were added in plasmid form, since this is the form of the promoter fragments in the expression 
studies. It is possible that the affinity and binding specificity of a DNA binding protein is 
affected by differences in DNA bending and superhelicity. 
1 2 3 4 5 6 7 8 9 
P-
Figure 7.4 Mobility shift assays with the HindIII-Sphl M tuberculosis katG UAR. The lanes were loaded as 
follows: 1) unbound template; 2) to 5) 10, 20, 30, and 40 µg of M smegmatis cell ex1ract, 
respectively; 6) to 9) 30 µg of M smegmatis cell extract and lµg unlabelled competitor DNA; 
6) pUCBM21, 7) pKup0.6, 8) pUC2IE and 9) pUC2I0.3. Labelled template DNA was included in 
all the reactions. P- unbound probe. Ci , C2, and C3- complexes 1, 2, and 3, respectively. 
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1 2 3 4 5 
P-· 
6 7 8 9 
"' / C, 
Figure 7.5 Mobility shift assays with the Sphl-BamHI M tuberculosis katG promoter region. The lanes were 
loaded as follows: 1) unbound template; 2) to 5) 10, 20, 30, and 40 µg of M smegmatis cell extract. 
respectively; 6) to 9) 30 µg of M smegmatis cell extract and 1 µg unlabelled competitor DNA; 
6) pUCBM21, 7) pKup0.6, 8) pUC21E and 9) pUC210.3. Labelled template DNA was included in 
all the reactions. P- unbound probe. C,, C2, and Cr complexes 1, 2, and 3, respectively. 
7.4.6. Electroporation and testing of the pJCluc constructs in M. bovis BCG 
To determine whether the same sequences were required for the expression of the 
M tuberculosis katG promoter in a slow-growing host, the following constructs were 
electroporated into M. bovis BCG and tested for luciferase activity (Table 7.4): pJCluc, 
pJCLK0.6, pJCLK0.3, pJCLKE, p0.6Del167, pJCLpan, and pJCLpanE. 
Table 7.4 Luciferase activities of the pJCluc constructs inM bovis BCG. 
Construct RLU/mg protcin1 
pJCluc 12.02 ± 2.563 
pJCLK0.6 25506.05 ± 2409.78 
pJCLK0.3 328.57 ± 53.42 
pJCLKE 45.85 ± 7.73 
p0.6Dcl167 3266.05 ± 1761.33 
pJCLpan 4832.02 ± 1331.26 
pJCLpanE 21423.90 ± 595.33 
1 The mean of three independent experiments± the standard error of the mean. 
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The background luciferase activity resulting from transcriptional readthrough in pJCluc was low 
in M bovis BCG. The activity of the katG promoter in this host was, however, comparable to 
that in M smegma/is. Removal of the katG UAR (pJCLK0.3) resulted in a 77.63-fold decrease 
in luciferase activity, indicating that the region also plays an important role in promoter activity 
in this host. The Bal31 nuclease deletion plasmid, p0.6Del 167, exhibited a 7.8-fold decrease in 
luciferase activity relative to the parent construct, pJCLK0.6. This plasmid contains an extra 
93 bp of insert sequence relative to pJCLK0.3, which may explain the smaller reduction in 
luciferase activity. The low background levels of luciferase activity resulting from pJCLKE 
indicates, as shown before, that the Hindlll-Sphl UAR of katG contains no active promoter 
sequences. The activity of the M paratuberculosis PAN promoter increased 4.4-fold in the 
presence of the katG UAR. This further confirms the importance of the region in enhancing 
transcription in this host. 
7.5. DISCUSSION 
The construction of deletions in pJCLK0.6, making use of the restriction endonuclease sites 
present on the insert, facilitated the assessment of the relative importance of various regions of 
the insert in promoter activity in E. coli and M smegmatis. The successive deletion of 
sequences from the 5' end of the 559 bp M tuberculosis katG promoter fragment in pJCLK0.6, 
using Bal31 nuclease, confirmed the observed results. The various deletion plasmids constructed 
in this study, and the relative luciferase activities are summarized in figure 7.6. 
The first 111 bp at the 5' end of the HindIII-BamHI M tuberculosis katG promoter fragment 
are essential for promoter activity in E. coli, and are required for optimal expression m 
M smegmatis. Mobility shift assays revealed that one or more proteins from a total 
M smegmatis extract bind to this region. The requirement for the region may, therefore, be due 
to necessary interactions between the protein bound to this region and the RNA polymerase 
holoenzyme bound to the promoters. As mentioned in Chapter 6, the first nucleotide of both 
the putative -10 hexamers of the katG promoter deviates from the consensus sequence, which 
normally has a conserved T in this position. E. coli promoters which deviate in this position 
generally require the help of activators for efficient transcription initiation. These activators 
normally bind to sites upstream of the -35 region (Raibaud and Schwartz, 1984). Activators 
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which bind further upstream of the -35 region, such as the CAP, may induce a bend in the 
intervening DNA, to facilitate interaction of the activator with the RNA polymerase bound at 
the -35 region, to activate transcription (Zhou et al., 1994a; 1994b ). It is possible, therefore, 
that a protein binds to the katG UAR, and facilitates the binding of the RNA polymerase 
holoenzyme further downstream, and the formation of the open complex for transcription 
initiation. The results of the mobility shift assays suggest the possibility of co-operative binding 
of the protein to the DNA. It is possible that the protein/s bind to the DNA in more than one 
region, and that the interaction of the subunits or different proteins bound to the different 
regions results in a bend in the intervening sequences. The protein/s evidently also bind to the 
downstream promoter region, which suggests an even more complicated scenario. The 
experiments reported here do not conclusively prove that binding of proteins to the UAR and 
promoter regions is sequence-specific. This will require further experimentation, which should 
preferably be carried out using proteins isolated from the native host, M. tuberculosis. 
Purification of the protein/s which bind to the katG fragments, DNase I foot printing analysis to 
locate the binding sites, and competition studies to determine the relative binding efficiencies of 
the protein/s to the different regions, will be required in order to elucidate the mechanism of 
transcription enhancement employed here. 
In the absence of either the UAR, or the putative katG promoters, PA and P8 , the M smegmatis 
machinery recognizes and utilizes a third promoter, Pc. It is possible that a similar situation 
occurs in E. coli. This promoter apparently functions as efficiently as the other two in 
M smegmatis, since the luciferase activities associated with the constructs p0.6De1EN13 and 
p0.6De1SE106 are comparable to that of the parent construct, pJCLK0.6, in which PA and P8 are 
utilized. The presence of the UAR is, however, also essential for the optimal activity of 
promoter C, since M smegmatis cells harbouring pJCLK0.3, which contains PA and Ps but no 
UAR, exhibit a 4-fold reduction in luciferase activity relative to the undeleted parent plasmid, 
pJCLK0.6. If promoter Pc is used to promote expression of the luciferase gene in p0.6DelEN13 
and p0.6DelSE106 in E. coli, then the promoter is evidently not as efficient as promoters PA and 
P8 in this host, since E. coli cells harbouring these constructs exhibit a 3-fold lower luciferase 
activity than the parent plasmid, pJCLK0.6. The first putative -35 hexamer of Pc, TTCGCG, 
matches the consensus E. coli -35 region in 3/6 positions, the first two of which are highly 
conserved among E. coli cr70 promoters. The -10 hexamer, on the other hand, contains only one 
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of the highly conserved nucleotides of the E. coli consensus sequence, A at position 2. The 
spacings between the -10 and putative -35 regions also differ significantly from that found in 
most E. coli promoters ( 17 ± 1) (Harley and Reynolds, 1987). These factors may explain the 
reduced efficiency of transcription initiation in this host. 
Relative Decrease in 
Luciferase activity 
Deletion fragments 
.EcoRV M smegmatis E.coli 
fall I (ruI ramHI 
1 1 
p0.6Dcll23 6.4 38.1 
p0.6Dcll67 11.2 34.4 
p0.6Dcll73 712 85.8 
p0.6Dcl283 10.5 34.6 
p0.6DelAB111 54.6 82.l 
p0.6De1ENI3 1.3 3.1 
p0.6DelASm 0.85 1.4 
p0.6DclSE106 1.0 I 3.1 
pJCLKE 290 59.5 
PJCLK0.3 3.85 21.5 
Figure 7.6 Summary of results obtained from deletion analysis of the 559 bp M tuberculosis katG promoter 
region. 
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The absence of the 155 bp Alul-Sphl fragment had no significant effect on promoter activity in 
either E. coli or M smegmatis. This indicates that this region is not important for promoter 
activity, and that the distance between the UAR and the promoter sequences is not critical. The 
sequences necessary for maximal promoter activity, therefore, lie upstream of the Alu I site (see 
Fig. 7.6). This region does not contain a promoter but may act as a regulatory region which 
enhances transcription initiation. Within this region, lies a 45 bp sequence (-523 to -4 78 with 
respect to the GTG translation initiation codon), which has an A+ T content of 62.2%, and a 
24 bp sequence (-523 to -499 with respect to the GTG translation initiation codon), with an 
A+T content of 66.67%. These A+T contents are high in comparison to normal M tuberculosis 
promoter regions (Bashyam et al., 1996), and may be analagous to the UP elements found 
upstream of some E. coli promoters. These elements are usually AT-rich and can increase 
promoter activity up to 30-fold (Ross el al., 1993). These sequences are a frequent feature of 
gram-positive promoters, and may be involved in modulating promoter strength (Graves and 
Rabinowitz, 1986; Moran et al., 1982). Movahedzadeh et al. (1997b) have recently identified a 
41 bp region, located 269-310 bp upstream of the coding region of the M t11herc11/osis recA 
gene, which is essential for expression from the promoter. The region on its own exhibited no 
promoter activity, and the authors suggest that it may contain a binding site for a transcription-
activating protein. This region may, therefore, be analogous to, or perform the same function as 
that identified in this study. A database search oftheM tuberculosis katG UAR revealed that it 
is not dispersed in the M tuberculosis genome, but that it is similar to the region upstream of 
the M fortuitum katG gene. The 559 bp katG upstream sequence is 61 % homologous to the 
corresponding region fromMfortuitum. In addition, the 24 bp AT-rich sequence of the katG 
UAR, described above, is 79.2% homologous to a region located 489 bp upstream of the 
M fortuitum katG ATG translation initiation codon. This suggests possible similarities in the 
mode of regulation of the gene in the two mycobacterial hosts. 
As mentioned in section 6.4.2, Song and Deretic have identified an open reading frame upstream 
of the M tuberculosis katG gene with homology to the Fur protein. The translation start 
codon of this putative open reading frame lies just within the 45 bp AT-rich sequence described 
above, while the stop codon lies immediately downstream of the katG tssA. This overlap of the 
FurA ORF with the katG promoter region and UAR may have implications for the regulation of 
both genes. Transcription of either of the genes will interfere with transcription of the other. If 
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the furA promoter lies immediately upstream of the gene, within the katG UAR, then 
transcription of the former gene will regulate the availability of the UAR, and thus the 
expression of katG and the utilization of the different katG promoters. This suggests a possible 
coupling of the regulation of oxidative stress and iron metabolism genes in this organism, and 
warrants further investigation. 
The fact that the pJCluc promoter constructs in this study exhibited similar luciferase activities 
in M hovis BCG and M. smegma/is was not surprising. Dellagostin et al. ( 1995) also found no 
significant difference between promoter activity in M. smegmatis and M. hovis BCG In 
addition, Bashyam et al. (I 996) have demonstrated that the efficiency and specificity of 
transcriptional recognition is conserved in M. tuberculosis, M. smegmatis, and M. bovis BCG. 
M smegma/is is, therefore, a suitable host for the preliminary characterization of 





Several projects are in progress to sequence the M. tuberculosis genome. Results from these 
projects will provide a great deal of information on both the genetics of the organism, and its 
metabolic pathways. In addition, they will identify new avenues for biochemical and 
immunological investigation, and open up new leads for research in chcmothcrapy and drug 
design. However, sequencing data alone will not identify the physiological functions of the gene 
products or the mechanisms involved in their regulation. This requires further information 
based on molecular biological experimentation. In this study, molecular biological techniques 
have been used to identify a novel function of the M tuberculosis katG gene and to examine the 
mechanisms of regulation of the gene. 
The M tuberculosis katG gene plays an important role in the susceptibility of the organism to 
the antituberculosis drug, isoniazid, and in the virulence of the organism. The gene has been 
extensively studied with respect to its catalase and peroxidase activities, its role in virulence, and 
its role in susceptibility to isoniazid, however, this study provides the first report on the 
involvement of the gene in DNA repair processes and on the in-depth analysis of the regulation 
of expression of the gene. The following conclusions were drawn from the results obtained in 
the respective chapters: 
Chapters 3 and 4 
• The M tuberculosis KatG remains active when fused to the maltose binding protein. The 
dimerization and folding of the enzyme into the correct conformation for activity, therefore, 
can occur in the presence oflarge additions to the N-terminal end of the protein. 
• Removal of either the proximal two thirds or the terminal third of the protein results in a 
complete loss of catalase and peroxidase activity. The active sites lie in the N-terminal 
domain of the protein, but the presence of the C-terminal domain is essential, possibly for 
subunit-subunit interaction, tertiary folding of the protein, or substrate interaction. 
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• The KatG enzyme probably contains a cleavage recognition site for an E. coli protease, and 
is cleaved immediately after translation. The KatG cleavage product does not exhibit 
catalase or peroxidase activity. 
• The 2 putative ORFs downstream of the M tuberculosis katG gene either do not encode 
proteins, or do not contain promoters which function efficiently in E. coli. 
• Immediately downstream of the M tuberculosis katG gene is a 7 bp inverted repeat with 
dyad symmetry which may act as a transcriptional terminator. 
• The KatG protein enhances the survival of DNA repair mutants of E. coli after exposure to 
short wavelength UV light irradiation, mitomycin C, and hydrogen peroxide, possibly by 
enhancing excision repair pathways. This function is independent of its catalase and 
peroxidase activity, and, therefore, is not due to the removal of toxic oxygen species by the 
enzyme. KatG may stabilize intermediates in the excision repair pathway. 
• In repair-competent mycobacterial hosts, KatG does not play an additive role in repair of 
DNA damage caused by exposure to short wavelength UV light irradiation. These cells 
possess efficient DNA repair systems, therefore, any involvement of KatG in the repair 
processes may be masked by the high survival rate of the cells. 
Chapters 6 and 7: 
• The sequences required for promoting expression of the M tuberculosis katG gene are 
located within a 559 bp region immediately upstream of the gene. The sequences between 
559 and 448 bp upstream of the translation initiation codon are essential for promoter 
activity in E. coli and are required for maximal expression from the promoter in 
M. smegmatis. This region is referred to in this study as the upstream activator region 
(UAR). The UAR contains a 45 bp AT-rich sequence which may be analogous to the AT-
rich regions found upstream of some E. coli promoters, which enhance transcription. A 
similar region is present upstream of the M fortuitum katG gene, and the gene may be 
regulated in a similar manner in the two mycobacterial species. 
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• One or more proteins from a total M smegmatis extract bind to the M tuberculosis katG 
UAR. These protein/s also bind to a region further downstream, possibly in a co-operative 
manner. 
• The UAR is able to enhance transcription from the M paratuberculosis PAN promoter, in E. 
coli, M smegma/is, and M bovis BCG. The distance between the UAR and the promoter is 
not critical. 
• The region between 448 and 293 bp upstream of the translation initiation codon is not 
required for promoter activity. 
• The M tuberculosis katG utilizes two promoters, which are equally efficient, for expression 
under normal growth conditions. A third promoter is active in the absence of the UAR or 
the other two promoter sequences. All three promoters share strong similarity with other 
mycobacterial promoters and contain at least one of the three conserved bases of E. coli - l 0 
and -35 consensus sequences. These promoters, therefore, function in E. coli, and are 
probably transcribed by the Eo70 RNA polymerase holoenzyme. 
• Promoter activity peaks during late exponential phase and declines during stationary phase, 
and is induced by ascorbic acid and repressed by growth in oxygen limiting conditions and at 
elevated temperatures. 
• The M tuberculosis katG promoter shows similar activity in M smegma/is and M bovis 
BCG. In both hosts, the same regions upstream of the katG gene are required for optimal 
expression. 
FUTURE PROSPECTS 
A study of this kind is never complete. Each observation raises further questions, many of 
which warrant further investigation. For example, the extrapolation of the DNA repair activity 
of the KatG protein to mycobacteria. This will require the overexpression of the gene in DNA 
repair-deficient mutants of M tuberculosis, M bovis BCG, or M. smegma/is, once they become 
available, and testing the resulting transformants for sensitivity to a variety of DNA damaging 
agents. An investigation of the mechanism of enhancement of survival will require an in-depth 
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examination of the DNA lesions resulting from the DNA damaging agents, and their possible 
interaction with the KatG protein. 
The regulation of the M tuberculosis katG gene may be complex, and may involve a number of 
cellular factors. An investigation of the nature of the protein/s which bind to the upstream 
sequence, the DNA sequences involved in binding, and the role played by competition between 
two different regions for binding may shed more light on the mechanisms of regulation, and of 
transcription enhancement by the UAR. It is important that these experiments are performed in 
M. tuberculosis, since this organism probably has some unique regulatory mechanisms not 
present in M smegmatis. 
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APPENDIX A 
BACTERIAL STRAINS, PLASMIDS, AND CULTURE CONDITIONS 
A.1. BACTERIAL STRAINS 
The E. coli strains used in this study are summarized in table A. I, and the mycobacterial strains 
are summarized in table A.2. 
Table A.l E. coli strains used in this study. 
Strain Genotype Reference 
LIUII recA, lad, lacl, lacr Zabeau & Stanley, 1982 
UM255 katG, katE Mulvey et al., 1988 
MC1060 recA+ Meissner et al., 1987 
DKl recA(del). recE ATCC 35691 Willis et al., 1981 
CCl 18 recAJ, rec£ Manoil and Beckwith, 1985 
AB1157 uvr+. recE(del) Howard-Flanders et al., 1966 
AB1884 uvrC34, recE(de1) Howard-Flanders et al., 1966 
AB1885 uvrB5, recE(dcl) Howard-Flanders et al., 1966 
AB1886 uvrA6, recE(de1) Howard-Flanders et al.. 1966 
HBlOl recA 13, recE Boyer and Roulland-Dussoix, 1969 
JC5519 recE(de1), recB21, recC22 A. J. Clarke 
JC8679 recB21, recC22 ATCC 47001 
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Table A.2 Mycobacterial strains used in this study. 
Strain Description Reference 
M smegmatis LR222 High frequency transformation mutant Beggs et al., 1995 
Mfortuitum ATCC6841 ATCC1 
M intracellulare ATCC 13950 ATCC1 
M intracellulare 1403 katG+ katG+ parent Marklund, Stockholm 
Sweden 
M intracellulare 1403 katG- katG- mutant Marklund, Stockholm 
Sweden 
M bovis BCG. Tokyo Attenuated vaccine strain 172 State Vaccine Institute, 
Pinclands, S. A. 
M. tuberculosis H37Rv Virulent laboratory strain. ATCC 27294 ATCC1 
M tuberculosis H37Ra Avirulent laboratory strain. ATCC 25177 ATCC1 
M tuberculosis 34 !NH-resistant clinical isolate, katG (del) Heym et al., 1994 
M tuberculosis 255 !NH-susceptible clinical isolate, no T.C. Victor, University of 
detectable mutations in katG Stellenbosch, S.A. 
M tuberculosis 463 }NH-resistant clinical isolate, mutations T.C. Victor, University of 
in codon 463 and 315 of ka1G Stellenbosch, S.A. 
M tuberculosis 519 }NH-resistant clinical isolate, mutation in T.C. Victor, University of 
codon 315 of katG Stellenbosch, S.A. 
1 American Type Culture Collection (Rockville, Md.). 
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A. 2. PLASMIDS 
The vectors used in this study are summarized in table A.3, and the recombinant plasmids 
constructed during the study are described in tables A.4, A.5, and A.6. The recombinant 
plasmids are listed according to the chapter in which they were described. 
Table A.3 Vectors and cloning systems used in this study. 
Plasmid Size (hp) Markers Description Reference 
pUC18 2686 AmpR, lacT Ml3-based cloning vector1 Messing, 1983; Yanisch-
Perron et al., 1985 
pUC19 2686 AmpR, lacT Ml3-based cloning vector1 Messing, 1983; Yanisch-
Perron et al., 1985 
pUCBM21 2725 AmpR, lacT Ml3-based cloning vector Messing, 1983; Yanisch-
(Boehringer Mannheim) Perron et al., 1985 
pBluescript-SK 2959 AmpR, lacz+ Stratagene cloning vector Short et al., 1988 
pMALTM~2 6646 AmpR, lacz+ Protein fusion expression and New England Biolabs 
purification system 
pGEM®-luc 4933 AmpR, lacT Luciferase cassette vector Promega 
pEcoR252 3349 AmpR,EcoRI Suicide vector, derivative of Zappc et al., 1986 
pEcoR251 
pJC86 5720 KanR. lacz+ E. coli-mycobacterial shuttle Jack Crawford, CDC 
vector Atlanta U.S.A. 
1 pUCI8 and pUCl 9 differ in the orientation of the multiple cloning site v.ith respect to the Lael gene. 
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Table A.4 Recombinant plasmids described in Chapter 3. 
Construct Size (hp) Dcscri1>tion 
pD3 5096 1747 bp Pstl fragment fromM tuberculosis H37Rv in pEcoR252 
pSNSIOO 4433 1747 bp Pstl fragment fromM tuberculosis H37Rv in pUC19 
pSMK.3' 8393 1747 bp Pstl fragment from pD3 in pMAL ™-c2, in-frame with ma/E 
pSMK3'opp 8393 1747 bp Pstl fragment from pD3 in pMAL™-c2, in the opposite orientation to malE 
pSMK.3'a 8390 17 4 7 bp Pstl fragment from pD3 in pMAL ™ -c2, in frame 2, with respect to ma IE 
pSMK.3'b 8396 1747 bp Pstl fragment from pD3 in pMAL ™-c2, in frame 3, with respect to ma/E 
pSMK.d 7607 961 bpA/uI-Pstl fragment of the 1747 bp pD3 insert in pMAL ™-c2 
pSMKA 8888 2242 bp EcoRI- andXbal-digested katG PCR product in pMAL ™-c2 
pSMK.5' 8132 1486 bp EcoRI-Pstl fragment from pSMKA (5' end) in pMAL ™-c2 
pSMK.3'* 7402 756 bp Pstl fragment from pSMKA (3' end) in pMAL ™-c2 
Table A.5 Recombinant plasmids described in Chapter 6. 
Construct Size (b1>) Dcscri1>tion 
pJCluc 7427 Promoterlcss luciferasc gene in pJC86 
pJClucopp 7427 Luciferase gene in pJC86, in opposite orientation to that in pJCluc 
pJClucK 9370 1943 kb katG upstream region in pJCluc (HindIII-BamHI) 
pJCLK0.6 7956 559 bp katG upstream region in pJCluc (Smal-BamHI) 
pKup 4629 1943 bp katG upstream region in pUC18 (HindIII-BamHI) 
pKup0.6 3518 559 bp katG upstream region in pBluescript-SK (SmaI-BamHI) 
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Table A.6 Recombinant plasmids described in Chapter 7. 
Construct Size (hp} Description 
p0.6DelEN13 7943 pJCLK0.6 with the 13 bp EcoRV-Nrul fragment deleted 
p0.6DelAB111 7845 pJCLK0.6 with the 111 bp HindIII-Alul fragment deleted 
p0.6DelASm 7801 pJCLK0.6 with the 155 bpA/ul-Sphl fragment deleted 
p0.6De1SE106 7850 pJCLK0.6 with the 106 bp Safl-EcoRV fragment deleted 
pUC210.3 3025 300 bp Sphl-BamHJ. promoter fragment in pUCBM21 
pUC210.4 3136 111 bp HindIII-Alul fragment in pUC210.3 
pKup0.6D 3506 pKup0.6 with the 13 bp EcoRV-Nrul fragment deleted 
pKup0.5 3413 pKup0.6 with the 106 bp Safl-EcoRV fragment deleted 
p0.6Del0 7656 pJCLK0.6 with O bp insert and 300 bp vector deleted1 
p0.6Dell8 7588 pJCLK0.6 with 18 bp insert and 350 bp vector deletect1 
p0.6Dell23 7733 pJCLK0.6 with 123 bp insert and 100 bp vector deleted1 
p0.6Dell67 7521 pJCLK0.6 with 167 bp insert and 268 bp vector deletect1 
p0.6Dell73 7294 pJCLK0.6 with 173 bp insert and 489 bp vector deleted1 
p0.6Del283 7402 pJCLK0.6 with 283 bp insert and 271 bp vector deleted1 
pJCLKE 7689 262 bp Hindlll-Sphl katG UAR2 in pJCluc 
pUC21E 2987 262 bp llindlll-Sphl katG UAR in pUCBM2 l 
pJCLK0.3 7727 300 bp Sphl-BamHI katG promoter fragment in pJCluc 
pJCLpan 7646 218 bp PAN promoter in pJCluc 
pJCLpanE 7913 218 bp PAN promoter downstream of the katG UAR in pJCluc 
1 BaI3 l nuclease derivatives of pJCLK0.6. 
2 Upstream activator region. 
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A.3. CULTURE CONDITIONS 
A.3.1 E. coli 
E. coli cultures were grown aerobically in 2x YT (yeast tryptone) medium. Agar was added to 
the medium at a final concentration of 1.5% (w/v). The medium was supplemented with 
kanamycin (50 µg/ml), ampicillin (50 µg/ml), X-GAL (100 µg/ml), and IPTG (0.3 mM) where 
necessary (see Appendix C). 
2 x Yeast Tryptone (YT) 
16 g bacto-tryptone 
10 g bacto-yeast extract 
5 g sodium chloride 
Make up to 1 litre with water and autoclave. 
A.3.2 Mycobacteria 
Mycobacterial cultures were grown aerobically in Middlebrook 7H9 medium supplemented with 
catalase-free ADC and Tween 80. Agar was added to the medium at a final concentration of 
1.5% (w/v). The medium was supplemented with kanamycin (40 µg/ml), and cycloheximide 
(0.01% (w/v)) where necessary. 
Middlebrook 7H9 
4.7 g Middlebrook 7H9 (Difeo) 
2 g/1 asparagine 
0.5 g/1 casitone 
2.5 g/1 sodium phosphate 
I g/1 potassium phosphate 
50 mg/I ferric ammonium citrate 
IO mg/I magnesium sulphate 
0.5 mg/I calcium chloride 
0.1 mg/I zinc sulphate 
0.1 mg/ml copper sulphate 
Make up to 900 ml with water and autoclave. 
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ADC Supplement 
5 g bovine albumin fraction V 
2 g glucose 
Make up to I 00 ml with water and filter sterilize. 
Middlebrook-ADC-Tween 
900 ml Middlebrook 7H9 
I 00 ml ADC supplement 




































Figure A.l Schematic representation of the construction ofpKup and pJClucK (not to scale). 
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CCCGGGCGATCGGGTCCTAGCAGACGCCTGTCACGCTAGCCAAAGTCTTGACTGATTCCA 1475 GAAAAGGGAGTCATATTGTCTAGTGTGTCCTCTATACCGGACTACGCCGAACAGCTCCGG 1535 ACGGCCGACCTGCGCGTGACCCGACCGCGCGTCGCCGTCCTGGAAGCAGTGAATGCGCAT 1595 CCACACGCCGACACGGAAACGATTTTCGGTGCCGTGCGTTTTGCGCTGCCCGACGTATCC 1655 GGCAAGCCGTGTACGACGTGCTGCATGCCCTGACCGCCGCGGGCTTGGTGCGAAAGATCC 1715 AACCCTCGGGCTCCGTCGCGCGCTACGAGTCCAGGGTCGGCGACAACCACCATCACATCG 1775 TCTGCCGGTCTTGCGGGGTTATCGCCGATGTCGACTGTGCTGTTGGCGAGGCACCCTGTC 1835 TGACGGCCTCGGACCATAACGGCTTCCTGTTGGACGAGGCGGAGGTCATCTACTGGGGTC 1895 TATGTCCTGATTGTTCGATATCCGACACTTCGCGATCACATCCGTGATCACAGCCCGATA 1955 ACACCAACTCCTGGAAGGATCC 1977 
.EcoRI 


















CCCGGGCGATCGGGTCCTAGCAGACOCCTGTCACGCTAGCCAAAGTCTTGACTGATTCCA 1 4 7 5 
GAAAAGGGAGTCATATTGTCTAGTGTGTCCTCTATACCGGACTACGCCGAACAGCTCCGG 1535 
ACGGCCGACCTGCGCGTGACCCGACCGCGCGTCGCCGTCCTGGAAGCAGTGAATGCGCAT 1595 CCACACGCCGACACGGAAACGATTTTCGGTGCCGTGCGTTTTGCGCTGCCCGACGTATCC 1655 GGCAAGCCGTGTACGACGTGCTGCATGCCCTGACCGCCGCGGGCTTGGTGCGAAAGATCC 1715 AACCCTCGGGCTCCGTCGCGCGCTACGAGTCCAGGGTCGGCGACAACCACCATCACATCG 1775 TCTGCCGGTCTTGCGGGGTTATCGCCGATGTCGACTGTGCTGTTGGCGAGGCACCCTGTC 1835 TGACGGCCTCGGACCATAACGGCTTCCTGTTGGACGAGGCGGAGGTCATCTACTGGGGTC 1895 TATGTCCTGATTGTTCGATATCCGACACTTCGCGATCACATCCGTGATCACAGCCCGATA 1955 ACACCAACTCCTGGAAGGATCC 1977 
.Eco RI 
Figure A.4 A.) Schematic representation of the construction of p0.6DelABIIJ (not to scale). B.) Nucleotide 
sequence of the SmaI-BamIIl insert of pJCLK0.6, labelled with respect to the published sequence 












































Figure A.5 A.) Schematic representation of the construction of p0.6DelAS155 (not to scale). B.) Nucleotide 
sequence of the Smal-BamHI insert of pJCLK0.6, labelled with respect to the published sequence 
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Figure A.6 A.) Schematic representation of the construction of p0.6De1SE106 (not to scale). B.) Nucleotide 
sequence of the Smal-Bamlll insert of pJCLK0.6, labelled with respect to the published sequence 































AACCCTCGGGCTCCGTCGCGCGCTACGAGTCCAGGGTCGGCGACAACCACCATCACATCG 1775 TCTGCCGGTCTTGCGGGGTTATCGCCGATGTCGACTGTGCTGTTGGCGAGGCACCCTGTC 1835 TGACGGCCTCGGACCATAACGGCTTCCTGTTGGACGAGGCGGAGGTCATCTACTGGGGTC 1895 TATGTCCTGATTGTTCGATATCCGACACTTCGCGATCACATCCGTGATCACAGCCCGATA 1955 ACACCAACTCCTGGAAGGATCC 1977 
.Eco RI 
Figure A. 7 A.) Schematic representation of the construction of pJCLK0.3 (not to scale). B.) Nucleotide 
sequence of the SmaI-BamHI insert of pJCLK0.6, labelled with respect to the published sequence 
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GAAAAGGGAGTCATATTGTCTAGTGTGTCCTCTATACCGGACTACGCCGAACAGCTCCGG 1535 ACGGCCGACCTGCGCGTGACCCGACCGCGCGTCGCCGTCCTGGAAGCAGTGAATGCGCAT 1595 


















Figure A.8 A) Schematic representation of the construction of pJCLKE (not to scale). B.l.) Nucleotide 
sequence of the SmaI-BamHI insert of pJCLK0.6, labelled with respect to the published sequence 
(GenBank Accession Number X68081). The bases which have been deleted in pJCLKE are in 
boldtype. 2.) Nucleotide sequence of the insert ofpJCLKE. The bases from pUC2IE which have 





The enzymes and kits used in this study were supplied by Boehringer Mannheim (Mannheim 
Germany), Promega (Madison, U.S.A.), Amersham (UK), and Pharmacia (Uppsala, Sweden). 
Chemicals were supplied by Melford Laboratories (England), Bio-Rad Laboratories (CA, 
U.S.A.), BDH Chemicals Ltd (Poole, England), Sigma Chemicals (St. Louis, U.S.A.), Fluka 
Biochemicals, and Merck (Darmstadt, Germany). 
B.l. CLONING 
B.1.1. Restriction endonuclease digestion 
Restriction endonuclease digestions were carried out according to the method of Sambrook 
eta/. (1989), in a 20 µl volume containing 0.5 - 10 µg of DNA in a lx solution of the supplied 
restriction endonuclease incubation buffer, and 10 units of restriction endonuclease. The digests 
were incubated at 3 7°C for between 1 and 18 hours. 
B.1.2. Blunt-ending with T4 DNA polymerase and Mong Bean nuclease 
Cohesive ends resulting from restriction endonuclease digestion were blunt-ended using the 
Amersham DNA Blunting kit (Amersham Life Science, UK), according to the manufacturers' 
instructions. The T4 DNA polymerase from the kit fills in 5'-protruding ends with its 5'-3' 
polymerase activity and removes 3'-protruding ends with its 3'-5' exonuclease activity. 
Alternatively, cohesive ends were removed by digestion with Mung Bean nuclease (Boehringer 
Mannheim). The DNA was digested in a 50 µl reaction containing 5 µl of 1 Ox Mung Bean 
digestion buffer (0.5 M sodium acetate pH 5, 0.3 M sodium chloride, 0.01 M zinc sulphate), and 
10 units ofMung Bean nuclease. The reaction mix was incubated at 30°C for 30 minutes, and 
the DNA was recovered by phenol/chloroform/isoamyl alcohol (25:24: 1) extraction and 
precipitation with ethanol (see B.1.4). 
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B.1.3. Agarose gel electrophoresis 
For agarose gel electrophoresis, a horizontal, submerged gel system was used, as described by 
Sambrook et al. {1989), with a tris-acetate buffer (see Appendix C). Agarose concentrations 
varied from 0.8% (w/v) to 2% (w/v). Gel tracking dye (see Appendix C) was added to the 
DNA sample prior to electrophoresis. The DNA was stained with ethidium bromide 
(0.2 µg/ml), visualized using a 310 nm transilluminator, and photographed using a Mamiya 
RB67 Pro-S camera. 
B.1.4. Phenol squeeze extraction of DNA from agarose gels 
DNA was purified from agarose gels using a phenol extraction procedure (Seth, 1984). The gel 
band was finely chopped using a Feather surgical blade, an equal volume of phenol was added, 
and the sample was immediately frozen on dry ice for 10 minutes. The sample was centrifuged 
at 14 000 rpm for 10 minutes and the aqueous phase was recovered. The DNA was extracted 
twice more by adding an equal volume of phenol/chloroform/isoamyl alcohol (25:24: 1), 
vortexing and centrifuging for 5 minutes. The aqueous phase was recovered and I/10th of a 
volume of 3 M sodium acetate (pH 5.2) and 2.5 volumes of ice-cold absolute ethanol were 
added to precipitate the DNA. After incubation at -70°C for 15 minutes, the DNA was 
collected by centrifugation at 14 000 rpm for 15 minutes. The DNA was washed with 70% 
(v/v) ethanol, dried, and resuspended in a minimum volume of sterile distilled water. 
B.1.5. Ligation reactions 
Insert and vector DNA were recovered from restriction endonuclease digestion or blunt-end 
reactions by extraction with phenol/ chloroform/isoamyl alcohol (25 :24: 1) and precipitation with 
ethanol. The DNA was ligated according to the method of Sambrook et al. (1989) in a 15 µI 
reaction containing lOx T4 DNA ligase buffer and 10 units of T4 DNA ligase (Boehringer 
Mannheim). Ligations were carried out at 16°C for 3-4 hours or overnight. In each ligation 
experiment, reactions were included which had no DNA or the vector self-ligated, as controls. 
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B.1.6. Preparation and transformation of competent E. coli cells 
E. coli cells were made competent for the uptake of DNA according to the method of Chung 
and Miller ( 1988). Cells were grown in 5 ml of 2x YT broth to stationary phase. The culture 
was diluted 1/200 into 100 ml of 2x YT broth and grown to early exponential phase (OD600 = 
0.5) at 37°C. The cells were collected by centrifugation at 4000 rpm for 5 minutes at 4°C, 
resuspended in I/10th of the culture volume in ice cold TSB (2x YT broth containing 10% 
(w/v) PEG 4000, 5% (v/v) DMSO, 10 mM magnesium chloride, and 10 mM magnesium 
sulphate), and held on ice for 20 minutes before transformation. The competent E. coli cells 
were transformed by the addition of2-5 µl ofligated DNA to 50 µl of cells. The cells were held 
on ice for 20 minutes and heat shocked at 42°C for 2 minutes. TSB ( 450 µl) containing 20 mM 
glucose was added to the transformation mix, and the cells were incubated at 37°C for 1 hour to 
facilitate expression of the antibiotic resistance gene. A 200 µl aliquot of the cells was plated 
onto 2x YT agar plates with the appropriate antibiotic selection. Competent cells were frozen 
in dry-ice and ethanol and stored at -70°C. 
B.1. 7. Plasmid preparation from E. coli 
Plasmids were isolated from E. coli using the alkaline lysis method of Ish-Horowicz and Burke 
(1981). A 5 ml overnight culture was harvested by centrifugation and the pellet was 
resuspended in 200 µl of solution 1 (lOx stock: 0.25 M tris-Cl pH 8, 0.5 M glucose, 0.1 M 
EDT A pH 8). The sample was kept at room temperature for 5 minutes, and 400 µI of freshly 
prepared solution 2 (0.2 M sodium hydroxide, 1 % (w/v) SDS) was added. The sample was 
placed on ice for 5 minutes. This was followed by the addition of 300 µl of solution 3 (3 M 
potassium acetate, 2 M acetic acid, pH 4.8), and incubation on ice for a further 5 minutes. The 
precipitated proteins were removed by centrifugation at 14 000 rpm for 10 minutes and the 
DNA in the supernatant was precipitated by the addition of 0.8 volumes of isopropanol and 
recovered by centrifugation. The pellet was resuspended in water and reprecipitated with 1/10 
of a volume of 3 M sodium acetate (pH 4.5), and 2.5 volumes of ice-cold 100% (v/v) ethanol. 
The pellet was washed with 70% (v/v) ethanol and resuspended in water. Large-scale DNA 
preparations were performed using the Nucleobond AX PC-kit 100 (Macherey-Nagel), 
according to the manufacturers' instructions. 
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B.2. DNA SEQUENCING 
B.2.1. Denaturation of template DNA 
Template DNA (5-10 µgin 32 µI of sterile distilled water) was denatured by the addition of 8 µl 
of 2 M sodium hydroxide and incubation for IO minutes at room temperature. The denatured 
DNA was precipitated by the addition of 7 µI of 3 M sodium acetate (pH 4.8), 4 µI of distilled 
water and 120 µI of 100% (v/v) ethanol, and incubation on dry ice for 15 minutes. The DNA 
was recovered by centrifugation at 14 000 rpm for 15 minutes, washed with 70% (v/v) ethanol, 
and resuspended in 10 µl of sterile distilled water. 
B.2.2. Annealing reaction 
The denatured DNA was annealed to 2 µl of sequencing primer (10 pmoles) with 2µ1 of 
annealing buffer (T7 Sequencing kit, Pharmacia), by incubation at 65°C for 5 minutes, followed 
by incubation at 37°C for 10 minutes, and room temperature for 10 minutes. Sequencing 
reactions were performed using the dideoxynucleotide triphosphate chain termination method of 
Sanger et al. (1977), [a-35S]dATP (1000-1500 Ci/mmol, Amersham Life Science, UK), and the 
T7 Sequencing kit (Pharmacia), according to the manufacturers' instructions. 
B.2.3. Sequenase™ Version 2.1 protocol for GC-rich templates 
The Sequenase™Version 2.1 DNA Sequencing kit (United States Biochemical, Amersham Life 
Science, UK) was used for the resolution of band compressions. Templates for sequencing 
were denatured as described above, except that the DNA was resuspended in a final volume of 
7 µl of water. The sequencing primer (5 pmoles) was added to the denatured template, together 
with 2 µl of 5x Sequenase Reaction Buffer, and the reaction mixture was heated to 65°C for 
2 minutes, cooled slowly to 30°C, then placed on ice. Sequencing reactions were performed 
using the dITP and dGTP reagents of the Sequenase™Version 2.1 kit, and the manufacturers' 
protocol modified for Ge-rich templates. The dGTP and dITP reactions were loaded adjacent 
to each other on polyacrylamide gels. 
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B.2.4. Preparation of the acrylamide gel 
The glass plates, slides and comb were washed thoroughly with 70% (v/v) ethanol and acetone, 
and clamped together using filter paper as the bottom spacer. The 6% (w/v) acrylamide 
solution was prepared by dissolving 48 g of urea in 10 ml of I0x NNB (see Appendix C), 15 ml 
of 40% (w/v) acrylamide/2% (w/v) bis-acrylamide, and 39 ml of distilled water. For 
polymerization, 350 µI of freshly prepared 13% (w/v) ammonium persulphate and 80 µl of 
TEMED were added and the gel was poured. The acrylamide was left to polymerize overnight. 
B.2.5. Acrylamide gel electrophoresis 
The acrylamide gel was "prerun" in a vertical apparatus at 20 watts (W) in 1 x NNB 
electrophoresis buffer for 20 minutes. The sequencing reactions were heated to 80°C for 
2 minutes to denature the DNA, and 4 µl of each sample was loaded onto the gel in the order G, 
A, T, and C. The gel was run at 40 W. After electrophoresis, the gel was transferred onto 
blotting paper and dried under a vacuum on a Hoefer slab gel dryer Model SE 1160 for one 
hour. The dried gel was then exposed to an Agfa Curix X-Ray film for autoradiography. 
B.2.6. Computer analysis of DNA sequences 
The following computer software was used for the analysis of nucleic acid and amino acid 
sequences: 
GENE PRO™ Version 6.10: Riverside Scientific Enterprises; Bainbridge Enterprises, WA 
US.A Program for the analysis of DNA sequences, open reading frames, restriction 
endonuclease sites, and for protein sequence analysis. 
CLUSTAL W: Multiple sequence alignment program (Higgins et al., 1996). 
BLAST: Basic Local Alignment Research Tool at the National Centre for Biotechnology 
Information, National Institute of Health. Tool for searching the nucleotide and protein 
sequence database for homologous sequences (Altschul et al., 1990). 
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B.3. POLYMERASE CHAIN REACTION 
Taq polymerase, derived from Thermus aquaticus (Saiki et al., 1988) (Boehringer Mannheim), 
was used in all the polymerase chain reactions (PCRs). The reactions were carried out in a 
0.5 ml microfuge tube containing 5 µI of lOx Taq polymerase buffer, 0.4 µI of Taq DNA 
polymerase (2-3 units), 1 µl each of dATP, dGTP, dCTP and dTTP from IO mM stock 
solutions, 10% (v/v) DMSO, 50-100 pmoles of primer, and 100-200 ng of template DNA. The 
volume was made up to 50 µI with sterile distilled water, and an overlay of 50 µl of paraffin was 
added to prevent evaporation. The PCR was carried out in a JDI High Performance 
Temperature Profiler, Model 8012. The template DNA was denatured by heating to 95°C for 
5 minutes, and the temperature profile of the amplification was as follows: 30s at 94°C, 60s at 
the annealing temperature, and 90s at 72°C for 36 cycles, followed by further incubation at 
72°C for 5 min. 
B.4. ISOLATION OF CHROMOSOMAL DNA FROM MY CO BACTERIAL CELLS 
A 100 ml culture of mycobacterial cells was harvested by centrifugation at 3000 rpm for 
10 minutes at 4°C, and the pellet was resuspended in 500 µI of TES (10 mM tris, I mM EDTA, 
0.15 M sodium chloride) (Jacobs et al., 1991). The cells were disrupted by 2 cycles in a 
Biospec Mini-Beadbeater at 4200 rpm for 30 seconds each. The cell debris was removed by 
centrifugation. The supernatant was extracted twice with phenol/chloroform/isoamyl alcohol 
(25:24: 1) and the top aqueous phase was recovered. The DNA was precipitated with 1/10 of a 
volume of 3 M sodium acetate and 2.5 volumes of ethanol, and recovered by centrifugation. 
The pellet was washed with 70% (v/v) ethanol and resuspended in sterile distilled water. The 
RNA was removed by digestion with RNase A, and the DNA was extracted twice more with 
phenol/chlorofom/isoamyl alcohol (25:24:1). The aqueous phase was collected, and the DNA 
was precipitated as described above. The DNA pellet was resuspended in 150-200 µI of sterile 
distilled water. The quality of the chromosomal DNA was checked by electrophoresis on a 
0.8% (w/v) agarose gel, and the concentration of the DNA was determined by measuring the 
absorbance at 260 nm on a Beckman DU-40 Spectrophotometer. The concentration was 
calculated using the relationship OD260 = 1 for 50 µg of dsDNA. 
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B.5. PLASMID ISOLATION FROM MYCOBACTERIA 
Plasmids were isolated from mycobacteria using the method of Jacobs et al. ( 1991 ). A 5 ml 
culture was grown to late exponential phase and the cells were harvested by centrifugation. The 
pellet was resuspended in 150 µl of GTE (25 mM tris-Cl pH 8, 10 mM EDT A, 50 mM 
glucose), containing 10 mg/ml of lysozyme, and incubated at 37°C overnight. Two volumes of 
a freshly prepared 0.2 M sodium hydroxide, 1 % (w/v) SDS solution was added, and the 
suspension was incubated on ice for IO minutes. After incubation, 225 µl of 3 M potassium 
acetate was added and the sample was incubated for a further IO minutes on ice. The proteins 
and cell debris were removed by centrifugation at 14 000 rpm for 30 minutes, and the DNA in 
the supernatant was extracted with phenol/chloroform/isoamyl alcohol (25:24:1). The DNA 
was precipitated with 2 volumes of ethanol, and the pellet was washed with 70% (v/v) ethanol 
and resuspended in 25-50 µl of TE. 
B.6. BIO-RAD ASSAY 
Protein concentration was determined using a Bio-Rad DC Protein Assay kit. The protein 
standards, 0.2 mg/ml, 0.5 mg/ml, 0. 75 mg/ml and 1.0 mg/ml, were prepared by dilution of the 
Bio-Rad bovine serum albumin protein standard (1.5 mg/ml) in the appropriate buffer. For each 
assay, I 00 µl of solution A' (20 µl of solution S/ml of solution A) was mixed with 20 µl of 
protein sample, and 800 µl of solution B. The samples were incubated at room temperature for 
15-20 minutes, and the OD at 750 nm determined. The OD,so values of the Bio-Rad protein 
standards were plotted against concentration to give a linear graph. The concentration of 
protein in the samples was determined from the graph. 
B. 7. SDS-POLYACRYLAMIDE GEL ELECTROPHORESIS 
SDS-polyacrylamide gels were poured and electrophoresed in a Hoeffer gel pouring stand and a 
vertical electrophoresis apparatus. The gel preparation and electrophoresis were performed 
according to the method of Laemmli (1970). A resolving gel of acrylamide in 1.5 M tris 
(pH 8.8), 0.4% (w/v) SOS buffer was poured first and allowed to polymerize for at least I hour. 
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The stacking gel in a 0.5 M tris (pH 6.8), 0.4% (w/v) SDS buffer was then poured and allowed 
to polymerize overnight. Gels were electrophoresed at a constant current of 40 mA in a tris-
glycine based buffer (IOx solution: 15.15 g tris, 72.05 g glycine, 1% (w/v) SDS in I litre). 
Protein samples were mixed with a sample buffer (see Appendix C) and boiled for 5-10 minutes 
before loading. Proteins in the Pharmacia Low Molecular Weight Calibration kit were 
reconstituted in SDS-PAGE sample buffer, and used as molecular weight standards. Non-
denaturing polyacrylamide gel electrophoresis was performed as described for SDS-P AGE, 
except that SDS was omitted from all buffers. SDS-polyacrylamide gels were stained with 
Coomassie~ Brilliant Blue R-250 (Bio-Rad Laboratories) (1.25g Coomassie~ Brilliant Blue 
R-250 in 50% (v/v) methanol, 10% (v/v) acetic acid) for 4-8 hours, and destained with 30% 
(v/v) methanol, 10% (v/v) acetic acid, and 3% glycerol. 
B.8. ThfMUNOBLOTTING 
Immunoblotting was performed using a method adapted from Sambrook et al. (1989). The 
proteins of interest were electrophoresed in an SDS-polyacrylamide gel, as described above. 
The proteins were transferred to an Amersham Hybond-C Super nitrocellulose membrane in a 
transfer buffer (22.4 g glycine, 4.8 g tris, and 400 ml methanol in 2 litres of water), using an 
Omeg Scientific semi-dry blotter, at a constant current of 200 mA. After transfer, the 
membrane was washed twice in TBS (0.05 M tris-Cl pH 7.5, 0.15 M sodium chloride) and 
incubated in I% (w/v) blocking solution (Chemiluminescence Blotting Substrate-POD kit, 
Boehringer Mannheim) for 1 hour. This was followed by incubation in 0.5% (w/v) blocking 
solution containing the primary antibody for 1 hour. The unbound antibody was removed by 
washing the membrane twice in TBST (TBS+ 0.1% (v/v) Tween 20) for 10 minutes each. The 
membrane was soaked in 0.5% blocking solution for 2 x 10 minutes, then incubated with POD-
labelled anti-Rabbit-IgG (Boehringer Mannheim) diluted 1 in 10 000 in 0.5% (w/v) blocking 
solution for 30 minutes. The secondary antibody was removed by washing the membrane four 
times in TBST for 15 minutes each. The kit detection solution was prepared by mixing 
detection reagents A and B in a 100: 1 ratio and allowing them to stand at room temperature for 
30 minutes before use. The bound antibodies on the membrane were detected by incubating in 
detection reagent for 1 minute and exposure to X-Ray film for 30-60 seconds. 
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APPENDIX C 
BUFFERS AND SOLUTIONS 
Chemicals used in this study were supplied by Melford Laboratories (England), Bio-Rad 
Laboratories (CA, U.S.A.), BDH Chemicals Ltd (Poole, England), Sigma Chemicals (St. Louis, 
U.S.A.), Fluka Biochemicals, and Merck (Darmstadt, Germany). The compositions of the 
commonly used solutions are given below. 
Ampicillin 
100 mg/ml stock solution: 
2 g in 20 ml of water 
Filter sterilize and store at -20°C. 
Cell Culture Lysis Reagent (Promega) 
25 mM tris-phosphate (pH 7.8) 
2mMDTT 
2 mM 1,2-diaminocyclohexane-N,N,N' ,N' -tetraacetic acid 
10% (v/v) glycerol 
1 % (v/v) Triton X-100 
Column Buff er 
20 mM tris-CI 
0.2 M sodium chloride 
1 mMEDTA 
Ethidium Bromide 
10 mg/ml stock solution: 
0.2 g ethidium bromide in 20 ml of water 
Store in the dark. 
Gel Tracking Dye 
0.25 g bromophenol blue 
40.0 g sucrose 
4.0 ml 0.5 M EDTA (pH 8.0) 
Make up to 100 ml with water. 
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High ionic strength running buffer 
5x stock: 
30.28 g tris 
142.7 g glycine 
3.92 g EDTA 
Make up to 1 litre with water. 
IPTG 
0.056 g IPTG in 2 ml water 
Filter sterilize and store at -20°C. 









0.1 M tris-acetate (pH 7.75) 
2mMEDTA 
Luciferase Assay Reagent (Promega) 
20 mM tricine 
33.3 mMDTT 
270 µM coenzyme A 
470 µM luciferin 
530 µMATP 
0.1 mMEDTA 
1. 07 mM magnesium carbonate 
2.67 mM magnesium sulphate 
MOPS running buff er 
1 Ox solution: 
41.8 g MOPS 
800 ml DEPC-water 
Adjust pH to 7.0 with sodium hydroxide. 
16.6 ml 3M DEPC-sodium acetate 
20 ml 0.5 M DEPC-EDTA (pH 8.0) 
Make up to 1 I with DEPC-water. 
For details of MOPS-formaldehyde electrophoresis see Ausubel et al. (1987). 
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NNB 
10 x stock solution: 
162 g tris base 
27.5 g boric acid 
9.3 gEDTA 
Make up to 1 litre with water and autoclave. 
Non-denaturing polyacrylamide gel mix 
8 ml 5x tris-glycine stock (see high ionic strength running buffer) 
6.67 ml 30% (w/v) acrylamide 
I ml 2% (w/v) bis-acrylamide 
2 ml 50% glycerol 
22.37 ml water 
Phenol 
Melt 500 g phenol 
0.6 g 8-hydroxyquinoline 
7.5 ml 2 M sodium hydroxide 
Dissolve in 130 ml of water and 6 ml of 1 M tris-Cl (pH 7.6). 
Potassium Phosphate Buff er 
0.1 M solution (pH 7.0): 
61.5 ml 1 M di-potassium hydrogen phosphate 
38.5 ml lM potassium dihydrogen phosphate 
SDS-PAGE Sample Buffer 
3% (w/v) SOS 
5% (v/v) J3-mercaptoethanol 
10% (v/v) glycerol 
0.625 M tris-Cl (pH 6.8) 
0.01% (w/v) bromophenol blue 
TAE 
50x solution: 
242 g tris base 
57.1 ml glacial acetic acid 
100 ml 0.5 M EDTA (pH 8.0) 
Make up to 1 litre with water and autoclave. 
Dilute 1/50 for use and adjust the pH to 7.4 with acetic acid. 
X-GAL 
0.04 g ofX-gal in 2 ml of dimethyl formamide 
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